Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Kartagener Syndrome	17/111	5.5118975255211895E-8	2.8485486411893506E-4	0	0	5.784234854098303	96.67638139811383	RSPH4A;DNAH7;IDUA;DNAH5;DNAH6;DNAJB13;FOXJ1;LRRC6;AK7;ACTB;RSPH1;ERBB2;HYDIN;SDC1;TP53;DNAI1;CCDC40
Multicystic Dysplastic Kidney	13/81	1.1677019464747066E-6	0.003017341829690642	0	0	6.082372322899506	83.08808221738133	BBS2;CHRM3;SETD5;BBS1;IFT172;PEX26;TMEM231;FRAS1;PEX6;TMEM67;TMEM107;NPHP1;B9D1
Ciliary Motility Disorders	11/64	3.887402396907974E-6	0.006696698529073469	0	0	6.5866406419431796	82.05485015684083	RSPH4A;RSPH1;SPEF2;DNAH5;DNAH6;HYDIN;FOXJ1;LRRC6;AK7;DNAI1;CCDC40
Ciliopathies	18/181	1.4135628364086291E-5	0.016698627501283654	0	0	3.5251207631005035	39.36436123832762	BBS2;CEP104;BBS1;RSPH4A;IFT172;DNAH5;LRRC6;ACVR2B;TMEM231;RSPH1;SUFU;TMEM67;NPHP1;TMEM107;HYDIN;B9D1;DNAI1;CCDC40
Low-set, posteriorly rotated ears	16/149	1.6155792861149046E-5	0.016698627501283654	0	0	3.833491012298959	42.29579525440598	RERE;SETD5;INSR;CHD7;COG1;KCNAB2;PEX26;TMEM231;FRAS1;PEX6;TMEM67;ERCC1;NPHP1;TMEM107;OTX2;B9D1
Polynesian Bronchiectasis	8/39	2.143974020083854E-5	0.01846676289298893	0	0	8.158971115327851	87.7110962267594	RSPH4A;RSPH1;DNAH5;HYDIN;DNAJB13;LRRC6;DNAI1;CCDC40
Epileptic encephalopathy	31/468	6.596441154557528E-5	0.04870058269536187	0	0	2.2814645308924484	21.962279164379883	TSEN34;SETD5;CNTNAP2;GABRB1;KCNC1;PIGO;GLDC;HEXA;ROGDI;ATP1A3;HCCS;MTR;PTPN23;KCNT2;AKT1;PDSS2;OTX2;CHRNB2;MBD5;ALG9;MBOAT7;UBE2A;GABRG2;MTOR;GNAO1;COQ4;MAPK10;NDUFS8;KCNMA1;EFHC1;PLCB1
Epidermolysis Bullosa	7/35	8.395413009940719E-5	0.054234368044217045	0	0	7.892332789559544	74.07143722033301	LAD1;JUP;FLII;RPS27A;LDLR;TP53;PLEC
Congenital ocular coloboma (disorder)	12/108	1.3113090755830395E-4	0.07529828114014608	0	0	3.9646381578947367	35.44114713181362	RERE;MAF;SALL2;TMEM67;NPHP1;CHD7;OTX2;HCCS;FADD;TP53;ACTB;TMEM231
Abnormally small eyeball	14/145	1.7068034576152535E-4	0.07670191150994163	0	0	3.394628775854685	29.450842224722148	RERE;CHD7;XYLT2;HCCS;HDAC6;TMEM231;FRAS1;SUFU;TMEM67;ERCC1;TMEM107;TUBGCP6;OTX2;B9D1
Decreased size of eyeball	14/145	1.7068034576152535E-4	0.07670191150994163	0	0	3.394628775854685	29.450842224722148	RERE;CHD7;XYLT2;HCCS;HDAC6;TMEM231;FRAS1;SUFU;TMEM67;ERCC1;TMEM107;TUBGCP6;OTX2;B9D1
Depressed nasal ridge	10/80	1.7810041372277467E-4	0.07670191150994163	0	0	4.522248243559719	39.04130641521923	RERE;SOX3;PDE4D;TMEM67;TMEM107;OTX2;B9D1;KCNAB2;HDAC6;TMEM231
Other specified types of schizophrenia, unspecified	8/53	2.109539034554009E-4	0.08386229023519322	0	0	5.616557734204793	47.53781965115382	MDK;LRRTM1;AKT1;MAP6;PLCB1;CPLX2;YWHAZ;MTOR
Nasal inflammation	4/11	2.536529049796252E-4	0.0936341580667645	0	0	17.971243042671613	148.7936928574804	RSPH1;IDUA;HYDIN;LRRC6
Sclerocornea	6/31	3.290634923957204E-4	0.11337334191340553	0	0	7.565472312703583	60.669488286481595	TMEM67;TMEM107;HCCS;OTX2;B9D1;TMEM231
SCHIZOPHRENIA 1 (disorder)	8/58	3.9833946444651656E-4	0.12723496091473002	0	0	5.05359477124183	39.56058086163955	MDK;LRRTM1;AKT1;MAP6;PLCB1;CPLX2;YWHAZ;MTOR
Decreased corneal diameter	9/74	4.577522413456612E-4	0.12723496091473002	0	0	4.377061563640941	33.65602508019245	SETD5;MAF;JAG1;FLII;TMEM67;TMEM107;OTX2;B9D1;TMEM231
Meckel syndrome type 1	6/33	4.6964709244788757E-4	0.12723496091473002	0	0	7.004343105320304	53.677986600665896	TMEM67;NPHP1;TMEM107;B9D1;MTOR;TMEM231
Endometrial Neoplasms	18/238	4.739263878114725E-4	0.12723496091473002	0	0	2.6040471156750225	19.932570704768395	JUP;CTNNBIP1;MSI1;CASC2;CHD4;SEMA3F;FHIT;MTOR;CCND3;MDK;ARMC3;ERCC1;ERBB2;AKT1;SDC1;SHBG;TP53;EBAG9
Intraductal papillary-mucinous adenoma	3/6	5.528498339752078E-4	0.12723496091473002	0	0	31.40518638573744	235.55221812907826	JAG1;LMO4;GAPDH
Chorioretinal abnormality	6/34	5.555019583260087E-4	0.12723496091473002	0	0	6.75383899488134	50.6243350765127	TMEM67;PEX6;TMEM107;B9D1;PEX26;TMEM231
Microcornea	9/76	5.586238752844186E-4	0.12723496091473002	0	0	4.245963309475536	31.80241024738876	SETD5;MAF;JAG1;FLII;TMEM67;TMEM107;OTX2;B9D1;TMEM231
Microphthalmos	17/222	5.854131574464962E-4	0.12723496091473002	0	0	2.6370181612263885	19.627834348413476	RERE;CHD7;XYLT2;HCCS;HDAC6;TMEM231;RIMS2;MAPK10;FRAS1;SUFU;TMEM67;ERCC1;TMEM107;TUBGCP6;B9D1;OTX2;TP53
Mutism	5/23	5.96019204398975E-4	0.12723496091473002	0	0	8.745257452574526	64.93561506433907	PRDM8;ATP1A3;SMARCA2;ACTB;PLEC
Ulnar polydactyly of fingers	9/77	6.154941994714107E-4	0.12723496091473002	0	0	4.183306055646481	30.92753740299991	BBS2;BBS1;IFT172;SUFU;TMEM67;TMEM107;NPHP1;B9D1;TMEM231
Familial aplasia of the vermis	8/63	7.029329625032053E-4	0.13494251087132056	0	0	4.59298871063577	33.346241830601755	CEP104;IFT172;SUFU;TMEM67;TMEM107;NPHP1;B9D1;TMEM231
Intellectual Disability	105/2503	7.050015080351499E-4	0.13494251087132056	0	0	1.4438488384333223	10.478459503201968	PGAP3;GLDC;IFT172;ROGDI;ACTB;PEX26;RIMS2;SOX3;CDH3;ATCAY;WWC3;AP1S1;AKT1;CHRNB2;ALG9;CACNA2D1;COG1;GABRG2;TMEM135;MAF;TP53;CEP104;PSMD12;FLII;NPHP1;OTX2;NAA50;BBS2;BBS1;FZD3;JAG1;INSR;UBE2A;SMARCA2;TMEM231;COQ4;GNAO1;DLG1;TCN2;PPP1R1B;TUBGCP6;CNTN4;ABCD4;RERE;LAD1;SETD5;CNTNAP2;PIGO;KCNC1;HEXA;CHD7;ARHGAP1;LRRC6;HCCS;MTR;CHD4;PTPN23;LMNB2;SGSH;DHTKD1;CHMP1A;HYDIN;CHAMP1;PDE4D;TCF12;KCNAB2;SYP;SHROOM4;ANO3;NDUFS8;RABEP2;PEX6;KCNMA1;PIGG;PLCB1;ALDOA;CCDC40;PLEC;HDAC4;TSEN34;IDUA;ATP1A3;SPG7;PPOX;AGPAT2;HDAC6;TMEM67;PDSS2;PDE6B;CCT5;MBD5;AGK;MBOAT7;GDAP1;TTC19;MTOR;ARCN1;MAPK10;RSPH1;FRAS1;CAPN10;ERCC1;ERCC8;B9D1;ATP13A2
Neonatal thrombocytopenia (disorder)	4/15	9.503844162354991E-4	0.16479427002502173	0	0	11.433884297520661	79.56433043851612	CACNB2;PGAP3;DNAH5;DNAI1
Lens Opacities	22/339	9.564001267031496E-4	0.16479427002502173	0	0	2.212348205901902	15.380984071857641	BBS2;JAG1;AGK;IFT172;XYLT2;HCCS;NDRG2;ACTB;PEX26;TMEM231;MAF;SUFU;TMEM67;PEX6;ERCC1;TMEM107;AKT1;TUBGCP6;ERCC8;B9D1;OTX2;PDE6B
Hydrocephalus	18/253	9.667051099768765E-4	0.16479427002502173	0	0	2.4359228104898567	16.90924334424636	FZD3;IDUA;DNAH5;MBOAT7;TCF12;HCCS;HMGB1;AK7;HDAC6;SOX3;VANGL2;FRAS1;SUFU;TMEM67;OGDH;HYDIN;TP53;DNAI1
Nystagmus	29/500	9.885105206609275E-4	0.16479427002502173	0	0	1.969963464709496	13.630790407490286	CEP104;CTBP1;IFT172;CHD7;XYLT2;ATP1A3;SPG7;PEX26;LMNB1;SOX3;ATXN2;ATCAY;TMEM67;NPHP1;OTX2;PDE6B;BBS2;BBS1;AGK;TTC19;TMEM231;NDUFS8;PEX6;ERCC1;TUBGCP6;ERCC8;B9D1;ATP13A2;LY6E
Depressed nasal bridge	19/277	0.0010926442260109324	0.17078234361180555	0	0	2.343110320009287	15.978031575699292	RERE;HDAC4;SETD5;JAG1;IDUA;FLII;INSR;PDE4D;CHD7;ATP1A3;UBE2A;KCNAB2;SHROOM4;MTOR;PEX26;MAF;FRAS1;PEX6;AKT1
Mental Retardation	55/1158	0.0011037622518914514	0.17078234361180555	0	0	1.6130344434727493	10.983201055225917	RERE;LAD1;SETD5;CNTNAP2;PIGO;PGAP3;GLDC;IFT172;CHD7;ARHGAP1;MTR;CHD4;ACTB;LMNB2;SGSH;RIMS2;SOX3;ATCAY;CHMP1A;CHAMP1;AP1S1;AKT1;PDE4D;KCNAB2;SYP;SHROOM4;MAF;NDUFS8;RABEP2;PEX6;TP53;HDAC4;CEP104;IDUA;FLII;ATP1A3;AGPAT2;TMEM67;NPHP1;PDE6B;BBS2;BBS1;MBD5;UBE2A;SMARCA2;MTOR;ARCN1;TMEM231;MAPK10;FRAS1;TCN2;TUBGCP6;ERCC8;B9D1;CNTN4
Situs ambiguus	7/53	0.0011889006968872076	0.17078234361180555	0	0	4.799560252500178	32.32372409910442	SESN1;DNAH5;DNAH6;LRRC6;OTX2;DNAI1;ACVR2B
Cerebellar vermis hypoplasia	7/53	0.0011889006968872076	0.17078234361180555	0	0	4.799560252500178	32.32372409910442	RERE;TSEN34;CEP104;TMEM67;NPHP1;B9D1;TMEM231
Mental deficiency	50/1032	0.0012163758787245669	0.17078234361180555	0	0	1.643441597884732	11.030581859209281	RERE;SETD5;CNTNAP2;PIGO;PGAP3;GLDC;IFT172;HEXA;CHD7;MTR;CHD4;ACTB;LMNB2;SGSH;CHMP1A;CHAMP1;AP1S1;AKT1;PDE4D;KCNAB2;SYP;TMEM135;MAF;NDUFS8;PEX6;HDAC4;TSEN34;CEP104;IDUA;FLII;ATP1A3;AGPAT2;TMEM67;NPHP1;PDE6B;BBS2;BBS1;MBD5;UBE2A;SMARCA2;MTOR;ARCN1;TMEM231;MAPK10;FRAS1;TCN2;CAPN10;TUBGCP6;ERCC8;B9D1
Genetic Diseases, Inborn	29/507	0.0012227064074374623	0.17078234361180555	0	0	1.9403960382020404	13.013631815088758	SETD5;GLDC;CTBP1;DNAH5;HEXA;CHD7;XYLT2;ATP1A3;LRRC6;CHD4;MTR;SPG7;ACTB;SGSH;TMEM67;CHMP1A;CHAMP1;OTX2;LDLR;BBS2;CHRNB2;JAG1;AGK;ANO3;TMEM231;GNAO1;COQ4;AIMP2;PEX6
Hypoplastic feet	10/103	0.0013531167176781857	0.18402387360423325	0	0	3.399788471708091	22.45677465282553	RERE;HDAC4;BBS1;SETD5;MBD5;IFT172;UBE2A;KCNAB2;SHROOM4;HDAC6
Common wart	3/8	0.001477554080277203	0.19381195714357521	0	0	18.841166936790923	122.7948035316365	AKT2;AKT1;TP53
Seizures	55/1174	0.001500092547550892	0.19381195714357521	0	0	1.5885786139647442	10.329301097560295	RERE;CNTNAP2;GABRB1;KCNC1;PGAP3;GLDC;HEXA;ROGDI;HCCS;MTR;PTPN23;HMGB1;DNALI1;ACTB;LMNB2;PEX26;SGSH;SOX3;GRM5;AKT2;AKT1;ANKS1B;CHRNB2;ALG9;KCNAB2;GABRG2;MAF;NDUFS8;PEX6;EFHC1;AMPH;PIGG;TP53;LY6E;HDAC4;DNAH7;CTBP1;ATP1A3;SPG7;ATXN2;OTX2;FADD;MBD5;INSR;UBE2A;SMARCA2;MTOR;ARCN1;GNAO1;MAPK10;SGSM3;ERCC1;TUBGCP6;ERCC8;CNTN4
Broad flat nasal bridge	21/330	0.0015739785895049145	0.1983980817210097	0	0	2.1637518842083083	13.965176479135748	BBS2;RERE;PIGO;PGAP3;CTBP1;IDUA;IFT172;FLII;TPM2;PDE4D;HCCS;KCNAB2;ACTB;PEX26;MAF;FRAS1;SUFU;PEX6;ERCC1;TUBGCP6;PDE6B
Cerebellar Ataxia	31/565	0.0016294664358342211	0.19840903247594302	0	0	1.8574807806031934	11.924102807764404	CEP104;GABRB1;KCNC1;HEXA;ROGDI;ATP1A3;SPG7;LMNB2;PEX26;LMNB1;ATXN2;GRM5;ATCAY;TMEM67;NPHP1;AKT1;CAPN1;BBS1;MBD5;GABRG2;TMEM231;NDUFS8;TCN2;PEX6;OGDH;ERCC8;B9D1;ATP13A2;PIGG;TP53;LY6E
Upward slant of palpebral fissure	11/124	0.001661136622335277	0.19840903247594302	0	0	3.079718674164814	19.710979295333246	HDAC4;SETD5;JAG1;PGAP3;FLII;PEX6;CHAMP1;AP1S1;CHD4;UBE2A;PEX26
Nasal bridge wide	21/333	0.0017574582086235867	0.19840903247594302	0	0	2.1426094773340183	13.592471795348242	BBS2;RERE;PIGO;PGAP3;CTBP1;IDUA;IFT172;FLII;TPM2;PDE4D;HCCS;KCNAB2;ACTB;PEX26;MAF;FRAS1;SUFU;PEX6;ERCC1;TUBGCP6;PDE6B
Dull intelligence	46/947	0.0017975796161880783	0.19840903247594302	0	0	1.6436131746762213	10.389795261954749	HDAC4;RERE;SETD5;CEP104;CNTNAP2;PIGO;PGAP3;GLDC;IDUA;IFT172;FLII;CHD7;ATP1A3;MTR;CHD4;AGPAT2;ACTB;LMNB2;SGSH;TMEM67;CHMP1A;NPHP1;CHAMP1;AP1S1;AKT1;PDE6B;BBS2;BBS1;MBD5;PDE4D;KCNAB2;SYP;UBE2A;SMARCA2;MTOR;ARCN1;TMEM231;MAPK10;MAF;FRAS1;NDUFS8;TCN2;PEX6;TUBGCP6;ERCC8;B9D1
Low intelligence	46/947	0.0017975796161880783	0.19840903247594302	0	0	1.6436131746762213	10.389795261954749	HDAC4;RERE;SETD5;CEP104;CNTNAP2;PIGO;PGAP3;GLDC;IDUA;IFT172;FLII;CHD7;ATP1A3;MTR;CHD4;AGPAT2;ACTB;LMNB2;SGSH;TMEM67;CHMP1A;NPHP1;CHAMP1;AP1S1;AKT1;PDE6B;BBS2;BBS1;MBD5;PDE4D;KCNAB2;SYP;UBE2A;SMARCA2;MTOR;ARCN1;TMEM231;MAPK10;MAF;FRAS1;NDUFS8;TCN2;PEX6;TUBGCP6;ERCC8;B9D1
Smith-Magenis syndrome	5/29	0.0018044165105203795	0.19840903247594302	0	0	6.556910569105691	41.42340055997727	HDAC4;MBD5;FLII;ERBB2;TP53
Disease due to Papilloma virus	4/18	0.0019787489583722147	0.21304530451807513	0	0	8.982374768089054	55.91789207028268	ERBB2;SDC1;FHIT;TP53
invasive cancer	13/166	0.0020464690728302258	0.21583984017115526	0	0	2.6913783635365185	16.66404424700464	SLC35B2;JAG1;NDRG2;PUM1;FHIT;SMARCA2;YWHAZ;MAPK15;MTOR;CDH3;ERBB2;AKT1;TP53
Congenital coloboma of iris	3/9	0.0021654469967260395	0.22382060158160344	0	0	15.700162074554296	96.32251138747219	MAF;SALL2;CHD7
Drug Resistant Epilepsy	7/59	0.002243203666399775	0.22731130486184384	0	0	4.244447233027984	25.890492416494357	NT5C;PIGO;MAP2;EFHC1;AKT1;PLCB1;MTOR
Multiple Endocrine Neoplasia Type 1	10/111	0.00237335017801435	0.2305356625759291	0	0	3.1291998052264245	18.91117115184063	RIMS2;PLCB3;SSSCA1;CAPN1;FOXN3;TP53;GAPDH;ACTB;MTOR;PPP1CA
Concave bridge of nose	18/275	0.0024409336757389814	0.2305356625759291	0	0	2.224840673759324	13.383250208975134	RERE;HDAC4;SETD5;JAG1;IDUA;FLII;INSR;PDE4D;CHD7;UBE2A;KCNAB2;SHROOM4;MTOR;PEX26;MAF;FRAS1;PEX6;AKT1
Depressed nasal root/bridge	18/275	0.0024409336757389814	0.2305356625759291	0	0	2.224840673759324	13.383250208975134	RERE;HDAC4;SETD5;JAG1;IDUA;FLII;INSR;PDE4D;CHD7;UBE2A;KCNAB2;SHROOM4;MTOR;PEX26;MAF;FRAS1;PEX6;AKT1
Early infantile epileptic encephalopathy with suppression bursts	5/31	0.002453456161315035	0.2305356625759291	0	0	6.051907442151345	36.373522519606496	GNAO1;ERCC1;SGSM3;AKT1;TP53
Bronchiectasis	10/112	0.0025355689315313735	0.2339967899670382	0	0	3.098360655737705	18.51994651975722	RSPH4A;RSPH1;FCGRT;DPP9;HYDIN;LRRC6;ATP11A;DNAI1;TAPBP;CCDC40
Orbital separation excessive	22/368	0.00268257186845582	0.24321984940666105	0	0	2.0238366810369826	11.983095079260238	ALG9;JAG1;PIGO;PGAP3;CTBP1;FLII;INSR;PDE4D;XYLT2;CHD4;ACTB;SHROOM4;MTOR;TMEM231;MAF;FRAS1;SUFU;TMEM67;PEX6;TMEM107;AKT1;B9D1
Squamous cell carcinoma of penis	4/20	0.0029827999708404275	0.251947092843517	0	0	7.858766233766234	45.69788344164527	ERBB2;FHIT;TP53;MTOR
Aplasia/Hypoplasia of the iris	4/20	0.0029827999708404275	0.251947092843517	0	0	7.858766233766234	45.69788344164527	TMEM67;TMEM107;B9D1;TMEM231
Coloboma of iris	7/62	0.002986369542247087	0.251947092843517	0	0	4.012309061248702	23.326348467291872	MAF;SUFU;TMEM67;CHD7;HCCS;ACTB;TMEM231
HEMIHYPERPLASIA, ISOLATED	3/10	0.003022585092162936	0.251947092843517	0	0	13.456587172956702	78.0703123935751	IDUA;KCNQ1OT1;SHBG
Sex hormone binding globulin measurement	3/10	0.003022585092162936	0.251947092843517	0	0	13.456587172956702	78.0703123935751	SHBG;OSBPL1A;TP53
Mean blood pressure	5/33	0.003257088467880716	0.2671846540001197	0	0	5.619047619047619	32.17984512854999	CACNB2;ATXN2;KCNMA1;SLIT1;MAP4
Diastolic blood pressure	10/117	0.003484894234978613	0.281405209474523	0	0	2.952811398804964	16.71089747111854	SEMA5B;CACNB2;ATXN2;AKT2;INSR;FBXL19;KCNMA1;SLC35F1;MAP4;PLCB1
Poor school performance	46/985	0.0037991429072937004	0.301790364725049	0	0	1.5738553506027986	8.77106405877832	HDAC4;RERE;SETD5;CEP104;CNTNAP2;PIGO;PGAP3;GLDC;IDUA;IFT172;FLII;CHD7;ATP1A3;MTR;CHD4;AGPAT2;ACTB;LMNB2;SGSH;TMEM67;CHMP1A;NPHP1;CHAMP1;AP1S1;AKT1;PDE6B;BBS2;BBS1;MBD5;PDE4D;KCNAB2;SYP;UBE2A;SMARCA2;MTOR;ARCN1;TMEM231;MAPK10;MAF;FRAS1;NDUFS8;TCN2;PEX6;TUBGCP6;ERCC8;B9D1
Defective or absent horizontal voluntary eye movements	6/49	0.0039028897231837066	0.301790364725049	0	0	4.3944398151655175	24.371730403811537	CEP104;ATXN2;TMEM67;NPHP1;B9D1;TMEM231
Asymmetric overgrowth	3/11	0.00406093919285107	0.301790364725049	0	0	11.77390599675851	64.8311413652186	AKT2;KCNQ1OT1;AKT1
Acid reflux	11/140	0.00428284318241461	0.301790364725049	0	0	2.6954977660671324	14.698921822618487	RERE;SETD5;CTBP1;DPP9;FLII;CHD7;CHAMP1;ATP11A;KCNAB2;KIAA0319L;SHROOM4
Cockayne Syndrome, Type II	4/22	0.004287991476812179	0.301790364725049	0	0	6.984848484848484	38.08095279661507	RIMS2;ERCC1;ERCC8;TP53
Self-harm	4/22	0.004287991476812179	0.301790364725049	0	0	6.984848484848484	38.08095279661507	RERE;MBD5;FLII;KCNAB2
Self-Injurious Behavior	4/22	0.004287991476812179	0.301790364725049	0	0	6.984848484848484	38.08095279661507	RERE;MBD5;FLII;KCNAB2
Biparietal narrowing	6/50	0.00432130166208468	0.301790364725049	0	0	4.294344092389695	23.37926214484776	CEP104;TMEM67;NPHP1;TUBGCP6;B9D1;TMEM231
Congenital cerebral hernia	6/50	0.00432130166208468	0.301790364725049	0	0	4.294344092389695	23.37926214484776	BBS2;FRAS1;TMEM67;TMEM107;B9D1;TMEM231
Decreased width of the skull	6/50	0.00432130166208468	0.301790364725049	0	0	4.294344092389695	23.37926214484776	CEP104;TMEM67;NPHP1;TUBGCP6;B9D1;TMEM231
Inflammatory Breast Carcinoma	9/102	0.004425093393642689	0.30491843544460556	0	0	3.0548017528113616	16.558442606998824	KCNQ1OT1;STAT2;ERBB2;AKT1;SDC1;PUM1;RHOC;TP53;HDAC6
Global developmental delay	50/1102	0.004562839846249625	0.3102731095449745	0	0	1.5282502835034355	8.236978776674079	RERE;LAD1;SETD5;GABRB1;PIGO;PGAP3;CHD7;MTR;ACTB;LMNB2;PEX26;DHTKD1;SOX3;ATCAY;CHMP1A;CHAMP1;AP1S1;AKT1;ALG9;PDE4D;COG1;KCNAB2;SHROOM4;NDUFS8;PEX6;PIGG;HDAC4;CEP104;CTBP1;IDUA;FLII;ATP1A3;TMEM67;NPHP1;OTX2;BBS2;ZNF462;BBS1;MBOAT7;INSR;SMARCA2;TTC19;TMEM231;GNAO1;ERCC1;OGDH;CDK2AP2;TUBGCP6;B9D1;CNTN4
West Syndrome	7/67	0.004626142117770122	0.3104922398004674	0	0	3.6769983686786296	19.767660872346173	RIMS2;ATXN2;CACNA2D1;KCNAB2;PLCB1;SMARCA2;MTOR
Ovarian Mucinous Adenocarcinoma	5/36	0.004794380239626417	0.314751793118641	0	0	5.074482035142932	27.099311370851513	MAST2;NEK10;ULK1;TP53;MTOR
Erythrocyte Mean Corpuscular Hemoglobin Test	22/387	0.004872318778926332	0.314751793118641	0	0	1.9165712191322675	10.204180349448658	RHBDF1;STARD3;CEP104;FBXL19;HMGB1;MOSPD3;CHKB-CPT1B;FRS3;CORO1B;KLF16;ARMC2;DSTYK;ATXN2;CCND3;CDH3;ZNRF3;TEX9;SESN1;PPP1R1B;RANBP10;ZSCAN23;TP53
Finding of Mean Corpuscular Hemoglobin	22/387	0.004872318778926332	0.314751793118641	0	0	1.9165712191322675	10.204180349448658	RHBDF1;STARD3;CEP104;FBXL19;HMGB1;MOSPD3;CHKB-CPT1B;FRS3;CORO1B;KLF16;ARMC2;DSTYK;ATXN2;CCND3;CDH3;ZNRF3;TEX9;SESN1;PPP1R1B;RANBP10;ZSCAN23;TP53
Opitz GBBB Syndrome, X-Linked	4/23	0.005065251399859671	0.3231755461046269	0	0	6.616883116883117	34.97255315870615	ERCC1;SGSM3;AKT1;TP53
Carcinoma of anal margin	3/12	0.005290866777490371	0.32337800454825627	0	0	10.46515397082658	54.85596356014023	RIMS2;AKT1;TP53
Lymphoepithelial carcinoma	3/12	0.005290866777490371	0.32337800454825627	0	0	10.46515397082658	54.85596356014023	ERBB2;TP53;PDLIM7
MPS III B	3/12	0.005290866777490371	0.32337800454825627	0	0	10.46515397082658	54.85596356014023	IDUA;SYP;SGSH
Renal tubular acidosis	5/37	0.005404822369567161	0.32337800454825627	0	0	4.915650406504065	25.66197447230458	JAG1;ERBB2;KCNMA1;ATP11A;PFKP
Fundus coloboma	5/37	0.005404822369567161	0.32337800454825627	0	0	4.915650406504065	25.66197447230458	SALL2;TMEM67;CHD7;ACTB;TMEM231
Mucoepidermoid Carcinoma	7/69	0.005443863466659887	0.32337800454825627	0	0	3.558017155186023	18.54889083782541	RAD52;CDH3;NUMA1;ERBB2;TP53;FHIT;MTOR
Repeated speech	4/24	0.0059315386254590215	0.33720768831962145	0	0	6.285714285714286	32.22982170548413	UBE2A;SMARCA2;ACTB;PLEC
Echolalia	4/24	0.0059315386254590215	0.33720768831962145	0	0	6.285714285714286	32.22982170548413	UBE2A;SMARCA2;ACTB;PLEC
Gastrointestinal Stromal Tumors	19/323	0.005998685336916427	0.33720768831962145	0	0	1.9837770382695508	10.149429729306707	IFT172;INSR;TYK2;HMGB1;MTOR;HIPK2;TMEM231;RIMS2;CCND3;FER;AKT2;SUFU;SGSM3;ERBB2;AKT1;SSSCA1;B9D1;AMPH;TP53
Tented mouth	5/38	0.006068172409776469	0.33720768831962145	0	0	4.766444937176645	24.331261008221478	MBD5;PIGO;PGAP3;FLII;CHAMP1
Tented upper lip	5/38	0.006068172409776469	0.33720768831962145	0	0	4.766444937176645	24.331261008221478	MBD5;PIGO;PGAP3;FLII;CHAMP1
Tented upper lip vermilion	5/38	0.006068172409776469	0.33720768831962145	0	0	4.766444937176645	24.331261008221478	MBD5;PIGO;PGAP3;FLII;CHAMP1
Feeding difficulties in infancy	15/233	0.006268899308723084	0.34465608114341384	0	0	2.1793160967472893	11.05382792218585	RERE;SETD5;CEP104;MBD5;FLII;INSR;TPM2;CHD7;MTR;KCNAB2;PEX26;TMEM67;PEX6;ERCC1;B9D1
Broad face	3/13	0.006721221996256324	0.35890878623680633	0	0	9.418152350081037	47.11416864957313	IDUA;SUFU;UBE2A
Talipes foot deformities	5/39	0.0067867227719939785	0.35890878623680633	0	0	4.626016260162602	23.096714349805293	TMEM67;TPM2;TMEM107;B9D1;TMEM231
Benign Ovarian Neoplasm	5/39	0.0067867227719939785	0.35890878623680633	0	0	4.626016260162602	23.096714349805293	ERBB2;SHBG;FHIT;CLIC1;TP53
Recurrent respiratory infections	14/213	0.00680593286594563	0.35890878623680633	0	0	2.226760867041478	11.111448918461132	CHRM3;RSPH4A;IDUA;INSR;TPM2;DNAH5;DNAJB13;LRRC6;TYK2;RSPH1;CHAMP1;HYDIN;DNAI1;CCDC40
Cognitive delay	44/966	0.007082617439032212	0.3697269386355401	0	0	1.52926910098819	7.570052937789247	HDAC4;RERE;SETD5;CEP104;GABRB1;PGAP3;CTBP1;IDUA;FLII;CHD7;ATP1A3;MTR;ACTB;LMNB2;PEX26;DHTKD1;SOX3;ATCAY;TMEM67;CHMP1A;NPHP1;CHAMP1;AP1S1;AKT1;OTX2;BBS2;BBS1;ALG9;MBOAT7;INSR;PDE4D;COG1;KCNAB2;SMARCA2;SHROOM4;TMEM231;GNAO1;NDUFS8;PEX6;ERCC1;OGDH;TUBGCP6;B9D1;PIGG
Mental and motor retardation	46/1021	0.007229292824702669	0.37360985318063394	0	0	1.5127847761994104	7.457445100751342	HDAC4;RERE;SETD5;CEP104;GABRB1;PGAP3;GLDC;CTBP1;IDUA;FLII;CHD7;ATP1A3;MTR;PTPN23;ACTB;LMNB2;PEX26;DHTKD1;SOX3;ATCAY;TMEM67;CHMP1A;NPHP1;CHAMP1;AP1S1;AKT1;OTX2;BBS2;BBS1;ALG9;MBOAT7;INSR;PDE4D;COG1;KCNAB2;SMARCA2;SHROOM4;TMEM231;GNAO1;NDUFS8;PEX6;ERCC1;OGDH;TUBGCP6;B9D1;PIGG
Oculomotor apraxia	6/56	0.007557226775776016	0.3825014279186174	0	0	3.7778501628664496	18.455746228153924	CEP104;ATXN2;TMEM67;NPHP1;B9D1;TMEM231
Talipes	5/40	0.0075627247817373205	0.3825014279186174	0	0	4.493612078977932	21.94915484604292	TMEM67;TPM2;TMEM107;B9D1;TMEM231
Meckel-Gruber syndrome	4/26	0.00794778323156815	0.3825014279186174	0	0	5.713695395513577	27.624930050038234	TMEM67;TMEM107;B9D1;TMEM231
Molar tooth sign on MRI	4/26	0.00794778323156815	0.3825014279186174	0	0	5.713695395513577	27.624930050038234	TMEM67;NPHP1;B9D1;TMEM231
Gait abnormality	13/195	0.007968299720036834	0.3825014279186174	0	0	2.259119792892445	10.916708754457018	RERE;CEP104;FLII;MTR;KCNAB2;UBAC2;LMNB1;TMEM67;NPHP1;ERCC8;B9D1;ATP13A2;CCT5
Hypertrophy of clitoris	6/57	0.008230629739666014	0.3825014279186174	0	0	3.7035830618892507	17.776801486461324	FRAS1;PEX6;INSR;HCCS;AGPAT2;PEX26
Familial Partial Lipodystrophy, Type 2	3/14	0.008359459778475466	0.3825014279186174	0	0	8.561514660380139	40.96138089826599	CCND3;INSR;AKT2
Anal squamous cell carcinoma	3/14	0.008359459778475466	0.3825014279186174	0	0	8.561514660380139	40.96138089826599	RIMS2;AKT1;TP53
Congenital hemihypertrophy	3/14	0.008359459778475466	0.3825014279186174	0	0	8.561514660380139	40.96138089826599	AKT2;KCNQ1OT1;AKT1
Maxillary Sinus Squamous Cell Carcinoma	3/14	0.008359459778475466	0.3825014279186174	0	0	8.561514660380139	40.96138089826599	TP53;PPP1CA;TAPBP
Mucopolysaccharidosis I	3/14	0.008359459778475466	0.3825014279186174	0	0	8.561514660380139	40.96138089826599	IDUA;HEXA;TP53
Congenital Abnormality	30/607	0.008451956913569623	0.3825014279186174	0	0	1.656992626971771	7.909417813925166	HDAC4;CHRM3;TMEM87B;PIGO;CHD7;MTR;HMGB1;ACTB;RIMS2;SALL2;KCNQ1OT1;TMEM67;NPHP1;ERBB2;AKT1;OTX2;SYBU;BBS2;JAG1;ALG9;INSR;ZIC5;MTOR;VANGL2;TCN2;KCNMA1;TUBGCP6;TP53;LHX9;PLEC
Congenital defects	6/58	0.008946057137647595	0.3825014279186174	0	0	3.6321723878727137	17.13129502444765	TCN2;KCNQ1OT1;CHD7;HMGB1;TP53;PLEC
Fibular polydactyly	4/27	0.009105509264512287	0.3825014279186174	0	0	5.464991530208922	25.67931554659204	TMEM67;TMEM107;B9D1;TMEM231
Postaxial foot polydactyly	4/27	0.009105509264512287	0.3825014279186174	0	0	5.464991530208922	25.67931554659204	TMEM67;TMEM107;B9D1;TMEM231
Systemic arterial pressure	7/76	0.009172837531965529	0.3825014279186174	0	0	3.195900418469395	14.993594311287644	CACNB2;ATXN2;KCNMA1;MAP4;YWHAZ;FHIT;ZNF532
Blood Pressure	7/76	0.009172837531965529	0.3825014279186174	0	0	3.195900418469395	14.993594311287644	CACNB2;ATXN2;KCNMA1;MAP4;YWHAZ;FHIT;ZNF532
Blood pressure finding	7/76	0.009172837531965529	0.3825014279186174	0	0	3.195900418469395	14.993594311287644	CACNB2;ATXN2;KCNMA1;MAP4;YWHAZ;FHIT;ZNF532
Dystonia Disorders	10/135	0.009417463940389134	0.3825014279186174	0	0	2.5252459016393445	11.78075053243253	RIMS2;ATXN2;GRM5;ATCAY;HEXA;ATP1A3;ACTB;GABRG2;LY6E;ANO3
Non-small cell lung cancer stage I	7/77	0.009828307831134656	0.3825014279186174	0	0	3.1500815660685153	14.561215822551961	EIF5A;ERCC1;ERBB2;GAPDH;TP53;FHIT;KCNJ3
Epilepsy	51/1177	0.009911450241108077	0.3825014279186174	0	0	1.4530399847665187	6.704420356336394	RERE;CHRM3;CNTNAP2;GABRB1;KCNC1;PGAP3;GLDC;HEXA;ROGDI;HCCS;SLC35F1;MTR;WASL;HMGB1;ACTB;LMNB2;PEX26;SGSH;SOX3;AKT2;AKT1;CHRNB2;ALG9;KIRREL2;CACNA2D1;KCNAB2;GABRG2;MAF;NDUFS8;PEX6;KCNMA1;EFHC1;PIGG;PLCB1;TP53;HDAC4;CTBP1;ATP1A3;HDAC9;OTX2;FADD;MBD5;INSR;UBE2A;SMARCA2;MTOR;ARCN1;GNAO1;ERCC1;TUBGCP6;ERCC8
Breast Fibrocystic Change, Proliferative Type	3/15	0.010211734298532829	0.3825014279186174	0	0	7.8476499189627225	35.97533643486498	ERBB2;FHIT;TP53
Salivary gland carcinoma	3/15	0.010211734298532829	0.3825014279186174	0	0	7.8476499189627225	35.97533643486498	RAD52;ERBB2;ACTN4
Aplasia/Hypoplasia of the breasts	3/15	0.010211734298532829	0.3825014279186174	0	0	7.8476499189627225	35.97533643486498	SOX3;OTX2;ACTB
Goldenhar Syndrome	3/15	0.010211734298532829	0.3825014279186174	0	0	7.8476499189627225	35.97533643486498	FRAS1;CHD7;OTX2
Oestrogen receptor positive breast cancer	3/15	0.010211734298532829	0.3825014279186174	0	0	7.8476499189627225	35.97533643486498	SHARPIN;ERBB2;MTOR
Poor coordination	3/15	0.010211734298532829	0.3825014279186174	0	0	7.8476499189627225	35.97533643486498	BBS1;CHD7;MTR
Blindness, Legal	11/158	0.010361311977952736	0.3825014279186174	0	0	2.363225092992862	10.79917396220784	BBS2;CDH3;FRAS1;IFT172;TMEM67;CAPN5;HEXA;ATP1A3;PDE6B;ACTB;TMEM231
Cryptorchidism	22/414	0.010364486884092725	0.3825014279186174	0	0	1.7820285304757355	8.1427477757813	RERE;SETD5;CHRM3;JAG1;NUMA1;PDE4D;CHD7;CHD4;SMARCA2;ACTB;PEX26;TMEM231;SOX3;FRAS1;KCNQ1OT1;TMEM67;PEX6;HSF1;TMEM107;ERCC8;B9D1;OTX2
Agenesis of corpus callosum	18/317	0.010374837975694719	0.3825014279186174	0	0	1.9081212013466817	8.717007144053088	RERE;ZNF462;JAG1;NUMA1;GLDC;HCCS;KCNAB2;SMARCA2;ACTB;MTOR;SOX3;ZNRF3;TMEM67;ERCC1;ERBB2;AKT1;OTX2;TP53
Stereotyped Behavior	7/78	0.010517298026068168	0.3825014279186174	0	0	3.1055533855662523	14.144969427256106	RERE;MBD5;CTBP1;FLII;CHAMP1;KCNAB2;TP53
Abnormal skeletal development	7/78	0.010517298026068168	0.3825014279186174	0	0	3.1055533855662523	14.144969427256106	ALG9;IDUA;IFT172;PEX6;AKT1;ACTB;PEX26
Salivary duct carcinoma	4/29	0.011737924043705661	0.3825014279186174	0	0	5.027272727272727	22.345876911237337	CCND3;NUMA1;ERBB2;TP53
Stage IV Breast Cancer AJCC v6 and v7	4/29	0.011737924043705661	0.3825014279186174	0	0	5.027272727272727	22.345876911237337	ERBB2;AKT1;TP53;MTOR
Malformations of Cortical Development	8/99	0.011826779239698472	0.3825014279186174	0	0	2.770810888457947	12.295165457382737	CNTNAP2;PEX6;AKT1;HMGB1;TP53;ACTB;MTOR;PEX26
Bardet-Biedl Syndrome	6/62	0.012254991177650863	0.3825014279186174	0	0	3.372033503955328	14.84309120141469	BBS2;BBS1;IFT172;TMEM67;INSR;NPHP1
Cystadenocarcinoma, Mucinous	3/16	0.012282992082491197	0.3825014279186174	0	0	7.243610522378756	31.86855228921226	ERBB2;SHBG;TP53
Serous cystadenocarcinoma ovary	3/16	0.012282992082491197	0.3825014279186174	0	0	7.243610522378756	31.86855228921226	ERBB2;AKT1;TP53
Neuralgia, Atypical	3/16	0.012282992082491197	0.3825014279186174	0	0	7.243610522378756	31.86855228921226	GRM5;CACNA2D1;HMGB1
Neuralgia, Iliohypogastric Nerve	3/16	0.012282992082491197	0.3825014279186174	0	0	7.243610522378756	31.86855228921226	GRM5;CACNA2D1;HMGB1
Neuralgia, Ilioinguinal	3/16	0.012282992082491197	0.3825014279186174	0	0	7.243610522378756	31.86855228921226	GRM5;CACNA2D1;HMGB1
Neuralgia, Perineal	3/16	0.012282992082491197	0.3825014279186174	0	0	7.243610522378756	31.86855228921226	GRM5;CACNA2D1;HMGB1
Neuralgia, Stump	3/16	0.012282992082491197	0.3825014279186174	0	0	7.243610522378756	31.86855228921226	GRM5;CACNA2D1;HMGB1
Neuralgia, Supraorbital	3/16	0.012282992082491197	0.3825014279186174	0	0	7.243610522378756	31.86855228921226	GRM5;CACNA2D1;HMGB1
Neuralgia, Vidian	3/16	0.012282992082491197	0.3825014279186174	0	0	7.243610522378756	31.86855228921226	GRM5;CACNA2D1;HMGB1
Ovarian Granulosa Cell Tumor	3/16	0.012282992082491197	0.3825014279186174	0	0	7.243610522378756	31.86855228921226	ERBB2;TP53;MTOR
Paroxysmal Nerve Pain	3/16	0.012282992082491197	0.3825014279186174	0	0	7.243610522378756	31.86855228921226	GRM5;CACNA2D1;HMGB1
Pontoneocerebellar hypoplasia	3/16	0.012282992082491197	0.3825014279186174	0	0	7.243610522378756	31.86855228921226	TSEN34;CHMP1A;AKT1
Heartburn	11/162	0.012338222439763801	0.3825014279186174	0	0	2.300144629671919	10.1092582900212	RERE;SETD5;CTBP1;DPP9;FLII;CHD7;CHAMP1;ATP11A;KCNAB2;KIAA0319L;SHROOM4
Congenital hypoplasia of ovary	5/45	0.012379746223940318	0.3825014279186174	0	0	3.930894308943089	17.263283028264368	BBS2;BBS1;IFT172;CHD7;NPHP1
Hypoplastic ovary	5/45	0.012379746223940318	0.3825014279186174	0	0	3.930894308943089	17.263283028264368	BBS2;BBS1;IFT172;CHD7;NPHP1
Wide skull shape	9/121	0.013071735722735428	0.3825014279186174	0	0	2.534077624503156	10.99106237685782	RERE;SETD5;MBD5;ALG9;MAF;FLII;PDE4D;TCF12;KCNAB2
Broad cranium shape	9/121	0.013071735722735428	0.3825014279186174	0	0	2.534077624503156	10.99106237685782	RERE;SETD5;MBD5;ALG9;MAF;FLII;PDE4D;TCF12;KCNAB2
Bulbo-Spinal Atrophy, X-Linked	6/63	0.01320059202792449	0.3825014279186174	0	0	3.3127035830618894	14.335703553719052	RIMS2;ATXN2;JAG1;INSR;HSF1;LY6E
Heterotaxy, Visceral, 3, Autosomal	4/30	0.013219021772639986	0.3825014279186174	0	0	4.833666333666334	20.91091640157608	DNAH5;TMEM67;DNAI1;ACVR2B
HETEROTAXY, VISCERAL, 4, AUTOSOMAL	4/30	0.013219021772639986	0.3825014279186174	0	0	4.833666333666334	20.91091640157608	DNAH5;TMEM67;DNAI1;ACVR2B
Sleep disturbances	8/101	0.01323802751438794	0.3825014279186174	0	0	2.710942441492726	11.72390899872291	GNAO1;SETD5;ATXN2;MBD5;IDUA;FLII;LY6E;SGSH
Squamous cell carcinoma of pharynx	2/6	0.013246778455850332	0.3825014279186174	0	0	15.676375404530745	67.78466122498739	AKT1;TP53
Atrophy of the spinal cord	2/6	0.013246778455850332	0.3825014279186174	0	0	15.676375404530745	67.78466122498739	SYP;CCT5
Epithelial tumor of ovary	2/6	0.013246778455850332	0.3825014279186174	0	0	15.676375404530745	67.78466122498739	ERBB2;TP53
Equilibration disorder	2/6	0.013246778455850332	0.3825014279186174	0	0	15.676375404530745	67.78466122498739	ATXN2;LY6E
GLIOMA SUSCEPTIBILITY 1	2/6	0.013246778455850332	0.3825014279186174	0	0	15.676375404530745	67.78466122498739	ERBB2;TP53
Hypertrophy of tonsils	2/6	0.013246778455850332	0.3825014279186174	0	0	15.676375404530745	67.78466122498739	IDUA;AKT2
Immotile cilia	2/6	0.013246778455850332	0.3825014279186174	0	0	15.676375404530745	67.78466122498739	LRRC6;DNAI1
Keratoma	2/6	0.013246778455850332	0.3825014279186174	0	0	15.676375404530745	67.78466122498739	KEAP1;TP53
Keratosis Blennorrhagica	2/6	0.013246778455850332	0.3825014279186174	0	0	15.676375404530745	67.78466122498739	KEAP1;TP53
Mesenchymal Glioblastoma	2/6	0.013246778455850332	0.3825014279186174	0	0	15.676375404530745	67.78466122498739	HDAC4;TP53
Migrating partial seizures in infancy	2/6	0.013246778455850332	0.3825014279186174	0	0	15.676375404530745	67.78466122498739	IDUA;PLCB1
Multiple small medullary renal cysts	2/6	0.013246778455850332	0.3825014279186174	0	0	15.676375404530745	67.78466122498739	JAG1;TMEM67
Nasopharyngeal cancer recurrent	2/6	0.013246778455850332	0.3825014279186174	0	0	15.676375404530745	67.78466122498739	ERCC1;AKT1
Ossifying fibromyxoid tumor	2/6	0.013246778455850332	0.3825014279186174	0	0	15.676375404530745	67.78466122498739	PHF1;CREB3L2
Papillary transitional cell carcinoma	2/6	0.013246778455850332	0.3825014279186174	0	0	15.676375404530745	67.78466122498739	ERBB2;TP53
Blindness	11/164	0.01342831232854446	0.3825014279186174	0	0	2.2698412698412698	9.783900976365276	BBS2;CDH3;FRAS1;IFT172;TMEM67;CAPN5;HEXA;ATP1A3;PDE6B;ACTB;TMEM231
Bilateral single transverse palmar creases	5/46	0.013544765359661919	0.3825014279186174	0	0	3.8348205433273845	16.49645893191668	HDAC4;SETD5;TPM2;PEX6;PEX26
Absent speech	7/82	0.013626908265274684	0.3825014279186174	0	0	2.93931484502447	12.626440916373285	RERE;GNAO1;TMEM67;CHMP1A;KCNAB2;SMARCA2;TMEM231
Hypertrophy of lower jaw	8/102	0.0139880656522268	0.3825014279186174	0	0	2.681963565568071	11.450779596624953	IDUA;TPM2;FLII;INSR;SUFU;PDE4D;ERCC8;AGPAT2
mandibular excess (physical finding)	8/102	0.0139880656522268	0.3825014279186174	0	0	2.681963565568071	11.450779596624953	IDUA;TPM2;FLII;INSR;SUFU;PDE4D;ERCC8;AGPAT2
Mandibular hyperplasia	8/102	0.0139880656522268	0.3825014279186174	0	0	2.681963565568071	11.450779596624953	IDUA;TPM2;FLII;INSR;SUFU;PDE4D;ERCC8;AGPAT2
Hirsutism	6/64	0.014196078266135548	0.3825014279186174	0	0	3.2554195215096033	13.851124899003077	BBS1;IDUA;UBE2A;AGPAT2;SHROOM4;SGSH
Nephronophthisis	6/64	0.014196078266135548	0.3825014279186174	0	0	3.2554195215096033	13.851124899003077	JAG1;IFT172;TMEM67;MALL;NPHP1;ACTN4
Generalized hypotonia	30/633	0.014523146457508317	0.3825014279186174	0	0	1.5833544143688338	6.700774240422269	ABCD4;RERE;GABRB1;PIGO;PGAP3;GLDC;CTBP1;HEXA;MTR;CHD4;ACTB;DHTKD1;ATXN2;ATCAY;TMEM67;CHMP1A;NPHP1;CHAMP1;AP1S1;OTX2;ALG9;AGK;TPM2;MBOAT7;MTOR;NDUFS8;PEX6;OGDH;B9D1;PIGG
Tricuspid Valve Stenosis	3/17	0.014577059989369897	0.3825014279186174	0	0	6.7258624681639265	28.439006106007067	SPINT1;HEXA;TP53
Congenital pontocerebellar hypoplasia	3/17	0.014577059989369897	0.3825014279186174	0	0	6.7258624681639265	28.439006106007067	TSEN34;CHMP1A;AKT1
Nerve Pain	3/17	0.014577059989369897	0.3825014279186174	0	0	6.7258624681639265	28.439006106007067	GRM5;CACNA2D1;HMGB1
Urothelial Carcinoma	15/257	0.014578885842795026	0.3825014279186174	0	0	1.9607267263165085	8.290307435776713	NUMA1;MSI1;MTR;HMGB1;FHIT;HDAC9;MTOR;KAT2A;TMEM67;SGSM3;ERCC1;ERBB2;AKT1;SDC1;TP53
Neuroendocrine Tumors	15/257	0.014578885842795026	0.3825014279186174	0	0	1.9607267263165085	8.290307435776713	ALG9;FLII;ADCY2;ACTN4;SYP;FOXN3;SEMA3F;FHIT;MTOR;PLCB3;MAP2;ERBB2;AKT1;CYYR1;TP53
Sunken eyes	8/103	0.014768601275546927	0.3825014279186174	0	0	2.65359477124183	11.185570367586399	RERE;HDAC4;JAG1;FLII;ERCC1;UBE2A;KCNAB2;PLEC
Serum triglycerides raised	5/47	0.014781412421591825	0.3825014279186174	0	0	3.743321718931475	15.775798172481432	JAG1;FLII;AKT2;AGPAT2;LMF1
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 1, X-LINKED	4/31	0.014813923896390484	0.3825014279186174	0	0	4.654401154401154	19.60521146415977	DNAH5;TMEM67;DNAI1;ACVR2B
Sebaceous Adenocarcinoma	4/31	0.014813923896390484	0.3825014279186174	0	0	4.654401154401154	19.60521146415977	ERBB2;SSSCA1;FHIT;TP53
HETEROTAXY, VISCERAL, 1, X-LINKED	4/31	0.014813923896390484	0.3825014279186174	0	0	4.654401154401154	19.60521146415977	DNAH5;TMEM67;DNAI1;ACVR2B
HETEROTAXY, VISCERAL, 2, AUTOSOMAL	4/31	0.014813923896390484	0.3825014279186174	0	0	4.654401154401154	19.60521146415977	DNAH5;TMEM67;DNAI1;ACVR2B
HETEROTAXY, VISCERAL, 6, AUTOSOMAL	4/31	0.014813923896390484	0.3825014279186174	0	0	4.654401154401154	19.60521146415977	DNAH5;TMEM67;DNAI1;ACVR2B
Pericardial effusion	4/31	0.014813923896390484	0.3825014279186174	0	0	4.654401154401154	19.60521146415977	ALG9;ERBB2;AKT1;TP53
Strabismus	21/404	0.015131342579279708	0.3825014279186174	0	0	1.7389164708805362	7.287776356378307	RERE;SETD5;BBS1;JAG1;CTBP1;AGK;FLII;TCF12;CHD7;KCNAB2;SHROOM4;PEX26;SOX3;VANGL2;NDUFS8;SUFU;PEX6;CHAMP1;TUBGCP6;ERCC8;OTX2
Transitional cell carcinoma of bladder	11/167	0.015198210391781715	0.3825014279186174	0	0	2.2258431223948465	9.318664947192	ERCC1;ERBB2;AKT1;SDC1;MTR;SSSCA1;HMGB1;RIN1;TP53;FHIT;MTOR
Glomerular filtration rate finding	6/65	0.015242670186912095	0.3825014279186174	0	0	3.2000772925523107	13.388024277350759	ATXN2;SORT1;CHMP1A;PIP5K1B;RHOC;DNAJC16
Enophthalmos	8/104	0.015580292484998492	0.3825014279186174	0	0	2.6258169934640523	10.927989843519837	RERE;HDAC4;JAG1;FLII;ERCC1;UBE2A;KCNAB2;PLEC
Increased size of the mandible	8/104	0.015580292484998492	0.3825014279186174	0	0	2.6258169934640523	10.927989843519837	IDUA;TPM2;FLII;INSR;SUFU;PDE4D;ERCC8;AGPAT2
Macrostomia	8/104	0.015580292484998492	0.3825014279186174	0	0	2.6258169934640523	10.927989843519837	MBD5;FRAS1;INSR;TMEM67;UBE2A;SMARCA2;ACTB;MTOR
Infantile Spasm	5/48	0.01609143458477763	0.3825014279186174	0	0	3.656078653809794	15.097660398415393	RIMS2;ATXN2;KCNAB2;PLCB1;MTOR
Schizophrenia	76/1923	0.016204072943020422	0.3825014279186174	0	0	1.326184751106723	5.467186891774792	RERE;CHRM3;CNTNAP2;GABRB1;MIR137HG;HP1BP3;ARHGAP1;CLTB;DIXDC1;MTR;CHD4;ACTB;LMNB2;RIMS2;GRM5;ATCAY;MDK;AKT2;SUFU;LRRTM1;NDST3;CFL1;AKT1;SEPHS1;VPS39;ANKS1B;CHRNB2;ALG9;PDE4D;SYP;LEMD2;YWHAZ;GABRG2;TAPBP;CACNB2;TEP1;PKP4;ETF1;PLCB1;GAPDH;TP53;PLEC;HDAC4;GPM6A;AMBRA1;SPG7;CPLX2;FHIT;HDAC9;RELA;ATXN2;MAP2;MAN2A1;MAP6;OTX2;CKB;CTNNA2;KCNJ3;FZD3;JAG1;SORT1;LINC00271;INSR;FOXN3;SMARCA2;MTOR;GNAO1;BCL9;DLG1;CAPN10;PPP1R1B;SPATS2L;B9D1;CNTN4;SHBG;CNIH3
Pancreatic Neoplasm	31/665	0.016205857248050713	0.3825014279186174	0	0	1.5562012286236095	6.415256779158103	RPAIN;TACSTD2;MTR;HMGB1;NDRG2;FHIT;RELA;RIMS2;STK33;ZNRF3;AKT2;CHMP1A;ERBB2;AKT1;LDLR;EIF5A;JAG1;LMO4;SORBS2;RHOC;MTOR;TAPBP;AIMP2;GIPC1;ERCC1;MGAT4B;SDC1;TRIB3;EBAG9;TP53;LY6E
Deglutition Disorders	12/191	0.016243522422865298	0.3825014279186174	0	0	2.1171346662746253	8.722724118058784	COQ4;RERE;TSEN34;ATXN2;TPM2;CHD7;ATP1A3;KCNAB2;SPG7;KIAA0319L;ACTB;PLEC
Neurodegenerative Disorders	34/745	0.016254904370936834	0.3825014279186174	0	0	1.52346596391181	6.275705679822315	PSMD12;IDUA;HEXA;KEAP1;SPG7;NDRG2;HDAC9;HDAC6;SGSH;LMNB1;RIMS2;SOX3;ATXN2;HSF1;ERBB2;AKT1;RPS27A;SYBU;SORT1;PDE4D;YWHAZ;GDAP1;TTC19;MTOR;MAPK10;KAT2A;NDUFS8;SGSM3;KCNMA1;OGDH;ATP13A2;GAPDH;TP53;LY6E
Gastrinoma	4/32	0.0165252383818015	0.3825014279186174	0	0	4.487940630797774	18.413421123682298	BBS2;ERBB2;TP53;ACTB
Lobar Holoprosencephaly	4/32	0.0165252383818015	0.3825014279186174	0	0	4.487940630797774	18.413421123682298	TMEM67;TMEM107;B9D1;TMEM231
Oropharyngeal disorders	4/32	0.0165252383818015	0.3825014279186174	0	0	4.487940630797774	18.413421123682298	ERBB2;AKT1;TP53;PDLIM7
Congenital hypoplasia of penis	16/285	0.016639646786519576	0.3825014279186174	0	0	1.881976414978212	7.708513423370299	BBS2;BBS1;SETD5;IFT172;CHD7;HCCS;CHD4;UBE2A;ACTB;ARCN1;SOX3;FRAS1;NPHP1;ERCC8;OTX2;PDE6B
Smoldering myeloma	3/18	0.017096728340687362	0.3825014279186174	0	0	6.277147487844409	25.540885541911997	CCND3;SDC1;TP53
Papillary renal cell carcinoma, sporadic	3/18	0.017096728340687362	0.3825014279186174	0	0	6.277147487844409	25.540885541911997	ERBB2;TP53;MTOR
Acquired partial lipodystrophy	3/18	0.017096728340687362	0.3825014279186174	0	0	6.277147487844409	25.540885541911997	AKT2;LMNB2;LMNB1
Vitamin B 12 Deficiency	3/18	0.017096728340687362	0.3825014279186174	0	0	6.277147487844409	25.540885541911997	ABCD4;CFL1;MTR
Atypical Inclusion-Body Disease	3/18	0.017096728340687362	0.3825014279186174	0	0	6.277147487844409	25.540885541911997	PRDM8;KCNC1;LMNB2
Bilateral microphthalmos	3/18	0.017096728340687362	0.3825014279186174	0	0	6.277147487844409	25.540885541911997	FRAS1;ERCC1;OTX2
Biotin-Responsive Encephalopathy	3/18	0.017096728340687362	0.3825014279186174	0	0	6.277147487844409	25.540885541911997	PRDM8;KCNC1;LMNB2
Familial Progressive Myoclonic Epilepsy	3/18	0.017096728340687362	0.3825014279186174	0	0	6.277147487844409	25.540885541911997	PRDM8;KCNC1;LMNB2
Malignant neoplasm tonsil	3/18	0.017096728340687362	0.3825014279186174	0	0	6.277147487844409	25.540885541911997	TP53;ACTB;SKP1
May-White Syndrome	3/18	0.017096728340687362	0.3825014279186174	0	0	6.277147487844409	25.540885541911997	PRDM8;KCNC1;LMNB2
Cystadenocarcinoma, Serous	7/86	0.017345366962697784	0.3825014279186174	0	0	2.789910587069197	11.311496741002486	MAGED4B;ERBB2;AKT1;SSSCA1;SHBG;TP53;NEK11
Astigmatism	5/49	0.017476499014214407	0.3825014279186174	0	0	3.57280118255728	14.458762724820064	SETD5;MBD5;CHMP1A;CHD4;ARCN1
Nervous System Neoplasms	5/49	0.017476499014214407	0.3825014279186174	0	0	3.57280118255728	14.458762724820064	MDK;ERBB2;AKT1;MSI1;TP53
Social Communication Disorder	2/7	0.018167422979665306	0.3825014279186174	0	0	12.540453074433657	50.263706425211545	CNTNAP2;SMARCA2
Spinocerebellar Ataxia 10	2/7	0.018167422979665306	0.3825014279186174	0	0	12.540453074433657	50.263706425211545	ATXN2;LY6E
Unilateral Breast Carcinoma	2/7	0.018167422979665306	0.3825014279186174	0	0	12.540453074433657	50.263706425211545	ERBB2;TP53
Unilateral Breast Neoplasms	2/7	0.018167422979665306	0.3825014279186174	0	0	12.540453074433657	50.263706425211545	ERBB2;TP53
Adenosarcoma	2/7	0.018167422979665306	0.3825014279186174	0	0	12.540453074433657	50.263706425211545	ERBB2;TP53
Adenosis	2/7	0.018167422979665306	0.3825014279186174	0	0	12.540453074433657	50.263706425211545	ERBB2;TP53
Anus Neoplasms	2/7	0.018167422979665306	0.3825014279186174	0	0	12.540453074433657	50.263706425211545	FHIT;TP53
Asymmetry of the thorax	2/7	0.018167422979665306	0.3825014279186174	0	0	12.540453074433657	50.263706425211545	KCNQ1OT1;AKT1
Broad eyebrow	2/7	0.018167422979665306	0.3825014279186174	0	0	12.540453074433657	50.263706425211545	RERE;MAF
Calvarial hyperostosis	2/7	0.018167422979665306	0.3825014279186174	0	0	12.540453074433657	50.263706425211545	IDUA;AKT1
Central Neurocytoma	2/7	0.018167422979665306	0.3825014279186174	0	0	12.540453074433657	50.263706425211545	SYP;TP53
Choroid Plexus Neoplasms	2/7	0.018167422979665306	0.3825014279186174	0	0	12.540453074433657	50.263706425211545	OTX2;TP53
Desmoplastic infantile astrocytoma	2/7	0.018167422979665306	0.3825014279186174	0	0	12.540453074433657	50.263706425211545	TP53;HDAC6
Elongated superior cerebellar peduncle	2/7	0.018167422979665306	0.3825014279186174	0	0	12.540453074433657	50.263706425211545	TMEM67;NPHP1
Enlargement of calvarial bones	2/7	0.018167422979665306	0.3825014279186174	0	0	12.540453074433657	50.263706425211545	IDUA;AKT1
Increased body mass index	2/7	0.018167422979665306	0.3825014279186174	0	0	12.540453074433657	50.263706425211545	UBE2A;TP53
Increased ossification of calvarial bones	2/7	0.018167422979665306	0.3825014279186174	0	0	12.540453074433657	50.263706425211545	IDUA;AKT1
Intracortical osteosarcoma	2/7	0.018167422979665306	0.3825014279186174	0	0	12.540453074433657	50.263706425211545	ERBB2;TP53
Kaufman-McKusick syndrome	2/7	0.018167422979665306	0.3825014279186174	0	0	12.540453074433657	50.263706425211545	BBS2;JAG1
Long cerebellar peduncles	2/7	0.018167422979665306	0.3825014279186174	0	0	12.540453074433657	50.263706425211545	TMEM67;NPHP1
Medullary sponge kidney disease	2/7	0.018167422979665306	0.3825014279186174	0	0	12.540453074433657	50.263706425211545	JAG1;TMEM67
Peripheral axonal degeneration	2/7	0.018167422979665306	0.3825014279186174	0	0	12.540453074433657	50.263706425211545	LRSAM1;GDAP1
Recurrent sinus disease	4/33	0.01835533168030517	0.3825014279186174	0	0	4.3329601433049705	17.322460546002088	RSPH4A;RSPH1;HYDIN;LRRC6
Recurrent sinusitis	4/33	0.01835533168030517	0.3825014279186174	0	0	4.3329601433049705	17.322460546002088	RSPH4A;RSPH1;HYDIN;LRRC6
Hepatic Fibrosis, Congenital	4/33	0.01835533168030517	0.3825014279186174	0	0	4.3329601433049705	17.322460546002088	TMEM67;TMEM107;B9D1;TMEM231
Autosomal Dominant Parkinsonism	4/33	0.01835533168030517	0.3825014279186174	0	0	4.3329601433049705	17.322460546002088	ATXN2;ATP1A3;ATP13A2;LY6E
Low posterior hairline	6/68	0.01870080501420954	0.38662105169794925	0	0	3.044762004833456	12.115682585623015	SETD5;CTBP1;XYLT2;UBE2A;ALDOA;ACTB
Advanced bone age	5/50	0.018938190165209052	0.38662105169794925	0	0	3.4932249322493223	13.85613781934905	PDE4D;KCNQ1OT1;INSR;AGPAT2;ARCN1
Muscular fasciculation	5/50	0.018938190165209052	0.38662105169794925	0	0	3.4932249322493223	13.85613781934905	BBS2;LRSAM1;ATXN2;CNTN4;LY6E
Pointed chin	5/50	0.018938190165209052	0.38662105169794925	0	0	3.4932249322493223	13.85613781934905	RERE;CHAMP1;TUBGCP6;KCNAB2;ACTB
Vesico-Ureteral Reflux	8/108	0.019151507204851974	0.38662105169794925	0	0	2.5202614379084967	9.968576214990303	RERE;CHRM3;SETD5;DSTYK;JAG1;KCNQ1OT1;CHD7;CHD4
Class III malocclusion	8/108	0.019151507204851974	0.38662105169794925	0	0	2.5202614379084967	9.968576214990303	IDUA;TPM2;FLII;INSR;SUFU;PDE4D;ERCC8;AGPAT2
Long face	8/108	0.019151507204851974	0.38662105169794925	0	0	2.5202614379084967	9.968576214990303	CEP104;TPM2;TMEM67;NPHP1;CHAMP1;AKT1;B9D1;TMEM231
Physical aggression	8/108	0.019151507204851974	0.38662105169794925	0	0	2.5202614379084967	9.968576214990303	MAPK10;MBD5;GLDC;ATP13A2;UBE2A;SMARCA2;TTC19;TMEM231
Brain Tumor, Primary	7/88	0.019450098363519158	0.388827117584918	0	0	2.720741949126941	10.719459780273567	MDK;TRIM24;MTR;MIR92B;TP53;FHIT;RELA
Small head	27/570	0.019829380918842187	0.388827117584918	0	0	1.579504905294737	6.192592015424034	HDAC4;RERE;TSEN34;SETD5;PGAP3;CTBP1;HCCS;ACTB;PEX26;DHTKD1;DSTYK;TMEM67;TMEM107;CHAMP1;MBD5;ALG9;KCNAB2;SMARCA2;SHROOM4;ARCN1;TMEM231;FRAS1;PEX6;ERCC1;TUBGCP6;ERCC8;B9D1
Dystonia, Diurnal	3/19	0.019843829405673988	0.388827117584918	0	0	5.88452188006483	23.066514773000982	ATP1A3;ACTB;ANO3
Histiocytoma, Benign Fibrous	3/19	0.019843829405673988	0.388827117584918	0	0	5.88452188006483	23.066514773000982	CHAMP1;AKT1;TP53
Adult Non-Hodgkin Lymphoma	3/19	0.019843829405673988	0.388827117584918	0	0	5.88452188006483	23.066514773000982	CCND3;HDAC9;TP53
Fallopian Tube Carcinoma	3/19	0.019843829405673988	0.388827117584918	0	0	5.88452188006483	23.066514773000982	ERBB2;ACTN4;TP53
Thin lips	6/69	0.019963372838180084	0.388827117584918	0	0	2.996277338296882	11.72699816551575	HDAC4;SETD5;JAG1;UBE2A;SMARCA2;ACTB
Bowed and upward slanting eyebrows	6/69	0.019963372838180084	0.388827117584918	0	0	2.996277338296882	11.72699816551575	HDAC4;SETD5;MBD5;CTBP1;SMARCA2;ACTB
Highly arched eyebrow	6/69	0.019963372838180084	0.388827117584918	0	0	2.996277338296882	11.72699816551575	HDAC4;SETD5;MBD5;CTBP1;SMARCA2;ACTB
Brachycephaly	9/130	0.020013160463929605	0.388827117584918	0	0	2.344496895754149	9.17018356635823	RERE;SETD5;MBD5;ALG9;MAF;FLII;PDE4D;TCF12;KCNAB2
Cataract	25/519	0.020333300507441567	0.3935674045784945	0	0	1.6063348416289593	6.25746985449121	IFT172;XYLT2;KEAP1;HCCS;APEH;NDRG2;ACTB;PEX26;MAN2A1;TMEM67;SUFU;TMEM107;AKT1;OTX2;PDE6B;BBS2;JAG1;AGK;TMEM231;MAF;PEX6;ERCC1;TUBGCP6;ERCC8;B9D1
Bronchioloalveolar Adenocarcinoma	7/89	0.020566692331728104	0.3965994998894435	0	0	2.6874229101181712	10.43817199656498	ERBB2;TACSTD2;AKT1;MSI1;TP53;FHIT;MTOR
Status Epilepticus	13/221	0.020763225950630387	0.398900935735531	0	0	1.9740527182866556	7.648609073233936	PDXK;STAT2;ATP1A3;SMARCA2;RELA;LMNB2;MTOR;GRM5;KCNMA1;CFL1;CDK2AP2;PDSS2;TP53
Aggressive reaction	8/110	0.021140562204905677	0.40209967556507004	0	0	2.4705882352941178	9.527975975890904	MAPK10;MBD5;GLDC;ATP13A2;UBE2A;SMARCA2;TTC19;TMEM231
Bone Density	8/110	0.021140562204905677	0.40209967556507004	0	0	2.4705882352941178	9.527975975890904	RERE;TOM1L2;TMEM135;JAG1;IDUA;AMBRA1;DCDC1;SMG6
Myoclonus	10/154	0.021928821444115117	0.40209967556507004	0	0	2.189890710382514	8.365280595523192	PRDM8;MAPK10;ATXN2;KCNC1;GLDC;ATP13A2;PLCB1;LMNB2;LY6E;ANO3
Generalized hirsutism	5/52	0.022097362736569245	0.40209967556507004	0	0	3.344231101885487	12.749202233029106	SETD5;MBD5;IDUA;INSR;AGPAT2
Intrahepatic Cholestasis	4/35	0.02238011458906692	0.40209967556507004	0	0	4.052995391705069	15.399690184395345	JAG1;MAF;AP1S1;SHBG
Leiomyosarcoma of uterus	4/35	0.02238011458906692	0.40209967556507004	0	0	4.052995391705069	15.399690184395345	SPINT1;ERBB2;AKT1;TP53
Neoplasm of uncertain or unknown behavior of ovary	4/35	0.02238011458906692	0.40209967556507004	0	0	4.052995391705069	15.399690184395345	AKT2;ERBB2;AKT1;TP53
Retrusion of lower jaw	20/395	0.02241403086110657	0.40209967556507004	0	0	1.6893333333333334	6.4162031086153775	RERE;SETD5;MBD5;ALG9;CTBP1;IDUA;FLII;TPM2;HCCS;ACTB;ARCN1;PEX26;TMEM231;DSTYK;TMEM67;PEX6;ERCC1;TMEM107;AKT1;B9D1
Decreased projection of lower jaw	20/395	0.02241403086110657	0.40209967556507004	0	0	1.6893333333333334	6.4162031086153775	RERE;SETD5;MBD5;ALG9;CTBP1;IDUA;FLII;TPM2;HCCS;ACTB;ARCN1;PEX26;TMEM231;DSTYK;TMEM67;PEX6;ERCC1;TMEM107;AKT1;B9D1
Decreased projection of mandible	20/395	0.02241403086110657	0.40209967556507004	0	0	1.6893333333333334	6.4162031086153775	RERE;SETD5;MBD5;ALG9;CTBP1;IDUA;FLII;TPM2;HCCS;ACTB;ARCN1;PEX26;TMEM231;DSTYK;TMEM67;PEX6;ERCC1;TMEM107;AKT1;B9D1
Hypoplastic mandible condyle	20/395	0.02241403086110657	0.40209967556507004	0	0	1.6893333333333334	6.4162031086153775	RERE;SETD5;MBD5;ALG9;CTBP1;IDUA;FLII;TPM2;HCCS;ACTB;ARCN1;PEX26;TMEM231;DSTYK;TMEM67;PEX6;ERCC1;TMEM107;AKT1;B9D1
Spinal canal stenosis	3/20	0.0228193114748192	0.40209967556507004	0	0	5.538087520259319	20.934791056161544	IDUA;PDE4D;AKT1
Thymoma, type C	3/20	0.0228193114748192	0.40209967556507004	0	0	5.538087520259319	20.934791056161544	ERBB2;HMGB1;TP53
Action Myoclonus-Renal Failure Syndrome	3/20	0.0228193114748192	0.40209967556507004	0	0	5.538087520259319	20.934791056161544	PRDM8;KCNC1;LMNB2
Carcinoma ex pleomorphic adenoma	3/20	0.0228193114748192	0.40209967556507004	0	0	5.538087520259319	20.934791056161544	ERBB2;TYK2;TP53
Embryonal Rhabdomyosarcoma	7/91	0.02293220153885424	0.40209967556507004	0	0	2.6231647634584014	9.903006176337708	AIMP2;JUP;SUFU;ERBB2;AKT1;TP53;MTOR
Aggressive behavior	8/112	0.023271693026992585	0.40209967556507004	0	0	2.422825540472599	9.111077961985652	MAPK10;MBD5;GLDC;ATP13A2;UBE2A;SMARCA2;TTC19;TMEM231
Aplasia/Hypoplasia of the mandible	20/397	0.02349575910607682	0.40209967556507004	0	0	1.6801945181255526	6.3023009922280275	RERE;SETD5;MBD5;ALG9;CTBP1;IDUA;FLII;TPM2;HCCS;ACTB;ARCN1;PEX26;TMEM231;DSTYK;TMEM67;PEX6;ERCC1;TMEM107;AKT1;B9D1
Renal corticomedullary cysts	2/8	0.023730727756839466	0.40209967556507004	0	0	10.449838187702266	39.09268311390535	TMEM67;NPHP1
Shortened QT interval	2/8	0.023730727756839466	0.40209967556507004	0	0	10.449838187702266	39.09268311390535	CACNB2;CACNA2D1
Hyperthyroxinemia, Familial Dysalbuminemic	2/8	0.023730727756839466	0.40209967556507004	0	0	10.449838187702266	39.09268311390535	HCCS;SHBG
Neuroepithelioma, Peripheral	2/8	0.023730727756839466	0.40209967556507004	0	0	10.449838187702266	39.09268311390535	ERBB2;TP53
Seizure, Febrile, Simple	2/8	0.023730727756839466	0.40209967556507004	0	0	10.449838187702266	39.09268311390535	GABRG2;ANO3
Abnormality of secondary sexual hair	2/8	0.023730727756839466	0.40209967556507004	0	0	10.449838187702266	39.09268311390535	SOX3;OTX2
Ureterocele	2/8	0.023730727756839466	0.40209967556507004	0	0	10.449838187702266	39.09268311390535	PEX6;PLEC
Chromosome 1p36 Deletion Syndrome	2/8	0.023730727756839466	0.40209967556507004	0	0	10.449838187702266	39.09268311390535	RERE;KCNAB2
Collapsing glomerulopathy	2/8	0.023730727756839466	0.40209967556507004	0	0	10.449838187702266	39.09268311390535	PDSS2;ACTN4
Cystadenocarcinoma	2/8	0.023730727756839466	0.40209967556507004	0	0	10.449838187702266	39.09268311390535	ERBB2;TP53
Diabetic cataract	2/8	0.023730727756839466	0.40209967556507004	0	0	10.449838187702266	39.09268311390535	CAPN5;CAPN1
Hemifacial microsomia	2/8	0.023730727756839466	0.40209967556507004	0	0	10.449838187702266	39.09268311390535	CHD7;OTX2
Hyperhomocystinemia	2/8	0.023730727756839466	0.40209967556507004	0	0	10.449838187702266	39.09268311390535	ABCD4;MTR
Hyperphosphatasia with Mental Retardation	2/8	0.023730727756839466	0.40209967556507004	0	0	10.449838187702266	39.09268311390535	PIGO;PGAP3
Klippel-Trenaunay-Weber Syndrome	2/8	0.023730727756839466	0.40209967556507004	0	0	10.449838187702266	39.09268311390535	KCNQ1OT1;ROGDI
Liquid Tumor	2/8	0.023730727756839466	0.40209967556507004	0	0	10.449838187702266	39.09268311390535	HMGB1;TP53
Malignant tumor of extrahepatic bile duct	2/8	0.023730727756839466	0.40209967556507004	0	0	10.449838187702266	39.09268311390535	ERCC1;TP53
Non-small cell lung cancer stage II	2/8	0.023730727756839466	0.40209967556507004	0	0	10.449838187702266	39.09268311390535	FHIT;TP53
Stereotypic Movement Disorder	7/92	0.02418260078867574	0.40841725776430143	0	0	2.592169657422512	9.648371398774442	RERE;MBD5;CTBP1;FLII;CHAMP1;KCNAB2;TP53
Micrognathism	20/400	0.025192780162209168	0.4189671641757402	0	0	1.6666666666666667	6.135329711689652	RERE;SETD5;MBD5;ALG9;CTBP1;IDUA;FLII;TPM2;HCCS;ACTB;ARCN1;PEX26;TMEM231;DSTYK;TMEM67;PEX6;ERCC1;TMEM107;AKT1;B9D1
Reduced tendon reflexes	5/54	0.025579889702773424	0.4189671641757402	0	0	3.207400033184005	11.75816428575492	CNTNAP2;TPM2;PEX6;ERCC1;PEX26
Small midface	10/158	0.02563894248407737	0.4189671641757402	0	0	2.1302614089499334	7.804517070175168	RERE;HDAC4;MAF;FLII;KCNQ1OT1;PDE4D;HCCS;UBE2A;KCNAB2;MTOR
Decreased projection of midface	10/158	0.02563894248407737	0.4189671641757402	0	0	2.1302614089499334	7.804517070175168	RERE;HDAC4;MAF;FLII;KCNQ1OT1;PDE4D;HCCS;UBE2A;KCNAB2;MTOR
Hypotrophic midface	10/158	0.02563894248407737	0.4189671641757402	0	0	2.1302614089499334	7.804517070175168	RERE;HDAC4;MAF;FLII;KCNQ1OT1;PDE4D;HCCS;UBE2A;KCNAB2;MTOR
Midface retrusion	10/158	0.02563894248407737	0.4189671641757402	0	0	2.1302614089499334	7.804517070175168	RERE;HDAC4;MAF;FLII;KCNQ1OT1;PDE4D;HCCS;UBE2A;KCNAB2;MTOR
Brachydactyly	12/204	0.025657311556278647	0.4189671641757402	0	0	1.972450657894737	7.224942173431483	RERE;HDAC4;BBS1;JAG1;FRAS1;IFT172;FLII;INSR;SUFU;PDE4D;KCNAB2;SMARCA2
Sandhoff Disease	3/21	0.026023308765559715	0.4189671641757402	0	0	5.230145867098866	19.083560902215243	NFIC;HEXA;RPS27A
Xanthomatosis, Cerebrotendinous	3/21	0.026023308765559715	0.4189671641757402	0	0	5.230145867098866	19.083560902215243	AKT1;LDLR;TP53
Anaplastic Ependymoma	3/21	0.026023308765559715	0.4189671641757402	0	0	5.230145867098866	19.083560902215243	BCL7C;FOXJ1;TP53
Fibrolamellar Hepatocellular Carcinoma	3/21	0.026023308765559715	0.4189671641757402	0	0	5.230145867098866	19.083560902215243	ERBB2;IGF2BP1;TP53
Oculo-dento-digital syndrome	3/21	0.026023308765559715	0.4189671641757402	0	0	5.230145867098866	19.083560902215243	SUFU;HCCS;TP53
Olivopontocerebellar Atrophies	3/21	0.026023308765559715	0.4189671641757402	0	0	5.230145867098866	19.083560902215243	ATXN2;TTC19;LY6E
Papillon-Lefevre Disease	3/21	0.026023308765559715	0.4189671641757402	0	0	5.230145867098866	19.083560902215243	HCCS;SPG7;TP53
Paraplegia	3/21	0.026023308765559715	0.4189671641757402	0	0	5.230145867098866	19.083560902215243	AKT1;SPG7;CCT5
Mental impairment	11/182	0.02677648208098998	0.42910990505472074	0	0	2.0290093048713738	7.345483015836863	DSTYK;ALG9;INSR;PEX6;NPHP1;FAM19A2;AKT1;AGPAT2;TTC19;MTOR;PEX26
Atypical Lipoma	4/37	0.026902401168291318	0.42910990505472074	0	0	3.8069657615112162	13.764235975184375	AKT2;ERBB2;AKT1;TP53
Immunoblastic Large-Cell Lymphoma	4/37	0.026902401168291318	0.42910990505472074	0	0	3.8069657615112162	13.764235975184375	SDC1;TP53;PDLIM7;MTOR
Hamartoma	6/74	0.027146316963800043	0.43151719065204996	0	0	2.775244299674267	10.008957134103367	TEP1;AKT1S1;SSSCA1;TP53;ACTB;MTOR
Agenesis	7/95	0.028212815118904375	0.43151719065204996	0	0	2.503410944683375	8.932117597445918	GDF11;RSPH1;TMEM67;CHD7;SYBU;MTOR;LHX9
Apnea	6/75	0.028763394369960404	0.43151719065204996	0	0	2.734881744795355	9.705142832561075	CEP104;TMEM67;NPHP1;ATP1A3;B9D1;TMEM231
Carcinoma, Small Cell	8/117	0.029250793488638214	0.43151719065204996	0	0	2.3110871259818913	8.162409779199374	MAP2;AKT2;ERBB2;TP53;FHIT;SMARCA2;ACTB;MTOR
Breast cancer, lobular	3/22	0.02945520728395592	0.43151719065204996	0	0	4.954619124797407	17.464460486991932	ERBB2;FHIT;TP53
Dystonia, Paroxysmal	3/22	0.02945520728395592	0.43151719065204996	0	0	4.954619124797407	17.464460486991932	ATP1A3;ACTB;ANO3
Timothy syndrome	3/22	0.02945520728395592	0.43151719065204996	0	0	4.954619124797407	17.464460486991932	SPINT1;HEXA;TP53
Absent eyebrow	3/22	0.02945520728395592	0.43151719065204996	0	0	4.954619124797407	17.464460486991932	CDH3;FRAS1;SMARCA2
Agenesis of eyebrows	3/22	0.02945520728395592	0.43151719065204996	0	0	4.954619124797407	17.464460486991932	CDH3;FRAS1;SMARCA2
ANOPHTHALMIA AND PULMONARY HYPOPLASIA	3/22	0.02945520728395592	0.43151719065204996	0	0	4.954619124797407	17.464460486991932	CHRM3;KCNQ1OT1;TP53
Aplasia of eyebrows	3/22	0.02945520728395592	0.43151719065204996	0	0	4.954619124797407	17.464460486991932	CDH3;FRAS1;SMARCA2
Benign Rolandic Epilepsy	3/22	0.02945520728395592	0.43151719065204996	0	0	4.954619124797407	17.464460486991932	CNTNAP2;ERBB2;GABRG2
Epidermodysplasia Verruciformis	3/22	0.02945520728395592	0.43151719065204996	0	0	4.954619124797407	17.464460486991932	FOXK1;TP53;PDLIM7
Madarosis of eyebrow	3/22	0.02945520728395592	0.43151719065204996	0	0	4.954619124797407	17.464460486991932	CDH3;FRAS1;SMARCA2
Recurrent Chronic Lymphoid Leukemia	2/9	0.029892251210029776	0.43151719065204996	0	0	8.956541840036985	31.43885898078236	AKT1;TP53
Secondary malignant neoplasm of axilla	2/9	0.029892251210029776	0.43151719065204996	0	0	8.956541840036985	31.43885898078236	ERBB2;TP53
Epilepsy, Absence, Atypical	2/9	0.029892251210029776	0.43151719065204996	0	0	8.956541840036985	31.43885898078236	EFHC1;GABRG2
Neural tube defect, folate-sensitive	2/9	0.029892251210029776	0.43151719065204996	0	0	8.956541840036985	31.43885898078236	VANGL2;MTR
Stage I Endometrial Carcinoma	2/9	0.029892251210029776	0.43151719065204996	0	0	8.956541840036985	31.43885898078236	ERBB2;TP53
Supranuclear gaze palsy	2/9	0.029892251210029776	0.43151719065204996	0	0	8.956541840036985	31.43885898078236	ATP13A2;SPG7
Seizure, Febrile, Complex	2/9	0.029892251210029776	0.43151719065204996	0	0	8.956541840036985	31.43885898078236	GABRG2;ANO3
Akinetic Petit Mal	2/9	0.029892251210029776	0.43151719065204996	0	0	8.956541840036985	31.43885898078236	EFHC1;GABRG2
Amelogenesis imperfecta nephrocalcinosis	2/9	0.029892251210029776	0.43151719065204996	0	0	8.956541840036985	31.43885898078236	CACNB2;CACNA2D1
Broad philtrum	2/9	0.029892251210029776	0.43151719065204996	0	0	8.956541840036985	31.43885898078236	MAF;SMARCA2
Bruxism	2/9	0.029892251210029776	0.43151719065204996	0	0	8.956541840036985	31.43885898078236	PGAP3;SHROOM4
Decreased serum leptin	2/9	0.029892251210029776	0.43151719065204996	0	0	8.956541840036985	31.43885898078236	AKT2;AGPAT2
Female Pseudohermaphroditism	2/9	0.029892251210029776	0.43151719065204996	0	0	8.956541840036985	31.43885898078236	FRAS1;INSR
Glycogen Storage Disease Type IV	2/9	0.029892251210029776	0.43151719065204996	0	0	8.956541840036985	31.43885898078236	RBCK1;KCNJ3
Horizontal eyebrow	2/9	0.029892251210029776	0.43151719065204996	0	0	8.956541840036985	31.43885898078236	RERE;KCNAB2
Juvenile Absence Epilepsy	2/9	0.029892251210029776	0.43151719065204996	0	0	8.956541840036985	31.43885898078236	EFHC1;GABRG2
Malignant neoplasm of duodenum	2/9	0.029892251210029776	0.43151719065204996	0	0	8.956541840036985	31.43885898078236	MDK;ERBB2
Medullary carcinoma of breast	2/9	0.029892251210029776	0.43151719065204996	0	0	8.956541840036985	31.43885898078236	ERBB2;TP53
Megalencephaly cutis marmorata telangiectatica congenita	2/9	0.029892251210029776	0.43151719065204996	0	0	8.956541840036985	31.43885898078236	AKT1;MTOR
Metaplastic breast carcinoma	2/9	0.029892251210029776	0.43151719065204996	0	0	8.956541840036985	31.43885898078236	ERBB2;TP53
Amphetamine-Related Disorders	6/76	0.030442587053640863	0.4358096672942271	0	0	2.6956724057701256	9.413052873126048	PDE4D;AKT1;FHIT;GABRG2;RELA;MAP2K5
Amphetamine Abuse	6/76	0.030442587053640863	0.4358096672942271	0	0	2.6956724057701256	9.413052873126048	PDE4D;AKT1;FHIT;GABRG2;RELA;MAP2K5
Nonverbal	6/76	0.030442587053640863	0.4358096672942271	0	0	2.6956724057701256	9.413052873126048	RERE;GNAO1;CHMP1A;KCNAB2;SMARCA2;TMEM231
Neural Tube Defects	10/163	0.030883962594268646	0.44090695769939325	0	0	2.060109289617486	7.164067630430336	FZD3;VANGL2;TCN2;GLDC;KCNQ1OT1;MALL;MTR;ZIC5;TP53;LMNB1
Gilles de la Tourette syndrome	7/97	0.031138697516675355	0.4433189773172954	0	0	2.4475258292550297	8.49121100304702	CNTNAP2;ALG9;SPINT1;HEXA;TP53;MAP2K5;CBLN2
Anteverted nostril	15/283	0.03125057049266348	0.44368941842331	0	0	1.768101640557543	6.127741057725546	BBS2;RERE;HDAC4;SETD5;IDUA;IFT172;FLII;PDE4D;SMARCA2;ACTB;PEX26;TMEM67;PEX6;TUBGCP6;PDE6B
Cardiac defects	5/57	0.031430324949981034	0.44501895710000544	0	0	3.0218886804252656	10.455680710366975	HIC2;TMEM87B;JAG1;VANGL2;CHD7
Craniofacial Abnormalities	11/187	0.03177014357195975	0.4486013715297486	0	0	1.9708538587848932	6.797924927759015	FAM83H;ZNF462;TMEM87B;JAG1;BNC2;CHD7;FADD;CNTN4;ZIC5;TP53;ACTB
Anosmia	4/39	0.031932553808119754	0.4496660438157027	0	0	3.589053803339518	12.361165341790011	BBS2;CHD7;ATP13A2;DNAI1
Amphetamine Addiction	6/77	0.03218464092137164	0.4519843051131756	0	0	2.6575675551681424	9.132108847154676	PDE4D;AKT1;FHIT;GABRG2;RELA;MAP2K5
Stage IV Bladder Cancer AJCC v6	3/23	0.03311370696080958	0.45757122345845963	0	0	4.706645056726094	16.039342558584938	ERBB2;AKT1;MTOR
Anencephaly	3/23	0.03311370696080958	0.45757122345845963	0	0	4.706645056726094	16.039342558584938	VANGL2;LMO4;LMNB1
Episodic tachypnea	3/23	0.03311370696080958	0.45757122345845963	0	0	4.706645056726094	16.039342558584938	CEP104;TMEM67;B9D1
Hemimegalencephaly	3/23	0.03311370696080958	0.45757122345845963	0	0	4.706645056726094	16.039342558584938	MAP2;AKT1;MTOR
Involuntary Movements	3/23	0.03311370696080958	0.45757122345845963	0	0	4.706645056726094	16.039342558584938	GNAO1;PGAP3;PPP1R1B
Occipital Encephalocele	3/23	0.03311370696080958	0.45757122345845963	0	0	4.706645056726094	16.039342558584938	TMEM67;B9D1;TMEM231
Ambiguous Genitalia	5/58	0.033551485034254994	0.46115445387507925	0	0	2.9647185151096793	10.064253314839155	SOX3;FRAS1;CHD4;B9D1;SHBG
Maternal oligohydramnios	5/58	0.033551485034254994	0.46115445387507925	0	0	2.9647185151096793	10.064253314839155	CHRM3;TMEM67;TMEM107;B9D1;TMEM231
Rhizomelia	4/40	0.03464031645113569	0.47360094026314614	0	0	3.4891774891774894	11.733186451440753	COG1;HDAC6;MTOR;ARCN1
Chemical Carcinogenesis	4/40	0.03464031645113569	0.47360094026314614	0	0	3.4891774891774894	11.733186451440753	KEAP1;YWHAZ;TP53;PDLIM7
Intelligence	12/214	0.0352357100924317	0.47777483761597284	0	0	1.8738275143303804	6.269255756608464	CCDC134;RALYL;NEGR1;MAN2A1;PDE4D;MIR137HG;SCMH1;IGF2BP1;FOXN3;CNTN4;SEMA3F;DCAF5
Fibromatosis, Aggressive	5/59	0.035759507479972565	0.47777483761597284	0	0	2.9096657633242997	9.69191946394367	MDK;CREB3L2;CTNNBIP1;AKT1;TP53
Spinocerebellar Ataxia Type 1	6/79	0.03586008043508395	0.47777483761597284	0	0	2.584489759493106	8.601519370675327	RIMS2;ATXN2;HMGB1;PUM1;GAPDH;LY6E
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	2/10	0.0366096818297069	0.47777483761597284	0	0	7.836569579288026	25.919003615292418	RIMS2;ATXN2
Stage III Breast Cancer AJCC v6	2/10	0.0366096818297069	0.47777483761597284	0	0	7.836569579288026	25.919003615292418	ERBB2;TP53
Stage III Breast Cancer AJCC v7	2/10	0.0366096818297069	0.47777483761597284	0	0	7.836569579288026	25.919003615292418	ERBB2;TP53
Post-transplant lymphoproliferative disorder, polymorphic	2/10	0.0366096818297069	0.47777483761597284	0	0	7.836569579288026	25.919003615292418	SDC1;TP53
stage, endometrial cancer	2/10	0.0366096818297069	0.47777483761597284	0	0	7.836569579288026	25.919003615292418	ERBB2;TP53
Stuttering, Developmental	2/10	0.0366096818297069	0.47777483761597284	0	0	7.836569579288026	25.919003615292418	CNTNAP2;SHBG
Abnormal prolactin level	2/10	0.0366096818297069	0.47777483761597284	0	0	7.836569579288026	25.919003615292418	SOX3;OTX2
Adenosquamous cell lung cancer	2/10	0.0366096818297069	0.47777483761597284	0	0	7.836569579288026	25.919003615292418	ERBB2;AKT1
Bardet-Biedl syndrome 1 (disorder)	2/10	0.0366096818297069	0.47777483761597284	0	0	7.836569579288026	25.919003615292418	BBS1;TMEM67
Branchio-Oto-Renal Syndrome	2/10	0.0366096818297069	0.47777483761597284	0	0	7.836569579288026	25.919003615292418	SHARPIN;RBCK1
Duodenal Cancer	2/10	0.0366096818297069	0.47777483761597284	0	0	7.836569579288026	25.919003615292418	MDK;ERBB2
Epithelial inclusion cyst	2/10	0.0366096818297069	0.47777483761597284	0	0	7.836569579288026	25.919003615292418	ERBB2;SSSCA1
Hyperconvex fingernails	2/10	0.0366096818297069	0.47777483761597284	0	0	7.836569579288026	25.919003615292418	CTBP1;PLEC
Liver Dysplastic Nodule	2/10	0.0366096818297069	0.47777483761597284	0	0	7.836569579288026	25.919003615292418	ACTN4;TP53
NUT midline carcinoma	2/10	0.0366096818297069	0.47777483761597284	0	0	7.836569579288026	25.919003615292418	RIMS2;HDAC9
Severe postnatal growth retardation	3/24	0.03699688011384709	0.47799969107090434	0	0	4.482287566566335	14.777751104142029	SETD5;CTBP1;ERCC8
bilateral breast cancer	3/24	0.03699688011384709	0.47799969107090434	0	0	4.482287566566335	14.777751104142029	ERBB2;FHIT;TP53
Childhood Solid Neoplasm	3/24	0.03699688011384709	0.47799969107090434	0	0	4.482287566566335	14.777751104142029	MDK;INSR;HDAC6
Postural instability	3/24	0.03699688011384709	0.47799969107090434	0	0	4.482287566566335	14.777751104142029	ATXN2;ATP1A3;ATP13A2
Endometrioid carcinoma ovary	4/41	0.03747728608252143	0.4817975484439571	0	0	3.3946998946998947	11.148263142500944	FER;ERBB2;NEK10;TP53
Malignant Meningioma	4/41	0.03747728608252143	0.4817975484439571	0	0	3.3946998946998947	11.148263142500944	PRKCI;SGSM3;AKT1;TP53
Spasmodic movement	8/123	0.03772720244126727	0.4822792969551317	0	0	2.189826655299801	7.176880713678286	PRDM8;MAPK10;ATXN2;KCNC1;GLDC;ATP13A2;PLCB1;LMNB2
Involuntary jerking movements	8/123	0.03772720244126727	0.4822792969551317	0	0	2.189826655299801	7.176880713678286	PRDM8;MAPK10;ATXN2;KCNC1;GLDC;ATP13A2;PLCB1;LMNB2
Dyslexia	6/80	0.03779472044636772	0.4822792969551317	0	0	2.5494321683246763	8.350883953543548	RIMS2;CNTNAP2;LRRTM1;DIP2A;HMGB1;KIAA0319L
Gastrointestinal Stromal Sarcoma	5/60	0.0380550635897647	0.48440534145789155	0	0	2.8566149297856613	9.337477570602584	IFT172;SUFU;B9D1;HIPK2;TMEM231
Severe Combined Immunodeficiency	12/217	0.038547992516238694	0.48947426369513897	0	0	1.8461168164313222	6.010681753902789	SOX1;CDH3;CHD7;ERBB2;ACTN4;FADD;TP53;LDLR;ACTB;PDLIM7;MTOR;TAPBP
Polydactyly	9/147	0.0397588761888673	0.5028341341206822	0	0	2.0538675016010814	6.6235628246712075	BBS2;BBS1;FRAS1;IFT172;SUFU;TMEM67;TMEM107;B9D1;TMEM231
Congenital ear anomaly NOS (disorder)	6/81	0.03979472926767783	0.5028341341206822	0	0	2.5153094462540717	8.10940998805474	FRAS1;TPM2;PEX6;CHD7;TP53;PEX26
Bile duct carcinoma	5/61	0.04043873039010188	0.5035108627888142	0	0	2.805458768873403	8.999819936569585	MAGED4B;ERBB2;AKT1;TP53;LDLR
Ganglioglioma	5/61	0.04043873039010188	0.5035108627888142	0	0	2.805458768873403	8.999819936569585	GRM5;SGSM3;SYP;TP53;MTOR
Cervical intraepithelial neoplasia grade 2	4/42	0.040443756877146506	0.5035108627888142	0	0	3.3051948051948052	10.602545983508287	MSI1;MTR;FHIT;TP53
Disease due to Parvoviridae	4/42	0.040443756877146506	0.5035108627888142	0	0	3.3051948051948052	10.602545983508287	RIMS2;AIMP2;YWHAZ;TP53
Other ureteric obstruction	4/42	0.040443756877146506	0.5035108627888142	0	0	3.3051948051948052	10.602545983508287	CFL1;KEAP1;AKT1;MTOR
Hypospadias	11/195	0.041082320755331816	0.5035108627888142	0	0	1.8843792389519527	6.015272823305441	RERE;SETD5;FRAS1;BNC2;PDE4D;PEX6;KCNMA1;DNAH6;HCCS;PEX26;ARCN1
Abnormality of the clavicle	3/25	0.04110222651709429	0.5035108627888142	0	0	4.278326211875645	13.655103761330556	IDUA;IFT172;CHD4
Abnormality of the liver	3/25	0.04110222651709429	0.5035108627888142	0	0	4.278326211875645	13.655103761330556	JAG1;PEX6;PEX26
CNS metastases	3/25	0.04110222651709429	0.5035108627888142	0	0	4.278326211875645	13.655103761330556	ERBB2;AKT1;TP53
Lymphomatoid Papulosis	3/25	0.04110222651709429	0.5035108627888142	0	0	4.278326211875645	13.655103761330556	FCGRT;TYK2;PDLIM7
Malignant lymphoma - lymphoplasmacytic	3/25	0.04110222651709429	0.5035108627888142	0	0	4.278326211875645	13.655103761330556	SLC35B2;BCL9;CCND3
Pulmonary Sclerosing Hemangioma	3/25	0.04110222651709429	0.5035108627888142	0	0	4.278326211875645	13.655103761330556	PSMD7;ERBB2;TP53
Death in infancy	7/103	0.04111485760388537	0.5035108627888142	0	0	2.29384176182708	7.320533851642352	GLDC;IDUA;PEX6;ERCC1;HDAC6;PEX26;PLEC
Spinal Muscular Atrophy	11/196	0.04236620250065553	0.5052331455958086	0	0	1.8740957706474948	5.924774513094941	HDAC4;MAPK10;AIMP2;ATXN2;HEXA;AKT1;VPS54;TP53;HDAC9;ACVR2B;ACTB
Amyloidosis	35/833	0.0428240263049472	0.5052331455958086	0	0	1.393162393162393	4.389375413473173	DPP10;RPAIN;CHRM3;TACSTD2;HMGB1;HDAC6;LMNB1;RIMS2;NT5C;GRM5;ATCAY;FCGRT;MAP2;HSF1;ERBB2;RPS27A;LDLR;SYBU;ANKS1B;SORT1;INSR;SYVN1;ZDHHC12;SYP;TYK2;HOOK3;YWHAZ;PPP1CA;AIMP2;NFIC;PPP1R1B;SDC1;SCG3;GAPDH;TP53
Hereditary Malignant Neoplasm	5/62	0.042910990960339665	0.5052331455958086	0	0	2.7560975609756095	8.677923984247657	TEP1;CAPN10;ERBB2;XYLT2;TP53
Death in early childhood	7/104	0.04295755991602435	0.5052331455958086	0	0	2.270076184389768	7.1451615622841045	GLDC;IDUA;PEX6;ERCC1;HDAC6;PEX26;PLEC
Short stature	32/750	0.04309777211742017	0.5052331455958086	0	0	1.4145112083830746	4.447624923872894	HDAC4;RERE;SETD5;CTBP1;IDUA;IFT172;FLII;CHD7;HCCS;CHD4;HDAC6;ACTB;PEX26;SOX3;CDH3;NPHP1;OTX2;BBS2;BBS1;MBD5;RSPH4A;TPM2;INSR;PDE4D;SHROOM4;MAF;PEX6;ERCC1;OGDH;TUBGCP6;ALDOA;PLEC
Recurrent Endometrial Cancer	2/11	0.04384274921970644	0.5052331455958086	0	0	6.965480043149946	21.782072553536885	ERBB2;TP53
Respiratory insufficiency due to defective ciliary clearance	2/11	0.04384274921970644	0.5052331455958086	0	0	6.965480043149946	21.782072553536885	HYDIN;LRRC6
Retinoschisis	2/11	0.04384274921970644	0.5052331455958086	0	0	6.965480043149946	21.782072553536885	FNDC3A;ACTB
DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST	2/11	0.04384274921970644	0.5052331455958086	0	0	6.965480043149946	21.782072553536885	AKT2;INSR
INSULIN RESISTANCE, SUSCEPTIBILITY TO	2/11	0.04384274921970644	0.5052331455958086	0	0	6.965480043149946	21.782072553536885	AKT2;INSR
Thick nasal alae	2/11	0.04384274921970644	0.5052331455958086	0	0	6.965480043149946	21.782072553536885	INSR;SMARCA2
Congenital atresia of nasopharynx	2/11	0.04384274921970644	0.5052331455958086	0	0	6.965480043149946	21.782072553536885	DNAH5;DNAI1
Dysostoses	2/11	0.04384274921970644	0.5052331455958086	0	0	6.965480043149946	21.782072553536885	PDE4D;ACTB
Immunoproliferative Small Intestinal Disease	2/11	0.04384274921970644	0.5052331455958086	0	0	6.965480043149946	21.782072553536885	SDC1;TP53
Large face	2/11	0.04384274921970644	0.5052331455958086	0	0	6.965480043149946	21.782072553536885	IDUA;FLII
Lipoatrophic Diabetes Mellitus	2/11	0.04384274921970644	0.5052331455958086	0	0	6.965480043149946	21.782072553536885	INSR;AGPAT2
Microglossia	2/11	0.04384274921970644	0.5052331455958086	0	0	6.965480043149946	21.782072553536885	OTX2;LMNB2
Oral mucosal blisters	2/11	0.04384274921970644	0.5052331455958086	0	0	6.965480043149946	21.782072553536885	JUP;PLEC
Other specified congenital malformations of respiratory system	2/11	0.04384274921970644	0.5052331455958086	0	0	6.965480043149946	21.782072553536885	DNAH5;DNAI1
Pili Torti	2/11	0.04384274921970644	0.5052331455958086	0	0	6.965480043149946	21.782072553536885	CDH3;PEX6
Pulmonary Blastoma	2/11	0.04384274921970644	0.5052331455958086	0	0	6.965480043149946	21.782072553536885	ERBB2;TP53
Van der Woude syndrome	6/83	0.04399282421016135	0.5052331455958086	0	0	2.449722915520961	7.652269887264748	RIMS2;AIMP2;PSMD12;KEAP1;HMGB1;RELA
Chubby cheeks	6/83	0.04399282421016135	0.5052331455958086	0	0	2.449722915520961	7.652269887264748	IDUA;TMEM67;TMEM107;B9D1;ACTB;TMEM231
Full cheeks	6/83	0.04399282421016135	0.5052331455958086	0	0	2.449722915520961	7.652269887264748	IDUA;TMEM67;TMEM107;B9D1;ACTB;TMEM231
Gait Ataxia	6/83	0.04399282421016135	0.5052331455958086	0	0	2.449722915520961	7.652269887264748	ATCAY;CHAMP1;ATP1A3;SPG7;LMNB2;ARCN1
Hyperplasia of cheeks	6/83	0.04399282421016135	0.5052331455958086	0	0	2.449722915520961	7.652269887264748	IDUA;TMEM67;TMEM107;B9D1;ACTB;TMEM231
Hypertrophy of cheeks	6/83	0.04399282421016135	0.5052331455958086	0	0	2.449722915520961	7.652269887264748	IDUA;TMEM67;TMEM107;B9D1;ACTB;TMEM231
Puffy cheeks	6/83	0.04399282421016135	0.5052331455958086	0	0	2.449722915520961	7.652269887264748	IDUA;TMEM67;TMEM107;B9D1;ACTB;TMEM231
Congenital clubfoot	11/198	0.04501645088500666	0.5114712764431482	0	0	1.8538587848932677	5.7483105090614846	CHRM3;FRAS1;CTBP1;TPM2;CHMP1A;COG1;B9D1;SMARCA2;GDAP1;SHROOM4;PEX26
Bipolar Disorder	35/837	0.04530956771687418	0.5114712764431482	0	0	1.3859155529978473	4.288351267386352	DPP10;RERE;CHRM3;CNTNAP2;GABRB1;MIR137HG;DIXDC1;ATP1A3;ADCY2;MTR;CPLX2;SLC5A3;HDAC9;ACTB;GRM5;MAP2;LRRTM4;AKT2;NDST3;ERBB2;SLIT1;AKT1;OTX2;PRKCI;MBD5;LINC00271;FNDC3A;SYP;YWHAZ;CACNB2;BCL9;MAU2;PPP1R1B;CNTN4;PLCB1
Dystonia, Limb	3/26	0.04542672521041118	0.5114712764431482	0	0	4.092100627158058	12.651362079968454	ATP1A3;ACTB;ANO3
Septo-Optic Dysplasia	3/26	0.04542672521041118	0.5114712764431482	0	0	4.092100627158058	12.651362079968454	SOX3;CHD7;OTX2
Spasmodic torticollis	3/26	0.04542672521041118	0.5114712764431482	0	0	4.092100627158058	12.651362079968454	ATP1A3;ATP13A2;ANO3
Capuchin ears	3/26	0.04542672521041118	0.5114712764431482	0	0	4.092100627158058	12.651362079968454	MBD5;FRAS1;CHD4
Cupped ears (finding)	3/26	0.04542672521041118	0.5114712764431482	0	0	4.092100627158058	12.651362079968454	MBD5;FRAS1;CHD4
Increased drug resistance	3/26	0.04542672521041118	0.5114712764431482	0	0	4.092100627158058	12.651362079968454	ERBB2;AKT1;PDLIM7
Malignant Uterine Corpus Neoplasm	3/26	0.04542672521041118	0.5114712764431482	0	0	4.092100627158058	12.651362079968454	ERBB2;TP53;MTOR
Ependymoma	8/128	0.04594019045593722	0.5144807671659528	0	0	2.0980392156862746	6.462831336262979	EPB41;MAP2;BCL7C;ERBB2;FOXJ1;SYP;TP53;RELA
Situs Inversus	6/84	0.04619177166505459	0.5144807671659528	0	0	2.418190929591581	7.435824902608209	SESN1;DNAH5;LRRC6;OTX2;DNAI1;ACVR2B
Sloping forehead	6/84	0.04619177166505459	0.5144807671659528	0	0	2.418190929591581	7.435824902608209	SUFU;TMEM67;TMEM107;TUBGCP6;B9D1;TMEM231
Soft Tissue Neoplasms	6/84	0.04619177166505459	0.5144807671659528	0	0	2.418190929591581	7.435824902608209	AKT2;FLII;CREB3L2;ERBB2;AKT1;TP53
Kyphoscoliosis deformity of spine	6/84	0.04619177166505459	0.5144807671659528	0	0	2.418190929591581	7.435824902608209	SUFU;TPM2;ERCC1;AKT1;GDAP1;ACTB
Liposarcoma, Myxoid	4/44	0.04676534790485642	0.5153162430112963	0	0	3.1396103896103895	9.6154109024845	CREB3L2;TCF12;AKT1;MTOR
Strawberry nevus of skin	4/44	0.04676534790485642	0.5153162430112963	0	0	3.1396103896103895	9.6154109024845	JAG1;AKT1;TP53;MTOR
Abnormal form of the vertebral bodies	4/44	0.04676534790485642	0.5153162430112963	0	0	3.1396103896103895	9.6154109024845	CTBP1;FLII;PDE4D;AKT1
Amelogenesis Imperfecta	4/44	0.04676534790485642	0.5153162430112963	0	0	3.1396103896103895	9.6154109024845	FAM83H;PEX6;ROGDI;PEX26
Neoplasm of uncertain or unknown behavior of breast	4/44	0.04676534790485642	0.5153162430112963	0	0	3.1396103896103895	9.6154109024845	AKT2;ERBB2;AKT1;TP53
Rett Syndrome	8/129	0.047712571559653826	0.5234314730276644	0	0	2.0805920164208933	6.330326796788655	RIMS2;SOX3;MBD5;MAP2;AKT1;LDLR;ACTB;HDAC6
Endometrial adenocarcinoma	8/129	0.047712571559653826	0.5234314730276644	0	0	2.0805920164208933	6.330326796788655	TMEM54;ERBB2;AKT1;SHBG;RHOC;TP53;EBAG9;ACTB
Small nose	10/176	0.047961161947540444	0.5234314730276644	0	0	1.8974916057673317	5.763372165562075	SETD5;MBD5;MAF;PIGO;FLII;PDE4D;PEX6;ACTB;HDAC6;MTOR
Smooth philtrum	5/64	0.04812275946748382	0.5234314730276644	0	0	2.6623949290340363	8.077706331775522	ALG9;MAF;COG1;SMARCA2;MTOR
Synophrys	5/64	0.04812275946748382	0.5234314730276644	0	0	2.6623949290340363	8.077706331775522	SETD5;MBD5;FLII;UBE2A;SGSH
Oligohydramnios	5/64	0.04812275946748382	0.5234314730276644	0	0	2.6623949290340363	8.077706331775522	CHRM3;TMEM67;TMEM107;B9D1;TMEM231
Microstomia	7/107	0.0488024913565274	0.5234314730276644	0	0	2.20163132137031	6.648869161069657	RERE;MAF;TPM2;CHD7;AKT1;OTX2;KCNAB2
Hyperreflexia	15/301	0.04905456997944007	0.5234314730276644	0	0	1.6552620932786222	4.99032045456851	PRDM8;CHRNB2;GLDC;SPG7;PEX26;LMNB1;DSTYK;NDUFS8;TMEM67;PEX6;ERCC1;CHMP1A;ATP13A2;PLCB1;CCT5
Cervical Squamous Cell Carcinoma	9/153	0.049101581218802766	0.5234314730276644	0	0	1.9676759410801965	5.930307762476242	TMEM54;AKT2;ERBB2;KEAP1;AKT1;SSSCA1;HMGB1;TP53;FHIT
Cardiac Arrest	11/201	0.04920120410288297	0.5234314730276644	0	0	1.8243021346469623	5.494501000600806	RHBDF1;HDAC4;CACNB2;ATXN2;PDXK;ERBB2;SSSCA1;CAPN1;TP53;YWHAZ;LY6E
Intrahepatic Cholangiocarcinoma	10/177	0.04949320797568081	0.5234314730276644	0	0	1.8860312162560127	5.669258635648503	CAPNS1;TEP1;ERBB2;AKT1;SDC1;HMGB1;TP53;FHIT;EBAG9;PDLIM7
Thymic Lymphoma	3/27	0.04996688318907989	0.5234314730276644	0	0	3.9213938411669367	11.75004422898395	RIMS2;AKT1;TP53
Aphasia	3/27	0.04996688318907989	0.5234314730276644	0	0	3.9213938411669367	11.75004422898395	SMARCA2;ACTB;PLEC
Extraskeletal Myxoid Chondrosarcoma	3/27	0.04996688318907989	0.5234314730276644	0	0	3.9213938411669367	11.75004422898395	MAP2;TCF12;TP53
Mucopolysaccharidoses	3/27	0.04996688318907989	0.5234314730276644	0	0	3.9213938411669367	11.75004422898395	IDUA;TP53;SGSH
gallbladder neoplasm	4/45	0.05012004451210511	0.5234314730276644	0	0	3.062876148242002	9.168212111254775	ERBB2;KEAP1;CNTN4;TP53
Lipoatrophy	4/45	0.05012004451210511	0.5234314730276644	0	0	3.062876148242002	9.168212111254775	INSR;AGPAT2;ACTB;LMNB2
Myxoid/Round Cell Liposarcoma	4/45	0.05012004451210511	0.5234314730276644	0	0	3.062876148242002	9.168212111254775	TCF12;HCCS;TP53;MTOR
Muscle hypotonia	21/460	0.05084170774649292	0.5234314730276644	0	0	1.5126235449363215	4.50616338704878	HDAC4;RERE;CEP104;MBD5;ALG9;GLDC;IDUA;FLII;TPM2;HEXA;CHD7;COG1;KCNAB2;GABRG2;PEX26;TMEM231;TMEM67;PEX6;ERCC1;NPHP1;B9D1
Open mouth (finding)	5/65	0.05086276961983915	0.5234314730276644	0	0	2.6178861788617884	7.79769877103748	MBD5;PDE4D;FLII;CHAMP1;AKT1
CRANIOSYNOSTOSIS, TYPE 2	2/12	0.0515531385005962	0.5234314730276644	0	0	6.268608414239482	18.587315267374738	ERCC8;TP53
Stage IV Colorectal Cancer	2/12	0.0515531385005962	0.5234314730276644	0	0	6.268608414239482	18.587315267374738	TP53;ACTB
Tay-Sachs Disease	2/12	0.0515531385005962	0.5234314730276644	0	0	6.268608414239482	18.587315267374738	FCGRT;HEXA
Abnormal lung lobation	2/12	0.0515531385005962	0.5234314730276644	0	0	6.268608414239482	18.587315267374738	ALG9;AKT1
Abnormality of the nasolacrimal system	2/12	0.0515531385005962	0.5234314730276644	0	0	6.268608414239482	18.587315267374738	PEX6;HCCS
Urologic Neoplasms	2/12	0.0515531385005962	0.5234314730276644	0	0	6.268608414239482	18.587315267374738	FHIT;TP53
Breast cancer stage II	2/12	0.0515531385005962	0.5234314730276644	0	0	6.268608414239482	18.587315267374738	ERBB2;TP53
Cheilitis	2/12	0.0515531385005962	0.5234314730276644	0	0	6.268608414239482	18.587315267374738	TRAF3IP2;TP53
Childhood Absence Epilepsy	2/12	0.0515531385005962	0.5234314730276644	0	0	6.268608414239482	18.587315267374738	EFHC1;GABRG2
Gangliosidosis GM1	2/12	0.0515531385005962	0.5234314730276644	0	0	6.268608414239482	18.587315267374738	NFIC;HEXA
Gastric adenoma	2/12	0.0515531385005962	0.5234314730276644	0	0	6.268608414239482	18.587315267374738	ERBB2;TP53
Generalized neonatal hypotonia	2/12	0.0515531385005962	0.5234314730276644	0	0	6.268608414239482	18.587315267374738	PEX6;PEX26
Generalized tonic seizures	2/12	0.0515531385005962	0.5234314730276644	0	0	6.268608414239482	18.587315267374738	GNAO1;MAPK10
Hypoglycemic seizures	2/12	0.0515531385005962	0.5234314730276644	0	0	6.268608414239482	18.587315267374738	AKT2;INSR
Keratocystic Odontogenic Tumor	2/12	0.0515531385005962	0.5234314730276644	0	0	6.268608414239482	18.587315267374738	SUFU;TP53
Malignant neoplasm of anus	2/12	0.0515531385005962	0.5234314730276644	0	0	6.268608414239482	18.587315267374738	TP53;MTOR
Neuropil Threads	2/12	0.0515531385005962	0.5234314730276644	0	0	6.268608414239482	18.587315267374738	MAP2;SYBU
Non-small cell lung cancer recurrent	2/12	0.0515531385005962	0.5234314730276644	0	0	6.268608414239482	18.587315267374738	ERBB2;TP53
Progeroid facial appearance	2/12	0.0515531385005962	0.5234314730276644	0	0	6.268608414239482	18.587315267374738	ERCC8;LMNB2
PTEN Hamartoma Tumor Syndrome	2/12	0.0515531385005962	0.5234314730276644	0	0	6.268608414239482	18.587315267374738	AKT1;MTOR
Short nose	10/179	0.0526547135027155	0.5335677634941837	0	0	1.8635173149675042	5.486194079269418	SETD5;MBD5;MAF;PIGO;FLII;PDE4D;PEX6;ACTB;HDAC6;MTOR
Single tumor	4/46	0.05360340815796256	0.5367160915813256	0	0	2.989795918367347	8.748569285426848	ERBB2;AKT1;TP53;HIPK2
Infiltrating Cervical Carcinoma	4/46	0.05360340815796256	0.5367160915813256	0	0	2.989795918367347	8.748569285426848	GNAO1;ERBB2;TP53;ACTB
Round face	5/66	0.05369237990471079	0.5367160915813256	0	0	2.574836731973877	7.530069311275634	HDAC4;PDE4D;PEX6;TMEM67;AKT1
Round, full face	5/66	0.05369237990471079	0.5367160915813256	0	0	2.574836731973877	7.530069311275634	HDAC4;PDE4D;PEX6;TMEM67;AKT1
Wide spaced nipples	5/66	0.05369237990471079	0.5367160915813256	0	0	2.574836731973877	7.530069311275634	HDAC4;FRAS1;CHD7;UBE2A;SMARCA2
Cleft palate with cleft lip	5/66	0.05369237990471079	0.5367160915813256	0	0	2.574836731973877	7.530069311275634	DLG1;ACSS2;CHD7;MTR;ACTB
Dentatorubral-Pallidoluysian Atrophy	5/66	0.05369237990471079	0.5367160915813256	0	0	2.574836731973877	7.530069311275634	PRDM8;ATXN2;KCNC1;LMNB2;LY6E
Seborrheic keratosis	3/28	0.054718781176893	0.5438205021580443	0	0	3.764343598055105	10.937482065641639	TEP1;AKT1;TP53
Liposarcoma, well differentiated	3/28	0.054718781176893	0.5438205021580443	0	0	3.764343598055105	10.937482065641639	AKT2;AKT1;TP53
Centronuclear myopathy	3/28	0.054718781176893	0.5438205021580443	0	0	3.764343598055105	10.937482065641639	TPM2;AMPH;WASL
Hypogonadism	11/205	0.055179840888760746	0.5473501299675922	0	0	1.7863152370795456	5.175236753832526	BBS2;BBS1;IFT172;PDE4D;PEX6;ERCC1;NPHP1;CHD7;ERCC8;PDE6B;SHBG
Meningioma	20/438	0.055554643401458714	0.5500122549784265	0	0	1.5121212121212122	4.37061727341074	EIF5A;JAG1;EPB41;LMO4;MTR;TYK2;NDRG2;YWHAZ;MTOR;ACTB;TCN2;MDK;DPP9;SUFU;KCNMA1;CFL1;ERBB2;IGF2BP1;AKT1;TP53
Chordoma	6/88	0.05566127953946143	0.5500143263096303	0	0	2.2997537141495195	6.642770840288154	HDAC4;ERBB2;AKT1;TP53;FHIT;MTOR
Attention deficit hyperactivity disorder	19/412	0.05628264214446361	0.5529612567905902	0	0	1.52736533258818	4.3947938145675645	CHRNB2;RERE;SETD5;CNTNAP2;FLII;PDE4D;MIR137HG;CHD7;ADCY2;SYP;SPG7;CPLX2;DHTKD1;CACNB2;GRM5;ZBBX;PPP1R1B;ERBB2;AKT1
Cervical Adenocarcinoma	5/67	0.05661161524619055	0.5529612567905902	0	0	2.5331759769210596	7.274118927368506	TMEM54;ERBB2;SDC1;TP53;MTOR
Congenital Hypothyroidism	5/67	0.05661161524619055	0.5529612567905902	0	0	2.5331759769210596	7.274118927368506	SOX3;JAG1;PDE4D;CHD7;OTX2
Rhinovirus infection	4/47	0.05721476027620653	0.5529612567905902	0	0	2.9201147689519784	8.354282979397787	AIMP2;LDLR;EIF4G3;RELA
Abnormality of the outer ear	4/47	0.05721476027620653	0.5529612567905902	0	0	2.9201147689519784	8.354282979397787	FRAS1;PEX6;CHD7;PEX26
Muscular Atrophy	4/47	0.05721476027620653	0.5529612567905902	0	0	2.9201147689519784	8.354282979397787	CFL1;HSF1;AKT1;MTOR
Skin Carcinogenesis	8/134	0.057239142321611244	0.5529612567905902	0	0	1.997510115157174	5.713912257922052	PSME3;STAT2;ERCC1;ERBB2;AKT1;SDC1;HMGB1;TP53
Hydronephrosis	7/111	0.057346480891726205	0.5529612567905902	0	0	2.1165139917179068	6.050359598444279	CHRM3;DLG1;PEX6;CHD7;ACTB;PEX26;PLEC
Retinal Degeneration	6/89	0.05819823971594113	0.5529612567905902	0	0	2.2719281032926495	6.461136719483256	BBS2;BBS1;IFT172;TMEM67;NPHP1;PDE6B
Charcot-Marie-Tooth Disease, Type Ia (disorder)	3/29	0.059678116583906315	0.5529612567905902	0	0	3.6193741428749533	10.202255213706524	LRSAM1;CADM4;ERBB2
Stippled epiphyses	3/29	0.059678116583906315	0.5529612567905902	0	0	3.6193741428749533	10.202255213706524	PDE4D;PEX6;PEX26
Torticollis	3/29	0.059678116583906315	0.5529612567905902	0	0	3.6193741428749533	10.202255213706524	ATP1A3;ATP13A2;ANO3
Childhood Brain Neoplasm	3/29	0.059678116583906315	0.5529612567905902	0	0	3.6193741428749533	10.202255213706524	ERBB2;OTX2;TP53
Gall Bladder Diseases	3/29	0.059678116583906315	0.5529612567905902	0	0	3.6193741428749533	10.202255213706524	ERBB2;TP53;EBAG9
Methylmalonic aciduria	3/29	0.059678116583906315	0.5529612567905902	0	0	3.6193741428749533	10.202255213706524	ABCD4;TCN2;MTR
Paget Disease Extramammary	3/29	0.059678116583906315	0.5529612567905902	0	0	3.6193741428749533	10.202255213706524	ERBB2;AKT1;TP53
Pigmented Basal Cell Carcinoma	3/29	0.059678116583906315	0.5529612567905902	0	0	3.6193741428749533	10.202255213706524	SUFU;ERBB2;TP53
Breast Cancer, Familial Male	2/13	0.05970440814418524	0.5529612567905902	0	0	5.698440717858194	16.06019710945133	ERBB2;AKT1
Stage IV Colorectal Cancer AJCC v7	2/13	0.05970440814418524	0.5529612567905902	0	0	5.698440717858194	16.06019710945133	TP53;ACTB
Status Dysraphicus	2/13	0.05970440814418524	0.5529612567905902	0	0	5.698440717858194	16.06019710945133	VANGL2;CFL1
Other specified congenital malformation syndromes, not elsewhere classified in ICD10CM	2/13	0.05970440814418524	0.5529612567905902	0	0	5.698440717858194	16.06019710945133	BBS2;BBS1
Reticuloendotheliosis, X-linked	2/13	0.05970440814418524	0.5529612567905902	0	0	5.698440717858194	16.06019710945133	TP53;RELA
TUBEROUS SCLEROSIS 1 (disorder)	2/13	0.05970440814418524	0.5529612567905902	0	0	5.698440717858194	16.06019710945133	TP53;MTOR
Abnormally small eyeball on both sides	2/13	0.05970440814418524	0.5529612567905902	0	0	5.698440717858194	16.06019710945133	FRAS1;ERCC1
Bilateral nanophthalmos	2/13	0.05970440814418524	0.5529612567905902	0	0	5.698440717858194	16.06019710945133	FRAS1;ERCC1
Canine Osteosarcoma	2/13	0.05970440814418524	0.5529612567905902	0	0	5.698440717858194	16.06019710945133	TP53;ACTB
Cholera Infantum	2/13	0.05970440814418524	0.5529612567905902	0	0	5.698440717858194	16.06019710945133	KEAP1;MTR
Congenital absence of liver	2/13	0.05970440814418524	0.5529612567905902	0	0	5.698440717858194	16.06019710945133	JAG1;TP53
Currarino triad	2/13	0.05970440814418524	0.5529612567905902	0	0	5.698440717858194	16.06019710945133	GDF11;VANGL2
Delayed eruption of primary teeth	2/13	0.05970440814418524	0.5529612567905902	0	0	5.698440717858194	16.06019710945133	FLII;ERCC8
Gastrointestinal hamartomatous polyps	2/13	0.05970440814418524	0.5529612567905902	0	0	5.698440717858194	16.06019710945133	AKT1;TP53
Hypoglycemic coma	2/13	0.05970440814418524	0.5529612567905902	0	0	5.698440717858194	16.06019710945133	INSR;AKT2
Malignant Mixed Mesodermal (Mullerian) Tumor	2/13	0.05970440814418524	0.5529612567905902	0	0	5.698440717858194	16.06019710945133	ERBB2;TP53
Micropapillary carcinoma	2/13	0.05970440814418524	0.5529612567905902	0	0	5.698440717858194	16.06019710945133	ERBB2;TP53
Primary chondrosarcoma of bone	2/13	0.05970440814418524	0.5529612567905902	0	0	5.698440717858194	16.06019710945133	TP53;MTOR
Gallbladder Carcinoma	12/233	0.05994164051270949	0.5534284493581424	0	0	1.7110323886639676	4.81550191843786	AKT2;SGSM3;ERBB2;KEAP1;AKT1;FADD;NDRG2;SHBG;TP53;CLIC1;FHIT;HDAC9
Ataxia	11/208	0.05996902702023215	0.5534284493581424	0	0	1.7588374050828104	4.9492401795153285	ATXN2;ATCAY;KCNC1;ATP1A3;CAPN1;SPG7;TP53;LMNB2;ARCN1;LY6E;LMNB1
Sleep Disorders	4/48	0.060953248061425616	0.5585219609600134	0	0	2.853600944510035	7.983371357261893	CHRNB2;GNAO1;ATXN2;LY6E
Underdeveloped brows	4/48	0.060953248061425616	0.5585219609600134	0	0	2.853600944510035	7.983371357261893	JAG1;PEX6;TCF12;PEX26
Underdeveloped supraorbital ridges	4/48	0.060953248061425616	0.5585219609600134	0	0	2.853600944510035	7.983371357261893	JAG1;PEX6;TCF12;PEX26
Manic Disorder	4/48	0.060953248061425616	0.5585219609600134	0	0	2.853600944510035	7.983371357261893	DIXDC1;ATP1A3;CPLX2;SLC5A3
Adenocarcinoma, Clear Cell	7/113	0.061944392103601344	0.5665993245865695	0	0	2.0763643079196035	5.775445108049583	ERBB2;AKT1;SDC1;CAPN1;ACTN4;TP53;MTOR
Creatinine measurement, serum (procedure)	5/69	0.06271862117870079	0.5726675516811407	0	0	2.453760162601626	6.794699627556546	SORT1;CHMP1A;PIP5K1B;RHOC;DNAJC16
Waist Circumference	6/91	0.06347657761934662	0.5785660549149618	0	0	2.218241042345277	6.115877545955652	AGBL4;FER;ZNRF3;SUFU;GDAP1;MAP2K5
Adenomatous Polyposis Coli	18/392	0.0639600705896095	0.5819465577589821	0	0	1.5194805194805194	4.177806047034464	FZD3;CTBP1;CTNNBIP1;MSI1;FHIT;YWHAZ;MTOR;ACTB;RELA;HIPK2;FER;SGSM3;HSF1;ERBB2;AKT1;LDLR;TP53;ANKS1B
Head and Neck Carcinoma	7/114	0.06432536786660065	0.5837881185066021	0	0	2.0568523120550077	5.643593846062933	MAGED4B;JAG1;ERCC1;ERBB2;SDC1;TP53;FHIT
Serum cholesterol raised	3/30	0.06484024381245929	0.5837881185066021	0	0	3.485143165856294	9.534755121614541	JAG1;FLII;LDLR
Thymic Carcinoma	3/30	0.06484024381245929	0.5837881185066021	0	0	3.485143165856294	9.534755121614541	ERBB2;HMGB1;TP53
Tongue Neoplasms	3/30	0.06484024381245929	0.5837881185066021	0	0	3.485143165856294	9.534755121614541	ERBB2;KEAP1;TP53
TUBEROUS SCLEROSIS 2 (disorder)	3/30	0.06484024381245929	0.5837881185066021	0	0	3.485143165856294	9.534755121614541	AKT1;TP53;MTOR
Prostatic Hypertrophy	3/30	0.06484024381245929	0.5837881185066021	0	0	3.485143165856294	9.534755121614541	ERBB2;HMGB1;TP53
Collecting Duct Carcinoma of the Kidney	8/138	0.0656706781336061	0.5879625927735262	0	0	1.9356460532931121	5.270963095489609	KCNMA1;ERBB2;KEAP1;AKT1;TP53;SLC5A3;RELA;MTOR
Hereditary pancreatitis	5/70	0.06590600652272917	0.5879625927735262	0	0	2.41588492808005	6.5700611395434905	ERCC1;SGSM3;ERBB2;SYP;TP53
Sensory hearing loss	2/14	0.068261910925719	0.5879625927735262	0	0	5.223300970873787	14.021446577709218	FADD;ACTB
Skin tag	2/14	0.068261910925719	0.5879625927735262	0	0	5.223300970873787	14.021446577709218	SUFU;AKT1
Opitz-G syndrome, type 2	2/14	0.068261910925719	0.5879625927735262	0	0	5.223300970873787	14.021446577709218	SGSM3;SYBU
Very long chain fatty acid accumulation	2/14	0.068261910925719	0.5879625927735262	0	0	5.223300970873787	14.021446577709218	PEX6;PEX26
Zellweger-Like Syndrome	2/14	0.068261910925719	0.5879625927735262	0	0	5.223300970873787	14.021446577709218	PEX6;PEX26
Anteriorly placed anus	2/14	0.068261910925719	0.5879625927735262	0	0	5.223300970873787	14.021446577709218	CHD4;HCCS
Atony of facial musculature	2/14	0.068261910925719	0.5879625927735262	0	0	5.223300970873787	14.021446577709218	XYLT2;CHAMP1
Benign tumor of pancreas	2/14	0.068261910925719	0.5879625927735262	0	0	5.223300970873787	14.021446577709218	AKT2;TP53
Contralateral breast cancer	2/14	0.068261910925719	0.5879625927735262	0	0	5.223300970873787	14.021446577709218	TMEM135;ERBB2
dowling-degos disease	2/14	0.068261910925719	0.5879625927735262	0	0	5.223300970873787	14.021446577709218	SHBG;TP53
Facial hypotonia	2/14	0.068261910925719	0.5879625927735262	0	0	5.223300970873787	14.021446577709218	XYLT2;CHAMP1
Fibromatosis	2/14	0.068261910925719	0.5879625927735262	0	0	5.223300970873787	14.021446577709218	CHAMP1;GAPDH
Freeman-Sheldon syndrome	2/14	0.068261910925719	0.5879625927735262	0	0	5.223300970873787	14.021446577709218	FRAS1;TPM2
Fulminant Hepatic Failure with Cerebral Edema	2/14	0.068261910925719	0.5879625927735262	0	0	5.223300970873787	14.021446577709218	GABRB1;GABRG2
Hepatic Stupor	2/14	0.068261910925719	0.5879625927735262	0	0	5.223300970873787	14.021446577709218	GABRB1;GABRG2
Hypotonic facies	2/14	0.068261910925719	0.5879625927735262	0	0	5.223300970873787	14.021446577709218	XYLT2;CHAMP1
Lambert-Eaton Myasthenic Syndrome	2/14	0.068261910925719	0.5879625927735262	0	0	5.223300970873787	14.021446577709218	SOX1;PLEC
Limbic Encephalitis	2/14	0.068261910925719	0.5879625927735262	0	0	5.223300970873787	14.021446577709218	CNTNAP2;GRM5
Low Grade Cervical Squamous Intraepithelial Neoplasia	2/14	0.068261910925719	0.5879625927735262	0	0	5.223300970873787	14.021446577709218	FHIT;TP53
Miller Dieker syndrome	2/14	0.068261910925719	0.5879625927735262	0	0	5.223300970873787	14.021446577709218	ABR;TP53
Peripheral arterial stenosis	2/14	0.068261910925719	0.5879625927735262	0	0	5.223300970873787	14.021446577709218	JAG1;LDLR
Pituitary stalk interruption syndrome	2/14	0.068261910925719	0.5879625927735262	0	0	5.223300970873787	14.021446577709218	SOX3;OTX2
Poikiloderma with Neutropenia	2/14	0.068261910925719	0.5879625927735262	0	0	5.223300970873787	14.021446577709218	KCNMA1;TP53
Purpura Fulminans	2/14	0.068261910925719	0.5879625927735262	0	0	5.223300970873787	14.021446577709218	DNAH5;DNAI1
Sudden Cardiac Death	4/50	0.06880739081675882	0.5896099272111311	0	0	2.7292490118577075	7.304682456566231	CACNB2;JUP;CACNA2D1;LDLR
Atypical Ductal Breast Hyperplasia	4/50	0.06880739081675882	0.5896099272111311	0	0	2.7292490118577075	7.304682456566231	ERBB2;AKT1;TP53;LDLR
Cervical Squamous Intraepithelial Neoplasia	4/50	0.06880739081675882	0.5896099272111311	0	0	2.7292490118577075	7.304682456566231	HMGB1;TP53;FHIT;MAP2K5
PARKINSON DISEASE, LATE-ONSET	6/93	0.069027606050775	0.5896099272111311	0	0	2.167022352016174	5.792989829952063	ATXN2;ERBB2;ATP13A2;TP53;SKP1;LY6E
Intraepithelial Neoplasia	6/93	0.069027606050775	0.5896099272111311	0	0	2.167022352016174	5.792989829952063	LMO4;CFL1;ERBB2;TP53;RELA;PDLIM7
Rhabdoid Tumor	5/71	0.06918224970231128	0.5896099272111311	0	0	2.379157427937916	6.3547555571514325	CNTNAP2;KCNMA1;SYP;TP53;SMARCA2
Condition, Preneoplastic	7/116	0.06925178518133836	0.5896099272111311	0	0	2.0189023751440502	5.390482172677944	CCDC134;DPP10;CFL1;AKT1;MIR92B;TP53;TTLL9
Childhood Ataxia with Central Nervous System Hypomyelinization	3/31	0.07020021207900981	0.5907339589773152	0	0	3.3605001157675387	8.926845771037158	TCN2;MTR;HMGB1
Embryotoxon	3/31	0.07020021207900981	0.5907339589773152	0	0	3.3605001157675387	8.926845771037158	JAG1;PEX6;PEX26
ESTROGEN RESISTANCE	3/31	0.07020021207900981	0.5907339589773152	0	0	3.3605001157675387	8.926845771037158	INSR;ERBB2;AKT1
Impaired pain sensation	3/31	0.07020021207900981	0.5907339589773152	0	0	3.3605001157675387	8.926845771037158	FLII;CHAMP1;CCT5
Large hand	3/31	0.07020021207900981	0.5907339589773152	0	0	3.3605001157675387	8.926845771037158	INSR;PEX6;AGPAT2
Muscle weakness of limb	3/31	0.07020021207900981	0.5907339589773152	0	0	3.3605001157675387	8.926845771037158	TPM2;AMPD3;GDAP1
Myxoma	3/31	0.07020021207900981	0.5907339589773152	0	0	3.3605001157675387	8.926845771037158	AKT1;TYK2;TP53
Rhabdomyosarcoma	18/397	0.07029825556715343	0.5907339589773152	0	0	1.499040138851147	3.9799640025827174	PRKCI;JAG1;LMO4;INSR;HMGB1;HDAC6;MTOR;AIMP2;FCGRT;SUFU;SGSM3;ERBB2;IGF2BP1;AKT1;FADD;TP53;SYBU;PDLIM7
Long narrow head	6/94	0.07190524707429685	0.6002420698027422	0	0	2.1422860527095056	5.639366743550109	JAG1;IDUA;PEX6;CHD7;AKT1;PEX26
Electroencephalogram abnormal	8/141	0.07247306366207283	0.6002420698027422	0	0	1.891690009337068	4.964816705952638	RERE;FLII;PEX6;ERCC1;ROGDI;KCNAB2;GABRG2;PEX26
Cockayne Syndrome	5/72	0.07254695037059017	0.6002420698027422	0	0	2.3435262710836064	6.14829117225777	RIMS2;ERCC1;ERCC8;TP53;SMARCA2
Abnormality of the ribs	4/51	0.07292053327001202	0.6002420698027422	0	0	2.6710417242332136	6.993815628151342	CHRM3;JAG1;IDUA;IFT172
Hypsarrhythmia	4/51	0.07292053327001202	0.6002420698027422	0	0	2.6710417242332136	6.993815628151342	GNAO1;GABRB1;ROGDI;PLCB1
Systolic Pressure	7/118	0.07439769816368576	0.6002420698027422	0	0	1.9823200035271813	5.150722082443796	SEMA5B;CACNB2;INSR;ZNF318;CNTN4;FHIT;HIPK2
Erectile dysfunction	7/118	0.07439769816368576	0.6002420698027422	0	0	1.9823200035271813	5.150722082443796	CHRM3;CFL1;CHD7;KCNMA1;AKT1;SHBG;LMNB1
Clear-cell metastatic renal cell carcinoma	8/142	0.07483212308407415	0.6002420698027422	0	0	1.8774753682567555	4.867369974330641	INSR;ERBB2;AKT1;SSSCA1;ACTN4;NDRG2;FHIT;MTOR
Autistic Disorder	28/677	0.07526850156656816	0.6002420698027422	0	0	1.3650626743847083	3.5309987982218773	RERE;CNTNAP2;GABRB1;CHD7;DIXDC1;MTR;AMBRA1;ACTB;GRM5;MAP2;HYDIN;AKT1;CHRNB2;MBD5;MBD6;PDE4D;FBXO15;KCNAB2;YWHAZ;MTOR;CACNB2;FER;TCN2;KCNMA1;CNTN4;TP53;RAPGEF4;CAPS2
MICROPHTHALMIA, SYNDROMIC 7	3/32	0.0757528008251466	0.6002420698027422	0	0	3.244453138098698	8.371597091178185	ARHGAP1;HCCS;TP53
Zellweger Syndrome	3/32	0.0757528008251466	0.6002420698027422	0	0	3.244453138098698	8.371597091178185	CHRM3;PEX6;PEX26
Hallopeau-Siemens Disease	3/32	0.0757528008251466	0.6002420698027422	0	0	3.244453138098698	8.371597091178185	RIMS2;HMGB1;TP53
Lipomatosis	3/32	0.0757528008251466	0.6002420698027422	0	0	3.244453138098698	8.371597091178185	VANGL2;AKT1;MTOR
Posterior embryotoxon	3/32	0.0757528008251466	0.6002420698027422	0	0	3.244453138098698	8.371597091178185	JAG1;PEX6;PEX26
Prominent metopic ridge	3/32	0.0757528008251466	0.6002420698027422	0	0	3.244453138098698	8.371597091178185	KCNQ1OT1;ERCC1;ACTB
Cystic Kidney Diseases	5/73	0.07599962840335504	0.6002420698027422	0	0	2.3089430894308944	5.9502082861056325	BBS2;BBS1;TMEM67;NPHP1;TMEM231
Difficulty speaking	5/73	0.07599962840335504	0.6002420698027422	0	0	2.3089430894308944	5.9502082861056325	RERE;CHMP1A;KCNAB2;UBE2A;SMARCA2
Infertility	5/73	0.07599962840335504	0.6002420698027422	0	0	2.3089430894308944	5.9502082861056325	SOX3;RSPH1;OTX2;TTC19;CCDC40
Problems speaking	5/73	0.07599962840335504	0.6002420698027422	0	0	2.3089430894308944	5.9502082861056325	RERE;CHMP1A;KCNAB2;UBE2A;SMARCA2
Ataxias, Hereditary	9/167	0.07620325690158376	0.6002420698027422	0	0	1.7920197228034556	4.613287901096783	TSEN34;ATXN2;ATCAY;HEXA;CHMP1A;ATP1A3;SPG7;TTC19;LY6E
Retinal pigment epithelial abnormality	9/167	0.07620325690158376	0.6002420698027422	0	0	1.7920197228034556	4.613287901096783	BBS2;CDH3;IFT172;PEX6;NPHP1;TUBGCP6;HCCS;PDE6B;PEX26
Abnormality of retinal pigmentation	9/167	0.07620325690158376	0.6002420698027422	0	0	1.7920197228034556	4.613287901096783	BBS2;CDH3;IFT172;PEX6;NPHP1;TUBGCP6;HCCS;PDE6B;PEX26
Squamous cell carcinoma	69/1876	0.07635145372763079	0.6002420698027422	0	0	1.2178260183979022	3.132745644655375	CHRM3;LDB1;KEAP1;MSI1;MTR;HMGB1;ACCS;ACTB;SMG6;CCND3;CDH3;SOX1;MAGED4B;NKRF;MDK;AKT2;AKT1;SSSCA1;CAPN1;SYBU;ANKS1B;RHBDF1;PRKCI;LMO4;TPM2;PDE4D;ACTN4;SYP;RHOC;MAU2;SPINT1;RABEP2;TEP1;AMPH;RIN1;GAPDH;TP53;TACSTD2;SEMA3F;NDRG2;FHIT;HDAC9;HDAC6;RELA;WDR66;S100A16;MAP2;HSF1;ERBB2;OTX2;PDLIM7;JAG1;JUP;STAT2;INSR;SYVN1;SMARCA2;MTOR;PPP1CA;RAD52;AGBL4;LRFN2;AIMP2;SGSM3;ERCC1;PPP1R1B;SDC1;PLCH1;EBAG9
Reticular pattern on pulmonary HRCT	2/15	0.07719271799620196	0.6002420698027422	0	0	4.821259646502365	12.34941625858112	DPP9;ATP11A
Carcinoma of urinary bladder, invasive	2/15	0.07719271799620196	0.6002420698027422	0	0	4.821259646502365	12.34941625858112	INSR;AKT1
Stage 0 Breast Carcinoma	2/15	0.07719271799620196	0.6002420698027422	0	0	4.821259646502365	12.34941625858112	ERBB2;TP53
Symmetric Diabetic Proximal Motor Neuropathy	2/15	0.07719271799620196	0.6002420698027422	0	0	4.821259646502365	12.34941625858112	GRM5;INSR
Uterine Corpus Carcinosarcoma	2/15	0.07719271799620196	0.6002420698027422	0	0	4.821259646502365	12.34941625858112	ERBB2;TP53
Absent mandible	2/15	0.07719271799620196	0.6002420698027422	0	0	4.821259646502365	12.34941625858112	HCCS;OTX2
Anterior pituitary hypoplasia	2/15	0.07719271799620196	0.6002420698027422	0	0	4.821259646502365	12.34941625858112	SOX3;OTX2
Asymmetric Diabetic Proximal Motor Neuropathy	2/15	0.07719271799620196	0.6002420698027422	0	0	4.821259646502365	12.34941625858112	GRM5;INSR
COENZYME Q10 DEFICIENCY	2/15	0.07719271799620196	0.6002420698027422	0	0	4.821259646502365	12.34941625858112	COQ4;PDSS2
Congenital absence of mandible	2/15	0.07719271799620196	0.6002420698027422	0	0	4.821259646502365	12.34941625858112	HCCS;OTX2
Curly eyelashes	2/15	0.07719271799620196	0.6002420698027422	0	0	4.821259646502365	12.34941625858112	SETD5;SMARCA2
Cyclocephaly	2/15	0.07719271799620196	0.6002420698027422	0	0	4.821259646502365	12.34941625858112	FRAS1;OTX2
Decreased circulating ACTH level	2/15	0.07719271799620196	0.6002420698027422	0	0	4.821259646502365	12.34941625858112	SOX3;OTX2
Developmental reading disorder	2/15	0.07719271799620196	0.6002420698027422	0	0	4.821259646502365	12.34941625858112	DIP2A;KIAA0319L
Diabetic Amyotrophy	2/15	0.07719271799620196	0.6002420698027422	0	0	4.821259646502365	12.34941625858112	GRM5;INSR
Diabetic Asymmetric Polyneuropathy	2/15	0.07719271799620196	0.6002420698027422	0	0	4.821259646502365	12.34941625858112	GRM5;INSR
Diabetic Autonomic Neuropathy	2/15	0.07719271799620196	0.6002420698027422	0	0	4.821259646502365	12.34941625858112	GRM5;INSR
Diabetic Mononeuropathy	2/15	0.07719271799620196	0.6002420698027422	0	0	4.821259646502365	12.34941625858112	GRM5;INSR
Epithelial cyst	2/15	0.07719271799620196	0.6002420698027422	0	0	4.821259646502365	12.34941625858112	TP53;MTOR
Fast acetylator due to N-acetyltransferase enzyme variant	2/15	0.07719271799620196	0.6002420698027422	0	0	4.821259646502365	12.34941625858112	MTR;TP53
Ground-glass opacification on pulmonary HRCT	2/15	0.07719271799620196	0.6002420698027422	0	0	4.821259646502365	12.34941625858112	DPP9;ATP11A
Hepatic Coma	2/15	0.07719271799620196	0.6002420698027422	0	0	4.821259646502365	12.34941625858112	GABRB1;GABRG2
Honeycomb lung	2/15	0.07719271799620196	0.6002420698027422	0	0	4.821259646502365	12.34941625858112	DPP9;ATP11A
Jacobsen Distal 11q Deletion Syndrome	2/15	0.07719271799620196	0.6002420698027422	0	0	4.821259646502365	12.34941625858112	FLII;TMEM67
Limb-girdle muscular dystrophy type 2A	2/15	0.07719271799620196	0.6002420698027422	0	0	4.821259646502365	12.34941625858112	CAPN5;PLEC
Nevi and Melanomas	2/15	0.07719271799620196	0.6002420698027422	0	0	4.821259646502365	12.34941625858112	TP53;PDLIM7
Supratentorial atrophy	8/143	0.07723703104079403	0.6002420698027422	0	0	1.8634713144517066	4.772119450864698	GNAO1;ROGDI;TUBGCP6;ERCC8;MTR;FADD;PIGG;TTC19
Nasal Polyps	11/219	0.07982725590473104	0.6194403281015766	0	0	1.6648667424529493	4.208600455994053	TRAF3IP2;RNPEP;HYDIN;SDC1;LRRC6;TP53;YWHAZ;DNAI1;RELA;MTOR;TAPBP
Ataxic	3/33	0.08149255282157086	0.6277970663629557	0	0	3.13614262560778	7.863073650095708	ATXN2;ATCAY;LY6E
Harlequin Fetus	3/33	0.08149255282157086	0.6277970663629557	0	0	3.13614262560778	7.863073650095708	JAG1;CAPN1;RELA
Infantile Severe Myoclonic Epilepsy	3/33	0.08149255282157086	0.6277970663629557	0	0	3.13614262560778	7.863073650095708	GAPDH;MTOR;GABRG2
Primary Lesion	3/33	0.08149255282157086	0.6277970663629557	0	0	3.13614262560778	7.863073650095708	RIMS2;ERBB2;TP53
Rous Sarcoma	4/53	0.08151157730834815	0.6277970663629557	0	0	2.5617545719586534	6.422344882684388	RPS27A;GAPDH;LDLR;ACTB
Gastroesophageal reflux disease	12/246	0.08225630907094175	0.6300621273120691	0	0	1.6148785425101215	4.033829635283242	RERE;SETD5;CTBP1;DPP9;FLII;CHD7;CHAMP1;ATP11A;KCNAB2;TP53;KIAA0319L;SHROOM4
Central Nervous System Neoplasms	5/75	0.08316660906335654	0.6300621273120691	0	0	2.24274099883856	5.57749354861438	KAT2A;SGSM3;ERBB2;TP53;HDAC9
Ovarian Cysts	5/75	0.08316660906335654	0.6300621273120691	0	0	2.24274099883856	5.57749354861438	CDH3;AKT2;INSR;ERBB2;AKT1
Gastrointestinal Neoplasms	7/122	0.08534681131083635	0.6300621273120691	0	0	1.912972551244769	4.707887028335776	SPINT1;ERBB2;AKT1;PKP3;FADD;TP53;FHIT
Pilocytic Astrocytoma	7/122	0.08534681131083635	0.6300621273120691	0	0	1.912972551244769	4.707887028335776	SGSM3;ERBB2;AKT1;TP53;LHX9;MTOR;HIPK2
Uranostaphyloschisis	13/274	0.0857798057207884	0.6300621273120691	0	0	1.5688424321611847	3.8530325598459414	CTBP1;CHD7;ACTB;ARCN1;TMEM231;SOX3;FRAS1;SUFU;TMEM67;TMEM107;B9D1;OTX2;TP53
Action Tremor	4/54	0.08598611552084519	0.6300621273120691	0	0	2.5103896103896104	6.1594152385654	ATXN2;ATCAY;AKT1;LY6E
Autistic behavior	4/54	0.08598611552084519	0.6300621273120691	0	0	2.5103896103896104	6.1594152385654	RERE;MAPK10;CNTNAP2;TMEM231
Hepatocellular Adenoma	4/54	0.08598611552084519	0.6300621273120691	0	0	2.5103896103896104	6.1594152385654	AKT1;SHBG;TP53;MTOR
Malignant neoplasm of nasopharynx	4/54	0.08598611552084519	0.6300621273120691	0	0	2.5103896103896104	6.1594152385654	ERCC1;TP53;RELA;PDLIM7
Adrenoleukodystrophy, Neonatal	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	PEX6;PEX26
Gonadal Dysgenesis, 46,XY	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	SOX3;SGSM3
HYPERTRICHOSIS, CONGENITAL GENERALIZED	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	SOX3;ERBB2
Malignant melanoma, metastatic	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	ERBB2;TP53
Nystagmus, End-Position	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	ATXN2;LY6E
Sudden loss of muscle tone	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	MAPK10;GABRG2
Thinking and speaking disturbances	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	SHBG;LDLR
Tubular atrophy	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	TMEM67;NPHP1
Benign neurologic neoplasms	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	AKT1;TP53
BREAST CANCER 3	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	ERBB2;TP53
Chronic rhinitis	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	RSPH4A;DNAI1
Cleft face	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	FRAS1;CHD7
Condyloma	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	ERBB2;TP53
Congenital absence of jaw	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	HCCS;OTX2
Congenital total cataract	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	AGK;LEMD2
Elevated levels of phytanic acid	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	PEX6;PEX26
Growth hormone excess	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	INSR;AGPAT2
Hypotonic seizures	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	MAPK10;GABRG2
Infantile Neuroaxonal Dystrophy	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	ATP13A2;YWHAZ
Lhermitte-Duclos disease	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	AKT1;MTOR
Macroencephaly	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	AKT1;MTOR
Non-small cell carcinoma	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	FHIT;TP53
Orofaciodigital Syndromes	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	TMEM107;TMEM231
Papillary neoplasm	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	AKT1;TP53
Pineal Gland Neoplasm	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	SYP;TP53
Pleuropulmonary blastoma	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	KEAP1;TP53
Rachischisis	2/16	0.08646554593434787	0.6300621273120691	0	0	4.4766527970411465	10.958887488828417	VANGL2;CFL1
nervous system disorder	19/436	0.08667624000107352	0.6300621273120691	0	0	1.437639904715163	3.5158569017435335	ELOVL1;CNTNAP2;JAG1;ATP1A3;MTR;HMGB1;CPLX2;HDAC9;TTC19;HDAC6;MTOR;LMNB1;ATXN2;ATCAY;PEX6;OGDH;AKT1;CAPN1;TP53
Machado-Joseph Disease	5/76	0.08687957070449476	0.6300621273120691	0	0	2.211038589259132	5.402081039453144	ATXN2;PPP1R1B;TP53;SKP1;LY6E
Poor speech	5/76	0.08687957070449476	0.6300621273120691	0	0	2.211038589259132	5.402081039453144	RERE;CHMP1A;KCNAB2;UBE2A;SMARCA2
Tuberous Sclerosis	10/197	0.08714496298451907	0.6300621273120691	0	0	1.6825633383010432	4.105761286452696	GRM5;SPINT1;SGSM3;RAB1B;HEXA;AKT1;SSSCA1;TP53;SYBU;MTOR
Rhabdoid Tumor of the Kidney	3/34	0.0874138052017712	0.6300621273120691	0	0	3.0348198881162753	7.396165784488339	ERBB2;AKT1;TP53
Sarcoma, Spindle Cell	3/34	0.0874138052017712	0.6300621273120691	0	0	3.0348198881162753	7.396165784488339	CHAMP1;SYVN1;TP53
Trigonocephaly	3/34	0.0874138052017712	0.6300621273120691	0	0	3.0348198881162753	7.396165784488339	TCF12;CHD4;ACTB
Cancer of Urinary Tract	3/34	0.0874138052017712	0.6300621273120691	0	0	3.0348198881162753	7.396165784488339	ERBB2;FHIT;TP53
Cholangitis	3/34	0.0874138052017712	0.6300621273120691	0	0	3.0348198881162753	7.396165784488339	PDZD2;TP53;EBAG9
Infant, Small for Gestational Age	13/275	0.08763455977983442	0.6307735444877218	0	0	1.5627727404202876	3.804695009589833	RERE;SETD5;JAG1;CTBP1;INSR;PDE4D;SMARCA2;HDAC6;ARCN1;ERCC1;TUBGCP6;ERCC8;PIGG
Gastric Adenocarcinoma	17/383	0.08910400545901373	0.6404582756775841	0	0	1.4646168066769976	3.5413716589483073	JAG1;INSR;HMGB1;HDAC9;ACTB;MTOR;MDK;AKT2;ERCC1;PPP1R1B;ERBB2;AKT1;MAP6;RIN1;TP53;CLIC1;EBAG9
Severe mental retardation (I.Q. 20-34)	11/224	0.09006793117662064	0.646487594889966	0	0	1.6253613635838016	3.9125554127855207	SETD5;CNTNAP2;MBD5;PIGO;CTBP1;SUFU;TMEM67;ROGDI;CHD7;UBE2A;SMARCA2
Systemic onset juvenile chronic arthritis	4/55	0.09057754460128388	0.6474477876893985	0	0	2.461038961038961	5.91030552968285	ATXN2;TYK2;HDAC9;TAPBP
Anophthalmos	4/55	0.09057754460128388	0.6474477876893985	0	0	2.461038961038961	5.91030552968285	FRAS1;CHD7;HCCS;OTX2
Brugada Syndrome (disorder)	4/55	0.09057754460128388	0.6474477876893985	0	0	2.461038961038961	5.91030552968285	CACNB2;DLG1;CACNA2D1;FGF11
Uterine Cervical Neoplasm	7/124	0.09114820722516127	0.6506269819608197	0	0	1.880076964905676	4.503289030941411	DLG1;SOX1;ERCC1;CDK2AP2;TP53;FHIT;MTOR
Aplasia Cutis Congenita	10/199	0.09166111282810928	0.6533856980629914	0	0	1.6645849596669269	3.9777871994211234	JAG1;ZNRF3;NUMA1;ERCC1;ERBB2;AKT1;TP53;SMARCA2;MTOR;PLEC
Visual Impairment	12/251	0.09206536800321355	0.6544619282539308	0	0	1.5806815679365778	3.7703308775918845	TSEN34;SOX3;MBD5;SALL2;TMEM67;PEX6;ERCC1;NPHP1;TACSTD2;TUBGCP6;OTX2;PEX26
Dystonia	12/251	0.09206536800321355	0.6544619282539308	0	0	1.5806815679365778	3.7703308775918845	RIMS2;TSEN34;ATXN2;GRM5;ATCAY;NDUFS8;HEXA;ATP1A3;TTC19;ACTB;ANO3;LY6E
Fetal Growth Retardation	14/304	0.09222584892710611	0.6547021802957202	0	0	1.5207693183111415	3.6247762240937633	RERE;SETD5;JAG1;CTBP1;INSR;PDE4D;SMARCA2;HDAC6;MTOR;ARCN1;ERCC1;TUBGCP6;ERCC8;PIGG
Increase in blood pressure	9/174	0.09262405432039482	0.6566078704979343	0	0	1.7153697366463323	4.081218664688301	BBS2;BBS1;IDUA;IFT172;NPHP1;ERCC8;ACTN4;TP53;LDLR
Intrauterine retardation	13/278	0.09334856733554263	0.6566078704979343	0	0	1.5448385191632215	3.6634528605183427	RERE;SETD5;JAG1;CTBP1;INSR;PDE4D;SMARCA2;HDAC6;ARCN1;ERCC1;TUBGCP6;ERCC8;PIGG
Gait, Drop Foot	3/35	0.09351071839908663	0.6566078704979343	0	0	2.93982982171799	6.966453621143862	LRSAM1;GDAP1;TTC19
Abnormal pigmentation	3/35	0.09351071839908663	0.6566078704979343	0	0	2.93982982171799	6.966453621143862	ERCC8;TUBGCP6;AGPAT2
Acanthosis Nigricans	3/35	0.09351071839908663	0.6566078704979343	0	0	2.93982982171799	6.966453621143862	AKT2;INSR;AGPAT2
Acinar Cell Carcinoma	3/35	0.09351071839908663	0.6566078704979343	0	0	2.93982982171799	6.966453621143862	ERBB2;TP53;MTOR
Cervical Dystonia	3/35	0.09351071839908663	0.6566078704979343	0	0	2.93982982171799	6.966453621143862	ATP1A3;ATP13A2;ANO3
Intracranial Hypertension	3/35	0.09351071839908663	0.6566078704979343	0	0	2.93982982171799	6.966453621143862	PDE4D;TCF12;HMGB1
Dyskinetic syndrome	5/78	0.09456054499073477	0.6627369138327223	0	0	2.1502394475999553	5.071371908837593	ATXN2;KCNMA1;PPP1R1B;MTOR;LY6E
HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE	2/17	0.09605068662165421	0.6627369138327223	0	0	4.17799352750809	9.788534305497775	LDLR;LMNB1
UV-Sensitive Syndrome	2/17	0.09605068662165421	0.6627369138327223	0	0	4.17799352750809	9.788534305497775	ERCC8;TP53
Anal carcinoma	2/17	0.09605068662165421	0.6627369138327223	0	0	4.17799352750809	9.788534305497775	TP53;MTOR
Carcinoma in situ of bladder	2/17	0.09605068662165421	0.6627369138327223	0	0	4.17799352750809	9.788534305497775	TP53;MTOR
Chronic sinus disease	2/17	0.09605068662165421	0.6627369138327223	0	0	4.17799352750809	9.788534305497775	DNAI1;TAPBP
Curly hair (finding)	2/17	0.09605068662165421	0.6627369138327223	0	0	4.17799352750809	9.788534305497775	JUP;MTOR
Hyperkeratosis lenticularis perstans	2/17	0.09605068662165421	0.6627369138327223	0	0	4.17799352750809	9.788534305497775	LDLR;PDLIM7
Long foot	2/17	0.09605068662165421	0.6627369138327223	0	0	4.17799352750809	9.788534305497775	INSR;AGPAT2
Malignant Female Reproductive System Neoplasm	2/17	0.09605068662165421	0.6627369138327223	0	0	4.17799352750809	9.788534305497775	HSF1;TP53
Mucosal telangiectasiae	2/17	0.09605068662165421	0.6627369138327223	0	0	4.17799352750809	9.788534305497775	AKT1;KIAA0319L
Onychogryposis	2/17	0.09605068662165421	0.6627369138327223	0	0	4.17799352750809	9.788534305497775	INSR;PLEC
Rales	2/17	0.09605068662165421	0.6627369138327223	0	0	4.17799352750809	9.788534305497775	DPP9;ATP11A
Endometrial Carcinoma	33/840	0.09744162585202674	0.6714377632043655	0	0	1.293851288449238	3.0127350404831343	CTBP1;MSI1;CASC2;CHD4;SEMA3F;FHIT;HDAC9;AGPAT2;SOX3;CCND3;SOX1;AKT2;SUFU;HSF1;ERBB2;AKT1;SSSCA1;BBS2;INSR;CTNNBIP1;RHOC;MTOR;PSME3;ARMC3;SGSM3;ERCC1;KCNMA1;SDC1;ETF1;SHBG;EBAG9;TP53;OTUB1
Thickened facial skin with coarse facial features	8/151	0.0981223063801564	0.6752278020940723	0	0	1.758489876136935	4.0824055615303045	MBD5;IDUA;KCNQ1OT1;INSR;SUFU;CHD4;ACTB;SGSH
Astrocytoma, low grade	3/36	0.09977730320768603	0.6781363888080222	0	0	2.8505967290408134	6.570096801021216	GAPDH;TP53;ACTB
Squamous intraepithelial lesion	3/36	0.09977730320768603	0.6781363888080222	0	0	2.8505967290408134	6.570096801021216	ERCC1;FHIT;TP53
Barrett's Adenocarcinoma	3/36	0.09977730320768603	0.6781363888080222	0	0	2.8505967290408134	6.570096801021216	AIMP2;ERBB2;TP53
Exencephaly	3/36	0.09977730320768603	0.6781363888080222	0	0	2.8505967290408134	6.570096801021216	VANGL2;ZIC5;TP53
Hereditary Motor and Sensory-Neuropathy Type II	3/36	0.09977730320768603	0.6781363888080222	0	0	2.8505967290408134	6.570096801021216	LRSAM1;AGPAT2;DHTKD1
Large cell neuroendocrine carcinoma	3/36	0.09977730320768603	0.6781363888080222	0	0	2.8505967290408134	6.570096801021216	ERBB2;TP53;MTOR
Rapidly progressive	3/36	0.09977730320768603	0.6781363888080222	0	0	2.8505967290408134	6.570096801021216	ATP13A2;GDAP1;PLEC
Rapidly progressive disorder	3/36	0.09977730320768603	0.6781363888080222	0	0	2.8505967290408134	6.570096801021216	ATP13A2;GDAP1;PLEC
Malignant mesothelioma	15/335	0.09979883299609744	0.6781363888080222	0	0	1.4767561983471074	3.4033305465937396	HDAC4;JAG1;IDUA;HMGB1;SMARCA2;FHIT;MTOR;CDH3;MDK;SUFU;ERCC1;AKT1;SDC1;TP53;PDLIM7
Peutz-Jeghers Syndrome	4/57	0.10010301604264617	0.6781363888080222	0	0	2.3679245283018866	5.449909633655611	SGSM3;FNDC3A;TP53;MTOR
Coarse facial features	8/152	0.10093730169756772	0.6781363888080222	0	0	1.7461873638344227	4.00445417806938	MBD5;IDUA;KCNQ1OT1;INSR;SUFU;CHD4;ACTB;SGSH
Osteochondrodysplasias	8/152	0.10093730169756772	0.6781363888080222	0	0	1.7461873638344227	4.00445417806938	ALG9;IDUA;IFT172;PDE4D;PEX6;AKT1;ACTB;PEX26
Optic Atrophy	16/363	0.1012862618474466	0.6781363888080222	0	0	1.4529839494627554	3.327049179238021	BBS2;RERE;IFT172;CHD7;ATP1A3;SPG7;PEX26;TMEM231;NDUFS8;TMEM67;PEX6;TMEM107;TUBGCP6;ERCC8;B9D1;PDE6B
Peripheral Neuropathy	14/309	0.10169405282399883	0.6781363888080222	0	0	1.4946020025731386	3.4163410135125103	INSR;PDE4D;PPOX;HDAC9;GDAP1;HDAC6;POLD4;ATXN2;ERCC1;AP1S1;ERCC8;MAP4;LDLR;LY6E
Corneal Opacity	5/80	0.10257560187069548	0.6781363888080222	0	0	2.0926829268292684	4.7653637523936805	JAG1;FRAS1;IDUA;PEX6;PEX26
Desmoplastic	5/80	0.10257560187069548	0.6781363888080222	0	0	2.0926829268292684	4.7653637523936805	SUFU;ERBB2;OTX2;SYP;TP53
Extrahepatic Cholangiocarcinoma	5/80	0.10257560187069548	0.6781363888080222	0	0	2.0926829268292684	4.7653637523936805	AIMP2;ERBB2;SSSCA1;TP53;EBAG9
Paroxysmal kinesigenic choreoathetosis	5/80	0.10257560187069548	0.6781363888080222	0	0	2.0926829268292684	4.7653637523936805	AIMP2;ERBB2;AKT1;HDAC9;MTOR
Retinal Dystrophies	9/178	0.10286923938448059	0.6781363888080222	0	0	1.674420631615646	3.8081291792837817	BBS1;IFT172;TMEM67;NPHP1;TUBGCP6;OTX2;PDE6B;PEX26;TMEM231
Sarcomatoid Renal Cell Carcinoma	7/128	0.10339664296045155	0.6781363888080222	0	0	1.8175481644264084	4.124349003749424	KCNMA1;ERBB2;KEAP1;TP53;SLC5A3;RELA;MTOR
Blepharoptosis	15/337	0.10353132221224315	0.6781363888080222	0	0	1.4674298033981827	3.3279562902750053	SETD5;CTBP1;TPM2;CHD7;CHD4;ACTB;PEX26;TMEM231;MAF;NDUFS8;TMEM67;PEX6;AKT1;ALDOA;PLEC
Tooth Crowding	4/58	0.10503276191985347	0.6781363888080222	0	0	2.3239538239538238	5.2369903402659235	SETD5;BBS1;FRAS1;PEX6
Tooth mass arch size discrepancy	4/58	0.10503276191985347	0.6781363888080222	0	0	2.3239538239538238	5.2369903402659235	SETD5;BBS1;FRAS1;PEX6
Tooth size discrepancy	4/58	0.10503276191985347	0.6781363888080222	0	0	2.3239538239538238	5.2369903402659235	SETD5;BBS1;FRAS1;PEX6
Inadequate arch length for tooth size	4/58	0.10503276191985347	0.6781363888080222	0	0	2.3239538239538238	5.2369903402659235	SETD5;BBS1;FRAS1;PEX6
Cerebral atrophy	15/338	0.10542921813949328	0.6781363888080222	0	0	1.462809917355372	3.2909060997803317	RERE;ROGDI;MTR;SYP;PTPN23;KCNAB2;SPG7;TTC19;GNAO1;ERCC1;TUBGCP6;ERCC8;ATP13A2;FADD;PIGG
Cancer, Embryonal	2/18	0.10591993994330838	0.6781363888080222	0	0	3.9166666666666665	8.793197702360173	ERCC1;TP53
Hereditary motor and sensory neuropathy, types I-IV	2/18	0.10591993994330838	0.6781363888080222	0	0	3.9166666666666665	8.793197702360173	LRSAM1;GDAP1
Slowed saccades	2/18	0.10591993994330838	0.6781363888080222	0	0	3.9166666666666665	8.793197702360173	ATXN2;ATP13A2
Teratoma, Malignant	2/18	0.10591993994330838	0.6781363888080222	0	0	3.9166666666666665	8.793197702360173	ERBB2;TP53
Thymus Hyperplasia	2/18	0.10591993994330838	0.6781363888080222	0	0	3.9166666666666665	8.793197702360173	HMGB1;MTOR
Adrenomyeloneuropathy	2/18	0.10591993994330838	0.6781363888080222	0	0	3.9166666666666665	8.793197702360173	ABCD4;PEX26
Alexander Disease	2/18	0.10591993994330838	0.6781363888080222	0	0	3.9166666666666665	8.793197702360173	MTOR;PLEC
Atrophy/Degeneration affecting the brainstem	2/18	0.10591993994330838	0.6781363888080222	0	0	3.9166666666666665	8.793197702360173	ATXN2;LY6E
Autosomal Recessive Centronuclear Myopathy	2/18	0.10591993994330838	0.6781363888080222	0	0	3.9166666666666665	8.793197702360173	TPM2;AMPH
Choroid Plexus Carcinoma	2/18	0.10591993994330838	0.6781363888080222	0	0	3.9166666666666665	8.793197702360173	FLII;TP53
Coloboma of optic disc	2/18	0.10591993994330838	0.6781363888080222	0	0	3.9166666666666665	8.793197702360173	SALL2;TMEM67
Congenital cystic kidney disease	2/18	0.10591993994330838	0.6781363888080222	0	0	3.9166666666666665	8.793197702360173	TMEM67;B9D1
Diabetic Neuralgia	2/18	0.10591993994330838	0.6781363888080222	0	0	3.9166666666666665	8.793197702360173	GRM5;INSR
Disorders of Porphyrin Metabolism	2/18	0.10591993994330838	0.6781363888080222	0	0	3.9166666666666665	8.793197702360173	SLC15A2;PPOX
Hypertrophic neuropathy of infancy	2/18	0.10591993994330838	0.6781363888080222	0	0	3.9166666666666665	8.793197702360173	LRSAM1;GDAP1
Hypocupremia	2/18	0.10591993994330838	0.6781363888080222	0	0	3.9166666666666665	8.793197702360173	ERBB2;AP1S1
Malignant neoplasm of other specified sites of female breast	2/18	0.10591993994330838	0.6781363888080222	0	0	3.9166666666666665	8.793197702360173	ERBB2;TP53
Mouth Abnormalities	2/18	0.10591993994330838	0.6781363888080222	0	0	3.9166666666666665	8.793197702360173	TCN2;EFHC1
Odontogenesis	2/18	0.10591993994330838	0.6781363888080222	0	0	3.9166666666666665	8.793197702360173	CACNB2;IGF2BP1
Orofaciodigital Syndrome I	2/18	0.10591993994330838	0.6781363888080222	0	0	3.9166666666666665	8.793197702360173	FRAS1;TMEM107
Papillomatosis	2/18	0.10591993994330838	0.6781363888080222	0	0	3.9166666666666665	8.793197702360173	ERBB2;TP53
Peroneal muscular atrophy (axonal type) (hypertrophic type)	2/18	0.10591993994330838	0.6781363888080222	0	0	3.9166666666666665	8.793197702360173	LRSAM1;GDAP1
Pulpitis	2/18	0.10591993994330838	0.6781363888080222	0	0	3.9166666666666665	8.793197702360173	HMGB1;PDLIM7
Pyothorax-Associated Lymphoma	2/18	0.10591993994330838	0.6781363888080222	0	0	3.9166666666666665	8.793197702360173	TP53;PDLIM7
Aggressive Non-Hodgkin Lymphoma	3/37	0.10620744592215516	0.6781363888080222	0	0	2.766612641815235	6.2037444571357945	HMGB1;TP53;PDLIM7
Cervical intraepithelial neoplasia grade 1	3/37	0.10620744592215516	0.6781363888080222	0	0	2.766612641815235	6.2037444571357945	MSI1;FHIT;TP53
Juvenile Pilocytic Astrocytoma	3/37	0.10620744592215516	0.6781363888080222	0	0	2.766612641815235	6.2037444571357945	ABR;SGSM3;TP53
Malignant neoplasm of pharynx	3/37	0.10620744592215516	0.6781363888080222	0	0	2.766612641815235	6.2037444571357945	AKT2;AKT1;HDAC9
Narcolepsy	12/258	0.10695209113834832	0.6781363888080222	0	0	1.5351412066752246	3.431615186700824	NAA50;GNAO1;DPP10;GRM5;NDST3;FBXO15;CTNNA2;CHKB-CPT1B;FHIT;HDAC9;VAT1L;ANO3
Medulloblastoma	24/590	0.10747951385376843	0.6781363888080222	0	0	1.3385348732421087	2.985541825295637	CREBZF;CTNNBIP1;MSI1;SYP;HMGB1;FHIT;HDAC9;MTOR;RELA;ABR;AIMP2;MDK;MAP2;SUFU;SGSM3;ERBB2;CDK2AP2;AKT1;SDC1;SSSCA1;OTX2;TP53;MAP2K5;PLEC
Carotid Atherosclerosis	6/105	0.10797905373105934	0.6781363888080222	0	0	1.90316849274504	4.236106721685669	PDE4D;TRIB3;TP53;HDAC9;LDLR;LMNB1
Penile hypospadias	9/180	0.10822466215311283	0.6781363888080222	0	0	1.6546644844517184	3.6792226079351305	RERE;SETD5;FRAS1;BNC2;PDE4D;PEX6;HCCS;PEX26;ARCN1
Language Delay	10/206	0.10854713331985344	0.6781363888080222	0	0	1.6045500167280027	3.563016901211451	BBS1;SETD5;CNTNAP2;MBD5;PIGO;IFT172;FLII;PDE4D;PIGG;DHTKD1
Progeria	4/59	0.11007081953755536	0.6781363888080222	0	0	2.281582054309327	5.0346103890938	RIMS2;AKT1;TP53;LMNB1
Promyelocytic leukemia	11/233	0.11042395127463138	0.6781363888080222	0	0	1.5587360759774553	3.4345630553425024	RIMS2;AIMP2;JAG1;SGSM3;RNPEP;AKT1;TP53;HDAC9;SYBU;MTOR;HIPK2
Ataxia Telangiectasia	17/396	0.11127185502529406	0.6781363888080222	0	0	1.4134122702232024	3.103540878916405	HDAC4;TRAF3IP2;IFT172;SYP;SPG7;MTOR;ACTB;RIMS2;AIMP2;FCGRT;AKT2;PSME3;SGSM3;ERBB2;AKT1;TP53;PDLIM7
Spastic gait	3/38	0.11279493190122203	0.6781363888080222	0	0	2.687427645288261	5.86446126170846	SPG7;TTC19;CCT5
Bladder neck obstruction	3/38	0.11279493190122203	0.6781363888080222	0	0	2.687427645288261	5.86446126170846	KCNMA1;AKT1;RPS27A
Papillary adenoma	3/38	0.11279493190122203	0.6781363888080222	0	0	2.687427645288261	5.86446126170846	TBRG1;TCN2;TP53
Pituitary dwarfism	3/38	0.11279493190122203	0.6781363888080222	0	0	2.687427645288261	5.86446126170846	SOX3;OTX2;SHBG
Radioulnar Synostosis	3/38	0.11279493190122203	0.6781363888080222	0	0	2.687427645288261	5.86446126170846	SETD5;MAF;CTBP1
Epstein-Barr Virus Infections	11/234	0.11283739183012806	0.6781363888080222	0	0	1.5516652308054812	3.3854348489104846	RIMS2;AIMP2;JAG1;CAPNS1;ERBB2;CDK2AP2;TP53;EBAG9;FHIT;RELA;PDLIM7
Neurodevelopmental Disorders	10/208	0.11367770299205703	0.6781363888080222	0	0	1.5881768504719325	3.4533126876217164	SETD5;CNTNAP2;MBD5;APH1B;LRRTM1;CHD7;ATP1A3;CNTN4;SHROOM4;MTOR
Low Vision	12/261	0.11374254777366276	0.6781363888080222	0	0	1.51640773620799	3.2963940340614597	TSEN34;SOX3;MBD5;SALL2;TMEM67;PEX6;ERCC1;NPHP1;TACSTD2;TUBGCP6;OTX2;PEX26
Body mass index	16/370	0.11427906140730448	0.6781363888080222	0	0	1.423728813559322	3.088227132864454	SEMA5B;LRGUK;INSR;TCF12;FHIT;SMG6;AGBL4;CACNB2;STK33;FER;ZNRF3;SUFU;FAM19A2;ATP13A2;CTNNA2;MAP2K5
Finding of body mass index	16/370	0.11427906140730448	0.6781363888080222	0	0	1.423728813559322	3.088227132864454	SEMA5B;LRGUK;INSR;TCF12;FHIT;SMG6;AGBL4;CACNB2;STK33;FER;ZNRF3;SUFU;FAM19A2;ATP13A2;CTNNA2;MAP2K5
Absence Epilepsy	4/60	0.11521480474031547	0.6781363888080222	0	0	2.2407235621521338	4.842107324075098	PIGO;EFHC1;YWHAZ;GABRG2
Adenocarcinoma of lung, stage IV	2/19	0.11604654904566754	0.6781363888080222	0	0	3.686084142394822	7.938954897404655	ERBB2;TP53
Papilloma, Squamous Cell	2/19	0.11604654904566754	0.6781363888080222	0	0	3.686084142394822	7.938954897404655	ERBB2;TP53
stage, cervical cancer	2/19	0.11604654904566754	0.6781363888080222	0	0	3.686084142394822	7.938954897404655	URGCP;MDK
Borderline ovarian tumour	2/19	0.11604654904566754	0.6781363888080222	0	0	3.686084142394822	7.938954897404655	ERBB2;TP53
Carcinoma of extrahepatic bile duct	2/19	0.11604654904566754	0.6781363888080222	0	0	3.686084142394822	7.938954897404655	ERCC1;TP53
Cholecystitis	2/19	0.11604654904566754	0.6781363888080222	0	0	3.686084142394822	7.938954897404655	ALDOA;TP53
Communicating Hydrocephalus	2/19	0.11604654904566754	0.6781363888080222	0	0	3.686084142394822	7.938954897404655	HYDIN;DNAI1
Congenital Hydrocephalus	2/19	0.11604654904566754	0.6781363888080222	0	0	3.686084142394822	7.938954897404655	FZD3;HYDIN
Differentiating Neuroblastoma	2/19	0.11604654904566754	0.6781363888080222	0	0	3.686084142394822	7.938954897404655	RNPEP;TP53
Infective cystitis	2/19	0.11604654904566754	0.6781363888080222	0	0	3.686084142394822	7.938954897404655	ERBB2;TP53
Mandibulofacial Dysostosis	2/19	0.11604654904566754	0.6781363888080222	0	0	3.686084142394822	7.938954897404655	CHD7;TP53
Milium Cyst	2/19	0.11604654904566754	0.6781363888080222	0	0	3.686084142394822	7.938954897404655	SUFU;PLEC
Pyoderma Gangrenosum	2/19	0.11604654904566754	0.6781363888080222	0	0	3.686084142394822	7.938954897404655	LAD1;TRAF3IP2
Psychotic Disorders	14/317	0.11803071761633081	0.6781363888080222	0	0	1.454530601575009	3.1080560723620962	PRDM8;CNTNAP2;FZD3;ALG9;CPLX2;PPOX;TTC19;GABRG2;BCL9;GRM5;SGSM3;PPP1R1B;AKT1;SEPHS1
Abnormal behavior	16/372	0.11816707159815151	0.6781363888080222	0	0	1.415581516481881	3.0231948688296586	HDAC4;GPM6A;SYT4;CNTNAP2;DIXDC1;HDAC9;PEX26;SGSH;LRFN5;GRM5;PSME3;SGSM3;PEX6;AKT1;MAP6;TP53
Waldenstrom Macroglobulinemia	6/108	0.11917887036537879	0.6781363888080222	0	0	1.8469055374592833	3.928607810391446	SLC35B2;BCL9;CCND3;AKT1;TP53;MTOR
Esotropia	3/39	0.11953346728754499	0.6781363888080222	0	0	2.612641815235008	5.549666327339938	MBD5;ALG9;CHMP1A
Neuronal Ceroid-Lipofuscinoses	3/39	0.11953346728754499	0.6781363888080222	0	0	2.612641815235008	5.549666327339938	KCNMA1;ATP13A2;SGSH
Skin Ulcer	5/84	0.11957468490528089	0.6781363888080222	0	0	1.986312647936606	4.21855885744279	LAD1;TRAF3IP2;KIAA0319L;CCT5;TAPBP
PACHYONYCHIA CONGENITA 3	7/133	0.1198924781543324	0.6781363888080222	0	0	1.7449700924415443	3.7013606796926632	RPAIN;TEP1;MDK;ERBB2;TACSTD2;AKT1;TP53
Cognition Disorders	11/237	0.12025769200697439	0.6781363888080222	0	0	1.5308281383960358	3.242475255208312	MAPK10;GRM5;TCN2;AKT1;AMPH;SYP;YWHAZ;HDAC9;SHROOM4;HDAC6;MTOR
Depression, Bipolar	4/61	0.12046225109386068	0.6781363888080222	0	0	2.2012987012987013	4.658870052835591	DIXDC1;ATP1A3;CPLX2;SLC5A3
Bradykinesia	4/61	0.12046225109386068	0.6781363888080222	0	0	2.2012987012987013	4.658870052835591	ATXN2;PPP1R1B;ATP1A3;TTC19
High forehead	7/134	0.12334581281285042	0.6781363888080222	0	0	1.7311402551026962	3.622866935265112	MAF;CTBP1;PEX6;AP1S1;ACTB;MTOR;PEX26
Downturned corners of mouth	5/85	0.12401949140558305	0.6781363888080222	0	0	1.9613821138211383	4.094025321506346	HDAC4;SETD5;MBD5;CTBP1;UBE2A
Reticulosarcoma	4/62	0.12581061629246362	0.6781363888080222	0	0	2.1632333184057324	4.484334100214804	FPGS;HDAC9;PDLIM7;LMNB1
Sparse scalp hair	4/62	0.12581061629246362	0.6781363888080222	0	0	2.1632333184057324	4.484334100214804	HDAC4;CDH3;JUP;SMARCA2
Cancer of Nasopharynx	4/62	0.12581061629246362	0.6781363888080222	0	0	2.1632333184057324	4.484334100214804	ERCC1;TP53;RELA;PDLIM7
Marijuana Abuse	4/62	0.12581061629246362	0.6781363888080222	0	0	2.1632333184057324	4.484334100214804	AKT1;TRIB3;TP53;HIPK2
Phyllodes Tumor	4/62	0.12581061629246362	0.6781363888080222	0	0	2.1632333184057324	4.484334100214804	ERBB2;TP53;FHIT;MTOR
Rokitansky Kuster Hauser syndrome	2/20	0.1264051381660496	0.6781363888080222	0	0	3.481121898597627	7.1998761367313495	DLG1;AKT1
Solitary fibrous tumor	2/20	0.1264051381660496	0.6781363888080222	0	0	3.481121898597627	7.1998761367313495	AKT1;TP53
stage, gastric cancer	2/20	0.1264051381660496	0.6781363888080222	0	0	3.481121898597627	7.1998761367313495	KAT2A;ERBB2
Tonsillar Carcinoma	2/20	0.1264051381660496	0.6781363888080222	0	0	3.481121898597627	7.1998761367313495	TP53;SKP1
Triangular head shape	2/20	0.1264051381660496	0.6781363888080222	0	0	3.481121898597627	7.1998761367313495	CHD4;ACTB
Abnormal nasal morphology	2/20	0.1264051381660496	0.6781363888080222	0	0	3.481121898597627	7.1998761367313495	JAG1;ERCC1
Accessory nipple	2/20	0.1264051381660496	0.6781363888080222	0	0	3.481121898597627	7.1998761367313495	HDAC4;ACTB
Vulval intraepithelial neoplasia	2/20	0.1264051381660496	0.6781363888080222	0	0	3.481121898597627	7.1998761367313495	AKT1;TP53
Wedge shaped head	2/20	0.1264051381660496	0.6781363888080222	0	0	3.481121898597627	7.1998761367313495	CHD4;ACTB
Adenosis of Breast	2/20	0.1264051381660496	0.6781363888080222	0	0	3.481121898597627	7.1998761367313495	ERBB2;TP53
Zellweger Spectrum	2/20	0.1264051381660496	0.6781363888080222	0	0	3.481121898597627	7.1998761367313495	PEX6;PEX26
Carcinoma of ampulla of Vater	2/20	0.1264051381660496	0.6781363888080222	0	0	3.481121898597627	7.1998761367313495	ERBB2;TP53
Hereditary Motor and Sensory Neuropathy Type I	2/20	0.1264051381660496	0.6781363888080222	0	0	3.481121898597627	7.1998761367313495	LRSAM1;ERBB2
High Grade Intraepithelial Neoplasia	2/20	0.1264051381660496	0.6781363888080222	0	0	3.481121898597627	7.1998761367313495	ERBB2;TP53
Hypoplasia of the pituitary gland	2/20	0.1264051381660496	0.6781363888080222	0	0	3.481121898597627	7.1998761367313495	SOX3;OTX2
Infantile Refsum Disease (disorder)	2/20	0.1264051381660496	0.6781363888080222	0	0	3.481121898597627	7.1998761367313495	PEX6;PEX26
malignant neoplasm of breast staging	2/20	0.1264051381660496	0.6781363888080222	0	0	3.481121898597627	7.1998761367313495	SHARPIN;TP53
Morphologically abnormal structure (morphologic abnormality)	2/20	0.1264051381660496	0.6781363888080222	0	0	3.481121898597627	7.1998761367313495	CFL1;CDK2AP2
Multiple System Atrophy	2/20	0.1264051381660496	0.6781363888080222	0	0	3.481121898597627	7.1998761367313495	ATXN2;PPP1R1B
Peroxisome biogenesis disorders	2/20	0.1264051381660496	0.6781363888080222	0	0	3.481121898597627	7.1998761367313495	PEX6;PEX26
Peyronie Disease	2/20	0.1264051381660496	0.6781363888080222	0	0	3.481121898597627	7.1998761367313495	CHRM3;HDAC9
Prune Belly Syndrome	2/20	0.1264051381660496	0.6781363888080222	0	0	3.481121898597627	7.1998761367313495	CHRM3;SYP
Anxiety States, Neurotic	3/40	0.12641669942565442	0.6781363888080222	0	0	2.5418984624819307	5.2570824396881655	CHRNB2;MDK;DIXDC1
Xeroderma pigmentosum, group A	3/40	0.12641669942565442	0.6781363888080222	0	0	2.5418984624819307	5.2570824396881655	ERCC1;GAPDH;TP53
Abnormal coordination	3/40	0.12641669942565442	0.6781363888080222	0	0	2.5418984624819307	5.2570824396881655	TTC19;MAP2K5;ARCN1
Adrenal cortical hypofunction	3/40	0.12641669942565442	0.6781363888080222	0	0	2.5418984624819307	5.2570824396881655	VANGL2;PEX6;PEX26
Congenital omphalocele	3/40	0.12641669942565442	0.6781363888080222	0	0	2.5418984624819307	5.2570824396881655	GDF11;TCN2;KCNQ1OT1
Islet Cell Tumor	3/40	0.12641669942565442	0.6781363888080222	0	0	2.5418984624819307	5.2570824396881655	PLCB3;TP53;MTOR
Malignant neoplasm of stomach stage IV	3/40	0.12641669942565442	0.6781363888080222	0	0	2.5418984624819307	5.2570824396881655	ERCC1;ERBB2;MTOR
Prostate cancer recurrent	3/40	0.12641669942565442	0.6781363888080222	0	0	2.5418984624819307	5.2570824396881655	ERBB2;HDAC9;TP53
Hormone refractory prostate cancer	7/135	0.12684946910698663	0.6781363888080222	0	0	1.7175265089722676	3.5462700354816494	BBS2;DNAH5;ERBB2;AKT1;HMGB1;TP53;DNAI1
Motor Neuron Disease	7/135	0.12684946910698663	0.6781363888080222	0	0	1.7175265089722676	3.5462700354816494	RIMS2;ATXN2;HEXA;VPS54;TP53;HDAC6;LY6E
Unipolar Depression	21/517	0.12687180168497195	0.6781363888080222	0	0	1.334764930798643	2.7557264953599914	DPP10;RERE;CHRM3;CNTNAP2;GPM6A;CACNA2D1;MIR137HG;DIXDC1;TYK2;FHIT;HDAC9;MTOR;CACNB2;BCL9;LRFN5;GRM5;PDZD2;MAP2;SGSM3;PPP1R1B;PLCB1
Polymicrogyria	6/110	0.12695360262529756	0.6781363888080222	0	0	1.8112002004510148	3.7381969372382304	PEX6;MBOAT7;ERCC1;AKT1;ACTB;PEX26
Speech Delay	10/213	0.12708945135588406	0.6781363888080222	0	0	1.548655414681418	3.1946656567776097	BBS1;SETD5;CNTNAP2;MBD5;PIGO;IFT172;FLII;PDE4D;PIGG;DHTKD1
Familial multiple trichoepitheliomata	8/161	0.12826452358304974	0.6781363888080222	0	0	1.6427015250544663	3.373551328978425	BNC2;ERCC1;ERBB2;CDK2AP2;AKT1;TP53;FHIT;MTOR
Postnatal growth retardation	5/86	0.12853975524041505	0.6781363888080222	0	0	1.9370671484492623	3.973926268850853	MBD5;INSR;CHD7;COG1;ACTB
Amyotrophic Lateral Sclerosis, Sporadic	7/136	0.13040294076141756	0.6781363888080222	0	0	1.7041238286733185	3.471515091348448	ATXN2;FGGY;HSF1;VPS54;CNTN4;TP53;LDLR
Malignant Peripheral Nerve Sheath Tumor	9/188	0.13116830221601844	0.6781363888080222	0	0	1.580054677285154	3.2095240329371415	MDK;SGSM3;ERBB2;HSF1;AKT1;TYK2;TP53;HDAC9;MTOR
Papule	4/63	0.1312572885346075	0.6781363888080222	0	0	2.1264582874752365	4.317977368131438	TRAF3IP2;AKT1;PLEC;UBAC2
Malignant neoplasm of endometrium	23/577	0.13181757124224203	0.6781363888080222	0	0	1.309187332571401	2.6528538787652707	BBS2;INSR;CTNNBIP1;CASC2;SEMA3F;FHIT;HDAC9;AGPAT2;MTOR;AKT2;PSME3;ARMC3;SUFU;SGSM3;ERCC1;KCNMA1;HSF1;ERBB2;AKT1;SDC1;SHBG;TP53;OTUB1
Myopia	12/269	0.133037507939742	0.6781363888080222	0	0	1.468590006143764	2.9623284059283748	SETD5;CHRM3;MBD5;JAG1;MAF;AGK;FLII;CHMP1A;CHD7;AKT1;DNALI1;ARCN1
Everted lower lip vermilion	5/87	0.13313411192749283	0.6781363888080222	0	0	1.9133452310132857	3.8580660681761842	MBD5;IDUA;ERCC1;CHAMP1;SMARCA2
Gynecomastia	5/87	0.13313411192749283	0.6781363888080222	0	0	1.9133452310132857	3.8580660681761842	AKT2;INSR;CHD7;AKT1;SHBG
Lipoma	5/87	0.13313411192749283	0.6781363888080222	0	0	1.9133452310132857	3.8580660681761842	VANGL2;AKT1;SDC1;HMGB1;TP53
Protruding lower lip	5/87	0.13313411192749283	0.6781363888080222	0	0	1.9133452310132857	3.8580660681761842	MBD5;IDUA;ERCC1;CHAMP1;SMARCA2
AIDS related complex	3/41	0.13343823551887612	0.6781363888080222	0	0	2.4748784440842786	4.984693666852354	JAG1;TP53;PDLIM7
Alcoholic Intoxication	3/41	0.13343823551887612	0.6781363888080222	0	0	2.4748784440842786	4.984693666852354	MTR;TP53;RELA
Dysphasia	3/41	0.13343823551887612	0.6781363888080222	0	0	2.4748784440842786	4.984693666852354	SMARCA2;ACTB;PLEC
Gastrointestinal mucositis	3/41	0.13343823551887612	0.6781363888080222	0	0	2.4748784440842786	4.984693666852354	ERCC1;HMGB1;YWHAZ
Laryngeal neoplasm	3/41	0.13343823551887612	0.6781363888080222	0	0	2.4748784440842786	4.984693666852354	CAPN10;ERBB2;TP53
Prolymphocytic Leukemia	3/41	0.13343823551887612	0.6781363888080222	0	0	2.4748784440842786	4.984693666852354	RIMS2;AKT1;TP53
Curvature of spine	17/408	0.13446531784534368	0.6781363888080222	0	0	1.3691686495060926	2.7471670307717364	SETD5;CTBP1;IDUA;FLII;TPM2;PDE4D;CHD7;SPG7;SMARCA2;GDAP1;ACTB;LMNB2;SHROOM4;KCNQ1OT1;SUFU;AKT1;TUBGCP6
Adenocarcinoma of large intestine	13/297	0.13473021051938328	0.6781363888080222	0	0	1.4400538320532752	2.8865604599150854	INSR;DIXDC1;TYK2;TMEM91;FHIT;ZNRF3;SPINT1;AKT2;ERBB2;AKT1;TP53;LDLR;NEK11
Kidney Failure	13/297	0.13473021051938328	0.6781363888080222	0	0	1.4400538320532752	2.8865604599150854	CHRM3;KIRREL2;LDB1;CHD4;ACTN4;DLG1;TMEM67;NPHP1;SDC1;ERCC8;ETF1;TP53;LDLR
androgen independent prostate cancer	8/163	0.13481170642628174	0.6781363888080222	0	0	1.621336706725701	3.248958105835669	PDZD2;AKT2;SGSM3;ERBB2;AKT1;MOSPD3;TP53;MAP2K5
Merkel cell carcinoma	6/112	0.13496774108890222	0.6781363888080222	0	0	1.7768422346506054	3.558516563319981	SGSM3;ERBB2;CDK2AP2;AKT1;TP53;FHIT
Uterine Corpus Cancer	23/579	0.13521565847065875	0.6781363888080222	0	0	1.3043394430184496	2.6098323199135582	BBS2;INSR;CTNNBIP1;CASC2;SEMA3F;FHIT;HDAC9;AGPAT2;MTOR;AKT2;PSME3;ARMC3;SUFU;SGSM3;ERCC1;KCNMA1;HSF1;ERBB2;AKT1;SDC1;SHBG;TP53;OTUB1
Alzheimer's Disease	70/1982	0.13624953903182876	0.6781363888080222	0	0	1.1627615062761507	2.3176944052507746	PHF1;KEAP1;MSI1;MTR;HMGB1;APEH;ACTB;SGSH;LMNB1;RIMS2;GRM5;ATCAY;MDK;AKT1;SLC16A7;SSSCA1;CAPN1;SYBU;ANKS1B;CHRNB2;LMO4;SYP;TYK2;KIF6;YWHAZ;KCNMA1;PKP4;AMPH;SCG3;PLCB1;GAPDH;TP53;HDAC4;IDUA;ADCY2;SPG7;CPLX2;NDRG2;HDAC9;HDAC6;RELA;ATXN2;APH1B;MAP2;HSF1;NPHP1;ERBB2;PDSS2;CKB;CTNNA2;NCAM2;LDLR;VAT1L;GDF11;SORT1;INSR;SYVN1;HOOK3;MTOR;PPP1CA;MAPK10;AIMP2;DLG1;NFIC;SGSM3;PPP1R1B;OGDH;SHBG;APBA3;LRP10
Anus, Imperforate	4/64	0.13679959269204303	0.6781363888080222	0	0	2.090909090909091	4.159316343408701	CHRM3;FRAS1;PIGO;HCCS
Uterine Cancer	4/64	0.13679959269204303	0.6781363888080222	0	0	2.090909090909091	4.159316343408701	RIMS2;AKT2;ERBB2;AKT1
Adult Medulloblastoma	4/64	0.13679959269204303	0.6781363888080222	0	0	2.090909090909091	4.159316343408701	SUFU;ERBB2;OTX2;TP53
Cortical Dysplasia	4/64	0.13679959269204303	0.6781363888080222	0	0	2.090909090909091	4.159316343408701	CNTNAP2;MAP2;AKT1;MTOR
Febrile Convulsions	4/64	0.13679959269204303	0.6781363888080222	0	0	2.090909090909091	4.159316343408701	MBD5;MBOAT7;GABRG2;ANO3
High-Grade Squamous Intraepithelial Lesions	4/64	0.13679959269204303	0.6781363888080222	0	0	2.090909090909091	4.159316343408701	ERBB2;AKT1;TP53;FHIT
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, NONDELETION TYPE, X-LINKED	2/21	0.13697165308324677	0.6781363888080222	0	0	3.2977346278317152	6.555834727525091	SMARCA2;TP53
Regurgitation	2/21	0.13697165308324677	0.6781363888080222	0	0	3.2977346278317152	6.555834727525091	CKB;ACTB
response to anticoagulant	2/21	0.13697165308324677	0.6781363888080222	0	0	3.2977346278317152	6.555834727525091	FBXL19;BCL7C
response to risperidone	2/21	0.13697165308324677	0.6781363888080222	0	0	3.2977346278317152	6.555834727525091	PDE4D;ANKS1B
Small chin	2/21	0.13697165308324677	0.6781363888080222	0	0	3.2977346278317152	6.555834727525091	MBD5;MTOR
Meningiomas, Multiple	2/21	0.13697165308324677	0.6781363888080222	0	0	3.2977346278317152	6.555834727525091	SUFU;AKT1
Neoplasms, Neuroepithelial	2/21	0.13697165308324677	0.6781363888080222	0	0	3.2977346278317152	6.555834727525091	MAP2;IGF2BP1
Stricture of anus	2/21	0.13697165308324677	0.6781363888080222	0	0	3.2977346278317152	6.555834727525091	FRAS1;PIGO
Polyarticular Juvenile Idiopathic Arthritis, Rheumatoid Factor Negative	2/21	0.13697165308324677	0.6781363888080222	0	0	3.2977346278317152	6.555834727525091	ATXN2;TYK2
Urgency frequency syndrome	2/21	0.13697165308324677	0.6781363888080222	0	0	3.2977346278317152	6.555834727525091	SPG7;LMNB1
Urinary bladder sphincter dysfunction	2/21	0.13697165308324677	0.6781363888080222	0	0	3.2977346278317152	6.555834727525091	ATXN2;SPG7
Choroid Plexus Papilloma	2/21	0.13697165308324677	0.6781363888080222	0	0	3.2977346278317152	6.555834727525091	FOXJ1;TP53
Heparin-induced thrombocytopenia	2/21	0.13697165308324677	0.6781363888080222	0	0	3.2977346278317152	6.555834727525091	SYVN1;TP53
Hereditary Multiple Exostoses	2/21	0.13697165308324677	0.6781363888080222	0	0	3.2977346278317152	6.555834727525091	SLC35B2;LDLR
idiopathic epilepsy	2/21	0.13697165308324677	0.6781363888080222	0	0	3.2977346278317152	6.555834727525091	CHRNB2;EFHC1
Oropharynx (excludes nasopharynx)	2/21	0.13697165308324677	0.6781363888080222	0	0	3.2977346278317152	6.555834727525091	MAGED4B;TP53
Pseudomyxoma Peritonei	2/21	0.13697165308324677	0.6781363888080222	0	0	3.2977346278317152	6.555834727525091	AKT1;TP53
Long philtrum	9/190	0.13727597577703068	0.6781363888080222	0	0	1.562432747691946	3.102619511754249	RERE;SETD5;MAF;TPM2;KCNAB2;SMARCA2;ACTB;MTOR;PEX26
Ureteral obstruction	7/138	0.13765718882206082	0.6781363888080222	0	0	1.6779323312952195	3.3273210593599374	JAG1;AKT2;SYVN1;MSI1;SSSCA1;HMGB1;TP53
Psoriasis vulgaris	7/138	0.13765718882206082	0.6781363888080222	0	0	1.6779323312952195	3.3273210593599374	PSMD7;TRAF3IP2;KCNH7;STAT2;SYVN1;TRIB3;TYK2
Spina Bifida	5/88	0.13780115166259688	0.6781363888080222	0	0	1.890194926045646	3.7462596663856846	VANGL2;SUFU;CFL1;MTR;LMNB1
Myoclonic Epilepsies, Progressive	5/88	0.13780115166259688	0.6781363888080222	0	0	1.890194926045646	3.7462596663856846	PRDM8;KCNC1;MBOAT7;LMNB2;GABRG2
Lipodystrophy	6/113	0.1390625095849861	0.6781363888080222	0	0	1.7601449054765745	3.472469732467826	RIMS2;AKT2;INSR;AGPAT2;LMNB2;LMF1
Ewings sarcoma-primitive neuroectodermal tumor (PNET)	3/42	0.1405916601992746	0.6781363888080222	0	0	2.411295349707019	4.73070977826718	FLII;ERBB2;TP53
Late fontanel closure	3/42	0.1405916601992746	0.6781363888080222	0	0	2.411295349707019	4.73070977826718	RERE;KCNAB2;ACTB
Mesothelioma	16/383	0.1409321691444289	0.6781363888080222	0	0	1.3723586625042856	2.689104650650167	CHRM3;FHIT;HDAC9;RELA;MTOR;RIMS2;TCN2;MDK;SGSM3;ERCC1;AKT1;SDC1;SSSCA1;TP53;EBAG9;MAP2K5
TARSAL-CARPAL COALITION SYNDROME	8/165	0.14152539542395368	0.6781363888080222	0	0	1.6005162149785603	3.129451110878862	JUP;KCNQ1OT1;ERBB2;MTR;TYK2;SPG7;TP53;FHIT
Small hand	4/65	0.14243479632318848	0.6781363888080222	0	0	2.056525441771343	4.0079026989149495	HDAC4;SETD5;MBD5;SHROOM4
Syndactyly of the toes	4/65	0.14243479632318848	0.6781363888080222	0	0	2.056525441771343	4.0079026989149495	HDAC4;SETD5;FRAS1;FLII
FRIEDREICH ATAXIA 1	4/65	0.14243479632318848	0.6781363888080222	0	0	2.056525441771343	4.0079026989149495	PHF1;ERBB2;PIP5K1B;TP53
Limitation of joint mobility	4/65	0.14243479632318848	0.6781363888080222	0	0	2.056525441771343	4.0079026989149495	IDUA;ERCC8;TYK2;PLEC
Mammary Ductal Carcinoma	4/65	0.14243479632318848	0.6781363888080222	0	0	2.056525441771343	4.0079026989149495	DLG1;ERBB2;TP53;FHIT
Osteoarthrosis Deformans	5/89	0.14253942177322446	0.6781363888080222	0	0	1.867595818815331	3.6383319059275343	NDUFS8;ATP1A3;CLIC1;GAPDH;ACTB
Neuroectodermal Tumor, Primitive	6/114	0.1432145742388537	0.6781363888080222	0	0	1.743756786102063	3.3888365627391197	ABR;MAP2;MDK;FLII;SGSM3;TP53
Deafness	12/273	0.14332020543944063	0.6781363888080222	0	0	1.4457803992740472	2.8086799235933846	JAG1;IDUA;PDE4D;TCF12;CHD7;AKT1;AP1S1;ELMOD3;HCCS;CHD4;LMNB2;SGSH
B-Cell Lymphomas	28/730	0.1451485215717793	0.6781363888080222	0	0	1.2584315084315085	2.428770010109127	HDAC4;HCCS;MTR;SPG7;FHIT;DNALI1;HDAC6;ACTB;RELA;RIMS2;TBRG1;CCND3;FCGRT;AKT2;ERBB2;AKT1;SSSCA1;MAP4;PDLIM7;JAG1;INSR;MTOR;BCL9;AIMP2;ERCC1;SDC1;GAPDH;TP53
Developmental delay (disorder)	9/193	0.14670758760401223	0.6781363888080222	0	0	1.5367181384757702	2.9494444424698893	GNAO1;HDAC4;SOX3;ZNF462;ALG9;PIGO;CDK2AP2;OTX2;CNTN4
Delayed speech and language development	10/220	0.14723639768380625	0.6781363888080222	0	0	1.4964871194379392	2.866844073644591	BBS1;SETD5;MBD5;PIGO;IFT172;FLII;PDE4D;ATP1A3;PIGG;DHTKD1
Small cell carcinoma of lung	26/673	0.1473847555798078	0.6781363888080222	0	0	1.2673307000973153	2.426569151082697	CNTNAP2;SEMA3F;FHIT;HDAC9;ACTB;RIMS2;SOX3;POLD4;STK33;SOX1;MAGED4B;AKT2;ERBB2;AKT1;CKB;CAPN1;ACTN4;SYP;SMARCA2;MTOR;TAPBP;FER;ERCC1;PPP1R1B;SDC1;TP53
Roussy-Levy Syndrome (disorder)	2/22	0.14772330356446647	0.6781363888080222	0	0	3.132686084142395	5.9909937447857935	LRSAM1;GDAP1
Short lower third of face	2/22	0.14772330356446647	0.6781363888080222	0	0	3.132686084142395	5.9909937447857935	MBD5;MTOR
Shwachman syndrome	2/22	0.14772330356446647	0.6781363888080222	0	0	3.132686084142395	5.9909937447857935	MDK;TP53
Psychosis, Brief Reactive	2/22	0.14772330356446647	0.6781363888080222	0	0	3.132686084142395	5.9909937447857935	CNTNAP2;CPLX2
Adenoid cystic carcinoma of salivary gland	2/22	0.14772330356446647	0.6781363888080222	0	0	3.132686084142395	5.9909937447857935	FHIT;MTOR
Anaplastic large B-cell lymphoma	2/22	0.14772330356446647	0.6781363888080222	0	0	3.132686084142395	5.9909937447857935	INSR;SYBU
Angiomyolipoma of kidney	2/22	0.14772330356446647	0.6781363888080222	0	0	3.132686084142395	5.9909937447857935	TP53;MTOR
Diabetic Polyneuropathies	2/22	0.14772330356446647	0.6781363888080222	0	0	3.132686084142395	5.9909937447857935	GRM5;INSR
Early onset torsion dystonia	2/22	0.14772330356446647	0.6781363888080222	0	0	3.132686084142395	5.9909937447857935	GRM5;ANO3
Familial generalized lipodystrophy	2/22	0.14772330356446647	0.6781363888080222	0	0	3.132686084142395	5.9909937447857935	INSR;AGPAT2
Fibromyxosarcoma	2/22	0.14772330356446647	0.6781363888080222	0	0	3.132686084142395	5.9909937447857935	CREB3L2;TP53
Fragile skin	2/22	0.14772330356446647	0.6781363888080222	0	0	3.132686084142395	5.9909937447857935	JUP;PLEC
Gallbladder adenocarcinoma	2/22	0.14772330356446647	0.6781363888080222	0	0	3.132686084142395	5.9909937447857935	TYK2;TP53
Hypoplastic iliac wing	2/22	0.14772330356446647	0.6781363888080222	0	0	3.132686084142395	5.9909937447857935	ERCC8;HDAC6
Intracranial Meningioma	2/22	0.14772330356446647	0.6781363888080222	0	0	3.132686084142395	5.9909937447857935	AKT1;NDRG2
Minimal Brain Dysfunction	2/22	0.14772330356446647	0.6781363888080222	0	0	3.132686084142395	5.9909937447857935	CHRNB2;GRM5
Mucopolysaccharidosis Type IIIA	2/22	0.14772330356446647	0.6781363888080222	0	0	3.132686084142395	5.9909937447857935	IDUA;SGSH
Neurodegeneration with brain iron accumulation (NBIA)	2/22	0.14772330356446647	0.6781363888080222	0	0	3.132686084142395	5.9909937447857935	ATP13A2;YWHAZ
Sarcoma, Epithelioid	3/43	0.14787055159420653	0.6781363888080222	0	0	2.3508914100486225	4.493536249694582	RIMS2;HDAC9;TP53
Gemistocytic astrocytoma	3/43	0.14787055159420653	0.6781363888080222	0	0	2.3508914100486225	4.493536249694582	ERCC1;SSSCA1;TP53
High Grade Lymphoma (neoplasm)	3/43	0.14787055159420653	0.6781363888080222	0	0	2.3508914100486225	4.493536249694582	FPGS;GAPDH;TP53
Peroxisomal Disorders	3/43	0.14787055159420653	0.6781363888080222	0	0	2.3508914100486225	4.493536249694582	AGK;PEX6;PEX26
Primary Carcinoma	3/43	0.14787055159420653	0.6781363888080222	0	0	2.3508914100486225	4.493536249694582	USP22;ERBB2;TP53
Pyruvate Carboxylase Deficiency Disease	3/43	0.14787055159420653	0.6781363888080222	0	0	2.3508914100486225	4.493536249694582	ERBB2;OGDH;SDC1
Hypertrophic disorder of skin, unspecified	4/66	0.1481601155009178	0.6781363888080222	0	0	2.0232509426057814	3.8633202420891397	HDAC4;AIMP2;SSSCA1;NDRG2
stage, non-small cell lung cancer	4/66	0.1481601155009178	0.6781363888080222	0	0	2.0232509426057814	3.8633202420891397	ERCC1;ERBB2;AKT1;TP53
Addison Disease	4/66	0.1481601155009178	0.6781363888080222	0	0	2.0232509426057814	3.8633202420891397	GNAO1;VANGL2;PEX6;PEX26
Degenerative brain disorder	8/167	0.14840229852967554	0.6781363888080222	0	0	1.5802195091873228	3.014787752081215	GNAO1;ROGDI;TUBGCP6;ERCC8;MTR;FADD;PIGG;TTC19
Ischemic cardiomyopathy	6/116	0.1516869076399334	0.6781363888080222	0	0	1.7118744447734675	3.2284868422813684	ATXN2;ERBB2;AKT1;GAPDH;LDLR;SMG6
Growth retardation	8/168	0.1519008568269328	0.6781363888080222	0	0	1.5702614379084967	2.959200435862815	ABCD4;PIGO;AGK;TMEM67;NPHP1;AP1S1;RBCK1;ACTB
Poor growth	8/168	0.1519008568269328	0.6781363888080222	0	0	1.5702614379084967	2.959200435862815	ABCD4;PIGO;AGK;TMEM67;NPHP1;AP1S1;RBCK1;ACTB
Turridolichocephaly	5/91	0.15222364294558702	0.6781363888080222	0	0	1.8239742862544905	3.433457412210323	JAG1;IDUA;PEX6;AKT1;PEX26
Narrow cranium shape	5/91	0.15222364294558702	0.6781363888080222	0	0	1.8239742862544905	3.433457412210323	JAG1;IDUA;PEX6;AKT1;PEX26
Narrow head shape	5/91	0.15222364294558702	0.6781363888080222	0	0	1.8239742862544905	3.433457412210323	JAG1;IDUA;PEX6;AKT1;PEX26
Narrow skull shape	5/91	0.15222364294558702	0.6781363888080222	0	0	1.8239742862544905	3.433457412210323	JAG1;IDUA;PEX6;AKT1;PEX26
Tongue Carcinoma	4/67	0.15397272057403952	0.6781363888080222	0	0	1.9910327767470624	3.72518216892841	MAU2;ACTN4;FADD;TP53
Wide nose	4/67	0.15397272057403952	0.6781363888080222	0	0	1.9910327767470624	3.72518216892841	FRAS1;IDUA;HCCS;ACTB
Aplasia/Hypoplasia of the cerebellum	4/67	0.15397272057403952	0.6781363888080222	0	0	1.9910327767470624	3.72518216892841	TMEM67;ERCC1;TUBGCP6;OTX2
Metastatic Renal Cell Cancer	4/67	0.15397272057403952	0.6781363888080222	0	0	1.9910327767470624	3.72518216892841	AKT1;ULK1;TP53;MTOR
Multiple Chronic Conditions	4/67	0.15397272057403952	0.6781363888080222	0	0	1.9910327767470624	3.72518216892841	BCL9;ERBB2;HMGB1;MTOR
Pustulosis of Palms and Soles	4/67	0.15397272057403952	0.6781363888080222	0	0	1.9910327767470624	3.72518216892841	TRAF3IP2;FBXL19;TYK2;TP53
Pyramidal sign	4/67	0.15397272057403952	0.6781363888080222	0	0	1.9910327767470624	3.72518216892841	ATXN2;IDUA;LMNB1;LY6E
Herpes Simplex Infections	20/503	0.15411989195736522	0.6781363888080222	0	0	1.3041407867494823	2.4387751708360623	HDAC4;RPAIN;NUMA1;XYLT2;MSI1;HDAC9;MTOR;HIPK2;LMNB1;RIMS2;SOX3;AIMP2;FCGRT;MDK;NFIC;ERBB2;AKT1;ERCC8;TP53;PDLIM7
Thyroiditis	3/44	0.15526849616220448	0.6781363888080222	0	0	2.2934340040320986	4.271748862561686	ERBB2;AKT1;TP53
Alkaline phosphatase raised	3/44	0.15526849616220448	0.6781363888080222	0	0	2.2934340040320986	4.271748862561686	PIGO;PGAP3;TP53
Congenital anomaly of brain	3/44	0.15526849616220448	0.6781363888080222	0	0	2.2934340040320986	4.271748862561686	AKT1;ZIC5;MTOR
Linear atrophy	3/44	0.15526849616220448	0.6781363888080222	0	0	2.2934340040320986	4.271748862561686	CEP104;LDLR;TP53
Medullomyoblastoma	3/44	0.15526849616220448	0.6781363888080222	0	0	2.2934340040320986	4.271748862561686	SUFU;ERBB2;OTX2
Melanotic medulloblastoma	3/44	0.15526849616220448	0.6781363888080222	0	0	2.2934340040320986	4.271748862561686	SUFU;ERBB2;OTX2
Mitochondrial Encephalomyopathies	3/44	0.15526849616220448	0.6781363888080222	0	0	2.2934340040320986	4.271748862561686	RERE;COQ4;TTC19
Paranasal Sinus Diseases	3/44	0.15526849616220448	0.6781363888080222	0	0	2.2934340040320986	4.271748862561686	RSPH1;DNAI1;CCDC40
Cleft upper lip	8/169	0.15543886966251566	0.6781363888080222	0	0	1.560427069378476	2.904739274263375	FRAS1;JUP;TCN2;CTBP1;SUFU;CHD7;MTR;ACTB
Growth delay	8/169	0.15543886966251566	0.6781363888080222	0	0	1.560427069378476	2.904739274263375	ABCD4;PIGO;AGK;TMEM67;NPHP1;AP1S1;RBCK1;ACTB
Movement Disorders	8/169	0.15543886966251566	0.6781363888080222	0	0	1.560427069378476	2.904739274263375	GNAO1;TSEN34;PEX6;PPP1R1B;KCNMA1;OGDH;ATP1A3;PEX26
Papillary Renal Cell Carcinoma	8/169	0.15543886966251566	0.6781363888080222	0	0	1.560427069378476	2.904739274263375	KCNMA1;ERBB2;KEAP1;SYP;TP53;SLC5A3;RELA;MTOR
Hyperhomocysteinemia	6/117	0.15600526563859762	0.6781363888080222	0	0	1.6963641165595562	3.151616398482533	SPINT1;TCN2;ERBB2;HSF1;TRIB3;MTR
Joint stiffness	6/117	0.15600526563859762	0.6781363888080222	0	0	1.6963641165595562	3.151616398482533	SETD5;IDUA;TPM2;ERCC1;ACTB;SGSH
Profound Mental Retardation	9/196	0.15645565953297672	0.6781363888080222	0	0	1.5118285969349798	2.804415794129767	HDAC4;TSEN34;TMEM135;CAPN10;PEX6;HEXA;MTR;PIGG;SHROOM4
Thyroid Neoplasm	19/476	0.1576247104069971	0.6781363888080222	0	0	1.3090400026214515	2.41850156977771	JUP;SORT1;TACSTD2;APEH;NDRG2;FHIT;RIMS2;RAD52;CCND3;TEP1;SGSM3;CREB3L2;CAPN5;ERBB2;AKT1;SDC1;SSSCA1;GAPDH;TP53
Hodgkin Disease	23/592	0.15854752612449063	0.6781363888080222	0	0	1.2736588625611949	2.34569864958416	PSMD12;HEXA;FOXN3;HMGB1;FHIT;HDAC9;HDAC6;MTOR;ACTB;RIMS2;GRM5;FCGRT;MDK;ERBB2;AKT1;SDC1;SSSCA1;OTX2;LDLR;EBAG9;GAPDH;TP53;PDLIM7
Stomatitis	2/23	0.15863850853120853	0.6781363888080222	0	0	2.983356449375867	5.49273869552596	DMRTA1;MTOR
Psychomotor retardation, profound	2/23	0.15863850853120853	0.6781363888080222	0	0	2.983356449375867	5.49273869552596	PEX6;PEX26
Taurodontism	2/23	0.15863850853120853	0.6781363888080222	0	0	2.983356449375867	5.49273869552596	FLII;PEX6
Activated B-cell type diffuse large B-cell lymphoma	2/23	0.15863850853120853	0.6781363888080222	0	0	2.983356449375867	5.49273869552596	AKT1;TP53
Cellulitis of eyelid	2/23	0.15863850853120853	0.6781363888080222	0	0	2.983356449375867	5.49273869552596	SETD5;TRAF3IP2
Childhood Non-Hodgkin Lymphoma	2/23	0.15863850853120853	0.6781363888080222	0	0	2.983356449375867	5.49273869552596	CCND3;HDAC9
Clubbed Fingers	2/23	0.15863850853120853	0.6781363888080222	0	0	2.983356449375867	5.49273869552596	DPP9;ATP11A
External genital hypoplasia	2/23	0.15863850853120853	0.6781363888080222	0	0	2.983356449375867	5.49273869552596	BBS2;PEX6
Functional Gastrointestinal Disorders	2/23	0.15863850853120853	0.6781363888080222	0	0	2.983356449375867	5.49273869552596	KEAP1;MTR
Gait imbalance	2/23	0.15863850853120853	0.6781363888080222	0	0	2.983356449375867	5.49273869552596	BBS1;CHD4
Hypobetalipoproteinemias	2/23	0.15863850853120853	0.6781363888080222	0	0	2.983356449375867	5.49273869552596	LDLR;CCT5
Increased gastric cancer	2/23	0.15863850853120853	0.6781363888080222	0	0	2.983356449375867	5.49273869552596	AKT1;TP53
Large elongated pulp chamber	2/23	0.15863850853120853	0.6781363888080222	0	0	2.983356449375867	5.49273869552596	FLII;PEX6
Meningomyelocele	2/23	0.15863850853120853	0.6781363888080222	0	0	2.983356449375867	5.49273869552596	VANGL2;FRAS1
Multi-infarct dementia	2/23	0.15863850853120853	0.6781363888080222	0	0	2.983356449375867	5.49273869552596	TP53;MTOR
Neonatal Alloimmune Thrombocytopenia	2/23	0.15863850853120853	0.6781363888080222	0	0	2.983356449375867	5.49273869552596	CACNB2;PGAP3
Pre B-cell acute lymphoblastic leukemia	2/23	0.15863850853120853	0.6781363888080222	0	0	2.983356449375867	5.49273869552596	KAT2A;MTOR
Blood basophil count (lab test)	10/224	0.1594408759083556	0.6781363888080222	0	0	1.4682089780910066	2.6957522375886653	RERE;DSTYK;RAB5B;ATXN2;SHARPIN;SUFU;MAST2;CHD7;CNTN4;UBAC2
Carcinoma, Large Cell	4/68	0.15986974160038467	0.6781363888080222	0	0	1.9598214285714286	3.59312859209544	ERBB2;AKT1;TP53;FHIT
Angle class 2 malocclusion	4/68	0.15986974160038467	0.6781363888080222	0	0	1.9598214285714286	3.59312859209544	FAM83H;FRAS1;ERCC8;TYK2
Angle class 3 malocclusion	4/68	0.15986974160038467	0.6781363888080222	0	0	1.9598214285714286	3.59312859209544	FAM83H;FRAS1;ERCC8;TYK2
Migraine with Aura	4/68	0.15986974160038467	0.6781363888080222	0	0	1.9598214285714286	3.59312859209544	INSR;MTR;CSAD;LDLR
Cerebellar Hypoplasia	7/144	0.16055587454357675	0.6781363888080222	0	0	1.603946130672414	2.9337991503696212	TSEN34;CEP104;ERCC1;ROGDI;CHMP1A;TUBGCP6;PIGG
Infection caused by Helicobacter pylori	13/308	0.1626719039495959	0.6781363888080222	0	0	1.3855583168123307	2.516201567255453	JAG1;TACSTD2;NDRG2;FHIT;ACTB;RELA;HDAC6;ERBB2;AKT1;ERCC8;TRIB3;AMPH;TP53
Adenoma, Microcystic	3/45	0.16277910245758304	0.6781363888080222	0	0	2.2387126649687428	4.064072103072606	TCN2;CDK2AP2;TP53
RENAL ADYSPLASIA	3/45	0.16277910245758304	0.6781363888080222	0	0	2.2387126649687428	4.064072103072606	JAG1;FRAS1;PLEC
MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA	3/45	0.16277910245758304	0.6781363888080222	0	0	2.2387126649687428	4.064072103072606	ERBB2;SPG7;TP53
Widely spaced teeth	3/45	0.16277910245758304	0.6781363888080222	0	0	2.2387126649687428	4.064072103072606	SETD5;MBD5;CDH3
Atypical Teratoid Rhabdoid Tumor	3/45	0.16277910245758304	0.6781363888080222	0	0	2.2387126649687428	4.064072103072606	RIMS2;INSR;TP53
Bronchogenic Carcinoma	3/45	0.16277910245758304	0.6781363888080222	0	0	2.2387126649687428	4.064072103072606	AKT1;TP53;ACTB
Endometrial Stromal Sarcoma	3/45	0.16277910245758304	0.6781363888080222	0	0	2.2387126649687428	4.064072103072606	JAG1;PHF1;TP53
Malignant Central Nervous System Neoplasm	3/45	0.16277910245758304	0.6781363888080222	0	0	2.2387126649687428	4.064072103072606	RHBDF1;TP53;LMF1
Nerve Degeneration	7/145	0.16453124174707118	0.6781363888080222	0	0	1.5922405844386127	2.8734446252031938	CHRNB2;ATXN2;IDUA;VPS54;OTX2;ATP13A2;TTC19
Retrognathia	6/119	0.16480139391273596	0.6781363888080222	0	0	1.66616701738203	3.004122797466759	DSTYK;MBD5;ALG9;HCCS;ACTB;ARCN1
Tremor	10/226	0.1657249344998007	0.6781363888080222	0	0	1.4544626593806922	2.614288834320747	KCNC1;TMEM67;ERCC8;SLC35F1;ATP13A2;TTC19;GABRG2;MAP2K5;ANO3;LMNB1
Underdeveloped nasal alae	4/69	0.1658482737439434	0.6781363888080222	0	0	1.9295704295704297	3.4668243083850308	HDAC4;ALG9;FRAS1;PLEC
Chronic otitis media	4/69	0.1658482737439434	0.6781363888080222	0	0	1.9295704295704297	3.4668243083850308	FLII;CHD7;DNAI1;TAPBP
Diabetic Angiopathies	4/69	0.1658482737439434	0.6781363888080222	0	0	1.9295704295704297	3.4668243083850308	RIMS2;AKT1;HMGB1;RELA
Macroglossia	5/94	0.16724569024024116	0.6781363888080222	0	0	1.7622179592582443	3.1513591310213553	TRAF3IP2;IDUA;KCNQ1OT1;AKT1;ACTB
Anemia, Megaloblastic	2/24	0.16969684311760772	0.6781363888080222	0	0	2.8476022359517503	5.050910858371039	TCN2;MTR
Secondary hypothyroidism	2/24	0.16969684311760772	0.6781363888080222	0	0	2.8476022359517503	5.050910858371039	SOX3;OTX2
Spastic Ataxia	2/24	0.16969684311760772	0.6781363888080222	0	0	2.8476022359517503	5.050910858371039	PRDM8;SPG7
Thymus Neoplasms	2/24	0.16969684311760772	0.6781363888080222	0	0	2.8476022359517503	5.050910858371039	ERCC1;TP53
Abnormality of immune system physiology	2/24	0.16969684311760772	0.6781363888080222	0	0	2.8476022359517503	5.050910858371039	PDE4D;ERCC1
Abnormality of macular pigmentation	2/24	0.16969684311760772	0.6781363888080222	0	0	2.8476022359517503	5.050910858371039	CDH3;PDE6B
Elastosis perforans serpiginosa	2/24	0.16969684311760772	0.6781363888080222	0	0	2.8476022359517503	5.050910858371039	INSR;MTOR
Long nose	2/24	0.16969684311760772	0.6781363888080222	0	0	2.8476022359517503	5.050910858371039	JAG1;ACTB
Macular pigmentary changes	2/24	0.16969684311760772	0.6781363888080222	0	0	2.8476022359517503	5.050910858371039	CDH3;PDE6B
Norrie disease	2/24	0.16969684311760772	0.6781363888080222	0	0	2.8476022359517503	5.050910858371039	SYP;TP53
Paroxysmal nonkinesigenic dyskinesia	2/24	0.16969684311760772	0.6781363888080222	0	0	2.8476022359517503	5.050910858371039	HMGB1;TP53
Penis carcinoma	2/24	0.16969684311760772	0.6781363888080222	0	0	2.8476022359517503	5.050910858371039	FHIT;TP53
Profound global developmental delay	2/24	0.16969684311760772	0.6781363888080222	0	0	2.8476022359517503	5.050910858371039	PEX6;PEX26
Progressive neurologic deterioration	2/24	0.16969684311760772	0.6781363888080222	0	0	2.8476022359517503	5.050910858371039	IDUA;LMNB1
Speech impairment	9/200	0.16992880010576797	0.6781363888080222	0	0	1.4798587844148723	2.6228658267245355	BBS1;SETD5;MBD5;PIGO;IFT172;FLII;PDE4D;PIGG;DHTKD1
Acute Coronary Syndrome	11/255	0.17024983501326	0.6781363888080222	0	0	1.4165657218229293	2.5080130409722123	GABRB1;ACSS2;JUP;AKT1;CKB;ACCS;KIF6;LDLR;FHIT;GAPDH;TMEM231
Steatohepatitis	22/569	0.1703713078518917	0.6781363888080222	0	0	1.2666413945326591	2.241670349900476	SORT1;INSR;HMGB1;HDAC9;AGPAT2;ACVR2B;MTOR;ACTB;RELA;LMF1;SPINT1;AKT2;PSME3;SGSM3;ERCC1;HSF1;TRIM24;AKT1;SHBG;LDLR;GAPDH;TP53
Facial asymmetry	3/46	0.17039601377191804	0.6781363888080222	0	0	2.1865365044664733	3.8693607216944352	KCNQ1OT1;CHD7;TCF12
Hypoalbuminemia	3/46	0.17039601377191804	0.6781363888080222	0	0	2.1865365044664733	3.8693607216944352	ACTN4;FHIT;GABRG2
Pyloric Stenosis	3/46	0.17039601377191804	0.6781363888080222	0	0	2.1865365044664733	3.8693607216944352	PEX6;CHD7;PEX26
Colorectal Neoplasms	39/1073	0.1706681260907319	0.6781363888080222	0	0	1.1909933183965484	2.105717146774601	ABCD4;CTBP1;TACSTD2;TMEM97;HMGB1;PPOX;FHIT;ACTB;RELA;NT5C;CDH3;AKT2;KCNQ1OT1;HSF1;FPGS;ERBB2;SLIT1;AKT1;SLC16A7;LDLR;CLIC1;EIF5A;GDF11;JAG1;INSR;CTNNBIP1;LEMD1;MTOR;TAPBP;MAF;SPINT1;TCN2;CAPN10;GIPC1;ERCC1;SDC1;RIN1;GAPDH;TP53
Squamous cell carcinoma of oropharynx	4/70	0.17190538239618763	0.6781363888080222	0	0	1.9002361275088548	3.345956782096843	ERBB2;CDK2AP2;AKT1;TP53
Philadelphia chromosome-positive acute lymphoblastic leukemia	4/70	0.17190538239618763	0.6781363888080222	0	0	1.9002361275088548	3.345956782096843	AKT1;GAPDH;TP53;MTOR
Apraxia, oculomotor, Cogan type	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	NPHP1
Bulbocavernosus Reflex, Decreased	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHRNB2
Retinal Neoplasms	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TP53
Cataract, congenital, cerulean type 1	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	MAF
Round ear	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TPM2
DIABETES MELLITUS, INSULIN-DEPENDENT, 4	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	BBS1
Diaphragm, Complete Agenesis Of	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	FRAS1
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	GRM5
Familial Amyloid Polyneuropathy, Type V	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TACSTD2
Sequoiosis	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	GNAO1
Hemiplegia, Crossed	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	ATP1A3
Leukemia, Natural Killer Cell Large Granular Lymphocytic	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	AKT1
Small intestine carcinoma	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	ERBB2
Memory, Short-Term	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	ANKS1B
Spastic paraplegia 17	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	AGPAT2
Spastic Paraplegia Type 7	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	SPG7
Myositis, Focal	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TARS
Myositis, Infectious	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TARS
Myositis, Proliferative	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TARS
Splenic Neoplasms	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TP53
Neoplasms, Fibrous Tissue	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CREB3L2
Squamous Lung Dysplasia	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	ERBB2
Ovarian Small Cell Carcinoma, Hypercalcemic Type	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	SGSM3
Sunburn	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TP53
Reflex, Abnormal	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHRNB2
Reflex, Acoustic, Abnormal	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHRNB2
Reflex, Anal, Absent	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHRNB2
Reflex, Anal, Decreased	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHRNB2
Reflex, Ankle, Abnormal	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHRNB2
Reflex, Ankle, Decreased	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHRNB2
Reflex, Biceps, Abnormal	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHRNB2
Reflex, Biceps, Absent	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHRNB2
Reflex, Biceps, Decreased	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHRNB2
Reflex, Corneal, Absent	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHRNB2
Reflex, Gag, Absent	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHRNB2
Reflex, Gag, Decreased	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHRNB2
Reflex, Knee, Abnormal	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHRNB2
Reflex, Knee, Decreased	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHRNB2
Reflex, Moro, Asymmetric	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHRNB2
Reflex, Pendular	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHRNB2
Reflex, Triceps, Abnormal	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHRNB2
Reflex, Triceps, Absent	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHRNB2
Reflex, Triceps, Decreased	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHRNB2
Sarcoma, metastatic	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TP53
Serous cystadenoma, borderline malignancy	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	ERBB2
Skin Diseases, Vascular	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	AKT1
Spina Bifida, X-Linked	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	VANGL2
Testosterone measurement	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	SHBG
Sterility, Reproductive	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TTC19
Thymic hypoplasia or aplasia	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHD7
Xeroderma pigmentosum, group F	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	ERCC1
Abnormal ciliary motility	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	RSPH4A
Abnormal Deep Tendon Reflex	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHRNB2
Abnormal hair whorl	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	UBE2A
Abnormal light- and dark-adapted electroretinogram	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	PDE6B
Abnormal sternal ossification	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CTBP1
Ulcerative Colitis-Associated Colorectal Adenocarcinoma	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TP53
Ulnar deviation of the hand or of fingers of the hand	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TPM2
Upper eyelid coloboma	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	FRAS1
Vagina Carcinoma	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TP53
Vascular fragility	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	FLII
Absent/hypoplastic paranasal sinuses	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	PDE4D
Acinar cell carcinoma of pancreas	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TP53
Acrocallosal Syndrome	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	SUFU
Visual Pathway Glioma	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	MTOR
Vitreoretinopathy	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CAPN5
Vocal cord paresis in severe cases	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	GDAP1
Weakness of vocal cord	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	GDAP1
Wide pubic symphysis	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	FRAS1
Adiponectin Deficiency	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	LDLR
Yellow-brown discoloration of the teeth	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	ROGDI
Anemia in malignant neoplastic disease	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	ERBB2
Aplasia/Hypoplasia of the thymus	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHD7
Arcus juvenilis	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	LDLR
Aristolochic Acid Nephropathy	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TP53
Axenfeld anomaly (disorder)	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	JAG1
Axonal regeneration	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	GDAP1
Brain Stem Neoplasms	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TP53
Broad columella	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	HDAC4
Bulbocavernousus Reflex Absent	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHRNB2
C1q DEFICIENCY	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	JAG1
Cardiac rhabdomyoma	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	SUFU
Cecal Neoplasms	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TP53
Central Apnea	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	SLC5A3
Charcot-Marie-Tooth disease type 4	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	GDAP1
Childhood Malignant Liver Neoplasm	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TP53
Chronic ulcerative stomatitis	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TP53
Classic medulloblastoma	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	OTX2
Colpocephaly	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	HCCS
Congenital Generalized Lipodystrophy Type 2	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	AGPAT2
Congenital immunodeficiency disease	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	LAD1
Congenital pyloric atresia	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	PLEC
Corticospinal tract hypoplasia	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	FLII
Cri-du-Chat Syndrome	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	DNAH5
Decreased Libido	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	SHBG
Decreased methionine synthase activity	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	MTR
Decreased methylcobalamin	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	MTR
Decreased serum ceruloplasmin	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	AP1S1
Dental Diseases	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	FADD
Difficulty in tongue movements	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	FRAS1
Dilated fourth ventricle	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	ATXN2
EEG with focal sharp slow waves	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	MAPK10
Epicanthus inversus	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	PEX6
Eruptive xanthoma	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	LMF1
Familial hyperchylomicronemia syndrome	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	LMF1
Fibrocalculous pancreatic diabetes	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	INSR
Focal white matter lesions	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	MTOR
Gangliosidoses	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	HEXA
Gasping for breath	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	POLD4
Hairy cell leukemia variant	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TP53
HEPATIC LIPASE DEFICIENCY (disorder)	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	LDLR
Hepatobiliary disease	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TP53
Hereditary Ovarian Carcinoma	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TP53
Hidradenoma Papilliferum	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	AKT1
HMG CoA lyase deficiency	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	LDLR
Hoarse voice due to vocal cord paresis	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	GDAP1
Hoffman's Reflex	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHRNB2
Hydroa Vacciniforme	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	ERCC8
Hyperplasia of columella	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	HDAC4
Hypokinesia of the tongue	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	FRAS1
Hyporeflexia	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHRNB2
Impairment of urinary concentration	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	NPHP1
Infantile hemangioma	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	AKT1
Insulin resistance - type A	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	INSR
Interleukin 17 Measurement	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	ANKS1B
Intermediate Grade Ductal Breast Carcinoma In Situ	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	ERBB2
Intestinal-Type Sinonasal Adenocarcinoma	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TP53
Involuntary dystonic or choreiform movements	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	KCNMA1
Juvenile cataract	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	LEMD2
Lentigo maligna melanoma	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TP53
LIPOPROTEIN GLOMERULOPATHY	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	LDLR
Lower limb hypertonia	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	SPG7
Male Germ Cell Tumor	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TP53
Malignant neoplasm of cecum	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TP53
Malignant neoplasm of thymus	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TP53
Malignant neuroendocrine tumor	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	SGSM3
Megacystis microcolon intestinal hypoperistalsis syndrome	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHRM3
Midline facial cleft - Tessier cleft 0	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHD7
Mixed bipolar I disorder	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	ATP1A3
Mucopolysaccharidosis VI	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	ADAMTS5
Nasal and nasal-type NK/T-cell lymphoma	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	PDLIM7
Non-Metastatic Childhood Soft Tissue Sarcoma	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TP53
Opisthorchis Viverrini-Related Cholangiocarcinoma	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TP53
Orthostatic hypotension due to autonomic dysfunction	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	LMNB1
Ovarian Fibromata	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	SUFU
Ovarian papillary adenocarcinoma	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	AKT1
Palmo-Mental Reflex	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CHRNB2
Papillary and follicular adenocarcinoma	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TP53
Parietal bossing	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	SUFU
Physical addiction	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	CNIH3
Pleomorphic carcinoma	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TP53
Pontocerebellar Hypoplasia Type 2	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	TSEN34
Posterior polar cataract	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	BBS2
Processing speed	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	SPATS2L
Proteus Syndrome	1/6	0.17218661723431983	0.6781363888080222	0	0	6.260096930533118	11.012614822082824	AKT1
Fragile X Syndrome	5/95	0.17237874047285953	0.6781363888080222	0	0	1.7425474254742548	3.063505093650579	GRM5;MBD5;RABEP2;PKP4;SHBG
Very poor growth	8/174	0.17370341911185638	0.6781363888080222	0	0	1.513032522245846	2.6484210870008043	ABCD4;PIGO;AGK;TMEM67;NPHP1;AP1S1;RBCK1;ACTB
Autism Spectrum Disorders	22/572	0.17643586162813898	0.6781363888080222	0	0	1.2595317725752508	2.185033022229499	DPP10;RERE;CNTNAP2;MBD5;MIR137HG;CHD7;FHIT;SMARCA2;MTOR;TMEM231;MAPK10;CACNB2;LRFN2;GRM5;MDK;SLC16A7;DIP2A;ETF1;CNTN4;PLCB1;FEZF2;CBLN2
Amyotrophic Lateral Sclerosis	25/660	0.17649758365953142	0.6781363888080222	0	0	1.2403229008138688	2.151275690041641	HDAC4;HEXA;KEAP1;HDAC6;RELA;LMNB1;RIMS2;ATXN2;GRM5;FGGY;OSBP;HSF1;AKT1;VPS54;CAPN1;MAP2K5;BBS2;SORT1;FNDC3A;SYP;MTOR;AMPH;GAPDH;TP53;LY6E
Renal failure in adulthood	5/96	0.17757185364269146	0.6781363888080222	0	0	1.723309211114089	2.978533075603227	CHRM3;TMEM67;NPHP1;ERCC8;CHD4
Retinal Detachment	5/96	0.17757185364269146	0.6781363888080222	0	0	1.723309211114089	2.978533075603227	CAPN5;XYLT2;TUBGCP6;HMGB1;TP53
PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	5/96	0.17757185364269146	0.6781363888080222	0	0	1.723309211114089	2.978533075603227	ATP1A3;ATP13A2;TP53;FHIT;RELA
Werner Syndrome	5/96	0.17757185364269146	0.6781363888080222	0	0	1.723309211114089	2.978533075603227	RIMS2;AIMP2;INSR;TP53;MTOR
Cakut	4/71	0.17803810816343751	0.6781363888080222	0	0	1.8717774762550883	3.230234318957094	CHRM3;DSTYK;FRAS1;CHD7
Essential Tremor	4/71	0.17803810816343751	0.6781363888080222	0	0	1.8717774762550883	3.230234318957094	ATXN2;SORT1;ANO3;LY6E
Malocclusion	4/71	0.17803810816343751	0.6781363888080222	0	0	1.8717774762550883	3.230234318957094	FAM83H;FRAS1;ERCC8;TYK2
Pterygium	4/71	0.17803810816343751	0.6781363888080222	0	0	1.8717774762550883	3.230234318957094	AIMP2;HMGB1;TP53;LDLR
Carcinoma, Transitional Cell	16/399	0.17808343067867877	0.6781363888080222	0	0	1.3139211177009666	2.267174996991905	NUMA1;MSI1;MTR;HMGB1;FHIT;HDAC9;MTOR;KAT2A;MAGED4B;TMEM67;SGSM3;ERCC1;ERBB2;AKT1;SDC1;TP53
Carcinoma, Pancreatic Ductal	3/47	0.1781129196093342	0.6781363888080222	0	0	2.136731987623398	3.6865839325245693	JAG1;ACTN4;TP53
Smell Perception	3/47	0.1781129196093342	0.6781363888080222	0	0	2.136731987623398	3.6865839325245693	GRM5;BNC2;CHMP1A
Abnormality of the cornea	3/47	0.1781129196093342	0.6781363888080222	0	0	2.136731987623398	3.6865839325245693	MAF;TACSTD2;DNAI1
Failure to thrive in infancy	3/47	0.1781129196093342	0.6781363888080222	0	0	2.136731987623398	3.6865839325245693	FLII;ERCC1;COG1
FRAGILE X TREMOR/ATAXIA SYNDROME	3/47	0.1781129196093342	0.6781363888080222	0	0	2.136731987623398	3.6865839325245693	GRM5;YWHAZ;MTOR
Kidney damage	3/47	0.1781129196093342	0.6781363888080222	0	0	2.136731987623398	3.6865839325245693	TMEM67;NPHP1;TMEM231
Male sterility	3/47	0.1781129196093342	0.6781363888080222	0	0	2.136731987623398	3.6865839325245693	MTR;TP53;ENO4
Waist-Hip Ratio	6/122	0.17837849506162468	0.6781363888080222	0	0	1.6228237672694596	2.7975008718126895	TSEN34;ZNRF3;CACNA2D1;MBOAT7;FAM19A2;GDAP1
Congenital Disorders of Glycosylation	6/122	0.17837849506162468	0.6781363888080222	0	0	1.6228237672694596	2.7975008718126895	LAD1;ALG9;PIGO;PGAP3;XYLT2;COG1
Adenoma of large intestine	11/258	0.1794447248476154	0.6781363888080222	0	0	1.3991410887962612	2.403567767962519	CDH3;AKT2;INSR;MTR;HMGB1;SEMA3F;NDRG2;OSBPL1A;TP53;FHIT;MTOR
Malignant neoplasm of gallbladder	9/203	0.1803767488686881	0.6781363888080222	0	0	1.456746587477011	2.4949809024041234	RPAIN;AKT2;SGSM3;ERBB2;KEAP1;FADD;SHBG;TP53;CLIC1
Chromophobe Renal Cell Carcinoma	7/149	0.18086098865774564	0.6781363888080222	0	0	1.5470670679870413	2.645525778307047	KCNMA1;ERBB2;KEAP1;TP53;SLC5A3;RELA;MTOR
Dystonia, Primary	2/25	0.1808789878484148	0.6781363888080222	0	0	2.723652736738427	4.657247480464605	ATP1A3;GABRG2
Human T-cell lymphotrophic virus, type I [HTLV-I]	2/25	0.1808789878484148	0.6781363888080222	0	0	2.723652736738427	4.657247480464605	TP53;RELA
Hydrocephalus, Normal Pressure	2/25	0.1808789878484148	0.6781363888080222	0	0	2.723652736738427	4.657247480464605	NPHP1;ERCC8
Abnormality of nail of toe	2/25	0.1808789878484148	0.6781363888080222	0	0	2.723652736738427	4.657247480464605	TRAF3IP2;PEX6
Urgency of micturition	2/25	0.1808789878484148	0.6781363888080222	0	0	2.723652736738427	4.657247480464605	SPG7;LMNB1
Uroureter	2/25	0.1808789878484148	0.6781363888080222	0	0	2.723652736738427	4.657247480464605	CHRM3;ACTB
Uterine Carcinosarcoma	2/25	0.1808789878484148	0.6781363888080222	0	0	2.723652736738427	4.657247480464605	ERBB2;TP53
Atrioventricular Septal Defect	2/25	0.1808789878484148	0.6781363888080222	0	0	2.723652736738427	4.657247480464605	IFT172;MTR
Cervix Diseases	2/25	0.1808789878484148	0.6781363888080222	0	0	2.723652736738427	4.657247480464605	TACSTD2;TP53
Diabetes Insipidus	2/25	0.1808789878484148	0.6781363888080222	0	0	2.723652736738427	4.657247480464605	ERBB2;TP53
Hallervorden-Spatz Syndrome	2/25	0.1808789878484148	0.6781363888080222	0	0	2.723652736738427	4.657247480464605	ATP13A2;YWHAZ
Hepatic Veno-Occlusive Disease	2/25	0.1808789878484148	0.6781363888080222	0	0	2.723652736738427	4.657247480464605	ERCC1;XYLT2
Insulin-resistant diabetes mellitus	2/25	0.1808789878484148	0.6781363888080222	0	0	2.723652736738427	4.657247480464605	AKT2;INSR
Non-infiltrating lobular carcinoma	2/25	0.1808789878484148	0.6781363888080222	0	0	2.723652736738427	4.657247480464605	ERBB2;TP53
Perianal Squamous Intraepithelial Neoplasia	2/25	0.1808789878484148	0.6781363888080222	0	0	2.723652736738427	4.657247480464605	FHIT;TP53
Pseudohypoparathyroidism	2/25	0.1808789878484148	0.6781363888080222	0	0	2.723652736738427	4.657247480464605	SOX3;PDE4D
Liver Failure	8/176	0.18126751209298173	0.6781363888080222	0	0	1.4948646125116714	2.5529019381180147	ALG9;JAG1;IFT172;PEX6;AKT1;TP53;AGPAT2;PEX26
Mental Depression	22/575	0.182613161458805	0.6781363888080222	0	0	1.2524992893732574	2.1297312989130055	HDAC4;CHRNB2;GPM6A;PRKCI;SORT1;PDE4D;DIXDC1;ATP1A3;MTR;SYP;CPLX2;NDRG2;HDAC9;YWHAZ;HDAC6;GRM5;PPP1R1B;AKT1;SHBG;TP53;MAP2K5;RAPGEF4
Short neck	9/204	0.18392250985447858	0.6781363888080222	0	0	1.4492005539468715	2.4538454360154196	SETD5;ALG9;IDUA;TPM2;ERCC1;XYLT2;UBE2A;ALDOA;ACTB
Leukodystrophy	9/204	0.18392250985447858	0.6781363888080222	0	0	1.4492005539468715	2.4538454360154196	NDUFS8;PEX6;HEXA;ERCC8;SPG7;YWHAZ;LMNB2;PEX26;LMNB1
Papilloma	9/204	0.18392250985447858	0.6781363888080222	0	0	1.4492005539468715	2.4538454360154196	PSME3;ERBB2;XYLT2;AKT1;SDC1;OTX2;TP53;FHIT;PDLIM7
Spinocerebellar Ataxia Type 7	4/72	0.1842434716866816	0.6781363888080222	0	0	1.844155844155844	3.1193844105396256	KAT2A;ATXN2;TP53;LY6E
Isolated somatotropin deficiency	4/72	0.1842434716866816	0.6781363888080222	0	0	1.844155844155844	3.1193844105396256	SOX3;IFT172;PDE4D;OTX2
Hearing Loss, Partial	11/260	0.1857023017757049	0.6781363888080222	0	0	1.3877579282647832	2.336443702316367	IDUA;PDE4D;TCF12;CHD7;AKT1;AP1S1;ELMOD3;HCCS;CHD4;LMNB2;SGSH
Epilepsies, Partial	3/48	0.18592356636982926	0.6781363888080222	0	0	2.0891410048622365	3.5148118222554148	CNTNAP2;AKT1;MTOR
Embryonal Neoplasm	3/48	0.18592356636982926	0.6781363888080222	0	0	2.0891410048622365	3.5148118222554148	KCNQ1OT1;ERCC1;TP53
Hyperthyroidism	6/124	0.18767251926190132	0.6781363888080222	0	0	1.5951526527908133	2.6687809192158096	FCGRT;AKT1;SHBG;LDLR;ACTB;RELA
Congenital deafness	12/289	0.18845595305461657	0.6781363888080222	0	0	1.3611295838875166	2.271576871818062	IDUA;GIPC1;PDE4D;TCF12;CHD7;AKT1;AP1S1;ELMOD3;HCCS;CHD4;LMNB2;SGSH
Hepatitis, Alcoholic	4/73	0.19051847829584798	0.6781363888080222	0	0	1.8173348390739694	3.013152231101172	GAPDH;TP53;ACTB;RELA
Syndactyly of fingers	4/73	0.19051847829584798	0.6781363888080222	0	0	1.8173348390739694	3.013152231101172	HDAC4;CDH3;FRAS1;AKT1
Attention Deficit Disorder	4/73	0.19051847829584798	0.6781363888080222	0	0	1.8173348390739694	3.013152231101172	CHRNB2;GRM5;ERBB2;AKT1
Chorea	4/73	0.19051847829584798	0.6781363888080222	0	0	1.8173348390739694	3.013152231101172	TSEN34;GNAO1;CHMP1A;KCNMA1
Photosensitivity of skin	4/73	0.19051847829584798	0.6781363888080222	0	0	1.8173348390739694	3.013152231101172	ERCC1;ERCC8;PPOX;GABRG2
Epithelial ovarian cancer	47/1329	0.19101439167316844	0.6781363888080222	0	0	1.1579393018652684	1.916860252355456	BNC2;TACSTD2;KEAP1;MSI1;HCCS;HMGB1;FHIT;HDAC9;HDAC6;RELA;SOX3;CDH3;CAPNS1;SALL2;FCGRT;DPP9;AKT2;SUFU;HSF1;ERBB2;IGF2BP1;AKT1;SSSCA1;CKB;FADD;CLIC1;SYBU;PRKCI;JAG1;INSR;ACTN4;RHOC;YWHAZ;MTOR;RAD52;MAPK10;AIMP2;FRAS1;RABEP2;NFIC;SGSM3;ERCC1;NEK10;SDC1;SHBG;EBAG9;TP53
Schizophreniform Disorders	2/26	0.19216668000516288	0.6781363888080222	0	0	2.6100323624595467	4.304966912150447	CNTNAP2;CPLX2
Tachypnea	2/26	0.19216668000516288	0.6781363888080222	0	0	2.6100323624595467	4.304966912150447	ABCD4;TMEM231
Abnormality of the eyelashes	2/26	0.19216668000516288	0.6781363888080222	0	0	2.6100323624595467	4.304966912150447	TUBGCP6;HCCS
Abnormality of the palate	2/26	0.19216668000516288	0.6781363888080222	0	0	2.6100323624595467	4.304966912150447	PEX6;PEX26
Yellow Fever	2/26	0.19216668000516288	0.6781363888080222	0	0	2.6100323624595467	4.304966912150447	STAT2;FADD
Anhidrosis	2/26	0.19216668000516288	0.6781363888080222	0	0	2.6100323624595467	4.304966912150447	NAA50;ERCC8
ANONYCHIA	2/26	0.19216668000516288	0.6781363888080222	0	0	2.6100323624595467	4.304966912150447	JUP;PLEC
Blepharitis	2/26	0.19216668000516288	0.6781363888080222	0	0	2.6100323624595467	4.304966912150447	SETD5;TRAF3IP2
Cortical gyral simplification	2/26	0.19216668000516288	0.6781363888080222	0	0	2.6100323624595467	4.304966912150447	ERCC1;TUBGCP6
Defect of vertebral segmentation	2/26	0.19216668000516288	0.6781363888080222	0	0	2.6100323624595467	4.304966912150447	TPM2;COG1
Generalized pustular psoriasis	2/26	0.19216668000516288	0.6781363888080222	0	0	2.6100323624595467	4.304966912150447	TRAF3IP2;STAT2
Hereditary nonpolyposis colorectal carcinoma	2/26	0.19216668000516288	0.6781363888080222	0	0	2.6100323624595467	4.304966912150447	AKT1;TP53
Metastatic osteosarcoma	2/26	0.19216668000516288	0.6781363888080222	0	0	2.6100323624595467	4.304966912150447	ERBB2;TP53
MOHR-TRANEBJAERG SYNDROME	2/26	0.19216668000516288	0.6781363888080222	0	0	2.6100323624595467	4.304966912150447	FHIT;TP53
Multiple lipomata	2/26	0.19216668000516288	0.6781363888080222	0	0	2.6100323624595467	4.304966912150447	VANGL2;AKT1
Overactive Bladder	2/26	0.19216668000516288	0.6781363888080222	0	0	2.6100323624595467	4.304966912150447	SPG7;LMNB1
Overactive bladder syndrome	2/26	0.19216668000516288	0.6781363888080222	0	0	2.6100323624595467	4.304966912150447	SPG7;LMNB1
Pfaundler-Hurler Syndrome	2/26	0.19216668000516288	0.6781363888080222	0	0	2.6100323624595467	4.304966912150447	IDUA;SGSH
Pharyngeal Carcinoma	2/26	0.19216668000516288	0.6781363888080222	0	0	2.6100323624595467	4.304966912150447	HDAC9;PDLIM7
Pituitary carcinoma	2/26	0.19216668000516288	0.6781363888080222	0	0	2.6100323624595467	4.304966912150447	ERBB2;TP53
Plasmablastic lymphoma	2/26	0.19216668000516288	0.6781363888080222	0	0	2.6100323624595467	4.304966912150447	SDC1;MTOR
Thin upper lip vermilion	6/125	0.19238895007465376	0.6781363888080222	0	0	1.5816658911121453	2.6069589376156115	SETD5;MBD5;MAF;PGAP3;ACTB;MTOR
Congenital hypoplasia of lung	6/125	0.19238895007465376	0.6781363888080222	0	0	1.5816658911121453	2.6069589376156115	ALG9;FRAS1;ERBB2;SSSCA1;TP53;FHIT
Myotonic Dystrophy	6/125	0.19238895007465376	0.6781363888080222	0	0	1.5816658911121453	2.6069589376156115	INSR;RAB1B;ERCC1;AMPH;WASL;PLCB1
Amenorrhea	3/49	0.19382176694986047	0.6781363888080222	0	0	2.043619195264604	3.3532036237821297	SOX3;CAPN10;OTX2
Dental Enamel Hypoplasia	3/49	0.19382176694986047	0.6781363888080222	0	0	2.043619195264604	3.3532036237821297	PEX6;ROGDI;PLEC
Female Breast Carcinoma	3/49	0.19382176694986047	0.6781363888080222	0	0	2.043619195264604	3.3532036237821297	ERBB2;ESYT1;TP53
ovarian neoplasm	34/938	0.1945452730263361	0.6781363888080222	0	0	1.185825606330605	1.9413036886954478	BNC2;EPB41;POP4;KEAP1;HCCS;WASL;FHIT;AGPAT2;HDAC6;RELA;SOX3;MAGED4B;MDK;AKT2;HSF1;ERBB2;IGF2BP1;AKT1;SSSCA1;PRKCI;JAG1;LMO4;INSR;ACTN4;RHOC;MTOR;IFFO1;BCL9;ERCC1;SDC1;SHBG;EBAG9;TP53;OTUB1
Malignant neoplasm of gastrointestinal tract	11/263	0.1952743856475545	0.6781363888080222	0	0	1.3710219720071937	2.239358194476453	RIMS2;JAG1;SPINT1;HSF1;ERBB2;SDC1;PKP3;NDRG2;TP53;EBAG9;HDAC9
Hepatoblastoma	10/235	0.19542542289396145	0.6781363888080222	0	0	1.3956284153005465	2.278470071080669	KCNQ1OT1;INSR;ERBB2;KEAP1;AKT1;SSSCA1;SHBG;TP53;LDLR;ACTB
Microcephaly	10/235	0.19542542289396145	0.6781363888080222	0	0	1.3956284153005465	2.278470071080669	TSEN34;MBD5;PEX6;CHMP1A;TUBGCP6;ATP1A3;MSI1;PTPN23;FEZF2;ARCN1
Acoustic Neuroma	4/74	0.19686012236132022	0.6781363888080222	0	0	1.7912801484230056	2.9112992721598063	ERBB2;AKT1;SSSCA1;TP53
Laryngeal Squamous Cell Carcinoma	6/126	0.19715012284004016	0.6781363888080222	0	0	1.5684039087947883	2.546758262448162	CCND3;SOX1;ERBB2;TACSTD2;TP53;RELA
Ceroid Lipofuscinosis, Neuronal, Parry Type	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	ATP13A2
Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	HMGB1
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	COG1
Corneal Dystrophy, Band-Shaped	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	JAG1
Corneal dystrophy, Lattice type 3	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TACSTD2
Scar Tissue	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	PPOX
Secondary malignant neoplasm of bone marrow	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	ERBB2
EPILEPSY, CHILDHOOD ABSENCE, 1	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	GABRG2
Selective tooth agenesis	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	CDH3
Hypomagnesemia 1, Intestinal	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	ACTN4
Kallmann syndrome, type 3, recessive	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	CHD7
Skin Pigmentation Disorder	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TP53
Skin Vesicle	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	PLEC
Spina bifida aperta of cervical spine	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	VANGL2
Myopathy, Centronuclear, Autosomal Recessive	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	AMPH
Spinocerebellar ataxia type 31	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	LMNB1
MYOPATHY, MYOSIN STORAGE (disorder)	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TPM2
Neoplasms, Bone Tissue	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TP53
NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	VANGL2
Periventricular Heterotopia, X-Linked	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	SOX3
Peroxisome Biogenesis Disorder, Complementation Group G	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	LDLR
Peroxisome Biogenesis Disorder, Complementation Group H	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	ERBB2
Pituitary Hormone Deficiency, Combined, 1	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	OTX2
Subcortical cerebral atrophy	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	ACTB
Subglottic stenosis	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	FRAS1
Pyloric Stenosis, Infantile Hypertrophic 1	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	GAPDH
Reflex, Corneal, Decreased	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	CHRNB2
Spina Bifida, Folate-Sensitive	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	VANGL2
Squamous cell carcinoma, metastatic	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TP53
Thick rib	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	SGSH
Thoracic Outlet Syndrome	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	RELA
Torre-Muir syndrome	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	FHIT
Transitional cell carcinoma in situ	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TP53
Abnormal hair pattern	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	SMARCA2
Abnormal isoelectric focusing of serum transferrin	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	COG1
Abnormal subcutaneous fat tissue distribution	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	AKT1
Tumor of Rete Testis	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	ERCC1
Type 1 fibers relatively smaller than type 2 fibers	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TPM2
Abnormality of internal carotid artery	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	LDLR
Absence of a tooth	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	CDH3
Absence of pain sensation	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	ZFHX2
Absent phalangeal crease	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TPM2
Vertebral wedging	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	SUFU
Acrocephalopolysyndactyly	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	FRAS1
Vision Disability	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TSEN34
Vision Disorders	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TSEN34
Vitreous Hemorrhage	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	CAPN5
Adenoid cystic breast carcinoma	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TP53
Adnexal mass	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TP53
Advanced breast cancer	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	ERBB2
Aplasia of the interphalangeal creases	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TPM2
Aplasia/Hypoplasia of the phalanges of the hand	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	FRAS1
Arcus Senilis	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	LDLR
Arthrogryposis renal dysfunction cholestasis syndrome	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	VPS39
Asterixis	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	PPP1R1B
Atypical absence seizure	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	MAPK10
Atypical fibroxanthoma of skin	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TP53
Axillary pterygia	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	PLEC
Ballismus	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	PPP1R1B
Basal Cell Cancer	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TP53
beta-Galactosidase Deficiency	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	HEXA
Brachydactyly type C	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	AKT1
Breathing dysregulation	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TMEM67
Broad distal phalanx of finger	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	SMARCA2
Bronchopneumonia	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	RELA
Calcification of falx cerebri	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	SUFU
Carcinoma of Endocrine Gland	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TP53
Cardiac dilatation	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TP53
Cataract and cardiomyopathy	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	AGK
Cellular Ependymoma	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	BCL7C
Cerebral artery atherosclerosis	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	LDLR
Cerebral ventriculomegaly	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	HYDIN
Chordee	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	HCCS
Chromosome 17 trisomy	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TP53
Chromosome 2q37 deletion syndrome	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	HDAC4
Chronic Lymphoproliferative Disorder of NK-Cells	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	AKT1
Cohen syndrome	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	BBS1
colon (non-specific) lesion	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	ERBB2
Complete Trisomy 21 Syndrome	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TP53
Congenital glucose-galactose malabsorption	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TP53
Congenital hypofibrinogenemia	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	FCGRT
Congenital macrodactylia	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	AKT1
Congenital malformation syndromes affecting facial appearance	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	FRAS1
Constrictive median neuropathy	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	IDUA
Cornela disease	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	DNAI1
Coxiella burnetii Infection	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	LDLR
Decreased adenosylcobalamin	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	ABCD4
Digitotalar Dysmorphism	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TPM2
Epidermolysis bullosa with pyloric atresia	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	PLEC
Euthyroid Goiter	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	KEAP1
Fetal Cerebral Ventriculomegaly	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	HYDIN
Head tremor	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	ANO3
Hemiballismus	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	PPP1R1B
Heparan sulfate excretion in urine	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	SGSH
Histiocytoid Cardiomyopathy	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	HCCS
Hydrocephalus Ex-Vacuo	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	HYDIN
Hypertrophic nerve changes	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	GDAP1
Hypointensity of cerebral white matter on MRI	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	UBE2A
Hypopharyngeal Neoplasms	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TP53
Hypoplastic superior helix	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	FRAS1
Impaired distal vibration sensation	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	LRSAM1
Impaired horizontal smooth pursuit	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	ATXN2
impaired motor coordination	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	ATP13A2
In situ cancer	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TP53
Increased megakaryocyte count	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TP53
Intratubular malignant germ cells	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TP53
Junctional split	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	PLEC
Kallmann Syndrome 2 (disorder)	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	CHD7
Labial hypoplasia	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	CHD7
Left Atrial Isomerism	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	ACVR2B
Lipidemia retinalis	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	LMF1
Macroprolactinoma	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TP53
Macropsia	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TSEN34
Malrotation of small bowel	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	CTBP1
Megaloblastic anemia due to inborn errors of metabolism	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	MTR
Meningeal Neoplasms	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	AKT1
Micropsia	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TSEN34
Mild depression	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	MTOR
MPS III C	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	SGSH
Mucopolysaccharidosis III	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	SGSH
Myasthenic Syndrome	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	PLEC
Myelolipoma	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	SDC1
Myocardial steatosis	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	LDLR
Narrow foramen obturatorium	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	KIAA0319L
Narrow vertebral interpedicular distance	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	PDE4D
Neointimal hyperplasia	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	HMGB1
Neural tube defects X-linked	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	VANGL2
Neuropathy ataxia and retinis pigmentosa	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	ATP11A
Non-small cell lung cancer stage III	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TP53
Normochromic anemia	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	ALDOA
Normocytic anemia	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	ALDOA
Oculomotor Nerve Paralysis	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	PLEC
Overriding aorta	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	HCCS
Papillary adenocarcinoma	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	ERBB2
Papillary ependymoma	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	BCL7C
Parasomnia	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	GNAO1
Parkinsonism with favorable response to dopaminergic medication	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	ATP13A2
Parotid Neoplasms	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TP53
POLYCYSTIC LIVER DISEASE 1	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	HDAC6
polyp benign	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	TP53
Pontocerebellar Hypoplasia Type 1	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	CHMP1A
Porphobilinogen synthase deficiency	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	PPOX
Post-Traumatic Hydrocephalus	1/7	0.19785649734591004	0.6781363888080222	0	0	5.216478190630048	8.451807197207739	HYDIN
Impaired cognition	25/671	0.19804014008115467	0.6781363888080222	0	0	1.218487394957983	1.9730790207307978	CNTNAP2;MTR;CPLX2;HDAC9;HDAC6;PEX26;LMNB1;DSTYK;GRM5;MAP2;NPHP1;AKT1;SYBU;BBS1;ALG9;INSR;PDE4D;SYP;YWHAZ;TTC19;MTOR;NFIC;PEX6;AMPH;ATP13A2
Burkitt Lymphoma	16/407	0.1983470765592292	0.6781363888080222	0	0	1.2864958249352145	2.0812117302943802	INSR;COG1;TYK2;FHIT;RIMS2;TBRG1;MAPK10;BCL9;AIMP2;CCND3;SGSM3;ERBB2;AKT1;SDC1;TP53;PDLIM7
Addictive Behavior	9/208	0.19840913677542105	0.6781363888080222	0	0	1.4197748151559764	2.296377907334136	GRM5;SGSM3;HSF1;ERBB2;KEAP1;AKT1;CNIH3;HDAC6;MTOR
Adenoid Cystic Carcinoma	9/208	0.19840913677542105	0.6781363888080222	0	0	1.4197748151559764	2.296377907334136	RAD52;JAG1;USP22;ERBB2;SDC1;ACCS;TP53;SMARCA2;MTOR
Rhinitis	5/100	0.19891041701138926	0.6781363888080222	0	0	1.6504065040650406	2.6652426539924496	RSPH1;IDUA;HYDIN;FOXJ1;LRRC6
Rash and Dermatitis Adverse Event Associated with Chemoradiation	5/100	0.19891041701138926	0.6781363888080222	0	0	1.6504065040650406	2.6652426539924496	RIMS2;ERCC1;ERBB2;SSSCA1;TP53
Low set ears	12/293	0.2006760025193582	0.6781363888080222	0	0	1.3414731223075482	2.1544911510980467	RERE;MBD5;ALG9;MAF;FRAS1;INSR;XYLT2;CHAMP1;CHD4;ACTB;HDAC6;PEX26
insulinoma	8/181	0.20078373805533642	0.6781363888080222	0	0	1.4512826325135064	2.3300732773030983	CCND3;MDK;INSR;ERBB2;AKT1;SSSCA1;TP53;KCNJ3
Small Lymphocytic Lymphoma	3/50	0.20180140954786585	0.6781363888080222	0	0	2.000034483947722	3.200997562987861	SLC35B2;WDR78;TP53
Carcinosarcoma	3/50	0.20180140954786585	0.6781363888080222	0	0	2.000034483947722	3.200997562987861	ERBB2;TACSTD2;TP53
Childhood onset	3/50	0.20180140954786585	0.6781363888080222	0	0	2.000034483947722	3.200997562987861	TPM2;TACSTD2;GDAP1
Hypertrichosis	3/50	0.20180140954786585	0.6781363888080222	0	0	2.000034483947722	3.200997562987861	NDUFS8;INSR;TP53
Gastritis, Atrophic	6/127	0.201954865412395	0.6781363888080222	0	0	1.5553611327967265	2.488128383253463	AKT1;FOXJ1;ERCC8;TP53;FHIT;PDLIM7
Hyperkeratosis	6/127	0.201954865412395	0.6781363888080222	0	0	1.5553611327967265	2.488128383253463	TRAF3IP2;INSR;KEAP1;AKT1;AP1S1;TP53
Undifferentiated carcinoma	10/237	0.20232494935994064	0.6781363888080222	0	0	1.3831876940853614	2.210168248476614	EIF5A;ERBB2;ACTN4;TP53;FHIT;YWHAZ;GAPDH;ACTB;RELA;PDLIM7
Angiogenic Switch	4/75	0.20326539168350166	0.6781363888080222	0	0	1.7659593927199562	2.8136020973998246	RPAIN;AIMP2;ERBB2;TP53
Breast Fibrocystic Disease	4/75	0.20326539168350166	0.6781363888080222	0	0	1.7659593927199562	2.8136020973998246	ERBB2;SHBG;TP53;FHIT
Clouding of corneal stroma	4/75	0.20326539168350166	0.6781363888080222	0	0	1.7659593927199562	2.8136020973998246	FRAS1;IDUA;PEX6;PEX26
Urogenital Abnormalities	2/27	0.20354266686533717	0.6781363888080222	0	0	2.5055016181229774	3.988456991052476	BBS1;PLEC
Vertebral body fusion	2/27	0.20354266686533717	0.6781363888080222	0	0	2.5055016181229774	3.988456991052476	CTBP1;SUFU
Basal cell nevus	2/27	0.20354266686533717	0.6781363888080222	0	0	2.5055016181229774	3.988456991052476	SUFU;KEAP1
Conotruncal defect	2/27	0.20354266686533717	0.6781363888080222	0	0	2.5055016181229774	3.988456991052476	TCN2;CHD7
Fused vertebrae	2/27	0.20354266686533717	0.6781363888080222	0	0	2.5055016181229774	3.988456991052476	CTBP1;SUFU
Gastric lymphoma	2/27	0.20354266686533717	0.6781363888080222	0	0	2.5055016181229774	3.988456991052476	CCND3;TP53
Hereditary Leiomyomatosis and Renal Cell Cancer	2/27	0.20354266686533717	0.6781363888080222	0	0	2.5055016181229774	3.988456991052476	AKT1;TP53
Homocystinuria	2/27	0.20354266686533717	0.6781363888080222	0	0	2.5055016181229774	3.988456991052476	ABCD4;MTR
Lobular carcinoma in situ of breast	2/27	0.20354266686533717	0.6781363888080222	0	0	2.5055016181229774	3.988456991052476	ERBB2;TP53
Long palpebral fissure	2/27	0.20354266686533717	0.6781363888080222	0	0	2.5055016181229774	3.988456991052476	PIGO;ACTB
Pelizaeus-Merzbacher Disease	2/27	0.20354266686533717	0.6781363888080222	0	0	2.5055016181229774	3.988456991052476	KCNQ1OT1;LMNB1
Hemangioma	5/101	0.20437778634515386	0.6781363888080222	0	0	1.633130081300813	2.5930596158701507	TBRG1;JAG1;CTBP1;AKT1;MTOR
Hematocrit procedure	5/101	0.20437778634515386	0.6781363888080222	0	0	1.633130081300813	2.5930596158701507	SEMA5B;GNB2;RANBP10;HYDIN;DCDC1
Adenocarcinoma of lung (disorder)	42/1187	0.2059748193252609	0.6781363888080222	0	0	1.1572354603284931	1.8284335941569996	ARHGAP1;TACSTD2;KEAP1;HMGB1;HDAC9;RELA;LMNB1;MDK;AKT2;KCNQ1OT1;CFL1;ERBB2;AKT1;DIP2A;SSSCA1;SEPHS1;CCT5;EIF5A;PRKCI;SLC15A2;INSR;USP22;CTNNBIP1;ACTN4;SMARCA2;YWHAZ;MTOR;SUPT7L;RAD52;AIMP2;FER;SGSM3;ERCC1;KCNMA1;NEK10;CDK2AP2;ULK1;PKP3;RIN1;ALDOA;GAPDH;TP53
Abnormality of metabolism/homeostasis	7/155	0.20655545235414727	0.6781363888080222	0	0	1.4838851902473436	2.3403634940724967	PEX6;AKT1;HCCS;TP53;ACTB;PEX26;LMF1
Biliary Tract Cancer	6/128	0.2068019916052757	0.6781363888080222	0	0	1.542532172798633	2.4310206868302364	SGSM3;ERBB2;KEAP1;AKT1;TP53;MTOR
Memory impairment	11/267	0.20837097238304178	0.6781363888080222	0	0	1.3493175287356323	2.116317198171808	CHRNB2;HDAC4;AIMP2;GRM5;MDK;PHF1;PDE4D;SYP;CAPN1;SPG7;CPLX2
Feeding difficulties	10/239	0.2093268221657629	0.6781363888080222	0	0	1.3709642780442408	2.1439941475997895	RERE;ABCD4;IDUA;TPM2;NPHP1;CHD7;CHAMP1;PDSS2;ACTB;PEX26
Early-Stage Breast Carcinoma	4/76	0.20973127150044982	0.6781363888080222	0	0	1.7413419913419914	2.719851209572339	JAG1;ERBB2;AKT1;TP53
Amaurosis congenita of Leber, type 1	3/51	0.2098564656982157	0.6781363888080222	0	0	1.9582658022690438	3.0575020406076314	RIMS2;ERBB2;PDE6B
Pain, Crushing	3/51	0.2098564656982157	0.6781363888080222	0	0	1.9582658022690438	3.0575020406076314	CACNA2D1;AKT1;PLCB1
Pain, Migratory	3/51	0.2098564656982157	0.6781363888080222	0	0	1.9582658022690438	3.0575020406076314	CACNA2D1;AKT1;PLCB1
Pain, Splitting	3/51	0.2098564656982157	0.6781363888080222	0	0	1.9582658022690438	3.0575020406076314	CACNA2D1;AKT1;PLCB1
Suffering, Physical	3/51	0.2098564656982157	0.6781363888080222	0	0	1.9582658022690438	3.0575020406076314	CACNA2D1;AKT1;PLCB1
Ache	3/51	0.2098564656982157	0.6781363888080222	0	0	1.9582658022690438	3.0575020406076314	CACNA2D1;AKT1;PLCB1
Autosomal recessive retinitis pigmentosa	3/51	0.2098564656982157	0.6781363888080222	0	0	1.9582658022690438	3.0575020406076314	BBS2;BBS1;PDE6B
Hermanski-Pudlak Syndrome	3/51	0.2098564656982157	0.6781363888080222	0	0	1.9582658022690438	3.0575020406076314	HPS6;RABGGTA;VPS39
Lafora Disease	3/51	0.2098564656982157	0.6781363888080222	0	0	1.9582658022690438	3.0575020406076314	PRDM8;HSF1;ATP13A2
Malignant neoplasm of female breast	3/51	0.2098564656982157	0.6781363888080222	0	0	1.9582658022690438	3.0575020406076314	ERBB2;ESYT1;TP53
Radiating pain	3/51	0.2098564656982157	0.6781363888080222	0	0	1.9582658022690438	3.0575020406076314	CACNA2D1;AKT1;PLCB1
Cleft palate, isolated	6/129	0.211690302245303	0.6781363888080222	0	0	1.5299118137761183	2.3753883729288474	DLG1;BNC2;CHD7;MTR;HMGB1;TP53
Hypothyroidism	11/268	0.21170258867089795	0.6781363888080222	0	0	1.3439969842760666	2.086653259047102	SOX3;ATXN2;JAG1;PGAP3;INSR;CHD7;AKT1;SPG7;SHBG;LDLR;ACTB
Growth failure	9/212	0.2133586725029023	0.6781363888080222	0	0	1.3915087113913234	2.149575691299766	ABCD4;PIGO;AGK;TMEM67;ERCC1;NPHP1;AP1S1;RBCK1;ACTB
Obesity	67/1961	0.2147642079200318	0.6781363888080222	0	0	1.1185622819563446	1.7205887884019673	CHRM3;GLDC;IFT172;XYLT2;HMGB1;ACTB;SOX3;CAPNS1;AKT2;CFL1;CAPN5;TRIM24;AKT1;SLC16A7;SSSCA1;THSD7A;CAPN1;PRKCI;LMO4;PDE4D;TYK2;C1QL3;YWHAZ;MAF;RABEP2;KCNMA1;ZNF318;TRIB3;SCG3;GAPDH;TP53;HDAC4;PDXK;CTBP1;FLII;SPG7;AGPAT2;STK33;ATXN2;HSF1;NPHP1;ERBB2;MAP6;PDE6B;FADD;NCAM2;LDLR;MAP2K5;BBS2;BBS1;SYT4;SLC37A2;NEGR1;SORT1;INSR;SYVN1;SMARCA2;MTOR;AIMP2;TCN2;CAPN10;SGSM3;SDC1;CNTN4;SHBG;OSBPL1A;PFKP
GASTRIC CANCER, INTESTINAL	2/28	0.21499066067300726	0.6781363888080222	0	0	2.4090117002738363	3.703038088683352	ERBB2;TP53
Short ulnae	2/28	0.21499066067300726	0.6781363888080222	0	0	2.4090117002738363	3.703038088683352	JAG1;PDE4D
Lymphoma, AIDS-Related	2/28	0.21499066067300726	0.6781363888080222	0	0	2.4090117002738363	3.703038088683352	TP53;PDLIM7
Lymphoma, Small Noncleaved-Cell	2/28	0.21499066067300726	0.6781363888080222	0	0	2.4090117002738363	3.703038088683352	FPGS;TP53
Parkinsonism, Experimental	2/28	0.21499066067300726	0.6781363888080222	0	0	2.4090117002738363	3.703038088683352	ATP1A3;ATP13A2
ULNAR HYPOPLASIA	2/28	0.21499066067300726	0.6781363888080222	0	0	2.4090117002738363	3.703038088683352	JAG1;PDE4D
Autosomal Dominant Juvenile Parkinson Disease	2/28	0.21499066067300726	0.6781363888080222	0	0	2.4090117002738363	3.703038088683352	ATP1A3;ATP13A2
Benign Meningioma	2/28	0.21499066067300726	0.6781363888080222	0	0	2.4090117002738363	3.703038088683352	AKT1;TP53
Childhood Burkitt Lymphoma	2/28	0.21499066067300726	0.6781363888080222	0	0	2.4090117002738363	3.703038088683352	AKT1;TP53
Condylomata Acuminata	2/28	0.21499066067300726	0.6781363888080222	0	0	2.4090117002738363	3.703038088683352	STAT2;TP53
Familial Juvenile Parkinsonism	2/28	0.21499066067300726	0.6781363888080222	0	0	2.4090117002738363	3.703038088683352	ATP1A3;ATP13A2
Hyperinsulinemic hypoglycemia	2/28	0.21499066067300726	0.6781363888080222	0	0	2.4090117002738363	3.703038088683352	INSR;MTOR
Malignant Bone Neoplasm	2/28	0.21499066067300726	0.6781363888080222	0	0	2.4090117002738363	3.703038088683352	TP53;MTOR
Malignant Mesothelioma of Peritoneum	2/28	0.21499066067300726	0.6781363888080222	0	0	2.4090117002738363	3.703038088683352	TEP1;TP53
Ramsay Hunt Paralysis Syndrome	2/28	0.21499066067300726	0.6781363888080222	0	0	2.4090117002738363	3.703038088683352	ATP1A3;ATP13A2
Anxiety disease	7/157	0.2154140647448564	0.6781363888080222	0	0	1.4639477977161501	2.247442734153001	SETD5;ATXN2;FLII;CHD7;ATP1A3;TP53;TTC19
Curvature of little finger	7/157	0.2154140647448564	0.6781363888080222	0	0	1.4639477977161501	2.247442734153001	RERE;HDAC4;SETD5;MBD5;JAG1;FLII;KCNAB2
Hyperkyphosis	7/157	0.2154140647448564	0.6781363888080222	0	0	1.4639477977161501	2.247442734153001	SETD5;CTBP1;IDUA;AKT1;ERCC8;ACTB;SHROOM4
Ichthyosis, X-Linked	5/103	0.215459261970811	0.6781363888080222	0	0	1.5996349759415962	2.455413177139409	ERCC1;ERBB2;AKT1;SHBG;TP53
Specific learning disability	5/103	0.215459261970811	0.6781363888080222	0	0	1.5996349759415962	2.455413177139409	BBS1;JAG1;PDE4D;SMARCA2;ACTB
Niemann-Pick Disease, Type C	4/77	0.21625474835870592	0.6781363888080222	0	0	1.7173990393168475	2.62985001582579	ERCC1;ULK1;LDLR;PDLIM7
Distal amyotrophy	4/77	0.21625474835870592	0.6781363888080222	0	0	1.7173990393168475	2.62985001582579	LRSAM1;ATXN2;GDAP1;CCT5
Parathyroid Adenoma	4/77	0.21625474835870592	0.6781363888080222	0	0	1.7173990393168475	2.62985001582579	SPG7;GAPDH;TP53;ACTB
Tauopathies	6/130	0.2166185863916937	0.6781363888080222	0	0	1.517495008931386	2.3211863730181106	AIMP2;MAP2;SGSM3;TP53;SYBU;HDAC6
Congenital pes cavus	6/130	0.2166185863916937	0.6781363888080222	0	0	1.517495008931386	2.3211863730181106	LRSAM1;IDUA;CHMP1A;ATP1A3;SPG7;GDAP1
Adrenocortical carcinoma	8/185	0.21697964786437496	0.6781363888080222	0	0	1.4181898748199846	2.166925656367153	AIMP2;JAG1;ZNRF3;KCNQ1OT1;ERCC1;AKT1;SYP;TP53
Malignant neoplasm of testis	8/185	0.21697964786437496	0.6781363888080222	0	0	1.4181898748199846	2.166925656367153	RIMS2;SPAG17;MAGED4B;ERCC1;ERBB2;SHBG;TP53;LEMD1
Big calvaria	9/213	0.2171646677451394	0.6781363888080222	0	0	1.3846153846153846	2.1144452894004506	IDUA;SUFU;PEX6;AKT1;CHD4;UBE2A;HDAC6;MTOR;PEX26
Increased size of skull	9/213	0.2171646677451394	0.6781363888080222	0	0	1.3846153846153846	2.1144452894004506	IDUA;SUFU;PEX6;AKT1;CHD4;UBE2A;HDAC6;MTOR;PEX26
Desmoplastic Medulloblastoma	3/52	0.2179809973569472	0.6781363888080222	0	0	1.9182019647405153	2.9220879527970136	SUFU;ERBB2;OTX2
Friedreich Ataxia	3/52	0.2179809973569472	0.6781363888080222	0	0	1.9182019647405153	2.9220879527970136	ATXN2;PIP5K1B;LY6E
Hereditary Breast and Ovarian Cancer Syndrome	3/52	0.2179809973569472	0.6781363888080222	0	0	1.9182019647405153	2.9220879527970136	RIMS2;ERBB2;TP53
Malignant ascites	3/52	0.2179809973569472	0.6781363888080222	0	0	1.9182019647405153	2.9220879527970136	ERBB2;FHIT;MTOR
Non-arthropod borne lymphocytic choriomeningitis	3/52	0.2179809973569472	0.6781363888080222	0	0	1.9182019647405153	2.9220879527970136	RPAIN;STAT2;MTOR
Depressive disorder	27/741	0.21895597135897235	0.6781363888080222	0	0	1.1903155866056372	1.8079520295862737	GPM6A;IDUA;CHD7;DIXDC1;ATP1A3;MTR;CPLX2;NDRG2;HDAC9;HDAC6;LMNB1;ATXN2;GRM5;AKT1;MAP2K5;CHRNB2;PRKCI;SORT1;PDE4D;SYP;YWHAZ;TTC19;AIMP2;PPP1R1B;SHBG;TP53;RAPGEF4
Craniosynostosis	9/214	0.2209970785851134	0.6781363888080222	0	0	1.3777893098079916	2.079918728612231	JAG1;IDUA;ERCC1;TCF12;KCNMA1;CHD7;SDC1;LDLR;ACTB
Parkinsonian Disorders	9/214	0.2209970785851134	0.6781363888080222	0	0	1.3777893098079916	2.079918728612231	RIMS2;ATXN2;PHF1;PPP1R1B;ATP1A3;ATP13A2;TP53;MTOR;LY6E
Recurrent mycobacterial infections	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TYK2
Red hair	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	PDE4D
Anticipation, Genetic	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	ATXN2
ARTHROGRYPOSIS, DISTAL, TYPE 1	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TPM2
Rhabdomyoma	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	SUFU
Roberts-SC phocomelia syndrome	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TP53
Schimke immunoosseous dysplasia	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	SMARCA2
Secondary malignant neoplasm of female breast	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TP53
Secondary malignant neoplasm of ovary	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TP53
Secretory breast carcinoma	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	ERBB2
Epilepsy, Frontal Lobe	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	CHRNB2
Fetal Membranes, Premature Rupture	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	RELA
Severe failure to thrive	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	INSR
Severe T-cell immunodeficiency	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	FRAS1
Short distal phalanx of the thumb	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	SUFU
Skin appendage adenoma	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TP53
Sleep-Related Neurogenic Tachypnea	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	CHRNB2
Leukocyte Adhesion Deficiency, Type III	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	LAD1
Slow channel syndrome	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	PLEC
MICROPHTHALMIA, ISOLATED 1	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	OTX2
MIGRAINE, FAMILIAL HEMIPLEGIC, 2	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	ATP1A3
Spindle Cell Oncocytoma of the Adenohypophysis	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	NDRG2
Nemaline Myopathy, Childhood Onset	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TPM2
Sprains and Strains	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	MTOR
NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	ACTN4
Squamous cell carcinoma of lip	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TP53
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	HMGB1
Subwakefullness Syndrome	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	CHRNB2
Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	HDAC4
PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	HDAC4
Pulmonary Hypertension, Primary, Fenfluramine-Associated	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	HDAC4
SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 2	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	JAG1
Thoracic dysplasia	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	IFT172
Tubular adenoma	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TP53
Abnormality of nail color	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	PEX6
Abnormality of the elbow	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	IDUA
Abnormality of the thymus	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	FRAS1
Uterine carcinoma	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TP53
Vitamin D measurement	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	NADSYN1
Acute blood cancer	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TP53
Weakness	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	ATP1A3
Acute Q fever	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	LDLR
Adenofibroma	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TP53
Xanthelasma of periocular region	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	LDLR
Xanthoma of periocular region	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	LDLR
Adrenocortical cytomegaly	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	KCNQ1OT1
Young adult onset	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	ATP1A3
Allergic bronchitis	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	YWHAZ
Alternating hemiplegia of childhood	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	ATP1A3
Angiosarcoma of liver	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TP53
Anterior pituitary agenesis	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	OTX2
Aplasia/Hypoplasia involving the nose	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	OTX2
Apocrine Carcinoma	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	ERBB2
Arima syndrome	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TMEM231
Auriculo-condylar syndrome	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	OTX2
Axonal degeneration/regeneration	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	GDAP1
Barretts esophagus with high grade dysplasia	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	SSSCA1
Brenner Tumor	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TP53
Cap Myopathy	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TPM2
Cardiac Carcinoma	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	MTR
Chronic cholecystitis	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TP53
Congenital atresia of extrahepatic bile duct	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	JAG1
Congenital hypoplasia of nose	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	OTX2
COWDEN-LIKE SYNDROME (disorder)	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	AKT1
Craniofacial asymmetry	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	CTBP1
Cryptophthalmos	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	FRAS1
Cryptophthalmos syndrome	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	FRAS1
Dental White Spot	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	AIMP2
Dilatation of the aortic arch	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	CHD7
Disorder of lymph node	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TP53
Encapsulated Thymoma	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	SSSCA1
Endometrial Stromal Tumors	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	PHF1
Environmental Carcinogenesis	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TP53
Epidermolysis Bullosa Simplex Kobner	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	PLEC
Erythroid hypoplasia	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TP53
Esophageal dysplasia	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TP53
Familial hypercholesterolemia - homozygous	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	LDLR
Familial meningioma	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	SUFU
Familial renal cell carcinoma	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	FHIT
Focal Dermal Hypoplasia	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	HCCS
Gastric erosions	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	RELA
Genitourinary Neoplasms	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TP53
Hereditary Clear Cell Renal Cell Carcinoma	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	FHIT
Hereditary Renal Cell Carcinoma	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	FHIT
High-functioning autism	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	CNTNAP2
Histiocytoma	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TP53
HTLV-II Infections	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	DNALI1
Hypocomplementaemia	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	LY6E
Hypotrophic nose	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	OTX2
Intractable diarrhea	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	PLEC
Irregular periods	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	ERCC8
Krukenberg Tumor	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	FHIT
KUFOR-RAKEB SYNDROME	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	ATP13A2
Leg Length Inequality	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	AKT1
Leukonychia	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	PEX6
Locally Advanced Malignant Neoplasm	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	ERCC1
Long Sleeper Syndrome	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	CHRNB2
Lymphedema praecox	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	AKT1
Maculopapular eruption	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	HDAC9
Malignant neoplasm of border of tongue	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TP53
Malignant neoplasm of dorsal surface of tongue	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TP53
Malignant neoplasm of ventral surface of tongue	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TP53
Malignant tumor of base of tongue	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TP53
Malignant tumor of junctional zone of tongue	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TP53
malignant tumor of lingual tonsil	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TP53
Meningeal Carcinomatosis	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	ERBB2
Morphological abnormality of the middle ear	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	FRAS1
Mucopolysacchariduria	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	IDUA
Multiple pterygium syndrome	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TPM2
Multiple Sulfatase Deficiency Disease	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	SGSH
Neonatal infection	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	ATP1A3
Nikolsky sign	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	JUP
Old myocardial infarction	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	ACTB
Oral Dyskinesia	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	PPP1R1B
Overgrowth of external genitalia	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	KCNQ1OT1
Pancreatic hyperplasia	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	KCNQ1OT1
Partial Paralysis (Paresis) Vocal Cords	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	GDAP1
Penile Neoplasms	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TP53
Peripheral hypomyelination	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	GDAP1
Perisylvian syndrome	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	AKT1
Periventricular cysts	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	CTBP1
Plantar hyperkeratosis	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	PLEC
Polysplenia Syndrome	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	ACVR2B
Portal hypertensive gastropathy	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	RELA
Precocious atherosclerosis	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	LDLR
Premature plaque build-up in arteries	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	LDLR
Progressive brain disease	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	TP53
Prominent glabella	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	CTBP1
Propionic acidemia	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	GLDC
Pseudoepiphyses of the metacarpals	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	CTBP1
Psychomotor deterioration	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	HEXA
Pyloric Atresia	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	PLEC
Qualitative abnormality of granulocyte	1/8	0.22273161759209054	0.6781363888080222	0	0	4.471036233556427	6.714547404566016	ACTB
Sicca Syndrome	4/78	0.2228328140303886	0.6781363888080222	0	0	1.694103194103194	2.5434138804161885	TRAF3IP2;DGKQ;HMGB1;TP53
Clinodactyly of the 5th finger	7/159	0.2244081153314902	0.6781363888080222	0	0	1.4445350734094617	2.158552785672742	RERE;HDAC4;SETD5;MBD5;JAG1;FLII;KCNAB2
Increased head circumference	9/215	0.2248553785391249	0.6781363888080222	0	0	1.3710295075715444	2.045984380246934	IDUA;SUFU;PEX6;AKT1;CHD4;UBE2A;HDAC6;MTOR;PEX26
Pain, Burning	3/53	0.226169163543788	0.6781363888080222	0	0	1.879740680713128	2.794181980212545	CACNA2D1;AKT1;PLCB1
Visual field constriction	3/53	0.226169163543788	0.6781363888080222	0	0	1.879740680713128	2.794181980212545	BBS2;PEX6;PEX26
Anxiety neurosis (finding)	3/53	0.226169163543788	0.6781363888080222	0	0	1.879740680713128	2.794181980212545	CHRNB2;MDK;DIXDC1
granulosa cell tumor	3/53	0.226169163543788	0.6781363888080222	0	0	1.879740680713128	2.794181980212545	ERBB2;AKT1;TP53
Mental deterioration	3/53	0.226169163543788	0.6781363888080222	0	0	1.879740680713128	2.794181980212545	MAPK10;ATP1A3;ACTB
Scrub Typhus	2/29	0.22649529571360022	0.6781363888080222	0	0	2.3196691837468535	3.444780888277039	AIMP2;RELA
Spinal Cord Myelodysplasia	2/29	0.22649529571360022	0.6781363888080222	0	0	2.3196691837468535	3.444780888277039	VANGL2;ZIC5
Staphylococcus aureus infection	2/29	0.22649529571360022	0.6781363888080222	0	0	2.3196691837468535	3.444780888277039	MDK;PSME3
Thyroid Agenesis	2/29	0.22649529571360022	0.6781363888080222	0	0	2.3196691837468535	3.444780888277039	SOX3;OTX2
Treatment related leukaemia	2/29	0.22649529571360022	0.6781363888080222	0	0	2.3196691837468535	3.444780888277039	FHIT;TP53
Breast cancer recurrent	2/29	0.22649529571360022	0.6781363888080222	0	0	2.3196691837468535	3.444780888277039	ERBB2;TP53
Costello syndrome (disorder)	2/29	0.22649529571360022	0.6781363888080222	0	0	2.3196691837468535	3.444780888277039	AKT1;TP53
Diastematomyelia	2/29	0.22649529571360022	0.6781363888080222	0	0	2.3196691837468535	3.444780888277039	VANGL2;ZIC5
Iniencephaly	2/29	0.22649529571360022	0.6781363888080222	0	0	2.3196691837468535	3.444780888277039	VANGL2;ZIC5
LEOPARD Syndrome	2/29	0.22649529571360022	0.6781363888080222	0	0	2.3196691837468535	3.444780888277039	AKT1;MTOR
Lymphoid hyperplasia	2/29	0.22649529571360022	0.6781363888080222	0	0	2.3196691837468535	3.444780888277039	TP53;PDLIM7
Neonatal hypoglycemia	2/29	0.22649529571360022	0.6781363888080222	0	0	2.3196691837468535	3.444780888277039	AKT2;KCNQ1OT1
Neurenteric Cyst	2/29	0.22649529571360022	0.6781363888080222	0	0	2.3196691837468535	3.444780888277039	VANGL2;ZIC5
Primary peritoneal carcinoma	2/29	0.22649529571360022	0.6781363888080222	0	0	2.3196691837468535	3.444780888277039	ERCC1;TP53
Acquired scoliosis	16/418	0.22788652856518535	0.6781363888080222	0	0	1.2505683503014728	1.8494748570532626	SETD5;CTBP1;IDUA;FLII;TPM2;PDE4D;SPG7;SMARCA2;GDAP1;ACTB;LMNB2;SHROOM4;KCNQ1OT1;SUFU;AKT1;TUBGCP6
Carcinoma	9/216	0.22873903474257234	0.6781363888080222	0	0	1.3643350174339999	2.0126308785674296	EIF5A;MDK;ERBB2;AKT1;ACTN4;TP53;FHIT;YWHAZ;ACTB
Frontal bossing	9/216	0.22873903474257234	0.6781363888080222	0	0	1.3643350174339999	2.0126308785674296	RERE;HDAC4;MBD5;IDUA;FLII;SUFU;TCF12;HDAC6;MTOR
Mammary Neoplasms, Experimental	7/160	0.228953713595512	0.6781363888080222	0	0	1.4350190320826537	2.1155558853193703	EIF5A;RNPEP;ERBB2;ACTN4;TP53;YWHAZ;ACTB
Distal sensory impairment	4/79	0.22946246891792185	0.6781363888080222	0	0	1.6714285714285715	2.4603692606689163	LRSAM1;ATP13A2;GDAP1;CCT5
Lysosomal Storage Diseases	4/79	0.22946246891792185	0.6781363888080222	0	0	1.6714285714285715	2.4603692606689163	IDUA;HEXA;TP53;SGSH
synovial sarcoma	9/217	0.2326475082598573	0.6781363888080222	0	0	1.3577048973939319	1.9798471136266453	AIMP2;SALL2;ERBB2;SYVN1;AKT1;SYP;TP53;SMARCA2;MTOR
Severe muscular hypotonia	3/54	0.23441522599522785	0.6781363888080222	0	0	1.8427876823338736	2.6732607123552192	PEX6;PIGG;PEX26
Luminal B Breast Carcinoma	4/80	0.2361407254875165	0.6781363888080222	0	0	1.6493506493506493	2.38055291387415	CFL1;ERBB2;GAPDH;TP53
Squamous cell carcinoma of esophagus	36/1023	0.23741305596587317	0.6781363888080222	0	0	1.148748802931257	1.6518477094931558	HIST1H2BM;KEAP1;MSI1;MTR;HMGB1;NDRG2;FHIT;RELA;WDR66;RIMS2;SOX3;MDK;AKT2;CFL1;ERBB2;AKT1;SSSCA1;FADD;CLIC1;PDLIM7;PRKCI;AGK;TPM2;SORBS2;RHOC;AIMP2;TCN2;CAPN10;SGSM3;PEX6;ERCC1;PPP1R1B;ULK1;SHBG;GAPDH;TP53
Recurrent bronchitis	2/30	0.23804208679709357	0.6781363888080222	0	0	2.236708275543227	3.2103648021424283	HYDIN;TAPBP
Abnormality of the sternum	2/30	0.23804208679709357	0.6781363888080222	0	0	2.236708275543227	3.2103648021424283	IFT172;SUFU
African Burkitt's lymphoma	2/30	0.23804208679709357	0.6781363888080222	0	0	2.236708275543227	3.2103648021424283	TP53;PDLIM7
Amyotrophic Lateral Sclerosis With Dementia	2/30	0.23804208679709357	0.6781363888080222	0	0	2.236708275543227	3.2103648021424283	ATXN2;TP53
Broad foot	2/30	0.23804208679709357	0.6781363888080222	0	0	2.236708275543227	3.2103648021424283	BBS1;AGPAT2
Carney Complex	2/30	0.23804208679709357	0.6781363888080222	0	0	2.236708275543227	3.2103648021424283	SGSM3;MTOR
Cornelia De Lange Syndrome	2/30	0.23804208679709357	0.6781363888080222	0	0	2.236708275543227	3.2103648021424283	SETD5;MAU2
Dilatation of ureter	2/30	0.23804208679709357	0.6781363888080222	0	0	2.236708275543227	3.2103648021424283	CHRM3;ACTB
High grade serous carcinoma	2/30	0.23804208679709357	0.6781363888080222	0	0	2.236708275543227	3.2103648021424283	FHIT;TP53
Hyperplasia of supraorbital margins	2/30	0.23804208679709357	0.6781363888080222	0	0	2.236708275543227	3.2103648021424283	UBE2A;AGPAT2
Hyperplasia of supraorbital ridge	2/30	0.23804208679709357	0.6781363888080222	0	0	2.236708275543227	3.2103648021424283	UBE2A;AGPAT2
Hypertrophy of supraorbital margins	2/30	0.23804208679709357	0.6781363888080222	0	0	2.236708275543227	3.2103648021424283	UBE2A;AGPAT2
Hypertrophy of supraorbital ridge	2/30	0.23804208679709357	0.6781363888080222	0	0	2.236708275543227	3.2103648021424283	UBE2A;AGPAT2
Methylmalonic acidemia	2/30	0.23804208679709357	0.6781363888080222	0	0	2.236708275543227	3.2103648021424283	ABCD4;MTR
Narcolepsy-Cataplexy Syndrome	2/30	0.23804208679709357	0.6781363888080222	0	0	2.236708275543227	3.2103648021424283	GNAO1;CHKB-CPT1B
Noncancerous mole	2/30	0.23804208679709357	0.6781363888080222	0	0	2.236708275543227	3.2103648021424283	SUFU;AKT1
Pancreatic Insufficiency	2/30	0.23804208679709357	0.6781363888080222	0	0	2.236708275543227	3.2103648021424283	JAG1;TP53
Polydipsia	2/30	0.23804208679709357	0.6781363888080222	0	0	2.236708275543227	3.2103648021424283	TMEM67;NPHP1
Prominent supraorbital ridges	2/30	0.23804208679709357	0.6781363888080222	0	0	2.236708275543227	3.2103648021424283	UBE2A;AGPAT2
Splenomegaly	10/247	0.238291951118968	0.6781363888080222	0	0	1.3241336376841668	1.8991501523390137	IDUA;IFT172;TMEM67;CHD7;AKT1;ERCC8;ALDOA;TP53;AGPAT2;SGSH
Neurilemmoma	6/135	0.24181653123639735	0.6781363888080222	0	0	1.4582986137413831	2.070165677525428	AKT2;ERBB2;AKT1;SEMA3F;TP53;MTOR
Epilepsy, Generalized	3/55	0.24271355435316833	0.6781363888080222	0	0	1.807255953123052	2.558845485768544	GLDC;KCNMA1;GABRG2
Hallucinations, Sensory	3/55	0.24271355435316833	0.6781363888080222	0	0	1.807255953123052	2.558845485768544	PRDM8;ATP13A2;TTC19
Spinocerebellar Ataxia Type 2	3/55	0.24271355435316833	0.6781363888080222	0	0	1.807255953123052	2.558845485768544	ATXN2;YWHAZ;LY6E
Adenosquamous carcinoma	3/55	0.24271355435316833	0.6781363888080222	0	0	1.807255953123052	2.558845485768544	LMO4;ERBB2;TP53
Hantavirus Infections	3/55	0.24271355435316833	0.6781363888080222	0	0	1.807255953123052	2.558845485768544	HPS6;RELA;PDLIM7
Hypocholesterolemia	3/55	0.24271355435316833	0.6781363888080222	0	0	1.807255953123052	2.558845485768544	AKT1;LDLR;CCT5
Lymphocytic Choriomeningitis	3/55	0.24271355435316833	0.6781363888080222	0	0	1.807255953123052	2.558845485768544	RPAIN;STAT2;MTOR
Primary central nervous system lymphoma	3/55	0.24271355435316833	0.6781363888080222	0	0	1.807255953123052	2.558845485768544	TCN2;MTR;PDLIM7
Metastatic malignant neoplasm to brain	7/163	0.24277396760562525	0.6781363888080222	0	0	1.4072029112812148	1.9920708374490004	KCNMA1;ERBB2;AKT1;ACTN4;TP53;ST6GALNAC5;MTOR
Neoplasms, Experimental	4/81	0.24286461152902414	0.6781363888080222	0	0	1.6278461797942319	2.303811170018699	ERBB2;NDRG2;TP53;RELA
Insulin Resistance	4/81	0.24286461152902414	0.6781363888080222	0	0	1.6278461797942319	2.303811170018699	AKT2;INSR;TRIB3;AGPAT2
Red cell distribution width determination	5/108	0.24393387417299275	0.6781363888080222	0	0	1.5215881285026442	2.14674493277534	CCND3;CDH3;TEX9;ATP11A;SHBG
Tumor Promotion	5/108	0.24393387417299275	0.6781363888080222	0	0	1.5215881285026442	2.14674493277534	KEAP1;SSSCA1;SPG7;TP53;EBAG9
RDW - Red blood cell distribution width result	5/108	0.24393387417299275	0.6781363888080222	0	0	1.5215881285026442	2.14674493277534	CCND3;CDH3;TEX9;ATP11A;SHBG
FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)	10/249	0.24575539429993	0.6781363888080222	0	0	1.312915837848961	1.8425704674742722	RIMS2;CTBP1;INSR;PHF1;ERCC1;ERBB2;TP53;FHIT;RELA;MTOR
Arthrogryposis	12/307	0.2460306811396791	0.6781363888080222	0	0	1.2768733273862622	1.7905582293800444	TSEN34;TPM2;PEX6;ERCC1;VPS8;ERBB2;ERCC8;RBCK1;GDAP1;VPS39;PEX26;PLEC
Recurrent hypoglycemia	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	INSR
Refractory Thrombocytopenia	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TP53
Renal medullary carcinoma	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	MTOR
Bare Lymphocyte Syndrome, Type I	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TAPBP
response to SSRI	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	PDZD2
Retinal defect	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	OTX2
Right Atrial Isomerism	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	ACVR2B
Clinically Isolated Syndrome, CNS Demyelinating	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TP53
Congenital disorder of glycosylation, type 2C	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	LAD1
Dementia, familial Danish	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	SYP
Schwannomatosis	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	MED16
Sclerosing Epithelioid Fibrosarcoma	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	CREB3L2
Gait, Scissors	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TTC19
Gangliosidoses, GM2	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	HEXA
Short 4th metacarpal	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	SUFU
Hyperbilirubinemia, Hereditary	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	HMGB1
Short Qt Syndrome	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	CACNA2D1
Short Sleeper Syndrome	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	CHRNB2
Situs ambiguous	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	ACVR2B
Leydig cell tumor, benign	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TP53
Small cell osteosarcoma	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TP53
MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TPM2
Spinal Cord Contusion	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	AKT1S1
Spinal Cord Injuries	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	AKT1S1
Spinal Cord Laceration	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	AKT1S1
Spinal Cord transection injury	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	AKT1S1
PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP A	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	PEX26
Peroxisome Biogenesis Disorder, Complementation Group C	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	PEX6
Subcortical Band Heterotopia	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	SYBU
Prostatic Cancer, Castration-Resistant	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TRIM24
Retinoschisis, Juvenile, X-Linked	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	ATP1A3
Tendinitis	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TP53
Thin eyebrow	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	PEX6
Ventricular tachycardia, polymorphic	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	ATXN2
Abnormal auditory evoked potential	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	ERCC8
Abnormality of earlobe	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	ATP1A3
Abnormality of peripheral nerve conduction	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	CCT5
Ulnar claw	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	GDAP1
Abnormality of the anus	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	FRAS1
Undifferentiated Neuroblastoma	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TP53
Abnormality of the intestine	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	AP1S1
Abnormality of the penis	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	AKT1
Urine color abnormal	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	PPOX
Absent frontal sinuses	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	DNAI1
Actual Aspiration	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	HEXA
Acute Myeloid Leukemia with Myelodysplasia-Related Changes	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TP53
X-Linked Dyskeratosis Congenita	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TP53
Adult Soft Tissue Sarcoma	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TP53
AL-RAQAD SYNDROME	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	FOXJ1
Anemia of inadequate production	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	MAN2A1
Aplasia of frontal sinus	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	DNAI1
Argyrophilic grain disease	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	LDLR
Asplenia Syndrome	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	ACVR2B
Asthenia	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	MTOR
Atresia	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	CHD7
Axonal degeneration	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TTC19
body fat percentage (physical finding)	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	IGF2BP1
Broad nail	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TRAF3IP2
Bronchial carcinoid	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TP53
Burkitt-like lymphoma	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TP53
Butterfly vertebrae	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	COG1
Calcaneovalgus deformity	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TPM2
Carbamoyl-Phosphate Synthase I Deficiency Disease	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	ERCC1
Carcinoid tumor of lung	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TP53
Carcinoma in situ of fallopian tube	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TP53
Carcinoma in situ of prostate	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	PDZD2
Cerebrooculofacioskeletal Syndrome 1	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	ERCC1
Cherry red spot of the macula	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	HEXA
Chronic fatigue	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TP53
Cicatrization	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	PPOX
Cleft lip or lips	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	CHD7
Congenital lactic acidosis	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	OGDH
Conjunctival hamartoma	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	AKT1
Corneal infection	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	SDC1
Cranial nerve abnormality	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	OTX2
Cutaneous Candidiasis	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TRAF3IP2
Decreased LDL	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	CCT5
Degeneration of the lateral corticospinal tracts	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	SPG7
Demyelination	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TP53
Distal sensory impairment of all modalities	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	CCT5
Duodenal atresia	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	CHD7
Dyggve-Melchior-Clausen syndrome	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	HMGB1
Dysembryoplastic neuroepithelial tumor	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	SYP
Dysglycemia	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	INSR
Elliptocytosis found	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	EPB41
Facies	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	JAG1
Flexion contracture of toe	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	ERCC1
Frontonasal dysplasia	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	CHD7
Functional intestinal obstruction	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TP53
Hemiplegic migraine	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	ATP1A3
Hyperargininemia	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TP53
Hypoparathyroidism familial isolated	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TP53
Inherited Peripheral Neuropathy	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	GDAP1
Late-onset muscular dystrophy	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	PLEC
LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 2	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	LDLR
Lung cancer stage I	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	GAPDH
Mature Teratoma	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TP53
Narrow internal auditory canal	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	OTX2
Narrow pelvis bone	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	IDUA
NEPHRONOPHTHISIS 2	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	NPHP1
Nonketotic hypoglycemia	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	AKT2
Obstruction of aortic arch	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	CHD7
Obstructive Hydrocephalus	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	HYDIN
Obtundation status	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	GABRG2
Osteoporosis with pseudoglioma	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	LDLR
Other lesions of median nerve	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	ERBB2
Ovarian cancer stage III	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TP53
Persistent Polyclonal B-Cell Lymphocytosis	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	PDLIM7
Pitt-Rogers-Danks Syndrome	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	CTBP1
Porokeratosis of Mibelli	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TP53
Post-Traumatic Myelopathy	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	AKT1S1
Precursor B-lymphoblastic lymphoma/leukemia	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TP53
Premature hardening of arteries	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	LDLR
Premature tooth eruption	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	INSR
Progressive encephalopathy	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TP53
Prominent nasolabial fold	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TPM2
Pschomotor retardation	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	GABRG2
Pseudohypoparathyroidism Type 1B	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	SOX3
Pulmonary aspiration	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	HEXA
Radicular Cyst	1/9	0.24683654540840763	0.6781363888080222	0	0	3.9119547657512115	5.472937854514057	TP53
Follicular adenoma	6/136	0.24695869698268005	0.6781363888080222	0	0	1.447005762966675	2.023687010974786	TCN2;ERBB2;TP53;GAPDH;ACTB;HIPK2
Brain Diseases	10/250	0.24951797820646024	0.6781363888080222	0	0	1.3073770491803278	1.8149326012849816	GNAO1;MAPK10;CNTNAP2;IDUA;SGSM3;AKT1;ATP1A3;HMGB1;TTC19;MTOR
Albinism, Ocular	2/31	0.24961738971943745	0.6781363888080222	0	0	2.159468809284678	2.996966904784817	HPS6;FNDC3A
Hypophosphatemic Rickets, X-Linked Dominant	2/31	0.24961738971943745	0.6781363888080222	0	0	2.159468809284678	2.996966904784817	SHBG;ACTB
Spinal fusion	2/31	0.24961738971943745	0.6781363888080222	0	0	2.159468809284678	2.996966904784817	CTBP1;SUFU
Terminal tremor	2/31	0.24961738971943745	0.6781363888080222	0	0	2.159468809284678	2.996966904784817	ATCAY;AKT1
AIDS-Associated Nephropathy	2/31	0.24961738971943745	0.6781363888080222	0	0	2.159468809284678	2.996966904784817	ACTN4;MTOR
Histiocytic sarcoma	2/31	0.24961738971943745	0.6781363888080222	0	0	2.159468809284678	2.996966904784817	HDAC9;LMNB1
Invasive Skin Melanoma	2/31	0.24961738971943745	0.6781363888080222	0	0	2.159468809284678	2.996966904784817	AKT1;ACTN4
Metatarsus Varus	2/31	0.24961738971943745	0.6781363888080222	0	0	2.159468809284678	2.996966904784817	CTBP1;TPM2
Myelomonocytic leukemia	2/31	0.24961738971943745	0.6781363888080222	0	0	2.159468809284678	2.996966904784817	MAGED4B;TP53
Progressive muscle weakness	2/31	0.24961738971943745	0.6781363888080222	0	0	2.159468809284678	2.996966904784817	PEX6;PEX26
Protein C Deficiency	2/31	0.24961738971943745	0.6781363888080222	0	0	2.159468809284678	2.996966904784817	DNAH5;DNAI1
Salivary Gland Neoplasms	4/82	0.2496311732746274	0.6781363888080222	0	0	1.606893106893107	2.2299992639466275	JAG1;ERBB2;AKT1;TP53
Malignant neoplasm of tongue	4/82	0.2496311732746274	0.6781363888080222	0	0	1.606893106893107	2.2299992639466275	MAU2;ACTN4;TP53;FHIT
Flexion contracture of proximal interphalangeal joint	5/109	0.24974627631354104	0.6781363888080222	0	0	1.5068792995622264	2.090508376332	RERE;IDUA;TPM2;ERCC1;KCNAB2
Adenoviral infections	3/56	0.25105863083942814	0.6781363888080222	0	0	1.77306504388245	2.450497838737091	ERBB2;SPG7;TP53
Claw hand	3/56	0.25105863083942814	0.6781363888080222	0	0	1.77306504388245	2.450497838737091	CDH3;TP53;GDAP1
Cystitis	3/56	0.25105863083942814	0.6781363888080222	0	0	1.77306504388245	2.450497838737091	ERBB2;TP53;RELA
Gastrointestinal Diseases	3/56	0.25105863083942814	0.6781363888080222	0	0	1.77306504388245	2.450497838737091	KEAP1;MTR;TP53
HER2 gene amplification	3/56	0.25105863083942814	0.6781363888080222	0	0	1.77306504388245	2.450497838737091	AIMP2;SSSCA1;TP53
Holoprosencephaly	3/56	0.25105863083942814	0.6781363888080222	0	0	1.77306504388245	2.450497838737091	SUFU;OTX2;ZIC5
Small testicle	5/110	0.2555935464581613	0.6781363888080222	0	0	1.4924506387921022	2.0359516201326167	CHRM3;SOX3;BBS1;CHD7;OTX2
Weight Gain	5/110	0.2555935464581613	0.6781363888080222	0	0	1.4924506387921022	2.0359516201326167	KCNMA1;SORBS2;MAP4;UBE2A;TP53
Glioma	74/2211	0.2564163175130587	0.6781363888080222	0	0	1.0935720027905333	1.4883000050848887	RERE;CNTNAP2;HEXA;KEAP1;MSI1;CASC2;TMEM97;WASL;HMGB1;ADAMTS5;CCND3;GRM5;MAGED4B;CAPNS1;MDK;AKT2;FPGS;TRIM24;AKT1;SSSCA1;CLIC1;SYBU;PRKCI;CTNNBIP1;ST7L;KAT2A;TEP1;KCNMA1;AKT1S1;ULK1;GAPDH;TP53;ST6GALNAC5;HDAC4;IGSF8;ADCY2;SEMA3F;SPG7;NDRG2;HDAC9;HDAC6;RELA;LMF1;SHARPIN;MAN2A2;S100A16;MAP2;HSF1;ERBB2;SLIT1;FADD;MIR92B;LDLR;KCNJ3;CADM4;JAG1;SORT1;INSR;SMARCA2;MTOR;ARCN1;HIPK2;RAD52;AIMP2;GIPC1;NFIC;SGSM3;ERCC1;CDK2AP2;PTPN9;SDC1;SHBG;EBAG9;LHX9
Testicular Neoplasms	4/83	0.2564374781890249	0.6781363888080222	0	0	1.5864704915337826	2.158980722618808	ERCC1;AKT1;TP53;SERINC2
Adverse reaction to drug	4/83	0.2564374781890249	0.6781363888080222	0	0	1.5864704915337826	2.158980722618808	TCN2;MTR;HMGB1;TP53
Drug toxicity	4/83	0.2564374781890249	0.6781363888080222	0	0	1.5864704915337826	2.158980722618808	TCN2;MTR;HMGB1;TP53
Paraganglioma	4/83	0.2564374781890249	0.6781363888080222	0	0	1.5864704915337826	2.158980722618808	ERBB2;SYP;CNTN4;TP53
Parkinson Disease	37/1064	0.256491809119113	0.6781363888080222	0	0	1.1341481542102512	1.5431883808833913	PDXK;IDUA;PHF1;RAB1B;HEXA;ATP1A3;MTR;ACTB;ATXN2;GRM5;APH1B;HSF1;AKT1;SLC16A7;PDSS2;FADD;CAPN1;RPS27A;SYBU;SKP1;INSR;SYP;YWHAZ;MTOR;ANO3;AIMP2;DLG1;RABEP2;DGKQ;SGSM3;OGDH;ULK1;SCG3;ATP13A2;GAPDH;TP53;LY6E
Malignant neoplasm of brain	7/166	0.2568501371493116	0.6781363888080222	0	0	1.3804364554156792	1.8763754910556294	INSR;TCF12;ERBB2;AKT1;OTX2;TP53;RELA
Mental Retardation, Psychosocial	6/138	0.25733552250361535	0.6781363888080222	0	0	1.4249333728161089	1.9341682394545159	HDAC4;TSEN34;TMEM135;CAPN10;PEX6;HEXA
Decreased tendon reflex	8/195	0.25944412667427075	0.6781363888080222	0	0	1.3416518122400476	1.810175288827784	CNTNAP2;LRSAM1;ATXN2;FLII;TPM2;PIGG;GDAP1;LY6E
Ameloblastoma	3/57	0.25944505409461965	0.6781363888080222	0	0	1.7401404646137224	2.3478155016251567	AKT1;TP53;MTOR
Broad nasal tip	3/57	0.25944505409461965	0.6781363888080222	0	0	1.7401404646137224	2.3478155016251567	PIGO;PGAP3;IDUA
Geographic Atrophy	3/57	0.25944505409461965	0.6781363888080222	0	0	1.7401404646137224	2.3478155016251567	KCNT2;TMEM97;HDAC9
Heart Septal Defects	3/57	0.25944505409461965	0.6781363888080222	0	0	1.7401404646137224	2.3478155016251567	CHD7;CHD4;HCCS
Malignant neoplasm of colon stage IV	3/57	0.25944505409461965	0.6781363888080222	0	0	1.7401404646137224	2.3478155016251567	ERCC1;AKT1;TP53
Obsessive compulsive behavior	3/57	0.25944505409461965	0.6781363888080222	0	0	1.7401404646137224	2.3478155016251567	SETD5;CHD7;TTC19
Pneumocystis jiroveci pneumonia	3/57	0.25944505409461965	0.6781363888080222	0	0	1.7401404646137224	2.3478155016251567	VANGL2;XYLT2;RELA
Nephroblastoma	14/370	0.26005755459465746	0.6781363888080222	0	0	1.2345459265027627	1.6627510312303293	JAG1;FLII;ACTN4;ACVR2B;RIMS2;TCN2;SALL2;MDK;KCNQ1OT1;SGSM3;ERBB2;RIN1;TP53;GAPDH
Epilepsy, Rolandic	2/32	0.26120836312090523	0.6781363888080222	0	0	2.087378640776699	2.8021740365435104	CNTNAP2;GABRG2
Unverricht-Lundborg Syndrome	2/32	0.26120836312090523	0.6781363888080222	0	0	2.087378640776699	2.8021740365435104	KCNC1;LMNB2
Acrania	2/32	0.26120836312090523	0.6781363888080222	0	0	2.087378640776699	2.8021740365435104	VANGL2;ZIC5
Aortic valve calcification	2/32	0.26120836312090523	0.6781363888080222	0	0	2.087378640776699	2.8021740365435104	AKT1;LDLR
Bowen's Disease	2/32	0.26120836312090523	0.6781363888080222	0	0	2.087378640776699	2.8021740365435104	FHIT;TP53
Cervical high grade squamous intraepithelial lesion	2/32	0.26120836312090523	0.6781363888080222	0	0	2.087378640776699	2.8021740365435104	FHIT;TP53
CHARGE Syndrome	2/32	0.26120836312090523	0.6781363888080222	0	0	2.087378640776699	2.8021740365435104	CHD7;TP53
Columnar Cell Change of the Breast	2/32	0.26120836312090523	0.6781363888080222	0	0	2.087378640776699	2.8021740365435104	FCGRT;TP53
Complete hydatidiform mole	2/32	0.26120836312090523	0.6781363888080222	0	0	2.087378640776699	2.8021740365435104	ERBB2;TP53
Dermatofibrosarcoma Protuberans	2/32	0.26120836312090523	0.6781363888080222	0	0	2.087378640776699	2.8021740365435104	INSR;TP53
Folic Acid Deficiency	2/32	0.26120836312090523	0.6781363888080222	0	0	2.087378640776699	2.8021740365435104	FPGS;MTR
Giant Cell Fibroblastoma	2/32	0.26120836312090523	0.6781363888080222	0	0	2.087378640776699	2.8021740365435104	INSR;TP53
Increased hepatocellular carcinoma risk	2/32	0.26120836312090523	0.6781363888080222	0	0	2.087378640776699	2.8021740365435104	JAG1;TP53
Increased incidence of hepatocellular carcinoma	2/32	0.26120836312090523	0.6781363888080222	0	0	2.087378640776699	2.8021740365435104	JAG1;TP53
Lipid Metabolism Disorders	2/32	0.26120836312090523	0.6781363888080222	0	0	2.087378640776699	2.8021740365435104	SORT1;LDLR
Overfolded helix	2/32	0.26120836312090523	0.6781363888080222	0	0	2.087378640776699	2.8021740365435104	CHD7;ACTB
Papillary serous cystadenocarcinoma	2/32	0.26120836312090523	0.6781363888080222	0	0	2.087378640776699	2.8021740365435104	ERBB2;TP53
Umbilical hernia	5/111	0.26147384792184786	0.6781363888080222	0	0	1.4782942169044333	1.9830149191892816	HDAC4;IDUA;INSR;CHD7;AGPAT2
Physical Activity Measurement	5/111	0.26147384792184786	0.6781363888080222	0	0	1.4782942169044333	1.9830149191892816	ZNF462;ZNRF3;ATP13A2;FHIT;MAP2K5
Short philtrum	4/84	0.26328061780853357	0.6781363888080222	0	0	1.5665584415584415	2.0906267999908703	CTBP1;FLII;ERCC1;CHAMP1
Squamous cell carcinoma of lung	11/283	0.26415530184378333	0.6781363888080222	0	0	1.2688834154351396	1.6891605494141508	RAD52;PRKCI;SGSM3;ERBB2;TRIM24;NEK10;KEAP1;AKT1;TP53;FHIT;GAPDH
Kyphosis deformity of spine	7/168	0.26636402861584446	0.6781363888080222	0	0	1.3631463224342153	1.8032945157436848	SETD5;CTBP1;IDUA;AKT1;ERCC8;ACTB;SHROOM4
Uric acid measurement (procedure)	5/112	0.2673853480892458	0.6781363888080222	0	0	1.464402401033356	1.9316410888249846	ATXN2;MBD5;IFT172;INSR;CNTN4
Cleft Palate	5/112	0.2673853480892458	0.6781363888080222	0	0	1.464402401033356	1.9316410888249846	DLG1;BNC2;CHD7;MTR;TP53
Neonatal Hypotonia	5/112	0.2673853480892458	0.6781363888080222	0	0	1.464402401033356	1.9316410888249846	COQ4;TPM2;PEX6;PDSS2;PEX26
Substance Dependence	6/140	0.26782720718253966	0.6781363888080222	0	0	1.4035198599834702	1.8490156682230825	AGBL4;GRM5;INSR;PPP1R1B;FHIT;GABRG2
Severe global developmental delay	3/58	0.2678675428070499	0.6781363888080222	0	0	1.7084131427729483	2.250428847502848	PEX6;ERCC1;PEX26
Sparse and thin eyebrow	3/58	0.2678675428070499	0.6781363888080222	0	0	1.7084131427729483	2.250428847502848	HDAC4;CDH3;JUP
Substance Withdrawal Syndrome	3/58	0.2678675428070499	0.6781363888080222	0	0	1.7084131427729483	2.250428847502848	CHRNB2;GNAO1;PPP1R1B
Wide anterior fontanel	3/58	0.2678675428070499	0.6781363888080222	0	0	1.7084131427729483	2.250428847502848	PEX6;MTOR;PEX26
Hepatosplenomegaly	3/58	0.2678675428070499	0.6781363888080222	0	0	1.7084131427729483	2.250428847502848	ALG9;IDUA;LMF1
Intestinal Cancer	3/58	0.2678675428070499	0.6781363888080222	0	0	1.7084131427729483	2.250428847502848	ERBB2;MSI1;TP53
Large cell carcinoma of lung	3/58	0.2678675428070499	0.6781363888080222	0	0	1.7084131427729483	2.250428847502848	STK33;ERCC1;MTOR
Nausea	3/58	0.2678675428070499	0.6781363888080222	0	0	1.7084131427729483	2.250428847502848	CHRNB2;NT5C;TP53
Nerve Sheath Tumors	3/58	0.2678675428070499	0.6781363888080222	0	0	1.7084131427729483	2.250428847502848	MDK;ERBB2;TP53
Malignant neoplasm of mouth	18/492	0.2684360241820204	0.6781363888080222	0	0	1.192606922074099	1.5684482453493909	TACSTD2;FOXN3;HMGB1;FHIT;MTOR;RELA;MAU2;GRM5;AKT2;PSME3;SGSM3;HSF1;ERBB2;AKT1;CNTN4;RIN1;GAPDH;TP53
Congenital Epicanthus	10/255	0.2686209279265697	0.6781363888080222	0	0	1.280361324857812	1.6829761712849713	RERE;CTBP1;PEX6;CHAMP1;CHD4;KCNAB2;ALDOA;ACTB;SHROOM4;PEX26
Ventricular Septal Defects	9/226	0.2688489609053981	0.6781363888080222	0	0	1.3007836364047758	1.7087165920258098	RERE;JAG1;CTBP1;CHD7;XYLT2;HCCS;FADD;ACVR2B;ARCN1
Body Height	12/314	0.27003103352191454	0.6781363888080222	0	0	1.2468194492854654	1.632358949045135	TSEN34;ZNF462;PSMD12;FER;INSR;STAT2;NFIC;SCMH1;PTPN9;ATP13A2;PLEC;PPIL6
Malformations of Cortical Development, Group II	4/85	0.2701577103246703	0.6781363888080222	0	0	1.5471380471380471	2.0248159571774043	PEX6;TUBGCP6;KIAA0319L;PEX26
Syndactyly	4/85	0.2701577103246703	0.6781363888080222	0	0	1.5471380471380471	2.0248159571774043	BBS1;CDH3;FRAS1;TCF12
Hyperopia	4/85	0.2701577103246703	0.6781363888080222	0	0	1.5471380471380471	2.0248159571774043	MBD5;CHMP1A;CHAMP1;ERCC8
46, XX Testicular Disorders of Sex Development	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	SOX3
Red and sore lips	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	TRAF3IP2
Apraxia, Verbal	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	CNTNAP2
Retinal pigment epithelial mottling	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	ERCC8
CEROID LIPOFUSCINOSIS, NEURONAL, 6	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	SYP
FAMILIAL ADENOMATOUS POLYPOSIS, ATTENUATED (disorder)	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	YWHAZ
Hemiplegic migraine, familial type 1	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	CSAD
Shield chest	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	XYLT2
Hyperferritinemia, hereditary, with congenital cataracts	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	TBC1D2
Short upper lip	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	CTBP1
Shoulder girdle muscle atrophy	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	ACTB
Leukemia, Megakaryoblastic, of Down Syndrome	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	TP53
Liver Diseases, Parasitic	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	TP53
Small cell carcinoma of the cervix	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	TP53
MENTAL RETARDATION, X-LINKED, SNYDER-ROBINSON TYPE	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	KCNQ1OT1
Spinocerebellar tract degeneration	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	ATXN2
Neuropathy, Painful	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	HMGB1
Stuttering	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	CNTNAP2
Subacute progressive viral hepatitis	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	TP53
Subcutaneous lipoma	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	AKT1
Porphyrias, Hepatic	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	PPOX
PSEUDOHYPOALDOSTERONISM, TYPE IID	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	KCNMA1
Schizoaffective disorder, bipolar type	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	GABRB1
Tuberculosis, Central Nervous System	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	RELA
Abdominal Cryptorchidism	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	CHRM3
True Hermaphroditism (disorder)	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	HCCS
Tubulovillous adenoma	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	TP53
Abnormality of female external genitalia	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	PDE4D
Abnormality of the cranial nerves	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	OTX2
Abnormality of the intervertebral disk	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	XYLT2
Variegate Porphyria	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	PPOX
Vascular degeneration	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	TP53
Accessory spleen	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	CTBP1
Xanthoma tendinosum	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	LDLR
Adult onset autosomal dominant leukodystrophy	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	LMNB1
Anal intraepithelial neoplasia	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	TP53
Angioid Streaks	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	AKT1
Bile Duct Neoplasms	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	LDLR
Bisphosphonate-associated osteonecrosis	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	SYP
Bladder Adenocarcinoma	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	TP53
Bladder Exstrophy	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	MEGF6
Broad chest	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	XYLT2
Broad neck	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	UBE2A
Cancer Cell Growth	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	LY6E
Childhood Soft Tissue Sarcoma	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	TP53
Chronic idiopathic neutropenia	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	HMGB1
Congenital ectopic pupil	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	CTBP1
Congenital euryblepharon	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	ACTB
Congenital posterior urethral valves	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	CHRM3
Deep plantar creases	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	MTOR
Deformity of spine	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	GDAP1
Dextrocardia	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	ACVR2B
Disorder of the genitourinary system	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	PLEC
Distemper	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	STAT2
Donohue Syndrome	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	INSR
Dysgenesis of corpus callosum	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	ZNF462
Ewing's sarcoma of bone	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	ERBB2
Exercise-induced muscle fatigue	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	AMPD3
Fasting hyperinsulinemia	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	INSR
Friend leukemia	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	FLII
Gliomatosis cerebri	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	TP53
Hereditary macular coloboma	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	SALL2
Heterotaxy Syndrome	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	ACVR2B
Hookworm Infections	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	HSF1
Increased connective tissue	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	PLEC
Increased size of penis	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	INSR
Infections specific to perinatal period	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	TP53
Inguinal Cryptorchidism	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	CHRM3
J-shaped hypophysial fossa	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	IDUA
J-shaped sella turcica	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	IDUA
Jaw Abnormalities	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	OTX2
Kabuki syndrome eyelids	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	ACTB
Large fleshy ears	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	ALG9
Laryngostenosis	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	FRAS1
Lennox-Gastaut syndrome	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	MAPK10
Leukostasis	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	HMGB1
Low-grade fibromyxoid sarcoma	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	CREB3L2
Lymphangioma	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	AKT1
Malignant tumor of eye	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	TP53
Merkel Cell Polyomavirus Infection	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	TP53
Metamorphopsia	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	TSEN34
Metastatic Malignant Neoplasm to the Leptomeninges	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	ERBB2
Miller-McKusick-Malvaux-Syndrome (3M Syndrome)	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	INSR
Motor Disorders	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	ATP1A3
Neurocutaneous Syndromes	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	AP1S1
Omega shaped hypophysial fossa	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	IDUA
Onycholysis	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	JUP
Papilledema	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	TP53
Perihilar Cholangiocarcinoma	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	TP53
Phthisis bulbi	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	SETD5
Polygenic hypercholesterolemia	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	LDLR
Premature arteriosclerosis	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	LDLR
Primary hypercholesterolemia	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	LDLR
Prostatic Adenoma	1/10	0.2701950902055904	0.6781363888080222	0	0	3.4771136241249327	4.550189222264238	TP53
Short metatarsal	2/33	0.2728029319527628	0.6781363888080222	0	0	2.019939450882138	2.6239126693516677	PDE4D;SMARCA2
Hyperkinesia, Generalized	2/33	0.2728029319527628	0.6781363888080222	0	0	2.019939450882138	2.6239126693516677	CNTNAP2;MAP6
Soluble Interleukin 6 Receptor Measurement	2/33	0.2728029319527628	0.6781363888080222	0	0	2.019939450882138	2.6239126693516677	CHRM3;SORBS2
Preauricular Fistulae, Congenital	2/33	0.2728029319527628	0.6781363888080222	0	0	2.019939450882138	2.6239126693516677	JAG1;CTBP1
Toeing-in	2/33	0.2728029319527628	0.6781363888080222	0	0	2.019939450882138	2.6239126693516677	CTBP1;TPM2
Trigeminal Neuralgia	2/33	0.2728029319527628	0.6781363888080222	0	0	2.019939450882138	2.6239126693516677	JAG1;ERBB2
Aplasia/Hypoplasia of the corpus callosum	2/33	0.2728029319527628	0.6781363888080222	0	0	2.019939450882138	2.6239126693516677	FLII;SUFU
Childhood T Acute Lymphoblastic Leukemia	2/33	0.2728029319527628	0.6781363888080222	0	0	2.019939450882138	2.6239126693516677	CCND3;TP53
Congenital preauricular sinus	2/33	0.2728029319527628	0.6781363888080222	0	0	2.019939450882138	2.6239126693516677	JAG1;CTBP1
CREST Syndrome	2/33	0.2728029319527628	0.6781363888080222	0	0	2.019939450882138	2.6239126693516677	HMGB1;KIAA0319L
Dysdiadochokinesis	2/33	0.2728029319527628	0.6781363888080222	0	0	2.019939450882138	2.6239126693516677	ATXN2;TTC19
Epithelial hyperplasia	2/33	0.2728029319527628	0.6781363888080222	0	0	2.019939450882138	2.6239126693516677	TACSTD2;TP53
Hereditary Motor and Sensory Neuropathies	2/33	0.2728029319527628	0.6781363888080222	0	0	2.019939450882138	2.6239126693516677	LRSAM1;GDAP1
High altitude pulmonary edema	2/33	0.2728029319527628	0.6781363888080222	0	0	2.019939450882138	2.6239126693516677	GAPDH;ACTB
Hypoplasia of scrotum	2/33	0.2728029319527628	0.6781363888080222	0	0	2.019939450882138	2.6239126693516677	FRAS1;ARCN1
Meniere Disease	2/33	0.2728029319527628	0.6781363888080222	0	0	2.019939450882138	2.6239126693516677	MTR;ACTB
MITOCHONDRIAL COMPLEX I DEFICIENCY	2/33	0.2728029319527628	0.6781363888080222	0	0	2.019939450882138	2.6239126693516677	NDUFS8;GDAP1
Paranoia	2/33	0.2728029319527628	0.6781363888080222	0	0	2.019939450882138	2.6239126693516677	PRDM8;TYK2
Periapical Periodontitis	2/33	0.2728029319527628	0.6781363888080222	0	0	2.019939450882138	2.6239126693516677	AIMP2;MDK
Pleural Tuberculosis	2/33	0.2728029319527628	0.6781363888080222	0	0	2.019939450882138	2.6239126693516677	FHIT;TP53
Preauricular dimple	2/33	0.2728029319527628	0.6781363888080222	0	0	2.019939450882138	2.6239126693516677	JAG1;CTBP1
Electroretinogram abnormal	6/141	0.2731129402722908	0.6784581676014456	0	0	1.3930510314875135	1.807998959352206	BBS2;BBS1;IFT172;CAPN5;NPHP1;PDE6B
Obesity, Morbid	5/113	0.2733262199973316	0.6784581676014456	0	0	1.4507678410117435	1.8817753739130403	BBS2;NEGR1;INSR;KCNMA1;TP53
Paresis	5/113	0.2733262199973316	0.6784581676014456	0	0	1.4507678410117435	1.8817753739130403	RIMS2;CCND3;TPM2;RBCK1;SHBG
Cervix carcinoma	38/1105	0.2756132131954201	0.6809419186637448	0	0	1.1206130816078739	1.4441977264153834	RPAIN;TACSTD2;KEAP1;MSI1;MTR;NDRG2;FHIT;HDAC6;RELA;RIMS2;SOX1;SHARPIN;MDK;HSF1;FPGS;ERBB2;AKT1;SSSCA1;CKB;PDLIM7;JAG1;URGCP;AGK;USP22;RHOC;MTOR;TAPBP;ST7L;RAD52;GNAO1;MAU2;TMEM54;GIPC1;SGSM3;ERCC1;SDC1;GAPDH;TP53
Respiratory function loss	7/170	0.27597297178972635	0.6809419186637448	0	0	1.3462804871946277	1.7332719720952114	COQ4;AGK;IFT172;TPM2;PEX6;PEX26;TMEM231
Developmental Disabilities	7/170	0.27597297178972635	0.6809419186637448	0	0	1.3462804871946277	1.7332719720952114	BBS2;JAG1;PDE4D;CHD7;HCCS;CNTN4;ACTB
Urinary Incontinence	3/59	0.2763209385738423	0.6809419186637448	0	0	1.6778189395693448	2.15799774700669	PRDM8;VANGL2;SPG7
Angina Pectoris	3/59	0.2763209385738423	0.6809419186637448	0	0	1.6778189395693448	2.15799774700669	ATXN2;LDLR;SMG6
Body fluid retention	3/59	0.2763209385738423	0.6809419186637448	0	0	1.6778189395693448	2.15799774700669	CHD7;PDSS2;ACTN4
Generalized myoclonic seizures	3/59	0.2763209385738423	0.6809419186637448	0	0	1.6778189395693448	2.15799774700669	PRDM8;MBOAT7;GABRG2
Leukocyte adhesion deficiency type 1	3/59	0.2763209385738423	0.6809419186637448	0	0	1.6778189395693448	2.15799774700669	LAD1;AKT1;TP53
Moderate mental retardation (I.Q. 35-49)	3/59	0.2763209385738423	0.6809419186637448	0	0	1.6778189395693448	2.15799774700669	PDE4D;TMEM67;AKT1
Chronic gastritis	4/86	0.2770659029971174	0.6809419186637448	0	0	1.5281913208742477	1.9614333832788926	ERBB2;AKT1;SSSCA1;TP53
Diabetic Neuropathies	4/86	0.2770659029971174	0.6809419186637448	0	0	1.5281913208742477	1.9614333832788926	RPAIN;GRM5;INSR;RELA
Intracranial Aneurysm	5/114	0.27929464381602637	0.6809419186637448	0	0	1.4373834564033714	1.83336532616076	TCN2;HCCS;MTR;TP53;HDAC9
Drug abuse	9/229	0.2812816620332882	0.6809419186637448	0	0	1.2828448147597085	1.627158766773505	AGBL4;GRM5;INSR;PPP1R1B;KEAP1;AKT1;TP53;FHIT;GABRG2
Endometrioma	9/229	0.2812816620332882	0.6809419186637448	0	0	1.2828448147597085	1.627158766773505	ERBB2;TACSTD2;AKT1;SYP;MED16;TP53;CNIH3;RELA;MTOR
Hyperactive behavior	25/709	0.2815317852271815	0.6809419186637448	0	0	1.1484593837535013	1.4556836662223704	RERE;CNTNAP2;TRAF3IP2;PGAP3;GLDC;RELA;SGSH;ATXN2;GRM5;AKT2;ERBB2;AKT1;MAP6;MAP2K5;PDLIM7;MBD5;KIRREL2;PDE4D;MTOR;SHROOM4;MAPK10;AIMP2;NFIC;SGSM3;TP53
Atrial Fibrillation	11/288	0.2825404117684687	0.6809419186637448	0	0	1.2456533466118926	1.574423228500366	LAD1;SEMA5B;CACNB2;CACNA2D1;SLC35F1;MTR;CAPN1;KCNAB2;MIR92B;TP53;PLEC
Triangular face	4/87	0.28400237449067955	0.6809419186637448	0	0	1.5097011422312627	1.9003705527650605	JAG1;TPM2;AGPAT2;SMARCA2
Hemangiosarcoma	4/87	0.28400237449067955	0.6809419186637448	0	0	1.5097011422312627	1.9003705527650605	ERBB2;AKT1;TP53;MTOR
Amyotrophic Lateral Sclerosis, Guam Form	2/34	0.2843897524245092	0.6809419186637448	0	0	1.956715210355987	2.460392517292881	ATXN2;TP53
Carcinoma, Ehrlich Tumor	2/34	0.2843897524245092	0.6809419186637448	0	0	1.956715210355987	2.460392517292881	ERBB2;TP53
Richter's syndrome	2/34	0.2843897524245092	0.6809419186637448	0	0	1.956715210355987	2.460392517292881	SLC35B2;TP53
Secondary malignant neoplasm of pancreas	2/34	0.2843897524245092	0.6809419186637448	0	0	1.956715210355987	2.460392517292881	ERBB2;TP53
Short long bone	2/34	0.2843897524245092	0.6809419186637448	0	0	1.956715210355987	2.460392517292881	ALG9;IFT172
Parkinson Disease, Familial, Type 1	2/34	0.2843897524245092	0.6809419186637448	0	0	1.956715210355987	2.460392517292881	AIMP2;PDSS2
Abnormality of the urinary system	2/34	0.2843897524245092	0.6809419186637448	0	0	1.956715210355987	2.460392517292881	DLG1;LMNB1
Adducted thumb	2/34	0.2843897524245092	0.6809419186637448	0	0	1.956715210355987	2.460392517292881	TPM2;ERCC1
Anoxemia	2/34	0.2843897524245092	0.6809419186637448	0	0	1.956715210355987	2.460392517292881	GAPDH;ACTB
Autosomal Recessive Parkinsonism	2/34	0.2843897524245092	0.6809419186637448	0	0	1.956715210355987	2.460392517292881	ATP1A3;ATP13A2
Coxa valga	2/34	0.2843897524245092	0.6809419186637448	0	0	1.956715210355987	2.460392517292881	IDUA;ARCN1
Coxa valga deformity	2/34	0.2843897524245092	0.6809419186637448	0	0	1.956715210355987	2.460392517292881	IDUA;ARCN1
Hypoxia	2/34	0.2843897524245092	0.6809419186637448	0	0	1.956715210355987	2.460392517292881	GAPDH;ACTB
Increased appetite (finding)	2/34	0.2843897524245092	0.6809419186637448	0	0	1.956715210355987	2.460392517292881	MBD5;AGPAT2
Metastatic Carcinoma	2/34	0.2843897524245092	0.6809419186637448	0	0	1.956715210355987	2.460392517292881	ERBB2;TP53
Parathyroid Gland Adenocarcinoma	2/34	0.2843897524245092	0.6809419186637448	0	0	1.956715210355987	2.460392517292881	RIMS2;TP53
Subfertility, Male	3/60	0.2848002084431822	0.6809419186637448	0	0	1.6482982171799028	2.070208772771089	MTR;TP53;ENO4
Ventricular arrhythmia	3/60	0.2848002084431822	0.6809419186637448	0	0	1.6482982171799028	2.070208772771089	CHRM3;JUP;PDE4D
Oropharyngeal Carcinoma	3/60	0.2848002084431822	0.6809419186637448	0	0	1.6482982171799028	2.070208772771089	ERCC1;AKT1;TP53
Spastic Paraplegia	5/115	0.2852888081217677	0.6809419186637448	0	0	1.4242424242424243	1.7863606893757258	DSTYK;ATP13A2;CAPN1;SPG7;CCT5
Ophthalmoplegia	6/144	0.28911442843739804	0.6809419186637448	0	0	1.3625548789123354	1.6908389362421596	BBS2;ATXN2;NDUFS8;IFT172;PDE6B;PLEC
Fanconi Anemia	11/290	0.290000233571212	0.6809419186637448	0	0	1.2365944523897805	1.5307475654121767	RIMS2;CTBP1;INSR;PHF1;ERCC1;ERBB2;TP53;FHIT;HDAC9;RELA;MTOR
Alcohol Use Disorder	4/88	0.2909643370412002	0.6809419186637448	0	0	1.4916512059369202	1.8415248167809053	PRKCI;ERCC1;SHBG;GABRG2
Atypical scarring of skin	4/88	0.2909643370412002	0.6809419186637448	0	0	1.4916512059369202	1.8415248167809053	BBS2;IFT172;ERCC8;PDE6B
Malignant neoplasm of liver	28/805	0.29125832169942856	0.6809419186637448	0	0	1.1323959094229366	1.3968609748070961	DPP10;ARHGAP1;MSI1;MTR;CHD4;HMGB1;NDRG2;PPOX;FHIT;HDAC6;RELA;LMNB1;NUDCD3;MAN2A1;ERBB2;IGF2BP1;TRIM24;AKT1;SSSCA1;CCDC134;URGCP;MTOR;AIMP2;FER;SDC1;GAPDH;TP53;TTLL9
Chronic Kidney Diseases	14/380	0.2921908176346085	0.6809419186637448	0	0	1.2001839528215117	1.4766441721344146	TRPC5;IFT172;INSR;PDE4D;KEAP1;HMGB1;DNAJC16;RELA;MTOR;ATXN2;AKT2;PIP5K1B;TP53;SYBU
Refractory Cytopenia of Childhood	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	MTOR
Arteriosclerotic cardiovascular disease, NOS	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	SORT1
Brain Stem Ischemia, Transient	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	NDRG2
Right bundle branch block	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	JUP
Right ventricular cardiomyopathy	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	JUP
Rotator cuff syndrome	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	ACTB
Rudiger syndrome 1	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	TP53
Familial Partial Lipodystrophy, Type 1	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	AKT2
Familial Partial Lipodystrophy, Type 3	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	AKT2
Gait, Shuffling	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	TTC19
Short Bowel Syndrome	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	INSR
SHORT syndrome	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	AKT1
Sinonasal undifferentiated carcinoma	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	ERBB2
Small face	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	INSR
Mixed Tumor, Mullerian	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	AKT1
Parkinson Disease, Secondary Vascular	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	ATP13A2
Porokeratosis, Disseminated Superficial Actinic	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	TP53
Sensory Neuropathy, Hereditary	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	CCT5
Thoracic kyphosis	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	XYLT2
Transient Ischemic Attack, Anterior Circulation	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	NDRG2
Transient Ischemic Attack, Vertebrobasilar Circulation	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	NDRG2
Abnormal diaphysis morphology	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	IDUA
Abnormal platelet morphology	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	TP53
Trisomy 4	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	TP53
Tuberculosis of intestines	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	SDC1
Abnormality of brainstem morphology	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	MAPK10
Type 1 muscle fiber predominance	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	TPM2
Ulnar deviation of the wrist	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	TPM2
Acantholysis	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	JUP
Acute recurrent pancreatitis	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	ERBB2
Adenolymphoma	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	PDLIM7
Alpers Syndrome (disorder)	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	RERE
AROMATASE EXCESS SYNDROME	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	SHBG
Arterial thrombosis	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	TP53
Atherosclerotic Parkinsonism	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	ATP13A2
Atrophy of corpus callosum	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	LMNB1
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	CHRNB2
Burn scar	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	TP53
Cannabis-Related Disorder	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	AKT1
Carotid Circulation Transient Ischemic Attack	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	NDRG2
Cataract microcornea syndrome	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	MAF
Cerebral Primitive Neuroectodermal Tumor	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	TP53
Congenital Mesoblastic Nephroma	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	TP53
Crescendo Transient Ischemic Attacks	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	NDRG2
Decreased vibratory sense	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	ATXN2
Dedifferentiated chondrosarcoma	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	TP53
Digestive System Disorders	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	TP53
Dimple chin	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	CHD7
Dry hair	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	ERCC8
Early onset schizophrenia	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	DLG1
Ectopic posterior pituitary	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	OTX2
Elfin facies	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	INSR
Exaggerated acoustic startle response	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	HEXA
Eyelid Xanthoma	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	LDLR
Fanconi-Bickel Syndrome	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	AGPAT2
Focal Clonic Seizures	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	GABRG2
Fundus Albipunctatus	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	KCNMA1
Gastrooesophageal cancer	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	ERBB2
Genitourinary dysplasia	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	PLEC
Glucocorticoid deficiency with achalasia	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	RIMS2
Hashish Abuse	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	AKT1
High Grade Ovarian Serous Adenocarcinoma	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	TP53
HODGKIN'S AND NON-HODGKIN'S LYMPHOMA	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	TP53
Hyperglycinemia	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	GLDC
Hypopigmentation-immunodeficiency disease	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	VPS39
Hypoplastic vertebral bodies	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	PDE4D
Increased startle response	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	HEXA
Isaacs syndrome	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	CNTNAP2
Jaw Keratocyst	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	TP53
Kallmann Syndrome 1	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	CHD7
Malignant neoplasm of body of pancreas	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	MTOR
Malignant neoplasm of fallopian tube	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	TP53
malignant neoplasm of head of pancreas	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	MTOR
Malignant neoplasm of other specified sites of pancreas	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	MTOR
Malignant neoplasm of tail of pancreas	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	MTOR
Marek Disease	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	TP53
MITOCHONDRIAL COMPLEX III DEFICIENCY (disorder)	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	TTC19
Multiple Endocrine Neoplasia Type 2b	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	SGSM3
Myxopapillary ependymoma	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	BCL7C
Nasopharyngeal Angiofibroma	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	TP53
Nemaline bodies	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	TPM2
Neurodevelopmental delay	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	GABRG2
Obstruction of pelviureteric junction	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	DSTYK
OROFACIODIGITAL SYNDROME VI	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	TMEM231
Osteochondromatosis	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	SLC35B2
Parapsoriasis	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	TP53
Peripheral Nerve Sheath Neoplasm	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	TP53
Pili torti-deafness syndrome	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	ANO3
Pityriasis Rubra Pilaris	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	RELA
Placental Steroid Sulfatase Deficiency	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	SHBG
Posterior Circulation Transient Ischemic Attack	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	NDRG2
Posterior helix pit	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	KCNQ1OT1
Pseudocholinesterase Measurement	1/11	0.29283032657130287	0.6809419186637448	0	0	3.1292407108239093	3.8432143042777063	RNPEP
Cholestasis, Extrahepatic	3/61	0.29330044716437614	0.6809419186637448	0	0	1.6197954507349244	1.986772709520123	HMGB1;TP53;RELA
Sinusitis	3/61	0.29330044716437614	0.6809419186637448	0	0	1.6197954507349244	1.986772709520123	RSPH1;DNAI1;CCDC40
Leukemia, Large Granular Lymphocytic	3/61	0.29330044716437614	0.6809419186637448	0	0	1.6197954507349244	1.986772709520123	PSMD12;AKT1;TP53
Aura	3/61	0.29330044716437614	0.6809419186637448	0	0	1.6197954507349244	1.986772709520123	CNTNAP2;AKT1;KCNAB2
Awakening Epilepsy	3/61	0.29330044716437614	0.6809419186637448	0	0	1.6197954507349244	1.986772709520123	CNTNAP2;AKT1;KCNAB2
Brain Infarction	3/61	0.29330044716437614	0.6809419186637448	0	0	1.6197954507349244	1.986772709520123	MDK;MSI1;TP53
Hemiparesis	3/61	0.29330044716437614	0.6809419186637448	0	0	1.6197954507349244	1.986772709520123	ATP1A3;MTOR;UBAC2
Hypoglycemia	9/232	0.29387081133464243	0.6812970449871658	0	0	1.2653886519929836	1.5496139562577016	RPAIN;SOX3;BNC2;AKT2;INSR;OTX2;CKB;TP53;MTOR
Sensorineural Hearing Loss (disorder)	17/471	0.2944472318877626	0.6812970449871658	0	0	1.1752617236869982	1.4369401758459603	BBS2;SETD5;IDUA;IFT172;CHD7;XYLT2;ATP1A3;ACTB;PEX26;MAF;NDUFS8;PEX6;ERCC1;OGDH;ERCC8;PDE6B;FADD
Melanocytic nevus	8/203	0.29507524147267883	0.6812970449871658	0	0	1.2860734037204626	1.5696846115991132	MAGED4B;MAP2;SUFU;CTNNBIP1;ERBB2;AKT1;HCCS;TP53
Sandal gap	2/35	0.295958178404835	0.6812970449871658	0	0	1.8973227419829362	2.3100608742192534	MBD5;SMARCA2
Prostate Cancer, Hereditary, 7	2/35	0.295958178404835	0.6812970449871658	0	0	1.8973227419829362	2.3100608742192534	AKT1;TP53
Therapy-related myelodysplastic syndrome	2/35	0.295958178404835	0.6812970449871658	0	0	1.8973227419829362	2.3100608742192534	HDAC9;TP53
Acanthosis	2/35	0.295958178404835	0.6812970449871658	0	0	1.8973227419829362	2.3100608742192534	JUP;AKT1
Asthenozoospermia	2/35	0.295958178404835	0.6812970449871658	0	0	1.8973227419829362	2.3100608742192534	TEKT2;LRRC6
Complete trisomy 18 syndrome	2/35	0.295958178404835	0.6812970449871658	0	0	1.8973227419829362	2.3100608742192534	KCNMA1;TP53
Congenital hemivertebra	2/35	0.295958178404835	0.6812970449871658	0	0	1.8973227419829362	2.3100608742192534	JAG1;SUFU
Deficiency of glucose-6-phosphate dehydrogenase	2/35	0.295958178404835	0.6812970449871658	0	0	1.8973227419829362	2.3100608742192534	RABEP2;LDLR
Esophageal Atresia	2/35	0.295958178404835	0.6812970449871658	0	0	1.8973227419829362	2.3100608742192534	CHD7;PLEC
HTLV-I Infections	2/35	0.295958178404835	0.6812970449871658	0	0	1.8973227419829362	2.3100608742192534	AKT1;TP53
Hyperphagia	2/35	0.295958178404835	0.6812970449871658	0	0	1.8973227419829362	2.3100608742192534	MBD5;AGPAT2
Juvenile Myoclonic Epilepsy	2/35	0.295958178404835	0.6812970449871658	0	0	1.8973227419829362	2.3100608742192534	EFHC1;GABRG2
Low Grade Squamous Intraepithelial Neoplasia	2/35	0.295958178404835	0.6812970449871658	0	0	1.8973227419829362	2.3100608742192534	FHIT;TP53
Multinodular goiter	2/35	0.295958178404835	0.6812970449871658	0	0	1.8973227419829362	2.3100608742192534	TRIM24;KEAP1
Nephrogenic Diabetes Insipidus	2/35	0.295958178404835	0.6812970449871658	0	0	1.8973227419829362	2.3100608742192534	BBS1;ARHGAP1
Polyuria	2/35	0.295958178404835	0.6812970449871658	0	0	1.8973227419829362	2.3100608742192534	TMEM67;NPHP1
Dilated ventricles (finding)	8/204	0.2996120872245201	0.6869262123934524	0	0	1.2794451113778844	1.5420725662537145	RERE;CTBP1;FLII;ROGDI;ATP1A3;CHD4;KCNAB2;LMNB2
Colonic Neoplasms	27/778	0.2997101147916353	0.6869262123934524	0	0	1.1294283282773054	1.360892867851684	CHRM3;TACSTD2;HMGB1;NDRG2;FHIT;ACTB;RELA;ATXN2;NKRF;MDK;CFL1;HSF1;ERBB2;IGF2BP1;AKT1;CKB;CLIC1;CACNA2D1;AMPD3;YWHAZ;BCL9;DLG1;ERCC1;PLCB1;GAPDH;TP53;LY6E
Lip and Oral Cavity Carcinoma	17/473	0.30036198624915633	0.6869262123934524	0	0	1.169983416252073	1.407217339343143	TACSTD2;FOXN3;HMGB1;FHIT;MTOR;RELA;MAU2;GRM5;AKT2;PSME3;SGSM3;HSF1;ERBB2;AKT1;CNTN4;RIN1;TP53
Abnormality of the pinna	3/62	0.30181687858464296	0.6869262123934524	0	0	1.592258879762657	1.9074223351309434	FRAS1;CTBP1;ERCC8
Xerostomia	3/62	0.30181687858464296	0.6869262123934524	0	0	1.592258879762657	1.9074223351309434	CHRM3;ATXN2;NDRG2
Low grade glioma	3/62	0.30181687858464296	0.6869262123934524	0	0	1.592258879762657	1.9074223351309434	HDAC4;AKT1;TP53
Pemphigus Vulgaris	3/62	0.30181687858464296	0.6869262123934524	0	0	1.592258879762657	1.9074223351309434	AIMP2;FCGRT;PKP3
Barrett Esophagus	12/323	0.3019467964531807	0.6869262123934524	0	0	1.2101666948722287	1.449179999703414	JAG1;BNC2;RABEP2;ERBB2;TRIB3;SSSCA1;MTR;HMGB1;TP53;FHIT;ACTB;RELA
Tumor Initiation	9/234	0.30234254799860993	0.6869262123934524	0	0	1.2540098199672667	1.5000398245297395	AIMP2;KCNMA1;HSF1;ERBB2;AKT1;SDC1;HMGB1;SPG7;TP53
Malignant Glioma	18/504	0.3023535390937937	0.6869262123934524	0	0	1.162421557770395	1.3904401793651084	KEAP1;MSI1;HMGB1;MTOR;AIMP2;CCND3;MDK;AKT2;ERCC1;CREB3L2;ERBB2;TRIM24;AKT1;SDC1;SSSCA1;FADD;TP53;LHX9
Mental Retardation, X-Linked	5/118	0.3034077844191365	0.6869262123934524	0	0	1.3862148355996835	1.6533073209879765	SOX3;ARHGAP1;UBE2A;SYP;SHROOM4
Endometriosis	26/749	0.30374875040171695	0.6869262123934524	0	0	1.1295108763988433	1.3458736526325674	BNC2;TACSTD2;MSI1;HMGB1;MED16;ACTB;RELA;CDH3;MDK;MAP2;CFL1;ERBB2;AKT1;SSSCA1;INSR;ACTN4;SYP;YWHAZ;MTOR;AGBL4;AIMP2;SDC1;PLCB1;EBAG9;CNIH3;TP53
Thymoma	8/205	0.304164898805922	0.6869262123934524	0	0	1.2728841113433529	1.5149679507395062	ERBB2;AKT1;SSSCA1;HMGB1;TP53;FHIT;GAPDH;MTOR
Cervical Intraepithelial Neoplasia	8/205	0.304164898805922	0.6869262123934524	0	0	1.2728841113433529	1.5149679507395062	GNAO1;ERBB2;KEAP1;MTR;HMGB1;TP53;FHIT;MAP2K5
Short palm	4/90	0.3049537636615726	0.6869262123934524	0	0	1.456810631229236	1.730101179539998	HDAC4;MBD5;SMARCA2;HDAC6
Skin carcinoma	4/90	0.3049537636615726	0.6869262123934524	0	0	1.456810631229236	1.730101179539998	ERCC1;AKT1;TP53;FHIT
Adenovirus Infections	4/90	0.3049537636615726	0.6869262123934524	0	0	1.456810631229236	1.730101179539998	AKT1;MAP4;YWHAZ;TP53
Cystic kidney	4/90	0.3049537636615726	0.6869262123934524	0	0	1.456810631229236	1.730101179539998	BBS2;PEX6;TMEM67;TMEM231
Gaucher Disease	4/90	0.3049537636615726	0.6869262123934524	0	0	1.456810631229236	1.730101179539998	RPAIN;AIMP2;HEXA;HDAC9
Micromelia	4/90	0.3049537636615726	0.6869262123934524	0	0	1.456810631229236	1.730101179539998	SETD5;IFT172;PDE4D;ACTB
hearing impairment	11/294	0.3050830311946115	0.6869262123934524	0	0	1.2188607866687555	1.4469965519399843	IDUA;PDE4D;TCF12;CHD7;AKT1;AP1S1;ELMOD3;HCCS;CHD4;LMNB2;SGSH
Well Differentiated Oligodendroglioma	7/176	0.30529437623244327	0.6869262123934524	0	0	1.2980781296755697	1.5401421814409717	RIMS2;CNTNAP2;ERBB2;HMGB1;SYP;TP53;SMARCA2
Carcinomatosis	7/176	0.30529437623244327	0.6869262123934524	0	0	1.2980781296755697	1.5401421814409717	EIF5A;ACTN4;TP53;FHIT;YWHAZ;ACTB;MAP2K5
Mammary Tumorigenesis	7/176	0.30529437623244327	0.6869262123934524	0	0	1.2980781296755697	1.5401421814409717	RHBDF1;PPP1R1B;ERBB2;AKT1;TP53;LDLR;MTOR
Multiple malignancy	7/176	0.30529437623244327	0.6869262123934524	0	0	1.2980781296755697	1.5401421814409717	GLDC;PSME3;INSR;ERBB2;AKT1;TP53;MTOR
Hematological Disease	6/147	0.305305702111704	0.6869262123934524	0	0	1.3333564349573774	1.581949678514698	AKT1;MTR;FADD;CKB;RIN1;TP53
Adenocarcinoma of pancreas	13/354	0.3056228463641822	0.6869262123934524	0	0	1.1957610864450425	1.4174593357090461	SPG7;RHOC;SMARCA2;AGPAT2;ACTB;RELA;AIMP2;GIPC1;ERBB2;AKT1;SDC1;TP53;GAPDH
Benign neoplasm of brain, unspecified	2/36	0.3074982292385908	0.6869262123934524	0	0	1.8414239482200647	2.1715653907294477	TP53;RELA
Scaphycephaly	2/36	0.3074982292385908	0.6869262123934524	0	0	1.8414239482200647	2.1715653907294477	TCF12;ARCN1
Seckel syndrome	2/36	0.3074982292385908	0.6869262123934524	0	0	1.8414239482200647	2.1715653907294477	AIMP2;TUBGCP6
EAR, PATELLA, SHORT STATURE SYNDROME	2/36	0.3074982292385908	0.6869262123934524	0	0	1.8414239482200647	2.1715653907294477	INSR;MTOR
Somatotropin deficiency	2/36	0.3074982292385908	0.6869262123934524	0	0	1.8414239482200647	2.1715653907294477	SOX3;IFT172
Tethered Cord Syndrome	2/36	0.3074982292385908	0.6869262123934524	0	0	1.8414239482200647	2.1715653907294477	VANGL2;ZIC5
Absence of septum pellucidum	2/36	0.3074982292385908	0.6869262123934524	0	0	1.8414239482200647	2.1715653907294477	CTBP1;HCCS
Autoimmune state	2/36	0.3074982292385908	0.6869262123934524	0	0	1.8414239482200647	2.1715653907294477	KIAA0319L;LMNB2
Avellino corneal dystrophy	2/36	0.3074982292385908	0.6869262123934524	0	0	1.8414239482200647	2.1715653907294477	AKT1;TP53
Craniorachischisis	2/36	0.3074982292385908	0.6869262123934524	0	0	1.8414239482200647	2.1715653907294477	VANGL2;ZIC5
Endometriosis of ovary	2/36	0.3074982292385908	0.6869262123934524	0	0	1.8414239482200647	2.1715653907294477	SHBG;TP53
Exocrine pancreatic insufficiency	2/36	0.3074982292385908	0.6869262123934524	0	0	1.8414239482200647	2.1715653907294477	JAG1;TP53
Germ Cell Cancer	2/36	0.3074982292385908	0.6869262123934524	0	0	1.8414239482200647	2.1715653907294477	ERCC1;TP53
Hepatic Encephalopathy	2/36	0.3074982292385908	0.6869262123934524	0	0	1.8414239482200647	2.1715653907294477	GABRB1;GABRG2
High-grade hypermetropia	2/36	0.3074982292385908	0.6869262123934524	0	0	1.8414239482200647	2.1715653907294477	RERE;KCNAB2
Inflammatory Myofibroblastic Tumor	2/36	0.3074982292385908	0.6869262123934524	0	0	1.8414239482200647	2.1715653907294477	ERBB2;TP53
Learning Disorders	2/36	0.3074982292385908	0.6869262123934524	0	0	1.8414239482200647	2.1715653907294477	SYP;KIAA0319L
Low Tension Glaucoma	2/36	0.3074982292385908	0.6869262123934524	0	0	1.8414239482200647	2.1715653907294477	PLXDC2;TP53
Mesenchymal Cell Neoplasm	2/36	0.3074982292385908	0.6869262123934524	0	0	1.8414239482200647	2.1715653907294477	AKT1;SDC1
Nail abnormality	2/36	0.3074982292385908	0.6869262123934524	0	0	1.8414239482200647	2.1715653907294477	CDH3;PDE4D
Parvovirus B19 (disease)	2/36	0.3074982292385908	0.6869262123934524	0	0	1.8414239482200647	2.1715653907294477	CHRM3;B3GALNT1
Infarction, Middle Cerebral Artery	5/119	0.3094870114038829	0.6869262123934524	0	0	1.3739837398373984	1.6114619272096078	HDAC4;FADD;HMGB1;HDAC9;MTOR
Increased serum lactate	5/119	0.3094870114038829	0.6869262123934524	0	0	1.3739837398373984	1.6114619272096078	COQ4;NDUFS8;AGK;OGDH;PDSS2
Epilepsy, Cryptogenic	3/63	0.3103448572964341	0.6869262123934524	0	0	1.5656401944894651	1.831910433682523	CNTNAP2;AKT1;KCNAB2
Simple ear	3/63	0.3103448572964341	0.6869262123934524	0	0	1.5656401944894651	1.831910433682523	FRAS1;CTBP1;ERCC8
Thin face	3/63	0.3103448572964341	0.6869262123934524	0	0	1.5656401944894651	1.831910433682523	DSTYK;TPM2;CHD7
Chronic ear infection	3/63	0.3103448572964341	0.6869262123934524	0	0	1.5656401944894651	1.831910433682523	FLII;DNAI1;TAPBP
Dystrophia myotonica 2	3/63	0.3103448572964341	0.6869262123934524	0	0	1.5656401944894651	1.831910433682523	ZNF273;INSR;SHBG
gliosarcoma	3/63	0.3103448572964341	0.6869262123934524	0	0	1.5656401944894651	1.831910433682523	AKT1;SSSCA1;TP53
Narrow face	3/63	0.3103448572964341	0.6869262123934524	0	0	1.5656401944894651	1.831910433682523	DSTYK;TPM2;CHD7
Neuro-degenerative disease	3/63	0.3103448572964341	0.6869262123934524	0	0	1.5656401944894651	1.831910433682523	ATXN2;IDUA;TTC19
Pallor of optic disc	3/63	0.3103448572964341	0.6869262123934524	0	0	1.5656401944894651	1.831910433682523	BBS2;IFT172;TUBGCP6
Refractory anemias	10/266	0.31210957143991125	0.6869262123934524	0	0	1.224641393442623	1.4259736170130122	RIMS2;CCND3;URGCP;PDE4D;CHD7;SSSCA1;FADD;HMGB1;TP53;YWHAZ
recurrent muscle twitches (symptom)	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	PRKCI
Anemia, Pernicious	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	TCN2
Arterial Diseases, Common Carotid	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	TP53
ARTHROGRYPOSIS, DISTAL, TYPE 2B	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	TPM2
Auditory Processing Disorder, Central	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	CNTNAP2
Autoimmune polyendocrinopathy syndrome, type 1	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	RIMS2
CATARACT, COPPOCK-LIKE	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	MAF
Cataract, Pulverulent	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	MAF
Rib segmentation abnormalities	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	CTBP1
Dyskinesias, Paroxysmal	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	KCNMA1
Secondary Parkinson Disease	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	ATP13A2
Semantic-Pragmatic Disorder	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	CNTNAP2
Sleep Wake Disorders	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	CHRNB2
Lymphoma, Lymphocytic, Intermediate	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	MTOR
Social Anxiety	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	CNTNAP2
NEVUS, EPIDERMAL (disorder)	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	AKT1
Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	MSI1
Xeroderma pigmentosum, group G	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	ERCC1
Abdominal Neoplasms	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	TP53
Abdominal obesity metabolic syndrome	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	PRKCI
Abnormal cortical gyration	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	FRAS1
Trichoepithelioma	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	MTOR
Abnormality of the tonsils	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	IDUA
VATER Association	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	IFT172
Accessory rib	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	SUFU
Vulvar Lichen Sclerosus	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	TP53
Adenocarcinoma of the gastroesophageal junction	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	ERBB2
Adrenocortical hyperplasia	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	TP53
Amaurosis Fugax	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	TP53
Amebiasis	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	RELA
Aplasia/Hypoplasia of the earlobes	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	CHD7
Biliary System Disorder	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	TP53
Cardiac sarcoidosis	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	PSMD7
Childhood Ependymoma	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	TP53
Chondroblastoma	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	TP53
Congenital exomphalos	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	GDF11
Congenital leukocyte adherence deficiency	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	LAD1
Cranioschisis	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	ACTB
Decreased facial muscle movement	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	ATP1A3
Dyssomnias	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	MBD5
Ependymoblastoma	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	TP53
Exaggerated startle response	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	HEXA
External Carotid Artery Diseases	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	TP53
Fair hair	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	PDE4D
Flaccid Muscle Tone	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	PLEC
Ganglioneuromatosis	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	AKT1
Generalized Epilepsy with Febrile Seizures Plus	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	GABRG2
Glycogen Storage Disease Type VII	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	AMPD3
Hamartomatous polyposis	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	AKT1
Hemeralopia	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	TSEN34
Heterochromia iridis	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	ACTB
HUNTINGTON DISEASE-LIKE 2	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	RIMS2
Hypersplenism	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	RELA
Increased IgE level	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	TYK2
increased risk of pancreatic cancer	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	TP53
Infarction	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	PDE4D
Internal Carotid Artery Diseases	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	TP53
Intestinal metaplasia of gastric mucosa	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	TP53
Inverted Squamous Cell Papilloma	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	TP53
Irido-corneal dysgenesis	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	MAF
Nevus sebaceous	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	HMGB1
Progressive hearing impairment	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	CHD7
Psychotic episodes	1/12	0.3147646169121063	0.6869262123934524	0	0	2.8446174181230726	3.2881790882728823	ATP13A2
Dyschezia	7/178	0.31520775285263075	0.6869262123934524	0	0	1.2827623708537248	1.4809790771817137	RERE;CHRM3;MBD5;FLII;KCNAB2;PPOX;LMNB1
Lymphoma, Non-Hodgkin	19/539	0.31534589586855866	0.6869262123934524	0	0	1.1466146166645335	1.3232909138880586	SLC35B2;INSR;MTR;HMGB1;SPG7;HDAC9;HDAC6;AIMP2;POLD4;CCND3;MDK;SGSM3;FPGS;ERBB2;AKT1;SDC1;SSSCA1;TP53;PDLIM7
Colorectal cancer metastatic	8/208	0.31791169965060956	0.6869262123934524	0	0	1.25359477124183	1.436596552750067	SPINT1;RASA4;INSR;ERCC1;ERBB2;AKT1;MSI1;TP53
Chronic kidney disease stage 5	14/388	0.31871957575364557	0.6869262123934524	0	0	1.174017401740174	1.3424227261985742	LRSAM1;KEAP1;MTR;ACTN4;YWHAZ;MTOR;RELA;DSTYK;TCN2;TMEM67;NPHP1;ETF1;LDLR;MAP2K5
Adenocarcinoma, Endometrioid	3/64	0.31887986933774165	0.6869262123934524	0	0	1.5398942529957222	1.7600080191289253	ERBB2;SHBG;TP53
Short metacarpal	3/64	0.31887986933774165	0.6869262123934524	0	0	1.5398942529957222	1.7600080191289253	HDAC4;PDE4D;SMARCA2
Polyp of large intestine	3/64	0.31887986933774165	0.6869262123934524	0	0	1.5398942529957222	1.7600080191289253	SGSM3;KEAP1;AKT1
Adenoma, Basal Cell	2/37	0.3190005587226974	0.6869262123934524	0	0	1.788719371243643	2.043723541946434	TCN2;TP53
Adenoma, Monomorphic	2/37	0.3190005587226974	0.6869262123934524	0	0	1.788719371243643	2.043723541946434	TCN2;TP53
Testicular hypogonadism	2/37	0.3190005587226974	0.6869262123934524	0	0	1.788719371243643	2.043723541946434	SOX3;CHD7
Tubular Aggregate Myopathy	2/37	0.3190005587226974	0.6869262123934524	0	0	1.788719371243643	2.043723541946434	TPM2;CHD7
Cone-shaped epiphysis	2/37	0.3190005587226974	0.6869262123934524	0	0	1.788719371243643	2.043723541946434	IFT172;PDE4D
Flat back of the head	2/37	0.3190005587226974	0.6869262123934524	0	0	1.788719371243643	2.043723541946434	PEX6;PEX26
Gowers sign	2/37	0.3190005587226974	0.6869262123934524	0	0	1.788719371243643	2.043723541946434	TPM2;PLEC
Hematopoetic Myelodysplasia	2/37	0.3190005587226974	0.6869262123934524	0	0	1.788719371243643	2.043723541946434	PLCB1;TP53
Hypoxemia	2/37	0.3190005587226974	0.6869262123934524	0	0	1.788719371243643	2.043723541946434	GAPDH;ACTB
Infantile uterus	2/37	0.3190005587226974	0.6869262123934524	0	0	1.788719371243643	2.043723541946434	CHD7;HCCS
Influenza due to Influenza A virus subtype H1N1	2/37	0.3190005587226974	0.6869262123934524	0	0	1.788719371243643	2.043723541946434	TBC1D2;NUMA1
Malignant neoplasm of oropharynx	2/37	0.3190005587226974	0.6869262123934524	0	0	1.788719371243643	2.043723541946434	ERCC1;TP53
Mitochondrial abnormalities	2/37	0.3190005587226974	0.6869262123934524	0	0	1.788719371243643	2.043723541946434	TP53;PLEC
Paget Disease	2/37	0.3190005587226974	0.6869262123934524	0	0	1.788719371243643	2.043723541946434	ERBB2;TP53
Adrenal Cortical Adenoma	4/92	0.3190126248004151	0.6869262123934524	0	0	1.4235537190082646	1.6264451445323393	SYP;GAPDH;TP53;MTOR
Cholestasis in newborn	4/92	0.3190126248004151	0.6869262123934524	0	0	1.4235537190082646	1.6264451445323393	JAG1;PEX6;NPHP1;PEX26
Epithelioma	11/298	0.3203609962536069	0.6869262123934524	0	0	1.201621439155982	1.367813862111329	LMO4;MDK;HSF1;ERBB2;TACSTD2;AKT1;SDC1;HMGB1;TP53;FHIT;PDLIM7
Adult Acute Lymphocytic Leukemia	5/121	0.32169429657315707	0.6869262123934524	0	0	1.3501541911970845	1.531282201286222	MYCBP2;ERBB2;MTR;TP53;FHIT
Speech Disorders	4/93	0.326061533294298	0.6869262123934524	0	0	1.407485772654312	1.57732590276145	SETD5;BBS1;FLII;CHAMP1
Childhood Medulloblastoma	4/93	0.326061533294298	0.6869262123934524	0	0	1.407485772654312	1.57732590276145	SUFU;ERBB2;OTX2;TP53
Manic	4/93	0.326061533294298	0.6869262123934524	0	0	1.407485772654312	1.57732590276145	FLII;DIXDC1;CPLX2;SLC5A3
Germ cell tumor	8/210	0.32714244921565744	0.6869262123934524	0	0	1.2410535171164174	1.3867030346930043	MDK;RAB1B;ERCC1;ERBB2;AKT1;PTPN23;TP53;FHIT
Neurofibromatosis 1	8/210	0.32714244921565744	0.6869262123934524	0	0	1.2410535171164174	1.3867030346930043	MDK;SGSM3;HSF1;ERBB2;TYK2;TP53;MTOR;HIPK2
Multiple, subcutaneous nodules	3/65	0.3274175330471897	0.6869262123934524	0	0	1.5149788257437131	1.6915027391435211	INSR;AKT1;UBAC2
Subcutaneous nodule	3/65	0.3274175330471897	0.6869262123934524	0	0	1.5149788257437131	1.6915027391435211	INSR;AKT1;UBAC2
Hepatic methionine adenosyltransferase deficiency	3/65	0.3274175330471897	0.6869262123934524	0	0	1.5149788257437131	1.6915027391435211	ERBB2;AKT1;TP53
Melanocytic nevus of skin	3/65	0.3274175330471897	0.6869262123934524	0	0	1.5149788257437131	1.6915027391435211	MAP2;CTNNBIP1;TP53
Congenital heart disease	5/122	0.32781890261536023	0.6869262123934524	0	0	1.3385449239107776	1.4928710544349282	CHRM3;HIC2;ALG9;FRAS1;MTR
Choriocarcinoma	11/300	0.3280647070352689	0.6869262123934524	0	0	1.1931807205640876	1.3298529052170902	RIMS2;JAG1;MAN2A1;INSR;SGSM3;MGAT4B;TACSTD2;IGF2BP1;TP53;CLIC1;GAPDH
Conductive hearing loss	7/181	0.33018269403857664	0.6869262123934524	0	0	1.2604488946391406	1.3967149651215824	BBS2;SETD5;FRAS1;IFT172;FLII;PDE6B;DNAI1
Malignant tumor of cervix	30/884	0.33022062277250513	0.6869262123934524	0	0	1.1030444964871193	1.222167008188896	TACSTD2;KEAP1;MSI1;MTR;NDRG2;FHIT;HDAC6;RELA;RIMS2;SOX1;SHARPIN;MDK;ERBB2;AKT1;CKB;PDLIM7;URGCP;AGK;USP22;MTOR;TAPBP;ST7L;RAD52;GNAO1;GIPC1;SGSM3;ERCC1;SDC1;GAPDH;TP53
Adenoma, Trabecular	2/38	0.3304564255646916	0.6869262123934524	0	0	1.738942826321467	1.9254974341403204	TCN2;TP53
Septic Shock	2/38	0.3304564255646916	0.6869262123934524	0	0	1.738942826321467	1.9254974341403204	FER;HMGB1
Shprintzen syndrome	2/38	0.3304564255646916	0.6869262123934524	0	0	1.738942826321467	1.9254974341403204	MBD5;PKP4
Vitamin D Deficiency	2/38	0.3304564255646916	0.6869262123934524	0	0	1.738942826321467	1.9254974341403204	NADSYN1;LDLR
Autosomal Recessive Polycystic Kidney Disease	2/38	0.3304564255646916	0.6869262123934524	0	0	1.738942826321467	1.9254974341403204	AKT1;MTOR
Comedone	2/38	0.3304564255646916	0.6869262123934524	0	0	1.738942826321467	1.9254974341403204	ERBB2;TP53
Gross motor development delay	2/38	0.3304564255646916	0.6869262123934524	0	0	1.738942826321467	1.9254974341403204	CNTNAP2;NPHP1
Idiopathic Membranous Glomerulonephritis	2/38	0.3304564255646916	0.6869262123934524	0	0	1.738942826321467	1.9254974341403204	YWHAZ;GAPDH
Keratosis	2/38	0.3304564255646916	0.6869262123934524	0	0	1.738942826321467	1.9254974341403204	KEAP1;TP53
Milroy Disease	2/38	0.3304564255646916	0.6869262123934524	0	0	1.738942826321467	1.9254974341403204	AKT1;TP53
Monoparesis - leg	2/38	0.3304564255646916	0.6869262123934524	0	0	1.738942826321467	1.9254974341403204	DSTYK;SPG7
Painful Bladder Syndrome	2/38	0.3304564255646916	0.6869262123934524	0	0	1.738942826321467	1.9254974341403204	CHRM3;SYP
Prominent back of the head	2/38	0.3304564255646916	0.6869262123934524	0	0	1.738942826321467	1.9254974341403204	KCNQ1OT1;SUFU
Prominent occiput	2/38	0.3304564255646916	0.6869262123934524	0	0	1.738942826321467	1.9254974341403204	KCNQ1OT1;SUFU
Respiratory Insufficiency	7/182	0.3351985596288818	0.6869262123934524	0	0	1.2531810766721043	1.3697672785485708	COQ4;AGK;IFT172;TPM2;PEX6;PEX26;TMEM231
Severe psychomotor retardation	3/66	0.3359535992733109	0.6869262123934524	0	0	1.490854364436212	1.6261974422161238	PEX6;ERCC1;PEX26
Skeletal dysplasia	3/66	0.3359535992733109	0.6869262123934524	0	0	1.490854364436212	1.6261974422161238	ALG9;IDUA;PDE4D
Beckwith-Wiedemann Syndrome	3/66	0.3359535992733109	0.6869262123934524	0	0	1.490854364436212	1.6261974422161238	SOX3;KCNQ1OT1;TP53
GRN-related frontotemporal dementia	3/66	0.3359535992733109	0.6869262123934524	0	0	1.490854364436212	1.6261974422161238	RIMS2;ATXN2;FNDC3A
Hip Dislocation	3/66	0.3359535992733109	0.6869262123934524	0	0	1.490854364436212	1.6261974422161238	CTBP1;ERCC1;SHROOM4
Proliferative vitreoretinopathy	3/66	0.3359535992733109	0.6869262123934524	0	0	1.490854364436212	1.6261974422161238	CAPN5;OTX2;TP53
Adenocarcinoma, intestinal type	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	TP53
refractory plasma cell neoplasm	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	HDAC6
Renal Cell Dysplasia	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	JAG1
Renal hypoplasia/aplasia	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	FRAS1
Reticulocytopenia	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	TCN2
Cerebral Amyloid Angiopathy, Hereditary	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	SYP
Ceroid lipofuscinosis, neuronal 1, infantile	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	SYP
Charcot-Marie-Tooth Disease, Type Ib	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	LRSAM1
Rieger syndrome	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	CTBP1
Salaam Seizures	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	SMARCA2
Cystadenoma, Mucinous	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	TP53
Secondary Open Angle Glaucoma	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	ATXN2
Eosinophilia, Tropical	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	SHARPIN
EPILEPSY, PYRIDOXINE-DEPENDENT	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	AIMP2
Short columella	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	ACTB
Hypothermia, Accidental	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	CHRNB2
Neoplasms, Vascular Tissue	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	JAG1
Night blindness, congenital stationary, type 1	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	PDE6B
Night Blindness, Congenital Stationary, Type 1A	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	PDE6B
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	PDE6B
Pemphigoid, Benign Mucous Membrane	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	LAD1
Pneumonia, Ventilator-Associated	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	MDK
Subependymal Glioma	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	ERBB2
Scleroderma, Limited	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	KIAA0319L
Tendinosis	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	ADAMTS5
Thin bony cortex	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	AKT1
Trophoblastic Neoplasms	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	TP53
Abnormality of aortic valve	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	CHD7
Ubiquinone dehydrogenase deficiency	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	TTC19
Abnormality of skin morphology	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	PLCB1
Abnormality of the abdominal wall	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	INSR
Abnormality of the vagina	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	TRAF3IP2
Abnormally low-pitched voice	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	SETD5
Valgus deformities of feet	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	CAPN1
X-Linked Csnb	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	PDE6B
Xanthomatous Meningioma	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	AKT1
Adrenal Gland Diseases	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	TP53
Angioblastic Meningioma	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	AKT1
Angiomatous Meningioma	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	AKT1
Arterial disease of legs	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	LDLR
Autosomal Recessive Hereditary Spastic Paraplegia	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	SPG7
Bacteroides fragilis infection in conditions classified elsewhere and of unspecified site	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	PGAP3
Behavioral tic	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	PRKCI
Benign symmetrical lipomatosis	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	MTOR
Bifid tongue	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	FRAS1
Blonde hair	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	PDE4D
Cerebral Cavernous Malformations 3	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	AIMP2
Cerebral Convexity Meningioma	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	AKT1
Cerebral metastasis	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	ERBB2
Cleft tongue	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	FRAS1
Coffin-Lowry syndrome	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	HSF1
Congenital emphysema	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	HMGB1
Congenital hypogonadotropic hypogonadism	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	CHD7
Decreased facial expression	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	ATP1A3
Delayed CNS myelination	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	ALG9
Diaphyseal thickening	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	IDUA
Dysmetric saccades	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	ATXN2
Expressionless face	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	ATP1A3
Extramedullary Plasmacytoma	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	TP53
Eye Color	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	CTNNA2
Familial Epilepsies	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	GABRG2
Hamartomatous polyp	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	TP53
Hearing abnormality	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	INSR
Hemangioblastic Meningioma	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	AKT1
Hemangiopericytic Meningioma	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	AKT1
Heymann Nephritis	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	LDLR
Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	TP53
Hypoplasia of columella	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	ACTB
Hypoplasia of teeth	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	ERCC8
Hypoplastic pelvis	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	ERCC8
Infrequent generalized seizures	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	PLCB1
Intraorbital Meningioma	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	AKT1
Intraventricular Meningioma	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	AKT1
Islets of Langerhans hyperplasia	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	INSR
Language Development Disorders	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	CNTNAP2
Lecithin Acyltransferase Deficiency	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	LMF1
Long toe	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	XYLT2
Low density lipoprotein increased	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	LDLR
Lymphatic Abnormalities	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	AKT1
Metabolic myopathy	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	CHD7
Microcystic meningioma	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	AKT1
Monosomy 22	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	ERBB2
Morphea	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	TP53
Mycetoma	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	TRAF3IP2
Neonatal hepatitis	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	SPINT1
Nicolaides Baraitser syndrome	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	SMARCA2
Non-toxic nodular goiter	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	TP53
Nonspherocytic hemolytic anemia	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	ALDOA
Olfactory Groove Meningioma	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	AKT1
Olfactory Neuroblastoma	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	TP53
Opioid abuse	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	PPP1R1B
OVERLAP CONNECTIVE TISSUE DISEASE	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	NEGR1
Paraparesis	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	ATP13A2
Parasagittal Meningioma	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	AKT1
Perivascular Epithelioid Cell Neoplasms	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	TP53
Persistent cavum septum pellucidum	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	CTBP1
Posterior Fossa Meningioma	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	AKT1
Primary Cutaneous Follicle Center Lymphoma	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	PDLIM7
Primary Focal Segmental Glomerulosclerosis	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	ACTN4
Pseudopseudohypoparathyroidism	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	SOX3
Pulmonary Valve Stenosis	1/13	0.3360196333070139	0.6869262123934524	0	0	2.607431340872375	2.8436273034882267	JAG1
Alcoholic Intoxication, Chronic	15/424	0.3372323169177409	0.689132706141117	0	0	1.1500131342318496	1.2500449778796432	SETD5;CNTNAP2;GABRB1;HMGB1;GABRG2;AIMP2;GRM5;PPP1R1B;CTNNA2;CNTN4;SHBG;CNIH3;SERINC2;GAPDH;TP53
Cachexia	6/153	0.33812200509695317	0.6905183389725947	0	0	1.2785348667154157	1.3863773480501143	MDK;INSR;AKT1;APEH;RPS27A;ACVR2B
Cholangiocarcinoma	16/455	0.33855296838391263	0.6905183389725947	0	0	1.142934725218362	1.237883706528767	HDAC4;PRKCI;HMGB1;RHOC;FHIT;HDAC6;AIMP2;MAGED4B;ERCC1;HSF1;ERBB2;AKT1;SSSCA1;LDLR;EBAG9;TP53
Polycystic Kidney Diseases	5/124	0.34010154220499184	0.6905183389725947	0	0	1.315911730545877	1.4192253453974997	ALG9;TMEM67;ERBB2;MTOR;TMEM231
Anorexia Nervosa	4/95	0.3401855634385178	0.6905183389725947	0	0	1.3764093049807336	1.484132651596977	FAM19A2;CNTN4;SHBG;LDLR
Recurrent Brain Neoplasm	2/39	0.3418576649151948	0.6905183389725947	0	0	1.6918569054491384	1.815972903524081	TP53;RELA
Sense of smell impaired	2/39	0.3418576649151948	0.6905183389725947	0	0	1.6918569054491384	1.815972903524081	CHD7;ATP13A2
Sialorrhea	2/39	0.3418576649151948	0.6905183389725947	0	0	1.6918569054491384	1.815972903524081	SETD5;ATP1A3
Liver dysfunction, mild	2/39	0.3418576649151948	0.6905183389725947	0	0	1.6918569054491384	1.815972903524081	FADD;PEX26
Stage IV Ovarian Carcinoma	2/39	0.3418576649151948	0.6905183389725947	0	0	1.6918569054491384	1.815972903524081	AKT2;ACTN4
Subependymal Giant Cell Astrocytoma	2/39	0.3418576649151948	0.6905183389725947	0	0	1.6918569054491384	1.815972903524081	TP53;MTOR
Absent auditory canals	2/39	0.3418576649151948	0.6905183389725947	0	0	1.6918569054491384	1.815972903524081	SETD5;FRAS1
Absent external auditory canals	2/39	0.3418576649151948	0.6905183389725947	0	0	1.6918569054491384	1.815972903524081	SETD5;FRAS1
Atresia of the external auditory canal	2/39	0.3418576649151948	0.6905183389725947	0	0	1.6918569054491384	1.815972903524081	SETD5;FRAS1
Atretic auditory canal	2/39	0.3418576649151948	0.6905183389725947	0	0	1.6918569054491384	1.815972903524081	SETD5;FRAS1
Broad hallux	2/39	0.3418576649151948	0.6905183389725947	0	0	1.6918569054491384	1.815972903524081	PIGO;UBE2A
Decreased liver function	2/39	0.3418576649151948	0.6905183389725947	0	0	1.6918569054491384	1.815972903524081	FADD;PEX26
Dislocations	2/39	0.3418576649151948	0.6905183389725947	0	0	1.6918569054491384	1.815972903524081	TYK2;SMARCA2
Drooling	2/39	0.3418576649151948	0.6905183389725947	0	0	1.6918569054491384	1.815972903524081	SETD5;ATP1A3
Flat occiput	2/39	0.3418576649151948	0.6905183389725947	0	0	1.6918569054491384	1.815972903524081	PEX6;PEX26
Gowers sign present	2/39	0.3418576649151948	0.6905183389725947	0	0	1.6918569054491384	1.815972903524081	TPM2;PLEC
Growth Disorders	2/39	0.3418576649151948	0.6905183389725947	0	0	1.6918569054491384	1.815972903524081	KCNMA1;CNTN4
Klinefelter's syndrome - male with more than two X chromosomes	2/39	0.3418576649151948	0.6905183389725947	0	0	1.6918569054491384	1.815972903524081	BBS1;SHBG
Low Grade Lymphoma (neoplasm)	2/39	0.3418576649151948	0.6905183389725947	0	0	1.6918569054491384	1.815972903524081	FPGS;TP53
Primary malignant neoplasm of brain	2/39	0.3418576649151948	0.6905183389725947	0	0	1.6918569054491384	1.815972903524081	TP53;RELA
Invasive Carcinoma	6/154	0.34363320231421	0.6905183389725947	0	0	1.2698300906769961	1.3564076939670988	MAST2;CFL1;ERBB2;SDC1;TP53;FHIT
Schistosomiasis	3/67	0.3444839515264325	0.6905183389725947	0	0	1.4674837925445705	1.5639088865830606	ERBB2;GAPDH;TP53
High, narrow palate	3/67	0.3444839515264325	0.6905183389725947	0	0	1.4674837925445705	1.5639088865830606	BBS1;INSR;SMARCA2
Skin blisters	3/67	0.3444839515264325	0.6905183389725947	0	0	1.4674837925445705	1.5639088865830606	PPOX;PLEC;UBAC2
Abnormal blistering of the skin	3/67	0.3444839515264325	0.6905183389725947	0	0	1.4674837925445705	1.5639088865830606	PPOX;PLEC;UBAC2
Flat face	3/67	0.3444839515264325	0.6905183389725947	0	0	1.4674837925445705	1.5639088865830606	MAF;PEX6;PEX26
Gestational Diabetes	3/67	0.3444839515264325	0.6905183389725947	0	0	1.4674837925445705	1.5639088865830606	CAPN10;INSR;SHBG
Meningococcal Infections	3/67	0.3444839515264325	0.6905183389725947	0	0	1.4674837925445705	1.5639088865830606	GRM5;FBXO15;GAPDH
Nail dysplasia	3/67	0.3444839515264325	0.6905183389725947	0	0	1.4674837925445705	1.5639088865830606	INSR;UBE2A;PLEC
Parasitemia	3/67	0.3444839515264325	0.6905183389725947	0	0	1.4674837925445705	1.5639088865830606	EIF5A;SYVN1;ERCC8
Hyperglycemia	17/488	0.34576362322060467	0.6905183389725947	0	0	1.1318249516747474	1.2019979937289138	CHRM3;GLDC;INSR;HMGB1;YWHAZ;MTOR;RELA;RIMS2;AIMP2;CAPN10;AKT2;SGSM3;AKT1;PTPN9;ULK1;TRIB3;SHBG
Tetralogy of Fallot	5/125	0.3462562324617824	0.6905183389725947	0	0	1.3048780487804879	1.3839226308239854	ATXN2;JAG1;DNAH5;CHD7;CHD4
Peripheral Arterial Diseases	5/125	0.3462562324617824	0.6905183389725947	0	0	1.3048780487804879	1.3839226308239854	ATXN2;JAG1;LRRTM4;LDLR;UBAC2
Steroid Sulfatase Deficiency Disease	4/96	0.3472557234561344	0.6905183389725947	0	0	1.3613777526821005	1.4399208292286592	ERCC1;ERBB2;AKT1;TP53
Aortic Aneurysm	4/96	0.3472557234561344	0.6905183389725947	0	0	1.3613777526821005	1.4399208292286592	SLC2A11;FCGRT;AKT2;GAPDH
Broad forehead	4/96	0.3472557234561344	0.6905183389725947	0	0	1.3613777526821005	1.4399208292286592	MBD5;JAG1;FLII;TCF12
Substance abuse problem	6/155	0.34915311072815336	0.6905183389725947	0	0	1.2612421572699648	1.3271354262292543	AGBL4;GRM5;EPB41;INSR;SGSM3;FHIT
Monocyte count procedure	6/155	0.34915311072815336	0.6905183389725947	0	0	1.2612421572699648	1.3271354262292543	CCND3;ATXN2;HYDIN;PLCB1;SMG6;OTUB1
Monocyte count result	6/155	0.34915311072815336	0.6905183389725947	0	0	1.2612421572699648	1.3271354262292543	CCND3;ATXN2;HYDIN;PLCB1;SMG6;OTUB1
Platelet hematocrit measurement	6/155	0.34915311072815336	0.6905183389725947	0	0	1.2612421572699648	1.3271354262292543	ST7L;MAU2;ATXN2;PLCB1;HDAC9;SMG6
Spastic Paraplegia, Hereditary	5/126	0.3524176407818716	0.6905183389725947	0	0	1.2940267419203118	1.3495900855712477	ATXN2;DSTYK;SPG7;CCT5;LY6E
Memory Loss	5/126	0.3524176407818716	0.6905183389725947	0	0	1.2940267419203118	1.3495900855712477	MDK;HSF1;SYP;SPG7;MTOR
Restless Legs Syndrome	3/68	0.3530046057764248	0.6905183389725947	0	0	1.4448323151726716	1.5044665764293657	ATXN2;MAP2K5;LY6E
Skin bullae	3/68	0.3530046057764248	0.6905183389725947	0	0	1.4448323151726716	1.5044665764293657	PPOX;PLEC;UBAC2
Alveolar rhabdomyosarcoma	3/68	0.3530046057764248	0.6905183389725947	0	0	1.4448323151726716	1.5044665764293657	ERBB2;SYP;TP53
Dystrophia unguium	3/68	0.3530046057764248	0.6905183389725947	0	0	1.4448323151726716	1.5044665764293657	JUP;UBE2A;PLEC
Precocious Puberty	3/68	0.3530046057764248	0.6905183389725947	0	0	1.4448323151726716	1.5044665764293657	CTBP1;INSR;AGPAT2
Neoplasm Recurrence, Local	2/40	0.3531966612094805	0.6905183389725947	0	0	1.6472491909385114	1.714342084158877	ERBB2;YWHAZ
Syncope	2/40	0.3531966612094805	0.6905183389725947	0	0	1.6472491909385114	1.714342084158877	CACNB2;JUP
stage, ovarian epithelial cancer	2/40	0.3531966612094805	0.6905183389725947	0	0	1.6472491909385114	1.714342084158877	YWHAZ;TP53
Anthrax disease	2/40	0.3531966612094805	0.6905183389725947	0	0	1.6472491909385114	1.714342084158877	ERBB2;YWHAZ
Aspirin exacerbated respiratory disease	2/40	0.3531966612094805	0.6905183389725947	0	0	1.6472491909385114	1.714342084158877	DPP10;TAPBP
Decreased motor nerve conduction velocity	2/40	0.3531966612094805	0.6905183389725947	0	0	1.6472491909385114	1.714342084158877	GDAP1;CCT5
Palpitations	2/40	0.3531966612094805	0.6905183389725947	0	0	1.6472491909385114	1.714342084158877	CACNA2D1;TP53
Hemoglobin measurement	4/97	0.3543280835691981	0.6905183389725947	0	0	1.3466694595726854	1.3972126648792553	CCND3;GNB2;RANBP10;DCDC1
Ovarian Serous Adenocarcinoma	4/97	0.3543280835691981	0.6905183389725947	0	0	1.3466694595726854	1.3972126648792553	KCNMA1;TRIM24;NEK10;TP53
Colorectal Cancer	106/3298	0.3562074964171863	0.6905183389725947	0	0	1.0458588104502502	1.0795792467455758	CHRM3;KEAP1;MSI1;CASC2;ZDHHC7;TMEM97;NADSYN1;ACTB;RIMS2;CCND3;CDH3;FCGRT;AKT2;NDST3;CFL1;OSBP;FPGS;TRIM24;AKT1;SLC16A7;ANKS1B;TPM2;ACTN4;EML2;LEMD1;CACNB2;MAU2;MAF;SPINT1;TRIB3;TP53;CTBP1;FLII;TACSTD2;NDRG2;FHIT;CORO1B;FAM83H;MAP2;KCNQ1OT1;AMDHD2;FADD;MAP2K5;FZD3;JAG1;JUP;INSR;BCL9;AIMP2;VANGL2;TCN2;GIPC1;SDC1;CNTN4;SHBG;ABCD4;SPAG17;PIGO;LDB1;MTR;CHD4;HMGB1;DNALI1;LMNB2;ADAMTS5;MDK;IQUB;SSSCA1;EIF5A;RHBDF1;TCF12;YWHAZ;TAPBP;DMRTA1;GAPDH;OTUB1;HIST1H2BM;RAB1B;WNT8B;FOXK1;AMBRA1;SEMA3F;SPG7;PPOX;HDAC9;RELA;MLLT6;NT5C;HSF1;ERBB2;CKB;LDLR;CCT5;GDF11;SORT1;USP22;MTOR;HIPK2;RAD52;TMEM54;CAPN10;SGSM3;ERCC1;NEK10;CBLN2;NEK11
Reduced concentration span	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	MBD5
Anemia, Hemolytic, Congenital	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	ALDOA
Renal cortical cysts	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	KCNQ1OT1
Cystadenoma, Serous	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	TP53
Sex Cord-Stromal Tumor	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	TP53
Short extremities	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	B9D1
Hydatidiform Mole, Partial	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	TP53
Skin callus	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	PDLIM7
Lymphoma, Extranodal NK-T-Cell	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	PDLIM7
Stage II Colorectal Cancer AJCC v7	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	TCF12
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder)	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	PDE6B
Stridor	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	PLEC
PSEUDOHYPOPARATHYROIDISM, TYPE IB	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	SOX3
Pyloric Stenosis, Hypertrophic	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	LDLR
Testicular embryonal carcinoma	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	TP53
Testicular Hydrocele	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	AKT1
Supratentorial Embryonal Tumor, Not Otherwise Specified	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	TP53
Thyroid Dysgenesis	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	JAG1
Thyroid Lymphoma	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	TP53
Transient neonatal diabetes mellitus	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	KCNQ1OT1
Transitional Meningioma	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	AKT1
Trisomy 11	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	TP53
Tubulointerstitial scarring	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	NPHP1
Ulnar deviation of hand	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	ALG9
Unilateral Cryptorchidism	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	CHRM3
Urinary Bladder Diseases	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	CHRM3
Abnormality of the thyroid gland	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	INSR
Absence of sensation	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	HEXA
Adenocarcinoma of small intestine	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	ERBB2
X-linked agammaglobulinemia with growth hormone deficiency	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	SPG7
AIDS-Related Non-Hodgkin Lymphoma	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	PDLIM7
ALZHEIMER DISEASE 5	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	FHIT
Aqueductal Stenosis	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	HYDIN
ARTERIAL TORTUOSITY SYNDROME	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	SLC2A11
Atherosclerotic occlusive disease	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	TP53
Atresia of vagina	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	FRAS1
Biconcave vertebral bodies	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	IDUA
Cancer Relapse	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	ULK1
Decreased number of large peripheral myelinated nerve fibers	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	GDAP1
Deep palmar crease	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	MTOR
Depressed mood	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	TYK2
Desmoplastic melanoma	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	TP53
Desquamation of skin soon after birth	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	CHD7
Diastolic hypertension	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	KCNMA1
Disorder of endocrine ovary	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	SHBG
Dyspareunia	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	TRAF3IP2
Easily distracted	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	MBD5
Eye Neoplasms	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	FLII
Facial diplegia	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	TPM2
Falls	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	MAPK10
First myocardial infarction	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	LDLR
Gastric Gastrointestinal Stromal Tumor	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	TP53
Germinoma	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	TP53
Glycinuria	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	GLDC
hemangiopericytoma	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	TP53
Hemophagocytic Syndrome	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	PDLIM7
Homocysteinemia	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	SPINT1
Hyperexplexia	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	HEXA
Hypochondroplasia (disorder)	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	LDLR
Hypoparathyroidism - autosomal dominant	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	SPG7
IgM deficiency	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	TCN2
Inversion of nipple (disorder)	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	ALG9
Junctional Epidermolysis Bullosa	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	LAD1
Leiomyomatosis	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	TP53
Loeys-Dietz Syndrome	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	SLC2A11
Long fingers	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	XYLT2
Lymphoid interstitial pneumonia	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	TP53
Manganese Poisoning	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	ATP13A2
Meningothelial meningioma	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	AKT1
Micronodular cirrhosis	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	TP53
Nephrogenic rest	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	ACVR2B
Neuroma	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	SEMA3F
Oral Mucositis	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	DMRTA1
Oropharyngeal Dysphagia	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	TSEN34
Pachyonychia Congenita	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	MTOR
Paraneoplastic Cerebellar Degeneration	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	ERBB2
Phosphate Diabetes	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	ACTB
POEMS Syndrome	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	SDC1
Radiation Damage	1/14	0.35661637900887294	0.6905183389725947	0	0	2.406735429352554	2.4815720096904355	TP53
Renal glomerular disease	5/127	0.3585841467408383	0.6940684907702819	0	0	1.2833533253365321	1.3161968106496849	CFL1;SSSCA1;ACTN4;LDLR;MTOR
Hypoplasia of corpus callosum	7/187	0.3604178566644784	0.6966042198579794	0	0	1.21805328983143	1.2430126727605924	GNAO1;RERE;GABRB1;PIGO;DNAH7;CHMP1A;PIGG
Muscle Weakness	12/339	0.3608659140162503	0.6966042198579794	0	0	1.1499879285369388	1.17212383798422	RIMS2;CCND3;TCN2;AGK;TPM2;XYLT2;ATP1A3;ERCC8;RBCK1;SHBG;TP53;TTC19
Central Serous Chorioretinopathy	4/98	0.3614002811354356	0.6966042198579794	0	0	1.3322741088698535	1.355947451270482	JAG1;HSF1;AKT1;SYBU
Frontotemporal Lobar Degeneration	4/98	0.3614002811354356	0.6966042198579794	0	0	1.3322741088698535	1.355947451270482	RIMS2;ATXN2;FNDC3A;SYP
Simple Partial Status Epilepticus	3/69	0.36151171007335536	0.6966042198579794	0	0	1.422867246205982	1.4477117105014259	GRM5;PDXK;KCNMA1
Status Epilepticus, Subclinical	3/69	0.36151171007335536	0.6966042198579794	0	0	1.422867246205982	1.4477117105014259	GRM5;PDXK;KCNMA1
Williams Syndrome	3/69	0.36151171007335536	0.6966042198579794	0	0	1.422867246205982	1.4477117105014259	RIMS2;FZD3;CACNA2D1
Complex Partial Status Epilepticus	3/69	0.36151171007335536	0.6966042198579794	0	0	1.422867246205982	1.4477117105014259	GRM5;PDXK;KCNMA1
Grand Mal Status Epilepticus	3/69	0.36151171007335536	0.6966042198579794	0	0	1.422867246205982	1.4477117105014259	GRM5;PDXK;KCNMA1
Kallmann Syndrome	3/69	0.36151171007335536	0.6966042198579794	0	0	1.422867246205982	1.4477117105014259	SOX3;CHD7;OTX2
Non-Convulsive Status Epilepticus	3/69	0.36151171007335536	0.6966042198579794	0	0	1.422867246205982	1.4477117105014259	GRM5;PDXK;KCNMA1
Progressive supranuclear palsy	3/69	0.36151171007335536	0.6966042198579794	0	0	1.422867246205982	1.4477117105014259	ATXN2;SPG7;MTOR
Anemia, Macrocytic	2/41	0.3644663218946676	0.6994308326233547	0	0	1.6049290515309933	1.6198887992916067	TCN2;TP53
Unable to walk	2/41	0.3644663218946676	0.6994308326233547	0	0	1.6049290515309933	1.6198887992916067	PGAP3;MBOAT7
Unilateral agenesis of kidney	2/41	0.3644663218946676	0.6994308326233547	0	0	1.6049290515309933	1.6198887992916067	DSTYK;FRAS1
Choreatic disease	2/41	0.3644663218946676	0.6994308326233547	0	0	1.6049290515309933	1.6198887992916067	TSEN34;CHMP1A
Chronic viral hepatitis	2/41	0.3644663218946676	0.6994308326233547	0	0	1.6049290515309933	1.6198887992916067	GAPDH;TP53
Cloudy cornea	2/41	0.3644663218946676	0.6994308326233547	0	0	1.6049290515309933	1.6198887992916067	IDUA;ERCC8
Corneal stromal opacities	2/41	0.3644663218946676	0.6994308326233547	0	0	1.6049290515309933	1.6198887992916067	IDUA;ERCC8
Freckles	2/41	0.3644663218946676	0.6994308326233547	0	0	1.6049290515309933	1.6198887992916067	BNC2;ERCC8
Genitourinary Cancer	2/41	0.3644663218946676	0.6994308326233547	0	0	1.6049290515309933	1.6198887992916067	SPG7;TP53
Gestational Trophoblastic Neoplasms	2/41	0.3644663218946676	0.6994308326233547	0	0	1.6049290515309933	1.6198887992916067	ERBB2;TP53
Invasive Ductal Breast Carcinoma	8/218	0.3644673437025337	0.6994308326233547	0	0	1.1932773109243697	1.2043966550329788	RHBDF1;CTBP1;LMO4;ERBB2;TACSTD2;ACTN4;TP53;FHIT
Peritonitis	5/128	0.3647541517774317	0.699721401776454	0	0	1.2728534602419195	1.2837130757108268	TMEM67;SDC1;HMGB1;TP53;LDLR
Intestinal Neoplasms	6/158	0.3657532390664166	0.7000506037151503	0	0	1.236156351791531	1.2433215876567856	CHRM3;BCL9;JAG1;ERBB2;AKT1;TP53
Central neuroblastoma	54/1655	0.36608339100318266	0.7000506037151503	0	0	1.0594813753771384	1.064666612060317	HMGB1;APEH;RIMS2;GRM5;MAGED4B;MDK;AKT2;CFL1;RNPEP;TRIM24;AKT1;SKP1;UNC45A;PRKCI;LMO4;CTNNBIP1;ACTN4;SYP;YWHAZ;ULK1;SCG3;GAPDH;TP53;RAB1B;ADCY2;NDRG2;HDAC9;HDAC6;RELA;ATXN2;MAP2;KCNQ1OT1;HSF1;ERBB2;IGF2BP1;LDLR;KCNJ3;NAA50;BBS2;JAG1;URGCP;NEGR1;GDAP1;MTOR;HIPK2;AIMP2;RALYL;VANGL2;NFIC;SGSM3;SDC1;SHBG;OSBPL1A;LRP10
Malignant neoplasm of pancreas	60/1846	0.36822041574352565	0.7000506037151503	0	0	1.0554711246200608	1.054493298480242	RPAIN;RERE;CHD7;ARHGAP1;KEAP1;MTR;HMGB1;ACTB;LMNB1;CCND3;CDH3;NKRF;MDK;AKT2;CFL1;OSBP;AKT1;SSSCA1;CAPN1;SYBU;EIF5A;RHBDF1;PRKCI;LMO4;ACTN4;EML2;SPINT1;ARMC3;GAPDH;TP53;LY6E;PLEC;DNAH5;TACSTD2;NDRG2;FHIT;HDAC9;AGPAT2;RELA;STK33;ZNRF3;KCNQ1OT1;HSF1;ERBB2;FADD;MIR92B;DNAI1;B3GALNT1;JAG1;SORT1;INSR;SORBS2;SMARCA2;MTOR;AIMP2;GIPC1;SGSM3;ERCC1;SDC1;EBAG9
Ischemia of kidney	4/99	0.36847000253780127	0.7000506037151503	0	0	1.3181818181818181	1.3160674214664674	AIMP2;SDC1;HMGB1;TP53
Leigh Disease	4/99	0.36847000253780127	0.7000506037151503	0	0	1.3181818181818181	1.3160674214664674	NDUFS8;OGDH;PDSS2;ATP11A
Palmoplantar Keratosis	4/99	0.36847000253780127	0.7000506037151503	0	0	1.3181818181818181	1.3160674214664674	JUP;PIGO;AKT1;PLEC
Benign Neoplasm	3/70	0.37000154377400973	0.7000506037151503	0	0	1.4015578509397906	1.3934962317250488	ERCC1;HSF1;CAPN1
liposarcoma	5/129	0.37092607981418574	0.7000506037151503	0	0	1.2625229478101232	1.252110267086087	AKT1;SDC1;HCCS;TP53;LDLR
Malignant neoplasm of larynx	5/129	0.37092607981418574	0.7000506037151503	0	0	1.2625229478101232	1.252110267086087	CAPN10;ERCC1;ERBB2;CAPN1;TP53
Pervasive Development Disorder	5/129	0.37092607981418574	0.7000506037151503	0	0	1.2625229478101232	1.252110267086087	CNTNAP2;MBD5;CNTN4;SMARCA2;CBLN2
Sporadic Breast Carcinoma	6/159	0.37129618388986846	0.7000506037151503	0	0	1.228013029315961	1.2166602890006408	ERBB2;DIXDC1;SHBG;FEZF2;TP53;FHIT
Cardiomegaly	6/159	0.37129618388986846	0.7000506037151503	0	0	1.228013029315961	1.2166602890006408	HDAC4;JUP;KCNQ1OT1;AKT1;RBCK1;TP53
cervical cancer	32/965	0.3721764112526211	0.7000506037151503	0	0	1.0760111118402345	1.0635157319344404	RPAIN;TACSTD2;KEAP1;MSI1;MTR;NDRG2;FHIT;HDAC6;RELA;RIMS2;SOX1;SHARPIN;MDK;ERBB2;AKT1;CKB;PDLIM7;URGCP;AGK;USP22;MTOR;TAPBP;ST7L;RAD52;GNAO1;GIPC1;SGSM3;ERCC1;SDC1;SHBG;GAPDH;TP53
Congenital chromosomal disease	17/497	0.37369545224664363	0.7000506037151503	0	0	1.1100746268656716	1.0926621207021787	HDAC4;PDXK;CHD7;SYVN1;HCCS;MTR;WDR78;FHIT;MTOR;FCGRT;KCNQ1OT1;ERCC1;ERBB2;AKT1;SDC1;TP53;PDLIM7
Nonorganic psychosis	8/220	0.3738698982528665	0.7000506037151503	0	0	1.181896658034283	1.162805963201068	FZD3;GRM5;ALG9;SGSM3;PPP1R1B;AKT1;SEPHS1;GABRG2
Mood swings	4/100	0.3755349836293304	0.7000506037151503	0	0	1.3043831168831168	1.277517581317029	ATXN2;NDUFS8;MAP6;ATP1A3
Neuralgia	4/100	0.3755349836293304	0.7000506037151503	0	0	1.3043831168831168	1.277517581317029	GRM5;PLCB3;CACNA2D1;HMGB1
Oral Cavity Carcinoma	4/100	0.3755349836293304	0.7000506037151503	0	0	1.3043831168831168	1.277517581317029	ERBB2;HSF1;TP53;FHIT
Polymyositis	4/100	0.3755349836293304	0.7000506037151503	0	0	1.3043831168831168	1.277517581317029	SDC1;HMGB1;TYK2;TP53
Short phalanx of finger	2/42	0.37566005250541273	0.7000506037151503	0	0	1.564724919093851	1.5319762596130955	PDE4D;SMARCA2
Memory Disorder, Semantic	2/42	0.37566005250541273	0.7000506037151503	0	0	1.564724919093851	1.5319762596130955	MDK;SYP
Memory Disorder, Spatial	2/42	0.37566005250541273	0.7000506037151503	0	0	1.564724919093851	1.5319762596130955	MDK;SYP
Parkinsonism, Juvenile	2/42	0.37566005250541273	0.7000506037151503	0	0	1.564724919093851	1.5319762596130955	ATP1A3;ATP13A2
Vertical Talus	2/42	0.37566005250541273	0.7000506037151503	0	0	1.564724919093851	1.5319762596130955	TPM2;ERCC1
Age-Related Memory Disorders	2/42	0.37566005250541273	0.7000506037151503	0	0	1.564724919093851	1.5319762596130955	MDK;SYP
Arrhythmogenic Right Ventricular Dysplasia	2/42	0.37566005250541273	0.7000506037151503	0	0	1.564724919093851	1.5319762596130955	JUP;GAPDH
Chronic diarrhea	2/42	0.37566005250541273	0.7000506037151503	0	0	1.564724919093851	1.5319762596130955	IDUA;CHD7
Defective tooth enamel	2/42	0.37566005250541273	0.7000506037151503	0	0	1.564724919093851	1.5319762596130955	PEX6;PLEC
Dystrophic tooth enamel	2/42	0.37566005250541273	0.7000506037151503	0	0	1.564724919093851	1.5319762596130955	PEX6;PLEC
exudative macular degeneration	2/42	0.37566005250541273	0.7000506037151503	0	0	1.564724919093851	1.5319762596130955	KCNT2;TMEM97
Eye Abnormalities	2/42	0.37566005250541273	0.7000506037151503	0	0	1.564724919093851	1.5319762596130955	JAG1;OTX2
Ganglioneuroblastoma	2/42	0.37566005250541273	0.7000506037151503	0	0	1.564724919093851	1.5319762596130955	GAPDH;TP53
Gonadal Dysgenesis	2/42	0.37566005250541273	0.7000506037151503	0	0	1.564724919093851	1.5319762596130955	SHBG;LHX9
Nail Diseases	2/42	0.37566005250541273	0.7000506037151503	0	0	1.564724919093851	1.5319762596130955	CDH3;PDE4D
Oligoarticular Juvenile Idiopathic Arthritis	2/42	0.37566005250541273	0.7000506037151503	0	0	1.564724919093851	1.5319762596130955	ATXN2;TYK2
Optic Neuritis	2/42	0.37566005250541273	0.7000506037151503	0	0	1.564724919093851	1.5319762596130955	SDC1;CAPN1
Undergrowth	18/529	0.37656986422763683	0.7000506037151503	0	0	1.1040887842872096	1.078310173329311	RERE;SETD5;JAG1;ALG9;CTBP1;TPM2;CHD7;MTR;KCNAB2;SMARCA2;ACTB;ARCN1;PEX26;NDUFS8;TCN2;PEX6;RBCK1;PLEC
Adenocarcinoma, metastatic	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	ERBB2
response to ACE inhibitor	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	ANKS1B
Cone-rod synaptic disorder, congenital nonprogressive	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	PDE6B
Saldino-Noonan Syndrome	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	IFT172
Scarring alopecia of scalp	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	PLEC
Selective immunoglobulin A deficiency	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	SDC1
Leukemia, Prolymphocytic, B-Cell	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	TP53
Smoker's lung	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	TP53
Soft Tissue Infections	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	HCCS
Sphenoid Wing Meningioma	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	AKT1
Stage II Colorectal Cancer	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	TCF12
Stage III Colorectal Cancer AJCC v7	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	ERCC1
Stromal keratitis	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	CHRM3
Sudden sensorineural hearing loss	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	MTR
Pyogenic Arthritis, Pyoderma Gangrenosum and Acne	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	RABEP2
Reflex, Ankle, Absent	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	CHRNB2
Thyroid stimulating hormone measurement	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	INSR
Tic disorder	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	PRKCI
3-Methylglutaconic Aciduria	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	AGK
Triglyceride storage disease with ichthyosis	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	AGK
Adult Synovial Sarcoma	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	TP53
Albright's hereditary osteodystrophy	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	SOX3
Anovulation	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	INSR
Aplasia/Hypoplasia of the thumb	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	FRAS1
Clear Cell Meningioma	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	AKT1
Complex partial seizure with impairment of consciousness	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	MTOR
Congenital abnormal Synostosis	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	TCF12
Ductal Carcinoma In Situ with Microinvasion	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	TP53
Foot-and-Mouth Disease	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	RIMS2
Group B streptococcal pneumonia	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	TP53
Hemangioendothelioma	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	YWHAZ
Hyperacusis	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	FLII
Hyperparathyroidism-Jaw Tumor Syndrome	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	RIMS2
Hypoketotic hypoglycemia	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	AKT2
Hypoplastic anemia	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	TP53
Immunologic hypersensitivity	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	UBAC2
Iridocyclitis	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	TYK2
Lethal skeletal dysplasia	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	ALG9
Low grade B-cell lymphoma	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	TP53
Malignant melanoma of ciliary body	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	SSSCA1
Mast-Cell Sarcoma	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	LAD1
Metaphyseal chondrodysplasia	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	HDAC6
Middle East Respiratory Syndrome	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	PPP1CA
Pancreatic Endocrine Carcinoma	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	TP53
Paraneoplastic Syndromes	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	ERBB2
Periodic fever	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	AIMP2
Progesterone Resistance	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	AKT1
Progressive pseudorheumatoid dysplasia	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	HP1BP3
Psammomatous Meningioma	1/15	0.3765752086548215	0.7000506037151503	0	0	2.2347103623355644	2.1825019287748897	AKT1
Dementia	15/436	0.376979095223436	0.7005494297427965	0	0	1.1165269625645355	1.089245232963136	NAA50;PRDM8;CHRNB2;HEXA;ROGDI;SYP;TOM1L2;ATXN2;AKT1;ERCC8;ATP13A2;SHBG;GAPDH;TP53;LY6E
Dysarthria	10/282	0.37781460899430575	0.7018497121792135	0	0	1.151639344262295	1.1209500629327072	PRDM8;RERE;ATXN2;ATCAY;NDUFS8;ATP1A3;ERCC8;ATP13A2;SPG7;TTC19
Splenic Marginal Zone B-Cell Lymphoma	3/71	0.37847051688548705	0.7020587334042344	0	0	1.380875202593193	1.3416819649987122	SLC35B2;SGSM3;TP53
Tracheal Diseases	3/71	0.37847051688548705	0.7020587334042344	0	0	1.380875202593193	1.3416819649987122	VANGL2;FHIT;DNAI1
Proximal muscle weakness	3/71	0.37847051688548705	0.7020587334042344	0	0	1.380875202593193	1.3416819649987122	TPM2;RBCK1;GDAP1
Proximal neurogenic muscle weakness	3/71	0.37847051688548705	0.7020587334042344	0	0	1.380875202593193	1.3416819649987122	TPM2;RBCK1;GDAP1
Anaplasia	10/283	0.38197795269256024	0.7034312042014531	0	0	1.1473608358854261	1.104211334178271	SPINT1;LDB1;LMO4;ERBB2;AKT1;SDC1;SSSCA1;SHBG;TP53;EBAG9
Xeroderma Pigmentosum	4/101	0.3825930106563845	0.7034312042014531	0	0	1.2908689248895435	1.240245550995315	ERCC1;XYLT2;AKT1;TP53
Juvenile rheumatoid arthritis	5/131	0.3832695177321216	0.7034312042014531	0	0	1.2423538521099498	1.191438259986895	HMGB1;TYK2;TP53;HDAC9;TAPBP
Neuroblastoma	55/1698	0.3858852529371759	0.7034312042014531	0	0	1.0508889954163279	1.0006725021608467	HMGB1;APEH;RIMS2;GRM5;MAGED4B;MDK;AKT2;CFL1;RNPEP;TRIM24;AKT1;SKP1;UNC45A;PRKCI;LMO4;CTNNBIP1;ACTN4;SYP;YWHAZ;ULK1;SCG3;GAPDH;TP53;EPB41;RAB1B;ADCY2;NDRG2;HDAC9;HDAC6;RELA;ATXN2;MAP2;KCNQ1OT1;HSF1;ERBB2;IGF2BP1;LDLR;KCNJ3;NAA50;BBS2;JAG1;URGCP;NEGR1;GDAP1;MTOR;HIPK2;AIMP2;RALYL;VANGL2;NFIC;SGSM3;SDC1;SHBG;OSBPL1A;LRP10
Neuropathy	10/284	0.38614501318126465	0.7034312042014531	0	0	1.1431135574967093	1.0877209016626417	SORT1;INSR;PDE4D;ERCC1;AP1S1;PPOX;GDAP1;ACTB;HDAC6;PLEC
Thin dental enamel	2/43	0.3867717328010313	0.7034312042014531	0	0	1.5264819638487648	1.4500366594751868	ROGDI;PLEC
Transient Cerebral Ischemia	2/43	0.3867717328010313	0.7034312042014531	0	0	1.5264819638487648	1.4500366594751868	NDRG2;TP53
Triploidy syndrome	2/43	0.3867717328010313	0.7034312042014531	0	0	1.5264819638487648	1.4500366594751868	GAPDH;TP53
Acute intermittent porphyria	2/43	0.3867717328010313	0.7034312042014531	0	0	1.5264819638487648	1.4500366594751868	PPOX;TP53
Defective enamel matrix	2/43	0.3867717328010313	0.7034312042014531	0	0	1.5264819638487648	1.4500366594751868	ROGDI;PLEC
Dropped beats - heart	2/43	0.3867717328010313	0.7034312042014531	0	0	1.5264819638487648	1.4500366594751868	CACNA2D1;TP53
Dysplasia of tooth enamel	2/43	0.3867717328010313	0.7034312042014531	0	0	1.5264819638487648	1.4500366594751868	ROGDI;PLEC
Hyperlipoproteinemias	2/43	0.3867717328010313	0.7034312042014531	0	0	1.5264819638487648	1.4500366594751868	SDC1;LDLR
Hyperplasia of nose	2/43	0.3867717328010313	0.7034312042014531	0	0	1.5264819638487648	1.4500366594751868	MBD5;ACTB
Hypertrophy of nose	2/43	0.3867717328010313	0.7034312042014531	0	0	1.5264819638487648	1.4500366594751868	MBD5;ACTB
Large nose	2/43	0.3867717328010313	0.7034312042014531	0	0	1.5264819638487648	1.4500366594751868	MBD5;ACTB
Macrocephaly	2/43	0.3867717328010313	0.7034312042014531	0	0	1.5264819638487648	1.4500366594751868	AKT1;MTOR
Non-small cell lung cancer metastatic	2/43	0.3867717328010313	0.7034312042014531	0	0	1.5264819638487648	1.4500366594751868	ERCC1;TP53
Benign melanocytic nevus	3/72	0.3869151688689175	0.7034312042014531	0	0	1.3607920513001197	1.2921398363058156	ERBB2;HCCS;TP53
Hallucinations	3/72	0.3869151688689175	0.7034312042014531	0	0	1.3607920513001197	1.2921398363058156	PRDM8;ATP13A2;TTC19
Learning Disabilities	3/72	0.3869151688689175	0.7034312042014531	0	0	1.3607920513001197	1.2921398363058156	GPM6A;GLDC;SYP
Rectal Neoplasms	3/72	0.3869151688689175	0.7034312042014531	0	0	1.3607920513001197	1.2921398363058156	ERCC1;MSI1;TP53
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	14/408	0.3872522745260239	0.7034312042014531	0	0	1.11324990367057	1.0561167231713309	HDAC4;LRSAM1;JAG1;LMO4;SEMA3F;TYK2;FHIT;MTOR;CCND3;SALL2;FCGRT;AKT1;TP53;SYBU
Sarcoma	22/658	0.38849595509761203	0.7034312042014531	0	0	1.08424307439894	1.0251220327312007	HDAC4;FZD3;FLII;PHF1;SPG7;MTOR;RIMS2;ATXN2;CCND3;SALL2;MDK;SGSM3;ERCC1;CREB3L2;ERBB2;IGF2BP1;CHAMP1;CDK2AP2;AKT1;SSSCA1;TP53;CLIC1
Thyroid carcinoma	24/721	0.38931051934502253	0.7034312042014531	0	0	1.0793910623669996	1.0182737854673234	LRRC34;TRAF3IP2;SORT1;TACSTD2;MIB2;CASC2;NDRG2;FHIT;MTOR;RELA;HIPK2;CCND3;VANGL2;ZNRF3;TEP1;SGSM3;CREB3L2;ERBB2;TRIM24;AKT1;SSSCA1;GAPDH;TP53;PDLIM7
Huntington Disease	21/627	0.3893699156311028	0.7034312042014531	0	0	1.0861171259029074	1.0244533118944334	HDAC4;TRPC5;KEAP1;CPLX2;HDAC9;HDAC6;RIMS2;MAPK10;AIMP2;ATXN2;GRM5;MAP2;PSME3;PPP1R1B;HSF1;AKT1;CKB;GAPDH;TP53;LY6E;SKP1
Sleep Apnea, Obstructive	5/132	0.3894379941030479	0.7034312042014531	0	0	1.232507521925613	1.1623169826051352	IDUA;CAPN10;ALDOA;PLCB1;ARCN1
Mouth Neoplasms	5/132	0.3894379941030479	0.7034312042014531	0	0	1.232507521925613	1.1623169826051352	MAP2;SDC1;TP53;FHIT;GAPDH
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	4/102	0.38964192068508174	0.7034312042014531	0	0	1.2776305327325737	1.2042014184013765	INSR;AKT1;TP53;ANKS1B
Cerebellar degeneration	7/193	0.39086941165855643	0.7034312042014531	0	0	1.1783928853338947	1.106960782962144	SOX3;ATXN2;ATP13A2;CNTN4;SPG7;TTC19;LY6E
Recurrent tumor	12/347	0.3909857292970332	0.7034312042014531	0	0	1.1220542026708562	1.0537033930473199	RIMS2;URGCP;HSF1;ERBB2;AKT1;TRIB3;RIN1;NDRG2;TP53;RELA;PDLIM7;MTOR
Retinitis Pigmentosa	14/410	0.3942167449700277	0.7034312042014531	0	0	1.1075107510751074	1.0309312632215026	HDAC4;BBS2;BBS1;JAG1;IFT172;HCCS;PEX26;ATXN2;NDUFS8;PEX6;NPHP1;ERCC8;OTX2;PDE6B
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1	3/73	0.39533216764066265	0.7034312042014531	0	0	1.341282704329706	1.244749161952512	AIMP2;AKT1;TP53
Bone neoplasms	3/73	0.39533216764066265	0.7034312042014531	0	0	1.341282704329706	1.244749161952512	ERBB2;AKT1;RELA
hypopigmented skin patch	3/73	0.39533216764066265	0.7034312042014531	0	0	1.341282704329706	1.244749161952512	HCCS;PPOX;KIAA0319L
mixed gliomas	3/73	0.39533216764066265	0.7034312042014531	0	0	1.341282704329706	1.244749161952512	MDK;ERBB2;TP53
Ataxia, Motor	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	ARCN1
Cancer, Embryonal and Mixed	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	ERCC1
Round cell liposarcoma	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	TP53
Congenital dyserythropoietic anemia, type II	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	MAN2A1
Depression, Postpartum	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	HP1BP3
Secretory meningioma	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	AKT1
Gaucher Disease, Type 3 (disorder)	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	AIMP2
Glioblastoma, IDH-Mutant	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	TP53
Severe chronic obstructive pulmonary disease	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	ADCY2
Guillain-Barre Syndrome, Familial	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	YWHAZ
Severe periodontitis	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	LAD1
Skin Manifestations	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	PLEC
Leukodystrophy, Metachromatic	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	ACTB
Sore to touch	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	CAPN1
Spinal Meningioma	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	AKT1
Necrotizing encephalopathy, infantile subacute, of Leigh	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	NDUFS8
Neoplasms, Embryonal and Mixed	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	ERCC1
NEPHROLITHIASIS, CALCIUM OXALATE	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	IDUA
Nephronophthisis, familial juvenile	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	NPHP1
Nuchal bleb, familial	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	LDLR
Stage III Colorectal Cancer	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	ERCC1
SPHEROCYTOSIS, TYPE 1 (disorder)	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	TP53
Tremor, Rubral	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	ARCN1
Thyroxine measurement	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	INSR
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	TP53
Tonsillitis	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	SKP1
Tracheal Stenosis	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	IDUA
Tumor thrombus	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	CLIC1
Abnormality of the fallopian tube	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	TP53
Uterine Corpus Sarcoma	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	ERBB2
Visceral angiomatosis	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	AKT1
Waxy flexibility	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	PPP1R1B
Widespread Chronic Pain	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	CCT5
Adenocarcinoma of salivary gland	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	ERBB2
Adult Neuronal Ceroid Lipofuscinosis	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	ATP13A2
Arnold Chiari Malformation	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	CHD4
Autosomal dominant hypocalcemia	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	SPG7
Autosomal Dominant Myotubular Myopathy	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	TPM2
Balkan Nephropathy	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	TP53
Basaloid squamous cell carcinoma	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	TP53
Benign neoplasm of bladder	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	MTOR
Blastoma	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	TP53
Cannabis Abuse	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	AKT1
Central nervous system lymphoma	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	PDLIM7
Cerebellar malformation	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	TMEM67
Cervical Disc Degenerative Disorder	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	ADAMTS5
Cervical Squamous Intraepithelial Neoplasia 1	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	FHIT
Childhood Synovial Sarcoma	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	TP53
Choanal stenosis	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	FRAS1
Chronic lymphocytic leukaemia refractory	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	TP53
Codependency	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	ERBB2
Common Cold	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	LDLR
Complete congenital stationary night blindness	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	PDE6B
Congenital absence of kidneys syndrome	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	FRAS1
Cortical cataract	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	MAF
Dermatofibrosarcoma	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	TP53
Diffuse mesangial sclerosis (disorder)	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	ACTN4
Disorder of skeletal muscle	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	AGK
Disproportionate tall stature	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	AKT1
Familial Dystonia	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	ATP1A3
Familial Hemiplegic Migraine	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	CSAD
Fibrous Meningioma	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	AKT1
Focal Nodular Hyperplasia	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	FHIT
Focal nodular hyperplasia of liver	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	TP53
Globoid cell leukodystrophy	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	YWHAZ
Group B Streptococcal Infection	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	YWHAZ
Hereditary Sensory and Autonomic Neuropathies	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	NAA50
HYPERGLYCINURIA (disorder)	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	GLDC
Idiopathic bronchiectasis	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	RSPH1
Inverted Papilloma	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	TP53
Juvenile polyp	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	TP53
Large for gestational age	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	AKT2
Lateral Sclerosis	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	SPG7
Leigh Syndrome Due To Mitochondrial Complex II Deficiency	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	NDUFS8
Leigh Syndrome due to Mitochondrial Complex V Deficiency	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	NDUFS8
Lingual-Facial-Buccal Dyskinesia	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	PPP1R1B
Malignant melanoma of choroid	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	TP53
Morphine Dependence	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	FADD
Mucolipidosis Type IV	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	HEXA
Neoplasm of uncertain or unknown behavior of bladder	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	MTOR
Optic Nerve Glioma	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	MTOR
Papillary Meningioma	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	AKT1
Ph-Like Acute Lymphoblastic Leukemia	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	TP53
Pleomorphic Xanthoastrocytoma	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	TP53
Q Fever	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	LDLR
Quadriparesis	1/16	0.3959158486924971	0.7034312042014531	0	0	2.08562197092084	1.9324405320717146	LMNB1
Mean Corpuscular Volume (result)	7/194	0.39595227806153777	0.7034312042014531	0	0	1.172030253596322	1.0858410063388237	CCND3;ATXN2;TEX9;FBXL19;ATP11A;HMGB1;KLF16
Ataxia, Truncal	2/44	0.3977956935199947	0.7042850784896653	0	0	1.4900601017105872	1.373562342922883	ATP1A3;ARCN1
Short ribs	2/44	0.3977956935199947	0.7042850784896653	0	0	1.4900601017105872	1.373562342922883	IFT172;SUFU
Apraxias	2/44	0.3977956935199947	0.7042850784896653	0	0	1.4900601017105872	1.373562342922883	TYK2;TTC19
Autonomic nervous system disorders	2/44	0.3977956935199947	0.7042850784896653	0	0	1.4900601017105872	1.373562342922883	CCT5;LMNB1
Behavior Disorders	2/44	0.3977956935199947	0.7042850784896653	0	0	1.4900601017105872	1.373562342922883	CNTNAP2;MAP6
CARCINOMA OF VULVA	2/44	0.3977956935199947	0.7042850784896653	0	0	1.4900601017105872	1.373562342922883	JUP;TP53
HELLP Syndrome	2/44	0.3977956935199947	0.7042850784896653	0	0	1.4900601017105872	1.373562342922883	GAPDH;ACTB
Memory Disorders	2/44	0.3977956935199947	0.7042850784896653	0	0	1.4900601017105872	1.373562342922883	MDK;SYP
Monoclonal Gammapathies	2/44	0.3977956935199947	0.7042850784896653	0	0	1.4900601017105872	1.373562342922883	SDC1;TP53
Oral Submucous Fibrosis	2/44	0.3977956935199947	0.7042850784896653	0	0	1.4900601017105872	1.373562342922883	ERBB2;TP53
Uterine Fibroids	12/349	0.3985527395203358	0.7053837526853067	0	0	1.1152779946899891	1.0259614521301297	RIMS2;SPINT1;INSR;SGSM3;AKT1;SSSCA1;FNDC3A;SHBG;TP53;SLC5A3;ACTB;MTOR
Thyroid Gland Follicular Adenoma	5/134	0.40176106406558754	0.7108186166008067	0	0	1.2132728304027227	1.1063807460611723	ERBB2;AKT1;NDRG2;TP53;ACTB
Anoxia	10/288	0.4028407433961586	0.7109985161924492	0	0	1.1264300035381531	1.0241658986157893	CTBP1;KCNMA1;ERBB2;AKT1;TRIB3;CAPN1;TP53;GAPDH;ACTB;MTOR
Acute Promyelocytic Leukemia	16/475	0.40291950801359283	0.7109985161924492	0	0	1.0919793966151583	0.9926294392477817	RERE;JAG1;NUMA1;STAT2;MYCBP2;HDAC9;MTOR;RIMS2;SGSM3;RNPEP;ERBB2;AKT1;TRIB3;RIN1;TP53;SYBU
Acquired flat foot	4/104	0.40370399454147526	0.7109985161924492	0	0	1.251948051948052	1.1356087214509212	FLII;PEX6;XYLT2;UBE2A
Xerosis	4/104	0.40370399454147526	0.7109985161924492	0	0	1.251948051948052	1.1356087214509212	INSR;CHD7;ERCC8;UBE2A
Carcinoid tumor no ICD-O subtype	4/104	0.40370399454147526	0.7109985161924492	0	0	1.251948051948052	1.1356087214509212	ERBB2;AKT1;SYP;TP53
Thick eyebrow	3/74	0.4037183079956086	0.7109985161924492	0	0	1.3223229164288812	1.1993970034274695	SETD5;MBD5;IDUA
DiGeorge Syndrome	3/74	0.4037183079956086	0.7109985161924492	0	0	1.3223229164288812	1.1993970034274695	CHD7;SYVN1;PKP4
Hereditary gingival fibromatosis	3/74	0.4037183079956086	0.7109985161924492	0	0	1.3223229164288812	1.1993970034274695	RIMS2;SSSCA1;TP53
Marginal Zone B-Cell Lymphoma	3/74	0.4037183079956086	0.7109985161924492	0	0	1.3223229164288812	1.1993970034274695	SLC35B2;AKT1;TP53
Photoreceptor degeneration	3/74	0.4037183079956086	0.7109985161924492	0	0	1.3223229164288812	1.1993970034274695	OTX2;PDE6B;HMGB1
Failure to gain weight	18/539	0.4070905397498609	0.7109985161924492	0	0	1.0823231582504893	0.9727051028401452	RERE;SETD5;JAG1;ALG9;CTBP1;TPM2;CHD7;MTR;KCNAB2;SMARCA2;ACTB;ARCN1;PEX26;NDUFS8;TCN2;PEX6;RBCK1;PLEC
Flexion contractures of joints	5/135	0.4079127751329398	0.7109985161924492	0	0	1.2038774233896186	1.0795191896212768	ALG9;IDUA;TPM2;GDAP1;PLEC
Hirschsprung Disease	5/135	0.4079127751329398	0.7109985161924492	0	0	1.2038774233896186	1.0795191896212768	BBS2;SUFU;ERCC1;ERBB2;GABRG2
Rough hair texture	2/45	0.40872669459603533	0.7109985161924492	0	0	1.4553322796718597	1.3020982696236936	INSR;SGSH
Liposarcoma, Dedifferentiated	2/45	0.40872669459603533	0.7109985161924492	0	0	1.4553322796718597	1.3020982696236936	SDC1;TP53
Age-related cataract	2/45	0.40872669459603533	0.7109985161924492	0	0	1.4553322796718597	1.3020982696236936	KEAP1;TP53
Cerebral Amyloid Angiopathy	2/45	0.40872669459603533	0.7109985161924492	0	0	1.4553322796718597	1.3020982696236936	HDAC9;LDLR
Coarse hair	2/45	0.40872669459603533	0.7109985161924492	0	0	1.4553322796718597	1.3020982696236936	INSR;SGSH
Hypoparathyroidism	2/45	0.40872669459603533	0.7109985161924492	0	0	1.4553322796718597	1.3020982696236936	SOX3;SPG7
Hypopituitarism	2/45	0.40872669459603533	0.7109985161924492	0	0	1.4553322796718597	1.3020982696236936	SOX3;CHD7
LATERAL MENINGOCELE SYNDROME	2/45	0.40872669459603533	0.7109985161924492	0	0	1.4553322796718597	1.3020982696236936	SPINT1;TP53
Mammary adenocarcinoma	2/45	0.40872669459603533	0.7109985161924492	0	0	1.4553322796718597	1.3020982696236936	ERBB2;TP53
Panhypopituitarism	2/45	0.40872669459603533	0.7109985161924492	0	0	1.4553322796718597	1.3020982696236936	SOX3;OTX2
Peripheral axonal neuropathy	2/45	0.40872669459603533	0.7109985161924492	0	0	1.4553322796718597	1.3020982696236936	GDAP1;CCT5
Leukoencephalopathy, Progressive Multifocal	4/105	0.41071309038008774	0.7109985161924492	0	0	1.2394882345377396	1.1029714778231743	TP53;HDAC9;MTOR;HIPK2
Mixed Salivary Gland Tumor	4/105	0.41071309038008774	0.7109985161924492	0	0	1.2394882345377396	1.1029714778231743	ERBB2;XYLT2;TYK2;TP53
Neurogenic Muscular Atrophy	8/228	0.41159501504624957	0.7109985161924492	0	0	1.1384432560903148	1.010613594811092	ATXN2;INSR;TPM2;OGDH;AKT1;TTC19;DHTKD1;PLEC
Shy-Drager Syndrome	3/75	0.41207051033859776	0.7109985161924492	0	0	1.3038897893030794	1.1559775782070456	MAP2;SGSM3;SYBU
Congenital Bilateral Cataracts	3/75	0.41207051033859776	0.7109985161924492	0	0	1.3038897893030794	1.1559775782070456	MAF;AGK;LEMD2
Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor	3/75	0.41207051033859776	0.7109985161924492	0	0	1.3038897893030794	1.1559775782070456	FLII;SPG7;TP53
Proliferative diabetic retinopathy	3/75	0.41207051033859776	0.7109985161924492	0	0	1.3038897893030794	1.1559775782070456	SDC1;HMGB1;RELA
Flexion contracture	5/136	0.41405605873284834	0.7109985161924492	0	0	1.1946254577049586	1.05336566444192	ALG9;IDUA;TPM2;GDAP1;PLEC
Recurrent fungal infections	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	TYK2
Relative short stature	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	PDE4D
Elliptocytosis, Hereditary	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	EPB41
Gonadal Dysgenesis, 45,X	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	GAPDH
Short 1st metacarpal	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	SETD5
Liposarcoma, Pleomorphic	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	TP53
Stiff-Person Syndrome	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	AMPH
Polyposis, Adenomatous Intestinal	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	AKT1
Synostotic Anterior Plagiocephaly	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	TCF12
Testicular dysfunction	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	AKT1
SYNOVITIS, GRANULOMATOUS, WITH UVEITIS AND CRANIAL NEUROPATHIES (disorder)	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	AIMP2
Tonic-Clonic Epilepsy	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	EFHC1
Abnormality of female internal genitalia	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	CHD7
Abnormality of the eyebrow	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	XYLT2
Vocal Cord Paralysis	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	GDAP1
Acute monoblastic leukemia	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	TP53
Adrenocorticotropic hormone (ACTH) deficiency (disorder)	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	TP53
Aggressive natural killer-cell leukemia	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	TP53
AICARDI-GOUTIERES SYNDROME	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	JAG1
Alagille Syndrome	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	JAG1
Aplasia/Hypoplasia of the lungs	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	CHRM3
Atypical Endometrial Hyperplasia	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	TP53
Autosome Abnormalities	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	ERCC1
Bicornuate uterus	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	FRAS1
Biliary stricture	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	TP53
Biliary Tract Neoplasm	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	ERBB2
Bone Cysts	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	AGPAT2
Brain Stem Glioma	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	TP53
Childhood Astrocytoma	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	FLII
Childhood Myelodysplastic Syndrome	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	TP53
Chromosome Aberrations	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	ERCC1
Colon diverticulum anatomic structure	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	AKT1
Completed Suicide	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	PPP1R1B
Congenital atresia of pulmonary artery	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	FADD
Coronary Restenosis	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	TP53
de novo myelodysplastic syndromes	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	TP53
Dermoid Cyst	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	TP53
Distal arthrogryposis syndrome	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	TPM2
Diverticular disease of colon	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	AKT1
Erythema Multiforme	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	GNAO1
Ethylmalonic encephalopathy	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	GRM5
Familial Intestinal Polyposis	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	AKT1
Familial partial lipodystrophy	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	AKT2
Flat acetabular roof	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	CHD4
Hepatic necrosis	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	JAG1
High blood phosphate levels	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	PDE4D
Hypopharyngeal Carcinoma	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	TP53
Interrupted aortic arch	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	CHD7
Leigh Syndrome due to Mitochondrial Complex III Deficiency	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	NDUFS8
Leigh Syndrome due to Mitochondrial Complex IV Deficiency	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	NDUFS8
Leydig Cell Tumor	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	TP53
Mesangial proliferative glomerulonephritis	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	SPG7
Mild short stature	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	PDE4D
Mouth Diseases	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	TP53
Multiple Organ Failure	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	HMGB1
Myoepithelioma	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	SDC1
Neonatal Deformity	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	CHD7
Neurofibrosarcoma	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	TP53
Occlusive vascular disease	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	LDLR
Overlapping fingers	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	TPM2
Post-transplant lymphoproliferative disorder	1/17	0.41465741637075115	0.7109985161924492	0	0	1.9551696284329563	1.7211409120185759	PDLIM7
Hereditary hemochromatosis	6/167	0.4156493841854811	0.7114521919869093	0	0	1.1665081837861897	1.0240929331258464	ERBB2;AKT1;SDC1;B9D1;TP53;MTOR
Progressive Neoplastic Disease	6/167	0.4156493841854811	0.7114521919869093	0	0	1.1665081837861897	1.0240929331258464	HDAC4;ERBB2;AKT1;SDC1;TP53;FHIT
Seminoma	8/229	0.41631223918165094	0.7114521919869093	0	0	1.1332327802916038	0.9930742387323206	KEAP1;RPS27A;TP53;FHIT;GAPDH;HDAC9;ACVR2B;ACTB
Pediatric failure to thrive	18/543	0.41936314370633465	0.7114521919869093	0	0	1.0738490745135263	0.9331942212077904	RERE;SETD5;JAG1;ALG9;CTBP1;TPM2;CHD7;MTR;KCNAB2;SMARCA2;ACTB;ARCN1;PEX26;NDUFS8;TCN2;PEX6;RBCK1;PLEC
Sparse or absent eyebrows	2/46	0.419559903978287	0.7114521919869093	0	0	1.422182994998529	1.2352355679933695	CHD7;OTX2
Sparse/absent eyebrows	2/46	0.419559903978287	0.7114521919869093	0	0	1.422182994998529	1.2352355679933695	CHD7;OTX2
Spinocerebellar Ataxia Type 5	2/46	0.419559903978287	0.7114521919869093	0	0	1.422182994998529	1.2352355679933695	BBS1;ATXN2
Abnormality of dental enamel	2/46	0.419559903978287	0.7114521919869093	0	0	1.422182994998529	1.2352355679933695	PEX6;PLEC
Absence of eyebrow	2/46	0.419559903978287	0.7114521919869093	0	0	1.422182994998529	1.2352355679933695	CHD7;OTX2
Aplasia/Hypoplasia of the eyebrow	2/46	0.419559903978287	0.7114521919869093	0	0	1.422182994998529	1.2352355679933695	CHD7;OTX2
Basal Cell Nevus Syndrome	2/46	0.419559903978287	0.7114521919869093	0	0	1.422182994998529	1.2352355679933695	SUFU;TP53
Cortical visual impairment	2/46	0.419559903978287	0.7114521919869093	0	0	1.422182994998529	1.2352355679933695	GABRB1;PDSS2
Decreased fertility	2/46	0.419559903978287	0.7114521919869093	0	0	1.422182994998529	1.2352355679933695	CHRM3;CHD7
Early gastric cancer	2/46	0.419559903978287	0.7114521919869093	0	0	1.422182994998529	1.2352355679933695	ERBB2;TP53
Exfoliative dermatitis	2/46	0.419559903978287	0.7114521919869093	0	0	1.422182994998529	1.2352355679933695	CHD7;TP53
Foot-drop	2/46	0.419559903978287	0.7114521919869093	0	0	1.422182994998529	1.2352355679933695	LRSAM1;GDAP1
Hereditary Diseases	2/46	0.419559903978287	0.7114521919869093	0	0	1.422182994998529	1.2352355679933695	MBD5;IDUA
Malignant neoplasm of male breast	2/46	0.419559903978287	0.7114521919869093	0	0	1.422182994998529	1.2352355679933695	ERBB2;TP53
Moyamoya disease 1	2/46	0.419559903978287	0.7114521919869093	0	0	1.422182994998529	1.2352355679933695	TCN2;ATP11A
Reflex, Deep Tendon, Absent	5/137	0.42018953954531313	0.7114521919869093	0	0	1.1855136733185514	1.027898901207376	CHRNB2;LRSAM1;JAG1;ATP1A3;GDAP1
Absent reflex	5/137	0.42018953954531313	0.7114521919869093	0	0	1.1855136733185514	1.027898901207376	CHRNB2;LRSAM1;JAG1;ATP1A3;GDAP1
Lymphopenia	5/137	0.42018953954531313	0.7114521919869093	0	0	1.1855136733185514	1.027898901207376	TCN2;CHD7;FOXJ1;HMGB1;ACTB
Prominent eyes	5/137	0.42018953954531313	0.7114521919869093	0	0	1.1855136733185514	1.027898901207376	JAG1;CTBP1;KCNQ1OT1;INSR;TCF12
Protruding eyes	5/137	0.42018953954531313	0.7114521919869093	0	0	1.1855136733185514	1.027898901207376	JAG1;CTBP1;KCNQ1OT1;INSR;TCF12
Varicosity	3/76	0.4203858189392124	0.7114521919869093	0	0	1.2859616793588065	1.1143917234964367	JAG1;AKT1;HCCS
Acromegaly	3/76	0.4203858189392124	0.7114521919869093	0	0	1.2859616793588065	1.1143917234964367	INSR;TP53;AGPAT2
Acute Undifferentiated Leukemia	3/76	0.4203858189392124	0.7114521919869093	0	0	1.2859616793588065	1.1143917234964367	SYVN1;TP53;RELA
Petit mal status	3/76	0.4203858189392124	0.7114521919869093	0	0	1.2859616793588065	1.1143917234964367	GRM5;PDXK;KCNMA1
Juvenile-Onset Still Disease	6/168	0.4211784697693646	0.7114521919869093	0	0	1.159247195077814	1.0023994456908925	RERE;ANKRD9;MAP2;ERBB2;SH3BGRL2;TAPBP
Retinal Diseases	12/355	0.42129668058600167	0.7114521919869093	0	0	1.0954235077489642	0.9469037856799574	BBS2;BBS1;CHRM3;POLD4;CDH3;IDUA;INSR;TUBGCP6;OTX2;RPS27A;TP53;HDAC9
Liver and Intrahepatic Biliary Tract Carcinoma	20/607	0.4221338196624756	0.7114521919869093	0	0	1.0671777399204998	0.9203692005353441	ARHGAP1;MSI1;CHD4;MTR;NDRG2;PPOX;FHIT;HDAC6;MTOR;RELA;LMNB1;AIMP2;FER;MAN2A1;ERBB2;IGF2BP1;TRIM24;AKT1;GAPDH;TP53
Kidney Diseases	21/639	0.4233315803042585	0.7114521919869093	0	0	1.0643467267452227	0.9149119452367716	TRPC5;JAG1;SLC15A2;INSR;XYLT2;KEAP1;ACTN4;HMGB1;MTOR;ACTB;HIPK2;TMEM231;FCGRT;KCNQ1OT1;TMEM67;ERCC1;NPHP1;AKT1;PDSS2;SSSCA1;TP53
White Blood Cell Count procedure	4/107	0.42467762087669364	0.7114521919869093	0	0	1.2152944143235405	1.0408084422328985	RERE;CHD7;PLCB1;SMG6
Alcohol abuse	4/107	0.42467762087669364	0.7114521919869093	0	0	1.2152944143235405	1.0408084422328985	ERCC1;SHBG;LDLR;GABRG2
Basal cell carcinoma	4/107	0.42467762087669364	0.7114521919869093	0	0	1.2152944143235405	1.0408084422328985	SUFU;ERBB2;KEAP1;TP53
Head and Neck Neoplasms	4/107	0.42467762087669364	0.7114521919869093	0	0	1.2152944143235405	1.0408084422328985	ERBB2;MTR;ABCC10;TP53
Hamartoma Syndrome, Multiple	5/138	0.42631186906439295	0.7114521919869093	0	0	1.1765389082462254	1.0030983821466934	RIMS2;TEP1;AKT1;TP53;MTOR
Progressive cGVHD	6/169	0.42670072741856774	0.7114521919869093	0	0	1.1520752982554305	0.9811907158536718	HDAC4;ERBB2;AKT1;SDC1;TP53;FHIT
Recurrent otitis media	3/77	0.42866140009350334	0.7114521919869093	0	0	1.2685181129265408	1.074546406381687	HYDIN;LRRC6;CCDC40
aggressive cancer	3/77	0.42866140009350334	0.7114521919869093	0	0	1.2685181129265408	1.074546406381687	VANGL2;IGF2BP1;TP53
Congenital anomaly of testis	3/77	0.42866140009350334	0.7114521919869093	0	0	1.2685181129265408	1.074546406381687	BBS2;IFT172;PDE6B
Progressive night blindness	3/77	0.42866140009350334	0.7114521919869093	0	0	1.2685181129265408	1.074546406381687	BBS2;IFT172;PDE6B
Male infertility	9/263	0.42923750917856945	0.7114521919869093	0	0	1.1091537043957884	0.9380610652995013	RIMS2;SOX3;ERCC1;SLC16A7;MTR;SHBG;TP53;DNAI1;ENO4
Blindness, Cortical	2/47	0.430290877450301	0.7114521919869093	0	0	1.3905070118662353	1.1726059973099074	GABRB1;PDSS2
Carcinoma in situ of uterine cervix	2/47	0.430290877450301	0.7114521919869093	0	0	1.3905070118662353	1.1726059973099074	GNAO1;TP53
Colonic Polyps	2/47	0.430290877450301	0.7114521919869093	0	0	1.3905070118662353	1.1726059973099074	AKT1;TP53
Foot dorsiflexor weakness	2/47	0.430290877450301	0.7114521919869093	0	0	1.3905070118662353	1.1726059973099074	LRSAM1;GDAP1
LIMB-MAMMARY SYNDROME	2/47	0.430290877450301	0.7114521919869093	0	0	1.3905070118662353	1.1726059973099074	SPINT1;TP53
Lower limb muscle weakness	2/47	0.430290877450301	0.7114521919869093	0	0	1.3905070118662353	1.1726059973099074	DSTYK;SPG7
Lumbar hyperlordosis	2/47	0.430290877450301	0.7114521919869093	0	0	1.3905070118662353	1.1726059973099074	TPM2;PLEC
Post MI	2/47	0.430290877450301	0.7114521919869093	0	0	1.3905070118662353	1.1726059973099074	CHRM3;HMGB1
Arthritis, Psoriatic	7/201	0.4314826716835099	0.7114521919869093	0	0	1.129328467398799	0.9492321162691717	JAG1;TRAF3IP2;FBXL19;TP53;RELA;PDLIM7;MTOR
Eosinophil count procedure	7/201	0.4314826716835099	0.7114521919869093	0	0	1.129328467398799	0.9492321162691717	RERE;RAB5B;ATXN2;SHARPIN;SUFU;CHD7;UBAC2
Eosinophil count result	7/201	0.4314826716835099	0.7114521919869093	0	0	1.129328467398799	0.9492321162691717	RERE;RAB5B;ATXN2;SHARPIN;SUFU;CHD7;UBAC2
Reduced visual acuity	4/108	0.43162930117106946	0.7114521919869093	0	0	1.2035464535464535	1.0112054781818054	CDH3;SALL2;TACSTD2;PDE6B
Flatfoot	4/108	0.43162930117106946	0.7114521919869093	0	0	1.2035464535464535	1.0112054781818054	FLII;PEX6;XYLT2;UBE2A
Differentiated Thyroid Gland Carcinoma	5/139	0.4324217262359839	0.7114521919869093	0	0	1.1676980948913966	0.9789443088470156	TRAF3IP2;ERBB2;CDK2AP2;TP53;RELA
Prominent globes	5/139	0.4324217262359839	0.7114521919869093	0	0	1.1676980948913966	0.9789443088470156	JAG1;CTBP1;KCNQ1OT1;INSR;TCF12
Recurrent Carcinoma	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	TP53
Adenoma, Villous	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	TP53
Reduced subcutaneous adipose tissue	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	ERCC8
Renal dysplasia and retinal aplasia (disorder)	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	NPHP1
Residual Cancer	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	TP53
B-CELL MALIGNANCY, LOW-GRADE	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	TP53
Cafe au lait spots, multiple	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	AKT1
Carney Complex, Type 1	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	SPG7
Central Nervous System Embryonal Tumor, Not Otherwise Specified	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	TP53
Sexually Transmitted Diseases	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	FCGRT
Short Rib-Polydactyly Syndrome	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	IFT172
Smith-Lemli-Opitz Syndrome	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	LDLR
Myopathy, Centronuclear, Autosomal Dominant	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	TPM2
Stenosis	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	LDLR
Storage disease	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	HEXA
Psychoses, Substance-Induced	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	AKT1
Tarsal Coalition	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	TPM2
Achromasia	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	HPS6
Acrodysostosis	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	PDE4D
Wolfram Syndrome	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	SYVN1
Wooly hair	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	JUP
Xanthomatosis	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	LDLR
Adult Burkitt Lymphoma	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	AKT1
Afro-textured hair	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	JUP
Barrel chest	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	TMEM67
Benign neoplasm of stomach	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	ERBB2
Canarypox (disorder)	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	MAGED4B
Carcinoma in situ of stomach	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	ERBB2
Centrally nucleated skeletal muscle fibers	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	TPM2
Chorioretinal atrophy	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	JAG1
Chorioretinal dysplasia	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	TUBGCP6
Chronic Q Fever	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	LDLR
Compression of spinal cord	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	AKT1
Congenital hernia of foramen of Bochdalek	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	INSR
Congenital hernia of foramen of Morgagni	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	INSR
Congenital scar	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	PLEC
Coxsackievirus Infections	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	TP53
Degeneration of lumbar intervertebral disc	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	ADAMTS5
Diastrophic dysplasia	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	SHBG
Elevated circulating parathyroid hormone level	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	PDE4D
Exercise-induced myalgia	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	AMPD3
Hartnup Disease	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	IDUA
Heart murmur	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	LDLR
Heat Stroke	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	RELA
Hyperlipoproteinemia Type I	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	LMF1
Hyperlipoproteinemia Type III	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	LDLR
Hypoplastic fingernail	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	PLEC
Hypoplastic scapulae	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	ACTB
Idiopathic scoliosis	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	CHD7
Immunosuppression	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	PSME3
Impaired vibration sensation in the lower limbs	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	SPG7
Infective vaginitis	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	FCGRT
Kabuki make-up syndrome	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	SOX3
Kinky hair texture	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	JUP
Late-Infantile Neuronal Ceroid Lipfuscinosis	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	ATP13A2
Majewski Syndrome	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	IFT172
Mobius Syndrome	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	FRAS1
Myeloid and Lymphoid Neoplasms with FGFR1 Rearrangement	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	TRIM24
Nail-Patella Syndrome	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	LDB1
Nappy hair texture	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	JUP
Narrowing	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	LY6E
Narrowing of ear canal	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	CTBP1
Neoplasm of uncertain or unknown behavior of stomach	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	ERBB2
Nongerminomatous Germ Cell Tumor	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	TP53
Oguchi disease	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	PDE6B
Onychomycosis	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	TRAF3IP2
Osteofibrous Dysplasia	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	TMEM107
Overgrowth Syndrome	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	KCNQ1OT1
Pancreatic carcinoma resectable	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	TP53
Peripheral pulmonary artery stenosis	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	JAG1
Periventricular Nodular Heterotopia	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	KIAA0319L
Primary Cutaneous Anaplastic Large Cell Lymphoma	1/18	0.4328184387784139	0.7114521919869093	0	0	1.8400646203554119	1.5409381014404915	TYK2
Pituitary Neoplasms	10/296	0.4362654152424962	0.7165569616691589	0	0	1.0944629141350453	0.9078618798420527	RIMS2;AIMP2;CTBP1;MAP2;ERBB2;AKT1;SSSCA1;TP53;GAPDH;MTOR
Lymphoma, Follicular	12/359	0.4364668917409411	0.7165569616691589	0	0	1.0825686333990596	0.8974956833597602	RIMS2;SLC35B2;CCND3;TMEM54;ERCC1;AKT1;SDC1;SSSCA1;AMPH;MTR;TP53;MTOR
Acute monocytic leukemia	3/78	0.43689454067715167	0.7165569616691589	0	0	1.2515397082658022	1.0363542744859748	HMGB1;TP53;RELA
Androgen-Insensitivity Syndrome	3/78	0.43689454067715167	0.7165569616691589	0	0	1.2515397082658022	1.0363542744859748	CNTNAP2;BNC2;SHBG
Klinefelter Syndrome	3/78	0.43689454067715167	0.7165569616691589	0	0	1.2515397082658022	1.0363542744859748	BBS1;CHD7;SHBG
Protruding ear	3/78	0.43689454067715167	0.7165569616691589	0	0	1.2515397082658022	1.0363542744859748	MBD5;TPM2;TUBGCP6
Pulmonary Embolism	3/78	0.43689454067715167	0.7165569616691589	0	0	1.2515397082658022	1.0363542744859748	AKT1;MTR;CBLN2
Keloid	6/171	0.4377207696440817	0.7176843075890273	0	0	1.1379923008587505	0.9401797469102703	EIF5A;JAG1;ERBB2;AKT1;TP53;CLIC1
Contracture of joint	5/140	0.4385178175185956	0.7187631084478598	0	0	1.1589882565492322	0.9554175731264272	ALG9;IDUA;TPM2;GDAP1;PLEC
Myasthenic Syndromes, Congenital	2/48	0.44091553940944567	0.7198368058147273	0	0	1.3602082453918671	1.1138771743439573	CHD7;PLEC
Spinocerebellar Ataxia Type 6 (disorder)	2/48	0.44091553940944567	0.7198368058147273	0	0	1.3602082453918671	1.1138771743439573	ATXN2;LY6E
Barrett Epithelium	2/48	0.44091553940944567	0.7198368058147273	0	0	1.3602082453918671	1.1138771743439573	TP53;RELA
Decreased muscle mass	2/48	0.44091553940944567	0.7198368058147273	0	0	1.3602082453918671	1.1138771743439573	CTBP1;AKT1
Dupuytren Contracture	2/48	0.44091553940944567	0.7198368058147273	0	0	1.3602082453918671	1.1138771743439573	AIMP2;GAPDH
Foot Deformities	2/48	0.44091553940944567	0.7198368058147273	0	0	1.3602082453918671	1.1138771743439573	GDAP1;CCT5
Progressive cerebellar ataxia	2/48	0.44091553940944567	0.7198368058147273	0	0	1.3602082453918671	1.1138771743439573	PRDM8;ATXN2
Non-Small Cell Lung Carcinoma	71/2243	0.4441528805465838	0.7198368058147273	0	0	1.0246052591854602	0.8315557452210622	DPP10;CHRM3;GLDC;ARHGAP1;KEAP1;MSI1;CASC2;MTR;TMEM97;HMGB1;ABCC10;ACTB;RIMS2;ADAMTS5;CCND3;SOX1;MAGED4B;MDK;AKT2;CFL1;TRIM24;CHAMP1;AKT1;SLC16A7;SSSCA1;FEZF2;SYBU;ANKRD6;EIF5A;LMO4;ACTN4;SYP;FRS3;YWHAZ;TAPBP;SPINT1;RABEP2;PSME3;AKT1S1;ULK1;PKP3;GAPDH;TP53;HDAC4;PDXK;FHIT;HDAC9;HDAC6;RELA;HSF1;ERBB2;PDSS2;RPS27A;MIR92B;PDLIM7;KCNJ3;B3GALNT1;JAG1;URGCP;INSR;USP22;SMARCA2;MTOR;AIMP2;FER;SGSM3;ERCC1;SDC1;PLCH1;ESYT1;SERINC2
Plaque, Amyloid	8/235	0.44455345028460497	0.7198368058147273	0	0	1.1029339782902883	0.8941320136036791	RIMS2;CHRM3;ATCAY;NFIC;SYP;HOOK3;LDLR;SYBU
Charcot-Marie-Tooth Disease	10/298	0.4446068888928087	0.7198368058147273	0	0	1.0867486338797814	0.8808801705814948	LRSAM1;JUP;SORT1;ERBB2;SYVN1;SPG7;GDAP1;CCT5;HDAC6;DHTKD1
Glioblastoma, IDH-Wildtype	3/79	0.445082645812771	0.7198368058147273	0	0	1.2350081037277147	0.9997332469478546	AKT1;NDRG2;TP53
Malignancy	3/79	0.445082645812771	0.7198368058147273	0	0	1.2350081037277147	0.9997332469478546	ERBB2;TP53;MTOR
Osteitis Deformans	3/79	0.445082645812771	0.7198368058147273	0	0	1.2350081037277147	0.9997332469478546	ERBB2;KEAP1;TP53
Dry skin	4/110	0.44546249908804875	0.7198368058147273	0	0	1.1807155109041902	0.954776403360581	INSR;CHD7;ERCC8;UBE2A
Hyperplastic Polyp	4/110	0.44546249908804875	0.7198368058147273	0	0	1.1807155109041902	0.954776403360581	ERCC1;AKT1;SSSCA1;TP53
Lethargy	4/110	0.44546249908804875	0.7198368058147273	0	0	1.1807155109041902	0.954776403360581	ABCD4;TCN2;GLDC;KCNMA1
Luminal A Breast Carcinoma	4/110	0.44546249908804875	0.7198368058147273	0	0	1.1807155109041902	0.954776403360581	ERBB2;SYP;TP53;RELA
Anaplastic carcinoma	7/204	0.44663901716957605	0.7198368058147273	0	0	1.1119566747542666	0.8962421709238321	EIF5A;ERBB2;ACTN4;TP53;FHIT;YWHAZ;ACTB
Adenocarcinoma of colon	9/267	0.4468876918630236	0.7198368058147273	0	0	1.0917291516005023	0.8793310230133086	BBS2;ELOVL1;SGSM3;MSI1;HMGB1;NDRG2;TP53;FHIT;YWHAZ
Adenocarcinoma Of Esophagus	10/299	0.4487729456377262	0.7198368058147273	0	0	1.0829315332690452	0.8676861212618587	SGSM3;ERCC1;ERBB2;MTR;TP53;SMARCA2;FHIT;YWHAZ;ACTB;MTOR
Arteriovenous Malformations, Cerebral	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	JAG1
RETINITIS PIGMENTOSA 1	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	PDE6B
Encephalopathy, Subacute Necrotizing, Infantile	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	NDUFS8
Encephalopathy, Subacute Necrotizing, Juvenile	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	NDUFS8
Self Mutilation	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	TMEM231
Hyperkeratosis, Epidermolytic	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	JUP
Hypothermia, natural	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	CHRNB2
Skeletal muscle hypertrophy	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	AGPAT2
Lupus Erythematosus, Cutaneous	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	HMGB1
Melanoma, Amelanotic	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	PDLIM7
Squamous cell carcinoma of vulva	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	TP53
Night blindness, stationary	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	PDE6B
Thrombosis of cerebral veins	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	PDE4D
Tuberculosis, Drug-Resistant	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	AIMP2
Thyrotoxicosis	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	PGAP3
Abnormality of body height	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	CHD7
Amyloid angiopathy	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	SYP
Anti-Glomerular Basement Membrane Disease	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	GNAO1
Aortopulmonary Septal Defect	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	GRM5
Apert syndrome	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	FRAS1
Asymmetric Septal Hypertrophy	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	SGSH
Back Pain	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	TP53
Bell-shaped thorax	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	IFT172
blue iris (physical finding)	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	PDE4D
CADASIL Syndrome	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	JAG1
Calvarial defect	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	FRAS1
Cavitation	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	TP53
Cone-shaped epiphyses of the phalanges of the hand	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	IFT172
Congenital absence of spleen	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	DNAI1
Congenital dyserythropoietic anemia	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	MAN2A1
Congenital Structural Myopathy	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	TPM2
Decreased calcification of skull	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	HDAC6
Defect of skull ossification	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	HDAC6
Dent's disease	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	SYP
Depressed nasal tip	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	ACTB
Enchondroma	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	TP53
Endocarditis	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	HCCS
Endogenous Hyperinsulinism	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	INSR
Epidermolysis Bullosa Acquisita	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	FLII
Exogenous Hyperinsulinism	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	INSR
Flared iliac wings	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	IDUA
Gastric Cardia Carcinoma	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	TP53
Generalized hyperkeratosis	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	AKT1
Global brain atrophy	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	ALG9
HER2-positive carcinoma of breast	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	ERBB2
Homocysteine measurement	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	MTR
Increased female libido	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	CHD7
Inflammatory disease of mucous membrane	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	ULK1
Lipidemias	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	LDLR
Mixed phenotype acute leukemia	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	ERCC1
Multiple adenomatous polyps	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	TP53
Myoclonic dystonia	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	ANO3
Nasal Type Extranodal NK/T-Cell Lymphoma	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	PDLIM7
Polydactyly of toes	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	BBS1
Pseudolymphoma	1/19	0.4504168709407754	0.7198368058147273	0	0	1.737749057619817	1.3859969260515754	TBRG1
Vascular inflammations	5/142	0.4506636671725038	0.7198368058147273	0	0	1.1419500326390126	0.9101729643466204	AKT2;KEAP1;AKT1;HMGB1;LDLR
Exophthalmos	5/142	0.4506636671725038	0.7198368058147273	0	0	1.1419500326390126	0.9101729643466204	JAG1;CTBP1;KCNQ1OT1;INSR;TCF12
Sparse body hair	2/49	0.45143016401809816	0.7198368058147273	0	0	1.3311987881291745	1.058748447123615	CDH3;CHD7
Aortic coarctation	2/49	0.45143016401809816	0.7198368058147273	0	0	1.3311987881291745	1.058748447123615	JAG1;CHD4
Cardiovascular Abnormalities	2/49	0.45143016401809816	0.7198368058147273	0	0	1.3311987881291745	1.058748447123615	AKT1;TRIB3
Central nervous system demyelination	2/49	0.45143016401809816	0.7198368058147273	0	0	1.3311987881291745	1.058748447123615	NDUFS8;LMNB1
Gingival Overgrowth	2/49	0.45143016401809816	0.7198368058147273	0	0	1.3311987881291745	1.058748447123615	IDUA;INSR
Hypermelanotic macule	2/49	0.45143016401809816	0.7198368058147273	0	0	1.3311987881291745	1.058748447123615	INSR;ACTB
Low anterior hairline	2/49	0.45143016401809816	0.7198368058147273	0	0	1.3311987881291745	1.058748447123615	SETD5;SMARCA2
Medullary carcinoma	2/49	0.45143016401809816	0.7198368058147273	0	0	1.3311987881291745	1.058748447123615	ERBB2;TP53
Multiple Endocrine Neoplasia	2/49	0.45143016401809816	0.7198368058147273	0	0	1.3311987881291745	1.058748447123615	SSSCA1;TP53
Neck webbing	2/49	0.45143016401809816	0.7198368058147273	0	0	1.3311987881291745	1.058748447123615	TPM2;XYLT2
Oral soft tissue hyperplasia	2/49	0.45143016401809816	0.7198368058147273	0	0	1.3311987881291745	1.058748447123615	IDUA;INSR
Plasmacytoma	4/111	0.4523405769942362	0.7208533019537656	0	0	1.1696200995266415	0.9278828933239581	SGSM3;AKT1;SDC1;TP53
Adenoma	32/1000	0.4523466056958324	0.7208533019537656	0	0	1.0351380221510091	0.8211817899480934	CTBP1;MTR;SPG7;NDRG2;FHIT;TBRG1;CCND3;CDH3;MDK;ERBB2;AKT1;SSSCA1;MAP2K5;FZD3;JAG1;KCNH7;SORT1;INSR;USP22;MIB2;SYP;YWHAZ;MAPK15;MTOR;BCL9;SPINT1;TCN2;MALL;SCG3;GAPDH;TP53;PLEC
Bloom Syndrome	3/80	0.453223237052017	0.7213605448367181	0	0	1.218905891515292	0.9646061378340453	RIMS2;POLD4;TP53
Dandy-Walker Syndrome	3/80	0.453223237052017	0.7213605448367181	0	0	1.218905891515292	0.9646061378340453	SUFU;KCNQ1OT1;ZIC5
Eosinophilic esophagitis	3/80	0.453223237052017	0.7213605448367181	0	0	1.218905891515292	0.9646061378340453	GRM5;CAPN5;CCDC81
Prominent ear	3/80	0.453223237052017	0.7213605448367181	0	0	1.218905891515292	0.9646061378340453	MBD5;TPM2;TUBGCP6
IGA Glomerulonephritis	8/237	0.45392830591851246	0.7222603094171405	0	0	1.0931872021006366	0.8634167540258902	FCGRT;MTR;ACTN4;SPG7;ACCS;TP53;GAPDH;RELA
Azoospermia	6/174	0.4541751212247084	0.7224306021819923	0	0	1.1174965100046532	0.882009181213472	RERE;SOX3;MAST2;ERCC1;MTR;WASL
Childhood Osteosarcoma	7/206	0.456704124843427	0.725273355097033	0	0	1.1006664644593276	0.8626138008969303	JAG1;USP22;ERCC1;HSF1;CASC2;TP53;YWHAZ
Substance Use Disorders	5/143	0.45671097816960904	0.725273355097033	0	0	1.1336161187698834	0.8884200774119696	CNTNAP2;AGBL4;GRM5;INSR;FHIT
Liver Cirrhosis	22/683	0.4577511173764108	0.725273355097033	0	0	1.0418439680427447	0.814127771898427	CHRM3;CNTNAP2;JAG1;MBOAT7;SYVN1;KEAP1;MTR;FHIT;SMARCA2;YWHAZ;AGPAT2;ACTB;RELA;BCL9;SPINT1;TMEM67;ERBB2;AP1S1;AKT1;PDSS2;GAPDH;TP53
Reduced fetal movement	3/81	0.4613139501978151	0.725273355097033	0	0	1.2032165565390849	0.9309003114243434	CTBP1;TPM2;FLII
Sensory neuropathy	3/81	0.4613139501978151	0.725273355097033	0	0	1.2032165565390849	0.9309003114243434	FZD3;GDAP1;CCT5
Vascular lesions	3/81	0.4613139501978151	0.725273355097033	0	0	1.2032165565390849	0.9309003114243434	HMGB1;TP53;MTOR
Acute myelomonocytic leukemia	3/81	0.4613139501978151	0.725273355097033	0	0	1.2032165565390849	0.9309003114243434	CCND3;FLII;TP53
Pancreatic carcinoma	59/1869	0.46162005508480375	0.725273355097033	0	0	1.0208979623994248	0.7891675169121212	RPAIN;RERE;CHD7;ARHGAP1;KEAP1;MTR;HMGB1;ACTB;LMNB1;RIMS2;CCND3;CDH3;NKRF;MDK;AKT2;CFL1;OSBP;AKT1;SSSCA1;CAPN1;SYBU;EIF5A;RHBDF1;PRKCI;LMO4;ACTN4;RHOC;EML2;SPINT1;ARMC3;GAPDH;TP53;PLEC;DNAH5;TACSTD2;NDRG2;FHIT;HDAC9;AGPAT2;RELA;STK33;ZNRF3;HSF1;ERBB2;FADD;MIR92B;DNAI1;B3GALNT1;JAG1;INSR;SORBS2;SMARCA2;MTOR;AIMP2;GIPC1;SGSM3;ERCC1;SDC1;EBAG9
Liver Dysfunction	7/207	0.46172272677186027	0.725273355097033	0	0	1.09510603588907	0.8462877891459822	JAG1;JUP;IFT172;TMEM67;FADD;AGPAT2;PEX26
Renal dysplasia	2/50	0.46183135797522407	0.725273355097033	0	0	1.3033980582524272	1.0069473132623459	JAG1;PLEC
Turcot syndrome (disorder)	2/50	0.46183135797522407	0.725273355097033	0	0	1.3033980582524272	1.0069473132623459	ERCC1;TP53
Dyspnea on exertion	2/50	0.46183135797522407	0.725273355097033	0	0	1.3033980582524272	1.0069473132623459	DPP9;ATP11A
Endocardial Cushion Defects	2/50	0.46183135797522407	0.725273355097033	0	0	1.3033980582524272	1.0069473132623459	IFT172;ACVR2B
Erythroblastosis	2/50	0.46183135797522407	0.725273355097033	0	0	1.3033980582524272	1.0069473132623459	ERBB2;MTOR
Idiopathic generalized epilepsy	2/50	0.46183135797522407	0.725273355097033	0	0	1.3033980582524272	1.0069473132623459	EFHC1;GABRG2
Li-Fraumeni Syndrome	2/50	0.46183135797522407	0.725273355097033	0	0	1.3033980582524272	1.0069473132623459	ERBB2;TP53
Opiate Addiction	2/50	0.46183135797522407	0.725273355097033	0	0	1.3033980582524272	1.0069473132623459	PPP1R1B;CNIH3
Disease Exacerbation	5/144	0.4627396287662738	0.725273355097033	0	0	1.1254021173305258	0.8672244503396808	ABCD4;CPSF1;ERBB2;RANBP10;KEAP1
Encephalitis	5/144	0.4627396287662738	0.725273355097033	0	0	1.1254021173305258	0.8672244503396808	CNTNAP2;MAP2;HEXA;TP53;RELA
Colorectal Carcinoma	92/2931	0.4655741813538127	0.725273355097033	0	0	1.015196878969334	0.7761016048588638	ABCD4;CHRM3;CHD7;KEAP1;MSI1;CASC2;MTR;CHD4;TMEM97;HMGB1;NADSYN1;ACTB;RIMS2;ADAMTS5;CCND3;CDH3;FCGRT;MDK;AKT2;CFL1;FPGS;TRIM24;AKT1;SLC16A7;SSSCA1;EIF5A;RHBDF1;TPM2;TCF12;ACTN4;YWHAZ;LEMD1;TAPBP;MAU2;SPINT1;AKT1S1;TRIB3;GAPDH;TP53;OTUB1;CTBP1;FLII;RAB1B;TACSTD2;WNT8B;FOXK1;AMBRA1;SEMA3F;SPG7;NDRG2;PPOX;FHIT;HDAC9;RELA;MLLT6;NT5C;FAM83H;KCNQ1OT1;HSF1;ERBB2;MAP6;CKB;FADD;RPS27A;MIR92B;LDLR;MAP2K5;CCT5;PDLIM7;GDF11;FZD3;JAG1;JUP;SORT1;INSR;USP22;MTOR;HIPK2;RAD52;BCL9;AIMP2;VANGL2;TCN2;TMEM54;CAPN10;GIPC1;SGSM3;ERCC1;CDK2AP2;SDC1;SHBG;NEK11
Cocaine-Related Disorders	4/113	0.4660114827233499	0.725273355097033	0	0	1.1480400333611342	0.8765802320059184	HDAC4;GRM5;TYK2;GABRG2
Erythema	4/113	0.4660114827233499	0.725273355097033	0	0	1.1480400333611342	0.8765802320059184	TRAF3IP2;AP1S1;HCCS;TP53
Nasopharyngeal carcinoma	25/782	0.4662717617103185	0.725273355097033	0	0	1.0336578488727062	0.7886671240633578	HMGB1;CSAD;FHIT;RELA;RIMS2;ZNRF3;SOX1;CAPNS1;AKT2;HSF1;ERBB2;AKT1;SSSCA1;FEZF2;LDLR;PDLIM7;AGK;STAT2;NICN1;USP22;AIMP2;ERCC1;SDC1;ULK1;TP53
Constipation	7/208	0.4667310691751014	0.725273355097033	0	0	1.0896009349662779	0.8302781528747132	RERE;CHRM3;MBD5;FLII;KCNAB2;PPOX;LMNB1
5,10-Methylenetetrahydrofolate reductase deficiency	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	ERCC1
Adenocarcinoma of lung, stage I	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	ACTN4
Recurrent viral infection	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	TYK2
Renal glomerular fibrosis	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	PLEC
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	RIMS2
Retinoic acid syndrome	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	HMGB1
Deafness, Acquired	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	JAG1
Hearing Loss, Extreme	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	JAG1
Mental Disorders, Severe	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	CNTNAP2
Sprengel deformity	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	SUFU
Stenosis of external auditory canal	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	CTBP1
Thoracic hypoplasia	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	IFT172
Abnormal vertebral bodies	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	IDUA
Abnormal vertebral morphology	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	IDUA
Undifferentiated (Embryonal) Sarcoma	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	TP53
Abnormality of the heart valves	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	IDUA
Acral pseudolymphomatous angiokeratoma of children (APACHE)	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	PPP6R2
Acth-Independent Macronodular Adrenal Hyperplasia	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	GAPDH
Wolf-Hirschhorn Syndrome	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	CTBP1
Adult Myelodysplastic Syndrome	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	TP53
Amebic colitis	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	RELA
Arteriosclerosis Obliterans	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	HMGB1
Atrophy of testis	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	LDLR
Autoimmune gastritis	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	TCN2
Autosomal dominant compelling helio ophthalmic outburst syndrome	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	FHIT
Basal Ganglia Diseases	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	DNAH7
Beta thalassemia intermedia	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	ACVR2B
Bifid scrotum	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	CHD7
Bilateral Deafness	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	JAG1
Calvarial skull defect	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	FRAS1
Chronic ulcerative colitis	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	TP53
Clear cell sarcoma of kidney	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	TP53
Compensatory Hyperinsulinemia	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	INSR
Complete Hearing Loss	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	JAG1
Congenital abnormality of vein	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	AKT1
Coronal craniosynostosis	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	TCF12
Cutaneous Fibrous Histiocytoma	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	TP53
Cutaneous finger syndactyly	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	FRAS1
Deaf Mutism	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	JAG1
Destructive Arthritis	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	AIMP2
Disproportionate short-trunk short stature	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	XYLT2
Dyslipoproteinemias	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	LDLR
Endometrial Endometrioid Adenocarcinoma	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	TP53
Endophthalmitis	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	HMGB1
Enteropathy-Associated T-Cell Lymphoma	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	TP53
Eunuchoid habitus	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	CHD7
Fissured tongue	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	AKT1
Gastric dysplasia	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	TP53
Gray Platelet Syndrome	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	RABGGTA
Impulsive Behavior	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	GLDC
Infantile neuronal ceroid lipofuscinosis	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	ATP13A2
Leukaemia recurrent	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	TP53
Mastocytoma	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	TP53
Motion Sickness	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	MAP2K5
Multiple vertebral anomalies	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	IDUA
Ovarian Clear Cell Adenocarcinoma	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	TP53
Panic Attacks	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	TP53
Perineurioma	1/20	0.4674701133568531	0.725273355097033	0	0	1.6462035541195477	1.2518058777113457	TP53
Mammary Carcinoma, Animal	5/145	0.46874846609185417	0.7260627899161405	0	0	1.1173054587688733	0.8465700267441567	EIF5A;ERBB2;ACTN4;YWHAZ;ACTB
Thrombocythemia, Essential	5/145	0.46874846609185417	0.7260627899161405	0	0	1.1173054587688733	0.8465700267441567	FLII;TYK2;TP53;HDAC9;HDAC6
Animal Mammary Neoplasms	5/145	0.46874846609185417	0.7260627899161405	0	0	1.1173054587688733	0.8465700267441567	EIF5A;ERBB2;ACTN4;YWHAZ;ACTB
Babinski Reflex	5/145	0.46874846609185417	0.7260627899161405	0	0	1.1173054587688733	0.8465700267441567	DSTYK;ATP13A2;SPG7;CCT5;LMNB1
Frontotemporal dementia	5/145	0.46874846609185417	0.7260627899161405	0	0	1.1173054587688733	0.8465700267441567	RIMS2;ATXN2;SORT1;SGSM3;SYBU
Cerebellar Dysmetria	3/82	0.4693525333805463	0.7260627899161405	0	0	1.187924419916706	0.8985473647622366	ATXN2;ATP1A3;TTC19
Decreased size of teeth	3/82	0.4693525333805463	0.7260627899161405	0	0	1.187924419916706	0.8985473647622366	CDH3;IDUA;ERCC8
Prediabetes syndrome	3/82	0.4693525333805463	0.7260627899161405	0	0	1.187924419916706	0.8985473647622366	CAPN10;SGSM3;TP53
Crohn Disease	29/912	0.4711402938556824	0.7260627899161405	0	0	1.0279005773656567	0.7735973223284884	TRAF3IP2;KEAP1;MTR;HMGB1;APEH;FHIT;HDAC6;RELA;ATXN2;CCND3;PSMD7;CDH3;SEPHS1;NICN1;FNDC3A;TYK2;YWHAZ;UBAC2;GNAO1;AIMP2;KAT2A;DLG1;TCN2;TEX9;SGSM3;SDC1;ULK1;GAPDH;TP53
Smoking Behaviors	7/209	0.4717284477883857	0.7260627899161405	0	0	1.0841503399932162	0.8145782893030084	STK33;FER;FGGY;ZNRF3;SUFU;FHIT;MAP2K5
Tardive Dyskinesia	2/51	0.47211604310905103	0.7260627899161405	0	0	1.2767320520441185	0.9582263065346377	PPP1R1B;AKT1
Tumors of Adrenal Cortex	2/51	0.47211604310905103	0.7260627899161405	0	0	1.2767320520441185	0.9582263065346377	KCNQ1OT1;TP53
Adult Lymphoma	2/51	0.47211604310905103	0.7260627899161405	0	0	1.2767320520441185	0.9582263065346377	SYVN1;SPG7
Angioimmunoblastic Lymphadenopathy	2/51	0.47211604310905103	0.7260627899161405	0	0	1.2767320520441185	0.9582263065346377	TP53;PDLIM7
Breast Diseases	2/51	0.47211604310905103	0.7260627899161405	0	0	1.2767320520441185	0.9582263065346377	ERBB2;TP53
Convex nasal ridge	2/51	0.47211604310905103	0.7260627899161405	0	0	1.2767320520441185	0.9582263065346377	ALG9;CTBP1
Cystadenoma	2/51	0.47211604310905103	0.7260627899161405	0	0	1.2767320520441185	0.9582263065346377	ERBB2;TP53
Drug-induced tardive dyskinesia	2/51	0.47211604310905103	0.7260627899161405	0	0	1.2767320520441185	0.9582263065346377	PPP1R1B;AKT1
Gingival Hyperplasia	2/51	0.47211604310905103	0.7260627899161405	0	0	1.2767320520441185	0.9582263065346377	IDUA;INSR
Metaplasia	2/51	0.47211604310905103	0.7260627899161405	0	0	1.2767320520441185	0.9582263065346377	TP53;SMARCA2
Prostatic Neoplasms	49/1554	0.4721807189709897	0.7260627899161405	0	0	1.0192237201156682	0.7648188418806092	CHD7;KEAP1;HMGB1;RIMS2;ADAMTS5;CCND3;CDH3;CAPNS1;AKT2;AKT1;CAPN1;STARD3;PDE4D;TYK2;RHOC;YWHAZ;TBC1D2;SPINT1;KCNMA1;PKP3;GAPDH;TP53;IGSF8;CTBP1;TACSTD2;FHIT;HDAC9;HDAC6;RELA;ABR;PDZD2;ERBB2;PLEK2;RPS27A;MAP2K5;CADM4;JAG1;JUP;INSR;SMARCA2;MTOR;FER;TCN2;NFIC;ERCC1;CDK2AP2;SDC1;SHBG;EBAG9
Chondrosarcoma	8/241	0.47259042436588417	0.7260627899161405	0	0	1.0741956296109287	0.8051377425798031	RIMS2;AIMP2;MAP2;ERBB2;AKT1;HMGB1;TP53;MTOR
Testicular Germ Cell Tumor	4/114	0.47280118321085673	0.7260627899161405	0	0	1.1375442739079102	0.852112017715721	JUP;AKT1;TP53;FHIT
Dermatomyositis	4/114	0.47280118321085673	0.7260627899161405	0	0	1.1375442739079102	0.852112017715721	TRIM24;HMGB1;TYK2;TP53
Obsessive-Compulsive Disorder	4/114	0.47280118321085673	0.7260627899161405	0	0	1.1375442739079102	0.852112017715721	CNTNAP2;SETD5;CHD7;TTC19
Posteriorly rotated ear	4/114	0.47280118321085673	0.7260627899161405	0	0	1.1375442739079102	0.852112017715721	RERE;ALG9;XYLT2;PEX26
Vascular Diseases	13/401	0.47443396053210785	0.7260627899161405	0	0	1.0483194347730092	0.781661405322155	TRAF3IP2;IDUA;SORT1;PDE4D;KEAP1;MTR;FNDC3A;YWHAZ;MTOR;SSSCA1;LDLR;TP53;MAP2K5
Neutropenia	6/178	0.47593401900123433	0.7260627899161405	0	0	1.0912809635633665	0.8102499791601747	CREBZF;STAT2;ERCC1;MTR;SPG7;TP53
Lymphoma, Large-Cell, Follicular	3/83	0.47733684454865727	0.7260627899161405	0	0	1.1730145867098865	0.8674828371267802	AIMP2;MTR;TP53
bone destruction	3/83	0.47733684454865727	0.7260627899161405	0	0	1.1730145867098865	0.8674828371267802	HMGB1;NDRG2;HDAC9
HIV-1 infection	3/83	0.47733684454865727	0.7260627899161405	0	0	1.1730145867098865	0.8674828371267802	GRM5;HDAC9;LY6E
Hydatidiform Mole	3/83	0.47733684454865727	0.7260627899161405	0	0	1.1730145867098865	0.8674828371267802	TEP1;ERBB2;TP53
MRSA - Methicillin resistant Staphylococcus aureus infection	3/83	0.47733684454865727	0.7260627899161405	0	0	1.1730145867098865	0.8674828371267802	SPINT1;HCCS;ZDHHC16
Protein Deficiency	3/83	0.47733684454865727	0.7260627899161405	0	0	1.1730145867098865	0.8674828371267802	ELOVL1;TP53;LDLR
Carcinoma, Cribriform	4/115	0.4795583830985515	0.7260627899161405	0	0	1.1272376272376272	0.8283952470678875	ERBB2;CKB;TP53;MTOR
Carcinoma, Granular Cell	4/115	0.4795583830985515	0.7260627899161405	0	0	1.1272376272376272	0.8283952470678875	ERBB2;CKB;TP53;MTOR
Glaucoma, Primary Open Angle	5/147	0.4807022316888137	0.7260627899161405	0	0	1.1014542539791594	0.8068232392627247	ATXN2;CNTN4;PLXDC2;TP53;LDLR
Mild Mental Retardation	5/147	0.4807022316888137	0.7260627899161405	0	0	1.1014542539791594	0.8068232392627247	SOX3;KCNQ1OT1;ACTB;HDAC6;DHTKD1
Monosomy	5/147	0.4807022316888137	0.7260627899161405	0	0	1.1014542539791594	0.8068232392627247	RASA4;SYVN1;HCCS;MIR92B;TP53
Vitiligo	8/243	0.48186836803828936	0.7260627899161405	0	0	1.0649422889723266	0.7774976430130406	RERE;AIMP2;DSTYK;PLCB3;ATXN2;SGSM3;ERCC1;TP53
Malignant neoplasm of skin	10/307	0.4819321364461644	0.7260627899161405	0	0	1.0533200861069714	0.7688730725253291	AIMP2;JAG1;STAT2;ERBB2;CDK2AP2;AKT1;SDC1;TP53;SMARCA2;RELA
Gait, Unsteady	2/52	0.48228144040280646	0.7260627899161405	0	0	1.2511326860841423	0.9123602783728961	ATP1A3;TTC19
Behavioral Symptoms	2/52	0.48228144040280646	0.7260627899161405	0	0	1.2511326860841423	0.9123602783728961	PEX6;PEX26
Carcinomatosis of peritoneal cavity	2/52	0.48228144040280646	0.7260627899161405	0	0	1.2511326860841423	0.9123602783728961	TP53;MTOR
Central visual impairment	2/52	0.48228144040280646	0.7260627899161405	0	0	1.2511326860841423	0.9123602783728961	GABRB1;PDSS2
Congenital neurologic anomalies	2/52	0.48228144040280646	0.7260627899161405	0	0	1.2511326860841423	0.9123602783728961	IDUA;ACTB
Coronary Stenosis	2/52	0.48228144040280646	0.7260627899161405	0	0	1.2511326860841423	0.9123602783728961	MDK;ADCY2
Decreased nerve conduction velocity	2/52	0.48228144040280646	0.7260627899161405	0	0	1.2511326860841423	0.9123602783728961	PEX6;ERCC8
Drug usage	2/52	0.48228144040280646	0.7260627899161405	0	0	1.2511326860841423	0.9123602783728961	INSR;TP53
Gingival Hypertrophy	2/52	0.48228144040280646	0.7260627899161405	0	0	1.2511326860841423	0.9123602783728961	IDUA;INSR
Hippocampal sclerosis	2/52	0.48228144040280646	0.7260627899161405	0	0	1.2511326860841423	0.9123602783728961	CHRNB2;NT5C
Hypocalcemia	2/52	0.48228144040280646	0.7260627899161405	0	0	1.2511326860841423	0.9123602783728961	PDE4D;CHD7
Invasive Lobular Breast Carcinoma	2/52	0.48228144040280646	0.7260627899161405	0	0	1.2511326860841423	0.9123602783728961	ERBB2;TP53
Lymphocytic infiltration	2/52	0.48228144040280646	0.7260627899161405	0	0	1.2511326860841423	0.9123602783728961	ERBB2;TP53
Progressive visual loss	2/52	0.48228144040280646	0.7260627899161405	0	0	1.2511326860841423	0.9123602783728961	NPHP1;ATP1A3
Anaplastic large cell lymphoma, ALK negative	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	TP53
Restlessness	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	GLDC
Rheumatoid Nodule	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	MTR
Severe diarrhea	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	ERCC1
Shared Paranoid Disorder	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	AKT1
Sinus Node Dysfunction (disorder)	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	NAA50
Lymphoma, Follicular, Grade 2	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	MTR
Lymphoma, Mixed-Cell, Follicular	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	MTR
Lymphoma, Small Cleaved-Cell, Follicular	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	MTR
Neoplasms, Radiation-Induced	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	TP53
Oncocytoma, renal	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	RNPEP
Syphilis	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	RERE
Abnormal hair quantity	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	PEX6
Tubulointerstitial fibrosis	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	NPHP1
Abnormality of the hip bone	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	TPM2
Absent eyelashes	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	FRAS1
Xanthoma	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	LDLR
Adult-Onset Still Disease	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	TP53
Allergic Conjunctivitis	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	CHRM3
Amyloid nephropathy	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	FCGRT
Aplasia of eyelashes	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	FRAS1
Atrophic scar	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	PLEC
Basal ganglia calcification	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	ERCC8
Bilateral Cryptorchidism	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	CHRM3
Bile duct proliferation	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	TMEM67
Biliary tract abnormality	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	BBS1
Chediak-Higashi Syndrome	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	VPS39
Chronic venous insufficiency	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	SGSM3
Clumsiness - motor delay	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	ATP1A3
CNS hypomyelination	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	GDAP1
Coloboma of eyelid	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	SALL2
Congenital anomaly of neck	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	SUFU
Deformity of neck	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	SUFU
Diabetic Ketoacidosis	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	INSR
Diastasis recti	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	KCNQ1OT1
Difficulty walking up stairs	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	PLEC
EMG: neuropathic changes	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	GDAP1
Failure of development of eyelashes	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	FRAS1
Fibrous skin tumor of tuberous sclerosis	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	AKT1
Glucose measurement	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	SEMA5B
Hemiplegia	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	ATP1A3
Herpes encephalitis	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	TYK2
Hypoalphalipoproteinemias	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	LDLR
Hypoplasia of the odontoid process	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	IDUA
Indolent Non-Hodgkin Lymphoma	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	TP53
LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	NDUFS8
Lower limb hyperreflexia	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	SPG7
Malformation of the neck	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	SUFU
Mild global developmental delay	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	ACTB
Myomatous neoplasm	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	TP53
Neonatal Death	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	KCNMA1
Neonatal respiratory distress	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	PLEC
Nodular Goiter	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	TP53
Otitis Media with Effusion	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	PDLIM7
pathologic fistula	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	AKT1
Pathological accumulation of air in tissues	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	TP53
Periapical Granuloma	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	MDK
Pleurisy	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	TP53
Progressive renal failure	1/21	0.4839950292687895	0.7260627899161405	0	0	1.5638126009693054	1.1348285329022303	IFT172
Hyperalgesia, Secondary	3/84	0.4852648494469021	0.7269126788236493	0	0	1.158472897532865	0.8376459412745483	CACNA2D1;INSR;HMGB1
Allodynia	3/84	0.4852648494469021	0.7269126788236493	0	0	1.158472897532865	0.8376459412745483	CACNA2D1;INSR;HMGB1
Chronic sinusitis	3/84	0.4852648494469021	0.7269126788236493	0	0	1.158472897532865	0.8376459412745483	YWHAZ;DNAI1;TAPBP
Hemochromatosis	3/84	0.4852648494469021	0.7269126788236493	0	0	1.158472897532865	0.8376459412745483	SHBG;GAPDH;TP53
Late tooth eruption	3/84	0.4852648494469021	0.7269126788236493	0	0	1.158472897532865	0.8376459412745483	SETD5;PDE4D;CHD7
Malignant neoplasm of stomach	75/2398	0.4859230561014218	0.7275922270312681	0	0	1.0104578467419938	0.7292524685562322	CHRM3;KEAP1;MSI1;CASC2;MTR;TMEM97;HMGB1;ACTB;MDK;AKT2;TRIM24;AKT1;SSSCA1;CLIC1;RHBDF1;STARD3;CACNA2D1;ACTN4;RHOC;YWHAZ;TAPBP;ST7L;SPINT1;KCNMA1;TRIB3;ULK1;RIN1;ALDOA;GAPDH;TP53;LY6E;OTUB1;HDAC4;CTBP1;IDUA;TACSTD2;WNT8B;FOXK1;NDRG2;FHIT;HDAC6;RELA;MED30;KCNQ1OT1;HSF1;ERBB2;PDSS2;CKB;CTNNA2;MIR92B;PDLIM7;CCDC134;JAG1;URGCP;CPSF1;INSR;USP22;FOXJ1;SORBS2;SMARCA2;MAPK15;MTOR;PPP1CA;AIMP2;VANGL2;CAPN10;NFIC;SGSM3;ERCC1;PPP1R1B;RANBP10;PTPN9;ERCC8;SHBG;EBAG9
Ataxia, Spinocerebellar	4/116	0.48628164709094435	0.7275922270312681	0	0	1.1171150278293136	0.8054034078340242	ATXN2;CAPN1;CNTN4;LY6E
Organic Mental Disorders, Substance-Induced	4/116	0.48628164709094435	0.7275922270312681	0	0	1.1171150278293136	0.8054034078340242	AGBL4;GRM5;INSR;FHIT
Prescription Drug Abuse	4/116	0.48628164709094435	0.7275922270312681	0	0	1.1171150278293136	0.8054034078340242	AGBL4;GRM5;INSR;FHIT
Hepatomegaly	12/373	0.4892686996891322	0.7295429538667005	0	0	1.039819944598338	0.7433084789709645	ADAMTS5;IDUA;IFT172;AKT2;KCNQ1OT1;TMEM67;PEX6;CHD7;ERCC8;AGPAT2;PEX26;SGSH
Carcinoid Tumor	7/213	0.49159464943676867	0.7295429538667005	0	0	1.0628771440789369	0.7547498947163267	MAP2;ERBB2;CDK2AP2;AKT1;SYP;TP53;FHIT
Epilepsy, Temporal Lobe	6/181	0.4920874090280007	0.7295429538667005	0	0	1.0724057701256398	0.7604417708708332	GRM5;MAP2;HMGB1;TP53;ACTB;MTOR
Leukemia, Lymphocytic, Acute, L2	2/53	0.49232505443749497	0.7295429538667005	0	0	1.226537216828479	0.8691440201874424	FPGS;TP53
Childhood Lymphoma	2/53	0.49232505443749497	0.7295429538667005	0	0	1.226537216828479	0.8691440201874424	SYVN1;SPG7
Choreoathetosis	2/53	0.49232505443749497	0.7295429538667005	0	0	1.226537216828479	0.8691440201874424	GLDC;ATP1A3
Hemiplegia/hemiparesis	2/53	0.49232505443749497	0.7295429538667005	0	0	1.226537216828479	0.8691440201874424	SOX3;OTX2
Interstitial Cystitis	2/53	0.49232505443749497	0.7295429538667005	0	0	1.226537216828479	0.8691440201874424	YWHAZ;TP53
Language Disorders	2/53	0.49232505443749497	0.7295429538667005	0	0	1.226537216828479	0.8691440201874424	CNTNAP2;MBD5
NEUROTICISM	2/53	0.49232505443749497	0.7295429538667005	0	0	1.226537216828479	0.8691440201874424	CNTNAP2;PDE4D
Nodular glomerulosclerosis	2/53	0.49232505443749497	0.7295429538667005	0	0	1.226537216828479	0.8691440201874424	MDK;RELA
Polycystic Kidney - body part	2/53	0.49232505443749497	0.7295429538667005	0	0	1.226537216828479	0.8691440201874424	ALG9;TMEM231
Adrenoleukodystrophy	5/149	0.4925636224111658	0.7295429538667005	0	0	1.0860433604336044	0.7690616704448622	ABCD4;ELOVL1;HMGB1;ACTB;PEX26
Adenocarcinoma, Basal Cell	4/117	0.4929695904724352	0.7295429538667005	0	0	1.1071715894724745	0.7831110894955944	ERBB2;CKB;TP53;MTOR
Teratoma	4/117	0.4929695904724352	0.7295429538667005	0	0	1.1071715894724745	0.7831110894955944	ERCC1;AKT1;TP53;FHIT
Muscle Hypertonia	4/117	0.4929695904724352	0.7295429538667005	0	0	1.1071715894724745	0.7831110894955944	SETD5;ERCC1;OGDH;TUBGCP6
Severe Acute Respiratory Syndrome	3/85	0.49313461924015445	0.7295429538667005	0	0	1.1442858837016248	0.808979316602142	AIMP2;NFIC;GAPDH
Hyperalgesia, Primary	3/85	0.49313461924015445	0.7295429538667005	0	0	1.1442858837016248	0.808979316602142	CACNA2D1;INSR;HMGB1
Abnormality of the retinal vasculature	3/85	0.49313461924015445	0.7295429538667005	0	0	1.1442858837016248	0.808979316602142	BBS2;IFT172;PDE6B
Hurthle Cell Tumor	3/85	0.49313461924015445	0.7295429538667005	0	0	1.1442858837016248	0.808979316602142	SCG3;GAPDH;TP53
Lesion of brain	3/85	0.49313461924015445	0.7295429538667005	0	0	1.1442858837016248	0.808979316602142	ERBB2;CPLX2;TP53
Prostatic Hyperplasia	3/85	0.49313461924015445	0.7295429538667005	0	0	1.1442858837016248	0.808979316602142	ERBB2;HMGB1;TP53
Fibroid Tumor	10/310	0.49426179315257396	0.7295429538667005	0	0	1.042622950819672	0.7347259218724013	RIMS2;SPINT1;ERBB2;AKT1;SHBG;TP53;SLC5A3;GAPDH;ACTB;MTOR
Kidney Neoplasm	8/246	0.49570629347087886	0.7295429538667005	0	0	1.0513538748832867	0.7378103728516499	CHMP1A;AKT1S1;ERBB2;AKT1;TP53;FHIT;GAPDH;MTOR
Aortic Valve Insufficiency	7/214	0.49652705726288676	0.7295429538667005	0	0	1.0576873064283518	0.7405051822616598	IDUA;ERBB2;AKT1;NDRG2;TP53;FGF11;HDAC6
Nephrotic Syndrome	6/182	0.4974358902411379	0.7295429538667005	0	0	1.0662570328694108	0.7445551248837711	MAF;CFL1;PDSS2;ACTN4;WASL;RELA
Primary Myelofibrosis	6/182	0.4974358902411379	0.7295429538667005	0	0	1.0662570328694108	0.7445551248837711	AKT1;TYK2;TP53;HDAC9;HDAC6;MTOR
Psychomotor regression, progressive	5/150	0.4984570982771612	0.7295429538667005	0	0	1.0784973366975048	0.7508905643833528	GABRB1;PEX6;ROGDI;PLCB1;PEX26
Loss of developmental milestones	5/150	0.4984570982771612	0.7295429538667005	0	0	1.0784973366975048	0.7508905643833528	GABRB1;PEX6;ROGDI;PLCB1;PEX26
Mental deterioration in childhood	5/150	0.4984570982771612	0.7295429538667005	0	0	1.0784973366975048	0.7508905643833528	GABRB1;PEX6;ROGDI;PLCB1;PEX26
Monoclonal Gammopathy of Undetermined Significance	5/150	0.4984570982771612	0.7295429538667005	0	0	1.0784973366975048	0.7508905643833528	CCND3;AKT2;AKT1;SDC1;TP53
Neurodevelopmental regression	5/150	0.4984570982771612	0.7295429538667005	0	0	1.0784973366975048	0.7508905643833528	GABRB1;PEX6;ROGDI;PLCB1;PEX26
Psychomotor regression	5/150	0.4984570982771612	0.7295429538667005	0	0	1.0784973366975048	0.7508905643833528	GABRB1;PEX6;ROGDI;PLCB1;PEX26
Psychomotor regression beginning in infancy	5/150	0.4984570982771612	0.7295429538667005	0	0	1.0784973366975048	0.7508905643833528	GABRB1;PEX6;ROGDI;PLCB1;PEX26
Subclinical abnormal liver function tests	4/118	0.4996208788867794	0.7295429538667005	0	0	1.0974025974025974	0.7614939289426217	JAG1;IFT172;TMEM67;AGPAT2
Transaminases increased	4/118	0.4996208788867794	0.7295429538667005	0	0	1.0974025974025974	0.7614939289426217	JAG1;IFT172;TMEM67;AGPAT2
Elevated liver enzymes	4/118	0.4996208788867794	0.7295429538667005	0	0	1.0974025974025974	0.7614939289426217	JAG1;IFT172;TMEM67;AGPAT2
Increased liver function tests	4/118	0.4996208788867794	0.7295429538667005	0	0	1.0974025974025974	0.7614939289426217	JAG1;IFT172;TMEM67;AGPAT2
Liver enzymes abnormal	4/118	0.4996208788867794	0.7295429538667005	0	0	1.0974025974025974	0.7614939289426217	JAG1;IFT172;TMEM67;AGPAT2
Liver function tests abnormal finding	4/118	0.4996208788867794	0.7295429538667005	0	0	1.0974025974025974	0.7614939289426217	JAG1;IFT172;TMEM67;AGPAT2
Renal Artery Stenosis	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	LDLR
Rib fusion	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	CTBP1
Saethre-Chotzen Syndrome	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	TCF12
Severe depression	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	MTR
Shock	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	HSF1
Lymphoma, Follicular, Grade 3	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	MTR
Lymphoma, Mixed-Cell	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	FPGS
Squamous cell carcinoma of tonsil	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	HIPK2
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	PDE6B
Pancreatic carcinoma, familial	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	TP53
Sudden death	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	JUP
Psychomotor retardation, mild	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	ACTB
Psychoses, Drug	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	AKT1
TDP-43 Proteinopathies	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	ATXN2
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	ACTB
22q11 Deletion Syndrome	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	HIC2
Abnormal lactate dehydrogenase activity	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	TP53
Urethral Stricture	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	PLEC
Weak cry	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	TPM2
Adrenal Cancer	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	TP53
XX males	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	SOX3
Adult Hodgkin Lymphoma	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	PDLIM7
Anti-nuclear factor positive	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	TYK2
Basal-Like Breast Carcinoma	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	ERBB2
Benign Mastocytoma	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	TP53
Biliary Tract Diseases	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	BBS1
Collapse of vertebra	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	XYLT2
Compression fracture of vertebral column	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	XYLT2
Death in childhood	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	OGDH
Disturbance of consciousness	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	ATP1A3
Dystonia Musculorum Deformans	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	ANO3
Hemoglobin F Disease	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	RIMS2
Hypothalamic gonadotropin-releasing hormone deficiency	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	CHD7
Impaired left ventricular function	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	LDLR
Infantile muscular hypotonia	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	TMEM67
Infiltrating duct carcinoma of female breast	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	RPS6KA4
Liver calculus	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	TEP1
myeloblastosis	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	TP53
Myopathic facies	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	TPM2
Nephrosclerosis	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	ACTN4
Nonketotic Hyperglycinemia	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	GLDC
Other specified manifestations of hyperkinetic syndrome	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	CHRNB2
Pancolitis	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	TP53
Peritoneal adhesion	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	ACTB
Personality Traits	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	FHIT
Pneumoconiosis	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	ERBB2
Prelingual Deafness	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	JAG1
Protein Misfolding Disorders	1/22	0.5000079610286093	0.7295429538667005	0	0	1.4892684052619432	1.032258484176331	HDAC9
Diabetic Retinopathy	8/247	0.5002957169023798	0.7297567781404174	0	0	1.046900210572374	0.7250369401386267	JAG1;IDUA;CAPN10;ERCC1;KEAP1;SDC1;PLXDC2;GAPDH
Malignant neoplasm of thyroid	16/505	0.5005529805457347	0.7299260167777532	0	0	1.0233616381586965	0.7082090614298919	SORT1;TACSTD2;NDRG2;FHIT;MTOR;RELA;HIPK2;VANGL2;TEP1;SGSM3;CREB3L2;ERBB2;AKT1;SSSCA1;GAPDH;TP53
Irritation - emotion	3/86	0.5009443281786803	0.7300846835948731	0	0	1.130440725625354	0.7814288013132652	TCN2;GLDC;TP53
Muscular hypotonia of the trunk	3/86	0.5009443281786803	0.7300846835948731	0	0	1.130440725625354	0.7814288013132652	MBOAT7;CHMP1A;PLCB1
Skeletal muscle atrophy	7/215	0.5014445245515536	0.7301959151542489	0	0	1.0525473710628686	0.7265337657760916	ATXN2;INSR;TPM2;OGDH;TTC19;DHTKD1;PLEC
Neurogenic muscle atrophy, especially in the lower limbs	7/215	0.5014445245515536	0.7301959151542489	0	0	1.0525473710628686	0.7265337657760916	ATXN2;INSR;TPM2;OGDH;TTC19;DHTKD1;PLEC
Lymphoproliferative Disorders	7/215	0.5014445245515536	0.7301959151542489	0	0	1.0525473710628686	0.7265337657760916	SLC35B2;SGSM3;ERBB2;TYK2;TP53;PDLIM7;MTOR
Rotavirus Infections	2/54	0.5022446584415103	0.7303321313522019	0	0	1.202887727159572	0.8283901777517287	AIMP2;TP53
Xeroderma Pigmentosum, Complementation Group D	2/54	0.5022446584415103	0.7303321313522019	0	0	1.202887727159572	0.8283901777517287	ERCC1;TP53
Dizziness	2/54	0.5022446584415103	0.7303321313522019	0	0	1.202887727159572	0.8283901777517287	CHRNB2;JUP
Drug Withdrawal Symptoms	2/54	0.5022446584415103	0.7303321313522019	0	0	1.202887727159572	0.8283901777517287	CHRNB2;GNAO1
Pancreatic Diseases	2/54	0.5022446584415103	0.7303321313522019	0	0	1.202887727159572	0.8283901777517287	TPM2;TP53
oligodendroglioma	6/183	0.5027650712550273	0.7308832315741157	0	0	1.0601777728703141	0.7290124518972783	RIMS2;CNTNAP2;HMGB1;SYP;TP53;SMARCA2
Pheochromocytoma	9/280	0.5035856084083403	0.7318701980467668	0	0	1.0386517776798063	0.7125167342243247	INSR;ERBB2;SSSCA1;FNDC3A;SYP;CNTN4;TP53;ACTB;MTOR
Malignant Squamous Cell Neoplasm	5/151	0.504324442786812	0.7325319618668478	0	0	1.0710546831495713	0.7331749341333001	RHBDF1;RAD52;TP53;FHIT;MTOR
Pulmonary Hypertension	5/151	0.504324442786812	0.7325319618668478	0	0	1.0710546831495713	0.7331749341333001	KCNMA1;HMGB1;RELA;MTOR;CBLN2
Von Hippel-Lindau Syndrome	4/119	0.5062342276925522	0.732737043367541	0	0	1.087803500846979	0.7405285601081539	RIMS2;SYVN1;TP53;FHIT
Drug Use Disorders	4/119	0.5062342276925522	0.732737043367541	0	0	1.087803500846979	0.7405285601081539	AGBL4;GRM5;INSR;FHIT
Elevated hepatic transaminases	4/119	0.5062342276925522	0.732737043367541	0	0	1.087803500846979	0.7405285601081539	JAG1;IFT172;TMEM67;AGPAT2
Muscle Rigidity	4/119	0.5062342276925522	0.732737043367541	0	0	1.087803500846979	0.7405285601081539	ATXN2;ERBB2;ATP13A2;LMNB1
Premature Birth	4/119	0.5062342276925522	0.732737043367541	0	0	1.087803500846979	0.7405285601081539	SETD5;PEX6;PEX26;PLEC
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site	7/216	0.5063464309506113	0.732737043367541	0	0	1.047456621681744	0.712830051777454	AIMP2;PSMD7;STAT2;FOXJ1;TP53;RELA;MTOR
Alopecia	7/216	0.5063464309506113	0.732737043367541	0	0	1.047456621681744	0.712830051777454	JUP;CTBP1;CHD7;ERBB2;SMARCA2;LDLR;PLEC
Pancreatic Ductal Adenocarcinoma	22/701	0.5075086948171021	0.732737043367541	0	0	1.013249860851833	0.6872280402136496	EIF5A;RERE;B3GALNT1;CHRM3;IDUA;USP22;CHD7;HMGB1;RHOC;FHIT;MTOR;RELA;AIMP2;CCND3;CDH3;MDK;AKT2;ERBB2;AKT1;LDLR;TP53;PLEC
Down Syndrome	15/475	0.508008665882285	0.732737043367541	0	0	1.0197628458498025	0.6906412939258735	CHRNB2;PDXK;MTR;SYP;MTOR;ACTB;RELA;RIMS2;MAPK10;NFIC;ERBB2;AMPH;SHBG;GAPDH;TP53
Actinic keratosis	3/87	0.5086922513245623	0.732737043367541	0	0	1.1169252141699468	0.7549432219043577	ERCC1;TP53;SMARCA2
Adrenal Gland Neoplasms	3/87	0.5086922513245623	0.732737043367541	0	0	1.1169252141699468	0.7549432219043577	SYP;TP53;LDLR
Adult type dermatomyositis	3/87	0.5086922513245623	0.732737043367541	0	0	1.1169252141699468	0.7549432219043577	TRIM24;TYK2;TP53
Chronic active hepatitis	3/87	0.5086922513245623	0.732737043367541	0	0	1.1169252141699468	0.7549432219043577	ERBB2;TP53;FHIT
Dysmorphic facies	3/87	0.5086922513245623	0.732737043367541	0	0	1.1169252141699468	0.7549432219043577	INSR;CHD7;HCCS
Generalized muscle weakness	3/87	0.5086922513245623	0.732737043367541	0	0	1.1169252141699468	0.7549432219043577	ATXN2;TPM2;PLEC
Malignant Childhood Neoplasm	3/87	0.5086922513245623	0.732737043367541	0	0	1.1169252141699468	0.7549432219043577	ERBB2;MTR;TP53
Nevus	3/87	0.5086922513245623	0.732737043367541	0	0	1.1169252141699468	0.7549432219043577	ERBB2;HCCS;TP53
Childhood Acute Lymphoblastic Leukemia	14/443	0.5091087277832475	0.732737043367541	0	0	1.0205405155900205	0.6889604468162016	HDAC4;MBD5;MTR;FHIT;HDAC9;MTOR;ACTB;RELA;MAN2A1;ERCC1;FPGS;CDK2AP2;MAP4;TP53
Aneurysm	5/152	0.510164702743823	0.732737043367541	0	0	1.0637132901941264	0.715902083100078	AKT1;FADD;TP53;LDLR;RELA
Secondary malignant neoplasm of liver	16/508	0.5101974920400059	0.732737043367541	0	0	1.0169601033758682	0.6843708158111849	USP22;TACSTD2;SEMA3F;ACTB;CCND3;PSMD7;AKT2;ERCC1;FPGS;ERBB2;AKT1;ULK1;CKB;GAPDH;TP53;OTUB1
Russell-Silver syndrome	2/55	0.5120382800373907	0.732737043367541	0	0	1.1801306710630763	0.7899274168723694	KCNQ1OT1;AGPAT2
Decreased visual acuity, progressive	2/55	0.5120382800373907	0.732737043367541	0	0	1.1801306710630763	0.7899274168723694	NPHP1;ATP1A3
Lymphoma, Diffuse	2/55	0.5120382800373907	0.732737043367541	0	0	1.1801306710630763	0.7899274168723694	FPGS;TP53
Spastic Quadriplegia	2/55	0.5120382800373907	0.732737043367541	0	0	1.1801306710630763	0.7899274168723694	PRDM8;ATP13A2
Common Migraine	2/55	0.5120382800373907	0.732737043367541	0	0	1.1801306710630763	0.7899274168723694	CACNB2;LDLR
Crohn's disease of the ileum	2/55	0.5120382800373907	0.732737043367541	0	0	1.1801306710630763	0.7899274168723694	TYK2;YWHAZ
Fetal Alcohol Syndrome	2/55	0.5120382800373907	0.732737043367541	0	0	1.1801306710630763	0.7899274168723694	OTX2;ACTB
Immunoglobulin A deficiency (disorder)	2/55	0.5120382800373907	0.732737043367541	0	0	1.1801306710630763	0.7899274168723694	TCN2;MTOR
Insulin Sensitivity	2/55	0.5120382800373907	0.732737043367541	0	0	1.1801306710630763	0.7899274168723694	INSR;TRIB3
Cholestasis	10/315	0.5146416387363641	0.732737043367541	0	0	1.0252620263370062	0.6810656393631722	JAG1;MAF;IFT172;INSR;PEX6;NPHP1;AP1S1;SPG7;RELA;PEX26
Renal sclerosis with hypertension	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	ACTN4
response to statin	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	IFT172
Bone Cysts, Aneurysmal	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	ERBB2
Rubinstein-Taybi Syndrome	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	SMARCA2
Lupus Erythematosus, Subacute Cutaneous	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	TYK2
Smallpox	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	TP53
Myopia, Degenerative	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	ZNF644
Neoplasms, Second Primary	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	TP53
Sporadic Burkitt's lymphoma	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	TP53
Squamous Cell Neoplasms	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	TP53
Stage III Colon Cancer AJCC v7	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	TP53
Superficial spreading malignant melanoma of skin	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	TP53
Schizophrenia, Childhood	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	RELA
Triphalangeal thumb	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	SUFU
Tumor Necrosis Factor Receptor 1-Associated Periodic Syndrome	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	PSMD12
Absence of pubertal development	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	CHD7
Varicocele	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	AKT1
Acute-On-Chronic Liver Failure	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	HMGB1
Akinesia	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	ATP13A2
Aniridia	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	OTX2
Bloch Sulzberger syndrome	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	SHARPIN
C-cell hyperplasia of thyroid	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	TP53
Capillary malformation (disorder)	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	TRAF3IP2
Cholesteatoma	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	HMGB1
cocaine use	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	STARD3
Congenital dislocation of radial head	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	ERCC1
Congenital hypoplasia of clavicle	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	IDUA
Diffuse Mixed-Cell Lymphoma	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	FPGS
Enlarged kidney	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	KCNQ1OT1
Esophageal Achalasia	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	ACTB
Exfoliation Syndrome	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	CNTNAP2
Familial benign pemphigus	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	ERBB2
fibroma	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	MTOR
Granulomatous Slack Skin	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	TP53
Hemorrhagic Fever with Renal Syndrome	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	RELA
Hepatocellular necrosis	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	NDUFS8
Hunger	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	LDLR
Hypomyelination	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	GDAP1
Hypoplasia of optic disc	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	PDE6B
Hypoxic-Ischemic Encephalopathy	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	ACTB
Job Syndrome	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	TYK2
Lipids measurement	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	LDLR
Lower limb spasticity	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	SPG7
Macule	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	AKT1
Neuroepithelioma	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	FLII
Posterior subcapsular cataract	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	TP53
Proximal placement of thumb	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	SETD5
Pseudoaphakia	1/23	0.5155247464559557	0.732737043367541	0	0	1.4215009546188868	0.9418438475762718	NDRG2
Primary Effusion Lymphoma	5/153	0.5159769532931169	0.7329766065472314	0	0	1.0564711052515932	0.6990597237949691	SDC1;FADD;TP53;FHIT;PDLIM7
Psychomotor regression in infants	5/153	0.5159769532931169	0.7329766065472314	0	0	1.0564711052515932	0.6990597237949691	GABRB1;PEX6;ROGDI;PLCB1;PEX26
Blepharophimosis	3/88	0.5163767621210276	0.7332444467230167	0	0	1.1037277147487845	0.7294741989570388	RERE;ERCC1;SMARCA2
Cerebral Infarction	9/283	0.5164492620107934	0.7332444467230167	0	0	1.0271184010895147	0.6786974785546565	MAP2;MDK;PDE4D;AKT1S1;SYP;CAPN1;HMGB1;TP53;YWHAZ
Diffuse Large B-Cell Lymphoma	18/575	0.5172364242128165	0.73416035164291	0	0	1.0104379775374723	0.666136499846136	HDAC4;SLC35B2;MTR;FHIT;HDAC9;HDAC6;MTOR;RELA;LMNB1;CCND3;AKT1;SDC1;SSSCA1;MAP4;FADD;EIF4G3;TP53;PDLIM7
Juvenile Myelomonocytic Leukemia	4/121	0.5193422139075522	0.7367886497357449	0	0	1.069097569097569	0.7004644325887901	RASA4;SGSM3;AKT1;TP53
Precancerous Conditions	14/446	0.5193732683798991	0.7367886497357449	0	0	1.0132929959662633	0.663841120404879	DPP10;CCDC134;FHIT;MAPK15;AKT2;CFL1;ERBB2;AKT1;SDC1;CKB;MIR92B;TP53;TTLL9;PDLIM7
Lupus Vulgaris	9/284	0.5207137628732935	0.7372322393846306	0	0	1.023329861627734	0.6677788005804818	PSME3;FLII;ERBB2;FOXJ1;TYK2;HMGB1;LDLR;HDAC9;MTOR
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	11/349	0.5207528703262219	0.7372322393846306	0	0	1.0175863040584525	0.6639543931146262	RIMS2;SLC35B2;CCND3;MAP2;AKT1;SSSCA1;FADD;MIR92B;TP53;HDAC6;MTOR
Vertigo	2/56	0.5217041878782273	0.7372322393846306	0	0	1.1582164688960805	0.7535988056632499	CHRNB2;JUP
Congenital hypoplasia of kidney	2/56	0.5217041878782273	0.7372322393846306	0	0	1.1582164688960805	0.7535988056632499	JAG1;FRAS1
Hyperandrogenism	2/56	0.5217041878782273	0.7372322393846306	0	0	1.1582164688960805	0.7535988056632499	INSR;SHBG
Hyperbilirubinemia	2/56	0.5217041878782273	0.7372322393846306	0	0	1.1582164688960805	0.7535988056632499	JAG1;HMGB1
Breast Cancer, Familial	5/154	0.5217602978742234	0.7372322393846306	0	0	1.049326130845201	0.6826359622860815	LMO4;ERBB2;AKT1;TP53;FHIT
Developmental regression	5/154	0.5217602978742234	0.7372322393846306	0	0	1.049326130845201	0.6826359622860815	GABRB1;PEX6;ROGDI;PLCB1;PEX26
Icterus	5/154	0.5217602978742234	0.7372322393846306	0	0	1.049326130845201	0.6826359622860815	PEX6;SPG7;ALDOA;TP53;PEX26
Premature Menopause	5/154	0.5217602978742234	0.7372322393846306	0	0	1.049326130845201	0.6826359622860815	NPHP1;SSSCA1;SHBG;DNAI1;ACVR2B
Tactile Allodynia	3/89	0.5239963299038494	0.7372322393846306	0	0	1.0908371339188119	0.7049759676065332	CACNA2D1;INSR;HMGB1
Chagas Disease	3/89	0.5239963299038494	0.7372322393846306	0	0	1.0908371339188119	0.7049759676065332	RABEP2;TCN2;TYK2
Hypotension	3/89	0.5239963299038494	0.7372322393846306	0	0	1.0908371339188119	0.7049759676065332	SOX3;OTX2;LMNB1
Non-obstructive azoospermia	3/89	0.5239963299038494	0.7372322393846306	0	0	1.0908371339188119	0.7049759676065332	GNAO1;CHD7;GAPDH
polyps	9/285	0.5249658846467529	0.7372322393846306	0	0	1.019568775350459	0.6570325494785247	JAG1;TRAF3IP2;ERBB2;CKB;SEMA3F;TP53;YWHAZ;RELA;MTOR
Adenocarcinoma, Oxyphilic	4/122	0.5258345262707875	0.7372322393846306	0	0	1.059982390490865	0.6813235080099093	ERBB2;CKB;TP53;MTOR
Hyperammonemia	4/122	0.5258345262707875	0.7372322393846306	0	0	1.059982390490865	0.6813235080099093	IDUA;OGDH;MTR;SGSH
Carcinoma, Spindle-Cell	6/188	0.5290955598388019	0.7372322393846306	0	0	1.0307835486988581	0.6561826039561208	EIF5A;ACTN4;TP53;FHIT;YWHAZ;ACTB
Familial Alzheimer Disease (FAD)	6/188	0.5290955598388019	0.7372322393846306	0	0	1.0307835486988581	0.6561826039561208	CHRNB2;INSR;NFIC;OGDH;AKT1;TP53
Mitochondrial Diseases	12/384	0.530014037452984	0.7372322393846306	0	0	1.0084889643463497	0.6402410212116472	COQ4;NDUFS8;AGK;STAT2;OGDH;PDSS2;HCCS;SPG7;GDAP1;TTC19;MTOR;DHTKD1
Candidiasis, Chronic Mucocutaneous	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	TRAF3IP2
Child Development Disorders, Specific	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	CNTN4
Sebaceous adenoma	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	AKT1
Epilepsy, Benign Psychomotor, Childhood	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	GRM5
Focal Segmental Glomerulosclerosis, Not Otherwise Specified	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	ACTN4
Skin tag on the posterior cheek	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	CTBP1
Lymphoma, Undifferentiated	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	FPGS
Microangiopathy, Diabetic	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	RELA
Stage III Colon Cancer	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	TP53
Pseudohypoparathyroidism, Type Ia	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	SOX3
Synostotic Posterior Plagiocephaly	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	TCF12
Signs and Symptoms, Respiratory	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	GDAP1
Thickened calvaria	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	ERCC8
Abnormal ocular motility	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	EFHC1
Uncinate Epilepsy	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	GRM5
Uterine Neoplasms	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	AKT1
X-linked centronuclear myopathy	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	TPM2
Asphyxia Neonatorum	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	MAP2
Asymptomatic human immunodeficiency virus infection	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	PDLIM7
Body Weight	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	MAP2K5
Bronchitis	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	FOXJ1
Catalepsy	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	PPP1R1B
Child Development Deviations	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	CNTN4
Chronic atrial fibrillation	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	CACNB2
Chronic thromboembolic pulmonary hypertension	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	MTOR
Cognitive changes	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	SORT1
Complications of Diabetes Mellitus	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	GAPDH
Congenital hypoplasia of adrenal gland	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	ATP1A3
Decreased fertility in females	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	AGPAT2
Dupuytren's Disease	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	AIMP2
Episodic Ataxia	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	ATP1A3
Erectile abnormalities	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	CHD7
Etat Marbre	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	TSEN34
Familial primary pulmonary hypertension	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	HDAC4
Fetal Alcohol Spectrum Disorders	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	OTX2
Fetal overgrowth	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	KCNQ1OT1
Generalized overgrowth	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	KCNQ1OT1
Hyperlipoproteinemia Type IIb	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	LDLR
Inattention	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	MAP2K5
Increased thickness of cranium	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	ERCC8
Intestinal Pseudo-Obstruction	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	TP53
Jeune thoracic dystrophy	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	IFT172
Lens dislocation	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	TAPBP
Orchitis	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	UBAC2
Ovarian Diseases	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	TACSTD2
Overgrowth	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	KCNQ1OT1
Pelger-Huet Anomaly	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	RELA
Peripheral demyelination	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	GDAP1
Pinched bridge of nose	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	SMARCA2
Pinched nasal bridge	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	SMARCA2
Precocious pubarche	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	SHBG
Precursor T-cell lymphoblastic lymphoma	1/24	0.5305607340638229	0.7372322393846306	0	0	1.3596263257708787	0.861759503845467	TP53
Ataxia, Appendicular	2/57	0.5312408783801015	0.7372322393846306	0	0	1.1370991468078846	0.7192603861668111	ATXN2;ARCN1
Sentinel node (disorder)	2/57	0.5312408783801015	0.7372322393846306	0	0	1.1370991468078846	0.7192603861668111	ERBB2;TP53
Respiratory Distress Syndrome, Newborn	2/57	0.5312408783801015	0.7372322393846306	0	0	1.1370991468078846	0.7192603861668111	RSPH1;AKT1
Atrophic	2/57	0.5312408783801015	0.7372322393846306	0	0	1.1370991468078846	0.7192603861668111	AKT1;MTOR
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	2/57	0.5312408783801015	0.7372322393846306	0	0	1.1370991468078846	0.7192603861668111	SSSCA1;TP53
Ectodermal Dysplasia	2/57	0.5312408783801015	0.7372322393846306	0	0	1.1370991468078846	0.7192603861668111	CDH3;FNDC3A
Hyperaldosteronism	2/57	0.5312408783801015	0.7372322393846306	0	0	1.1370991468078846	0.7192603861668111	INSR;TP53
Long eyelashes	2/57	0.5312408783801015	0.7372322393846306	0	0	1.1370991468078846	0.7192603861668111	SETD5;SMARCA2
Necrosis	2/57	0.5312408783801015	0.7372322393846306	0	0	1.1370991468078846	0.7192603861668111	HMGB1;GAPDH
Ewings sarcoma	11/352	0.532250770545372	0.7380855896872814	0	0	1.008475025160231	0.6359852218339492	CCND3;FCGRT;MDK;FLII;INSR;AKT1S1;ERBB2;ARHGAP1;AKT1;TP53;MTOR
Substance-Related Disorders	4/123	0.5322842478259477	0.7380855896872814	0	0	1.0510204081632653	0.6627499600617658	AGBL4;GRM5;INSR;FHIT
Hyperplasia	4/123	0.5322842478259477	0.7380855896872814	0	0	1.0510204081632653	0.6627499600617658	AKT1;SHBG;TP53;LDLR
Mucocutaneous Lymph Node Syndrome	5/156	0.5332368229843667	0.7392081279997873	0	0	1.0353200883002207	0.6509985380506381	JAG1;MED30;INSR;HMGB1;PLCB1
Noninfiltrating Intraductal Carcinoma	9/287	0.5334313895373439	0.7392795444164638	0	0	1.012127777319879	0.636046217229819	STARD3;BCL9;KCNQ1OT1;ERBB2;AKT1;SDC1;TP53;FHIT;ACTB
Metabolic Syndrome X	17/548	0.5339101154298064	0.7397446317804931	0	0	1.0007495479289055	0.6279981395008798	CTBP1;INSR;HMGB1;AGPAT2;MTOR;ACTB;RELA;RALYL;CAPN10;AKT2;OSBP;AKT1;TRIB3;FADD;PLCB1;SHBG;LDLR
Ovarian Carcinoma	68/2203	0.5348803562271248	0.740804414674197	0	0	0.9950276618131215	0.6226009376981911	CHRM3;BNC2;KEAP1;MSI1;HCCS;CHD4;TMEM97;HMGB1;ACTB;RIMS2;SOX3;SOX1;MAGED4B;SALL2;FCGRT;MDK;AKT2;AKT1;SSSCA1;EIF5A;PRKCI;ACTN4;RHOC;PLCB3;SPINT1;TEP1;KCNMA1;ZNF318;GAPDH;TP53;HDAC4;EPB41;TACSTD2;TARS;SPG7;FHIT;HDAC9;AGPAT2;HDAC6;RELA;ATXN2;DPP9;HSF1;ERBB2;IGF2BP1;MAP6;CKB;FADD;JAG1;INSR;FOXJ1;MTOR;IFFO1;HIPK2;RAD52;NBR2;MAPK10;BCL9;AIMP2;FRAS1;GIPC1;SGSM3;ERCC1;NEK10;SDC1;SHBG;EBAG9;NEK11
Brain Neoplasms	20/646	0.5349617019280385	0.740804414674197	0	0	0.998615548455804	0.6246940621558227	B3GALNT1;JAG1;MSI1;SEMA3F;HMGB1;SPG7;FHIT;MTOR;RELA;MDK;SUFU;ERCC1;ERBB2;IGF2BP1;AKT1;SSSCA1;FADD;MIR92B;GAPDH;TP53
Muscle Spasticity	11/353	0.5360634498535924	0.7421312373006606	0	0	1.0054734537493157	0.6269154617802947	ATXN2;NDUFS8;TMEM67;PEX6;CHMP1A;ROGDI;ATP13A2;SPG7;PLCB1;PEX26;LMNB1
Encephalitis, St. Louis	4/124	0.5386903345843039	0.7437264958058171	0	0	1.0422077922077921	0.6447247392646142	SGSM3;HMGB1;TYK2;RELA
Hernia, Inguinal	4/124	0.5386903345843039	0.7437264958058171	0	0	1.0422077922077921	0.6447247392646142	ABCD4;IDUA;INSR;RPS27A
CNS disorder	4/124	0.5386903345843039	0.7437264958058171	0	0	1.0422077922077921	0.6447247392646142	GRM5;PNMA1;ERBB2;SGSH
Acute Cerebrovascular Accidents	3/91	0.5390349800225129	0.7437264958058171	0	0	1.0659348754972742	0.6587209044793785	PDE4D;SPG7;HDAC9
Prolactinoma	3/91	0.5390349800225129	0.7437264958058171	0	0	1.0659348754972742	0.6587209044793785	ERBB2;GAPDH;TP53
Muscular Dystrophy, Duchenne	6/190	0.5394675017429129	0.7437264958058171	0	0	1.0194731624415805	0.6291910387319768	ADAMTS5;INSR;CAPN1;HDAC9;SYBU;RELA
Amnesia	2/58	0.5406470635581415	0.7437264958058171	0	0	1.1167360147942673	0.6867799081712226	HSF1;MTOR
Carcinoma of Male Breast	2/58	0.5406470635581415	0.7437264958058171	0	0	1.1167360147942673	0.6867799081712226	ERBB2;TP53
Inclusion Body Myositis (disorder)	2/58	0.5406470635581415	0.7437264958058171	0	0	1.1167360147942673	0.6867799081712226	SDC1;HMGB1
Mycoplasma Infections	2/58	0.5406470635581415	0.7437264958058171	0	0	1.1167360147942673	0.6867799081712226	GAPDH;TP53
Oncocytic Neoplasm	2/58	0.5406470635581415	0.7437264958058171	0	0	1.1167360147942673	0.6867799081712226	SCG3;TP53
Skin Neoplasms	8/256	0.5409795171306174	0.7437264958058171	0	0	1.0084334809192494	0.6195551722210902	ERBB2;XYLT2;AKT1;SDC1;TP53;RELA;HDAC6;MTOR
Platelet Count measurement	6/191	0.5446164971128918	0.7437264958058171	0	0	1.01390967514746	0.6161259467242123	ATXN2;TYK2;PLCB1;WDR66;SMG6;PLEC
Acute Erythroblastic Leukemia	7/224	0.5449311442421125	0.7437264958058171	0	0	1.0084197232015997	0.6122074120126192	RIMS2;IDUA;FLII;HSF1;ERBB2;TP53;RELA
Adenocarcinoma, Tubular	4/125	0.5450517890480315	0.7437264958058171	0	0	1.0335408393259633	0.6272295419137882	ERBB2;CKB;TP53;MTOR
Aganglionosis, Colonic	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	TP53
Apraxia, Developmental Verbal	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	CNTNAP2
Rhomboid shaped head	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	TCF12
Hemangioma, Cavernous	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	AKT1
Lymphoma, Follicular, Grade 1	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	MTR
Lymphoma, Intermediate-Grade	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	FPGS
Specific language impairment	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	CNTNAP2
Steroid resistant nephrotic syndrome of childhood	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	ACTN4
Plagiocephaly, Nonsynostotic	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	TCF12
Tooth Attrition	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	TP53
Type II Mucolipidosis	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	IDUA
Ulnar deviation of the fingers	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	TPM2
Acrocephaly	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	TCF12
Adolescent idiopathic scoliosis	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	BNC2
Astrocytosis	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	MTOR
Asymmetry of the posterior cranium	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	TCF12
Cancer of Digestive System	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	MTR
Down-sloping shoulders	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	SUFU
Dyspepsia	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	FHIT
ESR raised	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	TYK2
Excessive wrinkled skin	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	SMARCA2
Female hypogonadism syndrome	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	CHD7
Flat head	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	TCF12
Flattening of cranial vault	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	TCF12
Flattening of head	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	TCF12
Goiter	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	AKT1
Hepatic Form of Wilson Disease	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	ANKS1B
Hereditary macular dystrophy	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	CDH3
Hyperphosphatemia (disorder)	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	PDE4D
Hypokinesia	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	ATP13A2
Malignant neoplasm of penis	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	TP53
Onion bulb formation	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	GDAP1
Plagiocephaly	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	TCF12
Poor head control	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	HEXA
Port-Wine Stain	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	KCNQ1OT1
Preauricular skin tag	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	CTBP1
Prematurely aged appearance	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	INSR
Progressive macrocephaly	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	AKT1
Prolonged neonatal jaundice	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	JAG1
Pyemia	1/25	0.545130798396369	0.7437264958058171	0	0	1.302907915993538	0.7905126893363195	HMGB1
Metabolic Diseases	13/421	0.5455143994365427	0.7440534220871081	0	0	0.9958813838550247	0.6035300885039325	IDUA;INSR;HEXA;PPOX;HDAC9;MTOR;MAPK10;KAT2A;CAPN10;AKT2;SHBG;LDLR;TP53
Neoplasms	38/1236	0.5458982308494461	0.7443804899815138	0	0	0.990935637287805	0.5998358463853143	CHRM3;TACSTD2;CASC2;FOXK1;CHD4;HMGB1;ABCC10;NDRG2;HDAC9;HDAC6;RIMS2;MDK;AKT2;SUFU;HSF1;ERBB2;TRIM24;AKT1;CAPN1;MIR92B;LDLR;CLIC1;GDF11;JAG1;INSR;TCF12;SMARCA2;MTOR;RAD52;ERCC1;KCNMA1;OGDH;PTPN9;SDC1;PKP4;TRIB3;GAPDH;TP53
Dejerine-Sottas Disease (disorder)	3/92	0.5464514597137992	0.7447418628166967	0	0	1.053903447271138	0.6368841767984669	LRSAM1;GDAP1;RELA
Premature aging syndrome	3/92	0.5464514597137992	0.7447418628166967	0	0	1.053903447271138	0.6368841767984669	RIMS2;ERCC8;TP53
MYELODYSPLASTIC SYNDROME	21/683	0.5472894937525375	0.7456873460883507	0	0	0.9912744806298514	0.5975178318385682	JAG1;CTBP1;FLII;FHIT;HDAC9;TM9SF4;ACTB;RELA;HIPK2;RAD52;AIMP2;CCND3;ERCC1;CFL1;AKT1;ERCC8;TRIB3;SSSCA1;FADD;PLCB1;TP53
Gastrointestinal Carcinoid Tumor	7/225	0.5496671384908419	0.7471070277161559	0	0	1.0037415627759403	0.6006814964663016	RAB1B;ERBB2;AKT1;RHOC;TP53;FHIT;MTOR
Skin Abnormalities	2/59	0.5499216589458702	0.7471070277161559	0	0	1.0970873786407767	0.6560357063832052	CHRM3;JUP
Squamous cell carcinoma of mouth	2/59	0.5499216589458702	0.7471070277161559	0	0	1.0970873786407767	0.6560357063832052	TP53;FHIT
Paraparesis, Spastic	2/59	0.5499216589458702	0.7471070277161559	0	0	1.0970873786407767	0.6560357063832052	SPG7;TTC19
SVEINSSON CHORIORETINAL ATROPHY	2/59	0.5499216589458702	0.7471070277161559	0	0	1.0970873786407767	0.6560357063832052	GNAO1;ERBB2
Tooth problem	2/59	0.5499216589458702	0.7471070277161559	0	0	1.0970873786407767	0.6560357063832052	CDH3;KCNQ1OT1
Waddling gait	2/59	0.5499216589458702	0.7471070277161559	0	0	1.0970873786407767	0.6560357063832052	TPM2;TTC19
AICARDI-GOUTIERES SYNDROME 1	2/59	0.5499216589458702	0.7471070277161559	0	0	1.0970873786407767	0.6560357063832052	JAG1;TP53
Anaplastic Oligodendroglioma	2/59	0.5499216589458702	0.7471070277161559	0	0	1.0970873786407767	0.6560357063832052	TCF12;TP53
Conn Syndrome	2/59	0.5499216589458702	0.7471070277161559	0	0	1.0970873786407767	0.6560357063832052	KCNMA1;TP53
Cytokine Measurement	2/59	0.5499216589458702	0.7471070277161559	0	0	1.0970873786407767	0.6560357063832052	PDE4D;LINC00271
Secondary malignant neoplasm of lymph node	39/1271	0.5510027397641635	0.7482846803683457	0	0	0.9887956277801373	0.5893375180101142	LAD1;TACSTD2;MSI1;TMEM97;SEMA3F;HMGB1;NDRG2;FHIT;RELA;MDK;AKT2;ERBB2;AKT1;PDSS2;SSSCA1;FADD;CAPN1;CLIC1;PDLIM7;KCNJ3;B3GALNT1;GDF11;PRKCI;JAG1;AGK;USP22;FOXJ1;ACTN4;TYK2;RHOC;MTOR;SPINT1;ERCC1;PPP1R1B;SDC1;SHBG;RIN1;GAPDH;TP53
Congenital anomaly of face	4/126	0.5513676592187811	0.7482846803683457	0	0	1.0250159676389186	0.6102467764812085	HDAC4;INSR;HCCS;UBE2A
Hypogonadotropic hypogonadism	4/126	0.5513676592187811	0.7482846803683457	0	0	1.0250159676389186	0.6102467764812085	SOX3;CHD7;OTX2;SHBG
Nodule	4/126	0.5513676592187811	0.7482846803683457	0	0	1.0250159676389186	0.6102467764812085	JAG1;MDK;HMGB1;TP53
Esophageal carcinoma	21/685	0.5527807068117544	0.74972779856582	0	0	0.988183116439045	0.5857889313984695	SEMA5B;PRKCI;TPM2;FBXL19;PDE4D;CASC2;FOXK1;MTR;ABCC10;FHIT;HDAC9;ACVR2B;DNALI1;MTOR;SMG6;RIMS2;KCNQ1OT1;ERCC1;ERBB2;AKT1;TP53
Liver Cirrhosis, Alcoholic	3/93	0.5537977863011962	0.74972779856582	0	0	1.0421393841166937	0.6158581733287793	MBOAT7;GABRG2;RELA
Small for gestational age (disorder)	3/93	0.5537977863011962	0.74972779856582	0	0	1.0421393841166937	0.6158581733287793	CTBP1;INSR;ACTB
Edema	3/93	0.5537977863011962	0.74972779856582	0	0	1.0421393841166937	0.6158581733287793	CHD7;PDSS2;ACTN4
Low Birth Weights	3/93	0.5537977863011962	0.74972779856582	0	0	1.0421393841166937	0.6158581733287793	CTBP1;INSR;ACTB
Mucinous Adenocarcinoma	3/93	0.5537977863011962	0.74972779856582	0	0	1.0421393841166937	0.6158581733287793	SGSM3;ERBB2;TP53
Muscle degeneration	8/259	0.5542557525872887	0.74972779856582	0	0	0.9962242533135433	0.5879008736809443	RIMS2;ATXN2;INSR;TPM2;OGDH;TTC19;DHTKD1;PLEC
Heart Diseases	10/325	0.5546018201199936	0.74972779856582	0	0	0.9921935987509758	0.5849029524388492	CHRM3;ACSS2;JUP;IDUA;CHD7;ACCS;SHBG;GAPDH;ACTB;MTOR
Turner Syndrome	5/160	0.5558066510382023	0.74972779856582	0	0	1.008392341987936	0.5922639096041192	DNAH6;AKT1;SHBG;TP53;LHX9
Hypotrophic malar bone	5/160	0.5558066510382023	0.74972779856582	0	0	1.008392341987936	0.5922639096041192	MBD5;MAF;PDE4D;CHD7;UBE2A
Malar flattening	5/160	0.5558066510382023	0.74972779856582	0	0	1.008392341987936	0.5922639096041192	MBD5;MAF;PDE4D;CHD7;UBE2A
Interstitial lung fibrosis	4/127	0.5576370381694838	0.74972779856582	0	0	1.016629711751663	0.5937595306955205	AKT2;SDC1;TP53;MTOR
Impaired glucose tolerance	10/326	0.5585292846201939	0.74972779856582	0	0	0.9890018676073874	0.5760423847164056	CAPN10;AKT2;INSR;AKT1;MAP6;TRIB3;TP53;YWHAZ;ACVR2B;RELA
Fatty Liver, Alcoholic	2/60	0.5590637722968456	0.74972779856582	0	0	1.0781162816649927	0.6269157012416686	LDLR;RELA
Angelman Syndrome	2/60	0.5590637722968456	0.74972779856582	0	0	1.0781162816649927	0.6269157012416686	KCNQ1OT1;TP53
Cavernous Hemangioma of Brain	2/60	0.5590637722968456	0.74972779856582	0	0	1.0781162816649927	0.6269157012416686	ULK1;TP53
Cerebral calcification	2/60	0.5590637722968456	0.74972779856582	0	0	1.0781162816649927	0.6269157012416686	SUFU;ERCC1
Hypotrichosis	2/60	0.5590637722968456	0.74972779856582	0	0	1.0781162816649927	0.6269157012416686	CDH3;SMARCA2
Recurrent Childhood Acute Lymphoblastic Leukemia	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	TP53
Carcinoid, Goblet Cell	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	TP53
Epilepsy, Lateral Temporal	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	GRM5
Osteoarthrosis, localized, not specified whether primary or secondary	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	ADAMTS5
Steroid-resistant nephrotic syndrome	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	ACTN4
Thin rib	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	HDAC6
Trichothiodystrophy Syndromes	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	TP53
Abnormal pattern of respiration	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	NDUFS8
Amino acids measurement	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	NDRG2
ATRIOVENTRICULAR CANAL DEFECT	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	ACVR2B
Blurred vision	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	TACSTD2
Carpal Tunnel Syndrome	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	IDUA
Choroideremia	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	ACTB
Congenital contracture	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	TPM2
Dermatitis Herpetiformis	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	FCGRT
drug response	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	GDAP1
Ectrodactyly	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	CDH3
Epidermolysis Bullosa Simplex	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	PLEC
Fatty acid measurement	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	CHRM3
Hormone measurement	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	TP53
Hyperprolactinemia	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	INSR
Hypoplasia of nipple	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	SETD5
Indian childhood cirrhosis	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	ERBB2
Klatskin Tumor	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	TP53
Mast Cell Neoplasm	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	TP53
Menkes Kinky Hair Syndrome	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	AIMP2
MUTYH-Associate Polyposis	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	SGSM3
Neonatal onset	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	GDAP1
Personality change	1/26	0.5592493543868491	0.74972779856582	0	0	1.2507269789983846	0.7268722822924472	LMNB1
Eclampsia	6/194	0.5599082688446025	0.7504164765012722	0	0	0.9975743294753621	0.5785754683005673	INSR;HMGB1;EBAG9;GAPDH;ACTB;RELA
airway disease	3/94	0.5610728733045984	0.7515875088745891	0	0	1.0306338718008086	0.5956079348009135	DNAH5;DNAI1;RELA
AMYOTROPHIC LATERAL SCLEROSIS 1	3/94	0.5610728733045984	0.7515875088745891	0	0	1.0306338718008086	0.5956079348009135	HSF1;VPS54;LDLR
Pituitary Adenoma	9/294	0.5626138675219233	0.7534564569456594	0	0	0.9869067103109657	0.5676309750354461	MDK;AKT1;SSSCA1;SYP;KCNAB2;NDRG2;TP53;ACTB;MTOR
Malignant neoplasm of ovary	62/2026	0.5636163151093808	0.7545374516870312	0	0	0.9852907897714415	0.5649475615672358	CHRM3;BNC2;POP4;KEAP1;MSI1;CHD4;TMEM97;HMGB1;ACTB;RIMS2;SOX3;SOX1;MAGED4B;SALL2;FCGRT;MDK;AKT2;AKT1;SSSCA1;EIF5A;PRKCI;CTNNBIP1;ACTN4;PLCB3;SPINT1;TEP1;KCNMA1;ZNF318;GAPDH;TP53;HDAC4;EPB41;TACSTD2;TARS;SPG7;FHIT;HDAC9;AGPAT2;HDAC6;RELA;ATXN2;HSF1;ERBB2;IGF2BP1;MAP6;CKB;JAG1;INSR;FOXJ1;MTOR;IFFO1;HIPK2;RAD52;NBR2;MAPK10;BCL9;AIMP2;GIPC1;ERCC1;SHBG;EBAG9;NEK11
Ki-1+ Anaplastic Large Cell Lymphoma	7/228	0.5637467300320451	0.7545374516870312	0	0	0.989961099259631	0.5673963907163226	RIMS2;MDK;INSR;AKT1;TP53;PDLIM7;MTOR
Cocaine Abuse	4/128	0.5638590631608581	0.7545374516870312	0	0	1.0083787180561374	0.5777515411665499	HDAC4;GRM5;TYK2;GABRG2
Diabetes Mellitus	46/1507	0.5667632331127235	0.7556455500680934	0	0	0.9829003570176505	0.5581042302115995	RPAIN;LAD1;CHRM3;SEMA5B;BNC2;TRAF3IP2;KEAP1;HCCS;HMGB1;SLC5A3;AGPAT2;ACTB;RELA;RIMS2;FCGRT;AKT2;KCNQ1OT1;HSF1;AKT1;MAP6;FADD;LDLR;EIF5A;BBS1;JAG1;NEGR1;SORT1;INSR;PDE4D;SYP;PLXDC2;YWHAZ;ACVR2B;MTOR;GNAO1;AIMP2;MAF;CAPN10;SGSM3;PEX6;KCNMA1;TRIB3;SHBG;EBAG9;GAPDH;TP53
Disorders of Sex Development	2/61	0.5680726928357617	0.7556455500680934	0	0	1.0597882727222863	0.5993165083692081	DGKQ;CHD7
Epithelial hyperplasia of skin	2/61	0.5680726928357617	0.7556455500680934	0	0	1.0597882727222863	0.5993165083692081	PSME3;TYK2
Leukoplakia	2/61	0.5680726928357617	0.7556455500680934	0	0	1.0597882727222863	0.5993165083692081	TP53;FHIT
Profound intellectual disabilities	2/61	0.5680726928357617	0.7556455500680934	0	0	1.0597882727222863	0.5993165083692081	PIGG;SHROOM4
Renal cyst	3/95	0.5682757159238759	0.7556455500680934	0	0	1.0193784793178775	0.5761002824113559	PEX6;TP53;TMEM231
Rotting teeth	3/95	0.5682757159238759	0.7556455500680934	0	0	1.0193784793178775	0.5761002824113559	CDH3;ERCC8;PLEC
Sciatic Neuropathy	3/95	0.5682757159238759	0.7556455500680934	0	0	1.0193784793178775	0.5761002824113559	MAP2;HMGB1;MTOR
Congenital diaphragmatic hernia	3/95	0.5682757159238759	0.7556455500680934	0	0	1.0193784793178775	0.5761002824113559	ALG9;INSR;HCCS
Gastric ulcer	3/95	0.5682757159238759	0.7556455500680934	0	0	1.0193784793178775	0.5761002824113559	IDUA;SDC1;TP53
Membranous glomerulonephritis	3/95	0.5682757159238759	0.7556455500680934	0	0	1.0193784793178775	0.5761002824113559	THSD7A;ACTN4;YWHAZ
Pachygyria	3/95	0.5682757159238759	0.7556455500680934	0	0	1.0193784793178775	0.5761002824113559	CNTNAP2;TUBGCP6;ACTB
Polyneuropathy	3/95	0.5682757159238759	0.7556455500680934	0	0	1.0193784793178775	0.5761002824113559	NAA50;ERCC8;GDAP1
No development of motor milestones	7/229	0.5683955628158681	0.7556455500680934	0	0	0.9854503769675058	0.5567180588208257	MBD5;AGK;SUFU;TPM2;GDAP1;ARCN1;PLEC
Presenile dementia	11/362	0.5698725517034727	0.7556455500680934	0	0	0.9792289447461862	0.5506620887565028	NAA50;CHRNB2;TOM1L2;ATXN2;INSR;ATP13A2;SYP;SHBG;TP53;GAPDH;LY6E
Carcinoma, Papillary	6/196	0.5699677016894196	0.7556455500680934	0	0	0.9869706840390879	0.5548508201593287	MDK;ERBB2;TACSTD2;TP53;GAPDH;HDAC6
Mental disorders	10/329	0.5702281484919169	0.7556455500680934	0	0	0.9795467392980112	0.5502297579404096	CACNB2;SYT4;BCL9;CNTNAP2;LRFN5;GRM5;ATCAY;AKT1;HDAC9;PDLIM7
Respiratory Distress Syndrome	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	RSPH1
Chronic Infantile Neurological, Cutaneous, and Articular Syndrome	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	AIMP2
Rothmund-Thomson syndrome	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	TP53
Encephalopathy, Toxic	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	MTOR
Short femoral neck	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	CHD4
Skin toxicity	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	TP53
Night blindness, congenital stationary	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	PDE6B
stage, neuroblastoma	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	TP53
Toxic Encephalitis	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	MTOR
Visual field defects	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	TCF12
Apathy	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	HEXA
Attenuation of retinal blood vessels	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	IFT172
Bulbar palsy	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	TPM2
Cervical dysplasia	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	TP53
Childhood Cerebral Astrocytoma	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	TP53
Congenital hypoplasia of thymus	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	FRAS1
Cutaneous lymphoma	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	TP53
Decreased albumin	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	ACTN4
Decreased number of peripheral myelinated nerve fibers	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	GDAP1
Ectopia Lentis	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	TAPBP
Elevated C-reactive protein	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	TYK2
Elevated C-reactive protein level	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	TYK2
Episodic abdominal pain	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	LMF1
Flared metaphysis	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	ERCC1
Generalized hyperpigmentation	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	INSR
Generalized vitiligo	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	RERE
Herpesviridae Infections	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	CREBZF
Intermittent abdominal pain	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	LMF1
Intracranial Astrocytoma	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	TP53
Localized scleroderma	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	TP53
Loss of appetite (finding)	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	TP53
Metopic synostosis	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	TCF12
Mixed Oligodendroglioma-Astrocytoma	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	TP53
Neck muscle weakness	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	TPM2
Nevus elasticus	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	XYLT2
Personality Disorders	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	MAPK10
Pregnancy in Diabetics	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	ACTB
Premenopausal breast cancer	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	TP53
Primary Malignant Liver Neoplasm	1/27	0.5729303719109441	0.7556455500680934	0	0	1.2025599602336274	0.6698151765958469	TP53
Ductal Carcinoma	7/230	0.5730214610520236	0.7556455500680934	0	0	0.9809801095838302	0.5462412234300246	PPP1R1B;ERBB2;AKT1;TP53;EBAG9;FHIT;ACTB
Anxiety Disorders	12/396	0.573233292080817	0.7557320544575669	0	0	0.9763569078947368	0.5433060093983866	CHRNB2;LAD1;MBD5;TRPC5;GRM5;MDK;DIXDC1;NDRG2;FHIT;TP53;GABRG2;MAP2K5
Bladder Neoplasm	37/1217	0.5740792441253156	0.7566543059524691	0	0	0.9788644358519638	0.5432578552100783	HDAC4;NUMA1;XYLT2;CASC2;MTR;HMGB1;NDRG2;FHIT;HDAC9;ACTB;RELA;RIMS2;CCND3;MED30;MDK;AKT2;SUFU;ERBB2;TRIM24;AKT1;SSSCA1;MAP4;JAG1;URGCP;JUP;USP22;RHOC;MAPK15;MTOR;HIPK2;HIC2;SPINT1;ERCC1;SDC1;SHBG;EBAG9;TP53
IMMUNE SUPPRESSION	3/96	0.57540538854731	0.757922381241683	0	0	1.0083651382861922	0.557303711537985	PRKCI;HMGB1;TP53
Uveitis	4/130	0.5761578170735727	0.757922381241683	0	0	0.992269635126778	0.5471113482052605	SGSM3;CAPN5;CKB;RELA
Aortic Valve Stenosis	4/130	0.5761578170735727	0.757922381241683	0	0	0.992269635126778	0.5471113482052605	IDUA;AKT1;GAPDH;ACTB
Primary sclerosing cholangitis	4/130	0.5761578170735727	0.757922381241683	0	0	0.992269635126778	0.5471113482052605	PDZD2;SGSM3;AKT1;TP53
Arsenic Poisoning, Inorganic	2/62	0.576947880767179	0.757922381241683	0	0	1.0420711974110033	0.573142643797429	ERCC1;TP53
Nervous System, Organic Arsenic Poisoning	2/62	0.576947880767179	0.757922381241683	0	0	1.0420711974110033	0.573142643797429	ERCC1;TP53
Arsenic Encephalopathy	2/62	0.576947880767179	0.757922381241683	0	0	1.0420711974110033	0.573142643797429	ERCC1;TP53
Arsenic Induced Polyneuropathy	2/62	0.576947880767179	0.757922381241683	0	0	1.0420711974110033	0.573142643797429	ERCC1;TP53
Arsenic Poisoning	2/62	0.576947880767179	0.757922381241683	0	0	1.0420711974110033	0.573142643797429	ERCC1;TP53
Leber Congenital Amaurosis	2/62	0.576947880767179	0.757922381241683	0	0	1.0420711974110033	0.573142643797429	OTX2;PDE6B
Multiple polyps	2/62	0.576947880767179	0.757922381241683	0	0	1.0420711974110033	0.573142643797429	TP53;MTOR
Nijmegen Breakage Syndrome	2/62	0.576947880767179	0.757922381241683	0	0	1.0420711974110033	0.573142643797429	BBS1;TP53
Precursor cell lymphoblastic lymphoma	2/62	0.576947880767179	0.757922381241683	0	0	1.0420711974110033	0.573142643797429	IDUA;TP53
Leukemia, T-Cell	11/364	0.5772503265021504	0.7581269853527606	0	0	0.9735785688701583	0.534961236570209	LRSAM1;LDB1;FCGRT;IFT172;MIB2;AKT1;TARS;SSSCA1;HMGB1;TP53;RELA
Anemia, Sickle Cell	7/231	0.577623992026395	0.7584249976606732	0	0	0.9765497553017944	0.5359619064954819	LRSAM1;AKT2;AKT1;MAP6;CAPN1;GAPDH;RELA
Fibrosarcoma	9/298	0.5789435282265336	0.7598235332268183	0	0	0.9730432271108116	0.5318171060801766	RHBDF1;STAT2;CREB3L2;ERBB2;FADD;TYK2;TP53;LDLR;RELA
Anxiety	14/464	0.5795351193745291	0.7598235332268183	0	0	0.9718371837183718	0.5301653817190626	LAD1;SETD5;MBD5;TRPC5;FLII;CHD7;ATP1A3;NDRG2;FHIT;TTC19;GABRG2;ATXN2;TP53;MAP2K5
Metastasis from malignant tumor of prostate	7/232	0.5822027354125228	0.7598235332268183	0	0	0.9721587819467101	0.5258762168533564	JAG1;CTBP1;ERCC1;ERBB2;AKT1;TP53;MAP2K5
Motor delay	7/232	0.5822027354125228	0.7598235332268183	0	0	0.9721587819467101	0.5258762168533564	MBD5;AGK;SUFU;TPM2;GDAP1;ARCN1;PLEC
Neoplasms, Intracranial	3/97	0.5824610426702015	0.7598235332268183	0	0	0.9975861236594366	0.5391882921095986	MDK;TP53;RELA
Sweating	3/97	0.5824610426702015	0.7598235332268183	0	0	0.9975861236594366	0.5391882921095986	JUP;TP53;AGPAT2
Adult Hepatocellular Carcinoma	3/97	0.5824610426702015	0.7598235332268183	0	0	0.9975861236594366	0.5391882921095986	AKT2;TP53;FHIT
Ductal Breast Carcinoma	3/97	0.5824610426702015	0.7598235332268183	0	0	0.9975861236594366	0.5391882921095986	ERBB2;TP53;FHIT
Hyperhidrosis disorder	3/97	0.5824610426702015	0.7598235332268183	0	0	0.9975861236594366	0.5391882921095986	JUP;TP53;AGPAT2
Increased sweating	3/97	0.5824610426702015	0.7598235332268183	0	0	0.9975861236594366	0.5391882921095986	JUP;TP53;AGPAT2
Atrial Septal Defects	5/165	0.5832406500046698	0.7598235332268183	0	0	0.9766260162601627	0.5265531895317026	GRM5;JAG1;CHD7;XYLT2;HCCS
Bone Diseases	5/165	0.5832406500046698	0.7598235332268183	0	0	0.9766260162601627	0.5265531895317026	JAG1;IDUA;ERBB2;SDC1;RELA
Inclusion Body Myopathy, Sporadic	2/63	0.5856889575797208	0.7598235332268183	0	0	1.0249350098148442	0.5483058123559023	RIMS2;PHF1
Large, late-closing fontanelle	2/63	0.5856889575797208	0.7598235332268183	0	0	1.0249350098148442	0.5483058123559023	KCNQ1OT1;ACTB
Abnormality of the dentition	2/63	0.5856889575797208	0.7598235332268183	0	0	1.0249350098148442	0.5483058123559023	CDH3;KCNQ1OT1
Viral hepatitis	2/63	0.5856889575797208	0.7598235332268183	0	0	1.0249350098148442	0.5483058123559023	GAPDH;TP53
Wide bregma sutures	2/63	0.5856889575797208	0.7598235332268183	0	0	1.0249350098148442	0.5483058123559023	KCNQ1OT1;ACTB
Difficulty walking	2/63	0.5856889575797208	0.7598235332268183	0	0	1.0249350098148442	0.5483058123559023	TPM2;DHTKD1
Fibroadenoma	2/63	0.5856889575797208	0.7598235332268183	0	0	1.0249350098148442	0.5483058123559023	ERBB2;TP53
Large bregma sutures	2/63	0.5856889575797208	0.7598235332268183	0	0	1.0249350098148442	0.5483058123559023	KCNQ1OT1;ACTB
Large fontanelle	2/63	0.5856889575797208	0.7598235332268183	0	0	1.0249350098148442	0.5483058123559023	KCNQ1OT1;ACTB
AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	VPS54
Ataxia, Sensory	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	ARCN1
Sarcopenia	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	MTOR
Hyperglycemia, Postprandial	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	INSR
Small labia majora	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	SETD5
Spina Bifida Occulta	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	VANGL2
Vitamin D-Resistant Rickets, X-Linked	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	ACTB
Tumor Expansion	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	AKT1
Absence of secondary sex characteristics	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	CHD7
ADENOMAS AND ADENOCARCINOMAS	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	TP53
Aortic valve disorder	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	AKT1
Aphthous Stomatitis	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	UBAC2
Cartilage-hair hypoplasia	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	CHD7
Cerebral Astrocytoma	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	TP53
Chronic colitis	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	TP53
Corneal dystrophy	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	TACSTD2
Double Outlet Right Ventricle	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	CHD7
Elevated heart rate	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	PPOX
Esophageal atresia with or without tracheoesophageal fistula	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	CHD7
Familial Hypophosphatemic Rickets	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	ACTB
Febrile Neutropenia	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	TP53
Immunoglobulin G subclass deficiency (finding)	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	TCN2
Odontogenic Tumors	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	MDK
Oligomenorrhea	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	AKT2
Ovarian epithelial cancer recurrent	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	TP53
Paratuberculosis	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	SGSM3
Philadelphia chromosome positive chronic myelogenous leukemia	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	TP53
Plasma cell dyscrasia	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	TP53
Radial ray hypoplasia	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	PDE4D
Reactive airway disease	1/28	0.5861873891206123	0.7598235332268183	0	0	1.1579608687847782	0.6184851539584366	BBS1
Chronic myeloproliferative disorder	7/233	0.5867572831906921	0.7603715244557414	0	0	0.9678066667629098	0.5159803480902009	NUMA1;FLII;AKT1;ERCC8;SSSCA1;TYK2;TP53
Hereditary Diffuse Gastric Cancer	9/300	0.5870054038311173	0.7605023632487375	0	0	0.9662544080179527	0.5147442592954841	JUP;CPSF1;ERCC1;ERBB2;RANBP10;CKB;CTNNA2;TP53;FHIT
Precursor B-cell lymphoblastic leukemia	11/367	0.5882158181313778	0.7618266650778533	0	0	0.9652220438737292	0.5122060432635934	BCL9;FCGRT;MDK;INSR;FPGS;AKT1;SPG7;TP53;FHIT;ACTB;ANKS1B
Sclerocystic Ovaries	5/166	0.5886172356145256	0.7618266650778533	0	0	0.9705095187597839	0.5143498207101543	SOX3;AKT2;HOOK3;AGPAT2;TTLL9
Anaplastic astrocytoma	5/166	0.5886172356145256	0.7618266650778533	0	0	0.9705095187597839	0.5143498207101543	ABR;ERCC1;AKT1;NDRG2;TP53
Contracture	5/166	0.5886172356145256	0.7618266650778533	0	0	0.9705095187597839	0.5143498207101543	ALG9;IDUA;TPM2;GDAP1;PLEC
Senile Plaques	9/301	0.5910095353374969	0.7647314167812178	0	0	0.9628948725422056	0.5064086827858598	RIMS2;CHRM3;ATCAY;MAP2;SYP;HOOK3;NDRG2;LDLR;SYBU
Encephalopathies	7/234	0.5912872398872574	0.7648992379818139	0	0	0.9634928962062795	0.5062705759376048	GNAO1;MAPK10;GLDC;ATP1A3;FADD;TTC19;MTOR
Follicular thyroid carcinoma	5/167	0.5939557461866425	0.7663936580000157	0	0	0.9644685335742247	0.502440329851418	AKT1;TP53;FHIT;MTOR;HIPK2
Lewy Body Disease	4/133	0.5942316880709511	0.7663936580000157	0	0	0.9690425853216551	0.5043730878331589	GRM5;INSR;BCL7C;RPS27A
Congenital Camptodactyly	2/64	0.5942956962771233	0.7663936580000157	0	0	1.0083516024637227	0.524724270814187	CDH3;TPM2
Lissencephaly	2/64	0.5942956962771233	0.7663936580000157	0	0	1.0083516024637227	0.524724270814187	ACTB;SYBU
Multiple Endocrine Neoplasia Type 2a	2/64	0.5942956962771233	0.7663936580000157	0	0	1.0083516024637227	0.524724270814187	AKT1;TP53
Pancreatitis, Chronic	9/302	0.59499540824932	0.7663936580000157	0	0	0.9595582690492284	0.4982041796542466	JAG1;ERBB2;SDC1;SSSCA1;TP53;GAPDH;ACTB;RELA;LMF1
Malaria	14/469	0.5957138658178718	0.7663936580000157	0	0	0.9609037826859609	0.49774318013068236	EIF5A;PSMD12;AIMP2;POLD4;PSMD7;TCN2;TEP1;MAP2;SGSM3;SDC1;ERCC8;LDLR;GAPDH;TP53
Carcinoma of bladder	35/1162	0.5959074588246082	0.7663936580000157	0	0	0.9689971863884907	0.5016206711525941	HDAC4;NUMA1;XYLT2;MSI1;CASC2;MTR;HMGB1;NDRG2;FHIT;HDAC9;ACTB;RELA;RIMS2;CCND3;MED30;MDK;AKT2;SUFU;ERBB2;TRIM24;AKT1;MAP4;URGCP;USP22;RHOC;MTOR;HIPK2;HIC2;MAU2;SPINT1;SGSM3;ERCC1;SDC1;SHBG;TP53
Aortic Aneurysm, Thoracic	3/99	0.5963472714001354	0.7663936580000157	0	0	0.9767017828200972	0.5048885148684011	JAG1;FCGRT;ERBB2
Nephrolithiasis	3/99	0.5963472714001354	0.7663936580000157	0	0	0.9767017828200972	0.5048885148684011	KCNQ1OT1;AGPAT2;HIPK2
Mood Disorders	10/336	0.5970019408758475	0.7663936580000157	0	0	0.9581615206678065	0.49425316613542136	DPP10;HDAC4;CHRM3;FZD3;MAP2;PPP1R1B;AKT1;PLCB1;NDRG2;HDAC9
Hyalinosis, Segmental Glomerular	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	ACTN4
Social disinhibition	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	MTOR
T-Cell Prolymphocytic Leukemia	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	TP53
Sterility, Postpartum	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	TP53
Subfertility, Female	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	TP53
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	TP53
Abnormal visual evoked potential	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	ERCC8
Acute monocytic/monoblastic leukemia	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	FOXN3
Angiofibroma	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	MTOR
Anterior hypopituitarism	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	CHD7
Asbestosis	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	AIMP2
Aspartate aminotransferase measurement	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	LDLR
Brain Aneurysm	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	FHIT
Bulbar weakness	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	TPM2
Cardiac Lymphoma	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	TP53
Cholesterol gallstones	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	YWHAZ
Collagen Diseases	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	PDLIM7
Congenital Fiber Type Disproportion	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	TPM2
Congenital hypoplasia of radius	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	PDE4D
Coronary Aneurysm	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	PLCB1
Diffusely thickened skin	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	CHD7
Dysgerminoma	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	AKT1
Female sterility	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	TP53
Generalized amyotrophy	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	LMNB2
HMN (Hereditary Motor Neuropathy) Proximal Type I	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	VPS54
Juvenile Neuronal Ceroid Lipofuscinosis	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	ATP13A2
Keratosis Follicularis	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	SHBG
Left ventricular noncompaction	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	MIB2
Mask-like facies	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	ATP13A2
Microvascular Angina	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	SGSM3
Muckle-Wells Syndrome	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	AIMP2
Pierre Robin Syndrome	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	FRAS1
Pigmentary iris degeneration	1/29	0.599033526016222	0.7663936580000157	0	0	1.1165474267251327	0.5721610091996047	XYLT2
Breast adenocarcinoma	5/168	0.5992556592511429	0.7663936580000157	0	0	0.9585016709062796	0.49081703852241926	AIMP2;AKT2;ERBB2;AKT1;TP53
Renal fibrosis	6/202	0.5994517777194993	0.7663936580000157	0	0	0.9564581532938908	0.48945765170755	AIMP2;AKT2;SYVN1;MSI1;TP53;HIPK2
Reticulocyte count (procedure)	6/202	0.5994517777194993	0.7663936580000157	0	0	0.9564581532938908	0.48945765170755	AIMP2;PLCB3;CCND3;ATXN2;MAST2;ATP11A
Kidney Failure, Chronic	13/437	0.5999074524762272	0.7663936580000157	0	0	0.9574927729943117	0.4892595437162702	LRSAM1;INSR;KEAP1;MTR;ACTN4;YWHAZ;MTOR;RELA;TCN2;NPHP1;ETF1;LDLR;TP53
Absent tendon reflex	4/134	0.6001538571838358	0.7663936580000157	0	0	0.9615384615384616	0.4909319499985274	LRSAM1;JAG1;ATP1A3;GDAP1
Large auricle	4/134	0.6001538571838358	0.7663936580000157	0	0	0.9615384615384616	0.4909319499985274	JAG1;INSR;AKT1;AGPAT2
Large pinnae	4/134	0.6001538571838358	0.7663936580000157	0	0	0.9615384615384616	0.4909319499985274	JAG1;INSR;AKT1;AGPAT2
Macrotia	4/134	0.6001538571838358	0.7663936580000157	0	0	0.9615384615384616	0.4909319499985274	JAG1;INSR;AKT1;AGPAT2
Squamous cell carcinoma of the head and neck	28/934	0.60084968380452	0.7670926793235571	0	0	0.964426346876678	0.4912888939501265	IDUA;ARHGAP1;TACSTD2;MTR;FHIT;HDAC9;RELA;RIMS2;ERBB2;TRIM24;AKT1;SSSCA1;FADD;CTNNA2;JAG1;RHOC;SMARCA2;YWHAZ;MTOR;MAPK10;MAU2;SGSM3;ERCC1;SDC1;ULK1;GAPDH;TP53;PLEC
Rhabdomyolysis	2/65	0.602768012781406	0.7687339623144094	0	0	0.9922946524888272	0.5023222548415334	RBCK1;ALDOA
HEMOCHROMATOSIS, TYPE 1	2/65	0.602768012781406	0.7687339623144094	0	0	0.9922946524888272	0.5023222548415334	GAPDH;TP53
Adult Liver Carcinoma	2/65	0.602768012781406	0.7687339623144094	0	0	0.9922946524888272	0.5023222548415334	FER;MAN2A1
Lymphocytosis	2/65	0.602768012781406	0.7687339623144094	0	0	0.9922946524888272	0.5023222548415334	LMNB2;PDLIM7
Lupus Erythematosus	9/304	0.6029112579720799	0.7687339623144094	0	0	0.9529529251851646	0.4821801342153758	PSME3;FLII;ERBB2;FOXJ1;TYK2;HMGB1;LDLR;HDAC9;MTOR
Abnormal heart beat	3/100	0.6031765126131831	0.7687339623144094	0	0	0.9665825661247472	0.4886513710123953	PEX6;ERCC8;HCCS
ECG abnormality	3/100	0.6031765126131831	0.7687339623144094	0	0	0.9665825661247472	0.4886513710123953	PEX6;ERCC8;HCCS
Tuberculosis, Pulmonary	5/169	0.6045164769023336	0.7702517634692456	0	0	0.9526075748562364	0.4794724957523273	AIMP2;MSI1;PDE6B;FHIT;RELA
Retinoblastoma	16/539	0.6064463600405383	0.7715176702347168	0	0	0.955111240550568	0.4776883772248572	CHRM3;MTR;HMGB1;HDAC9;MTOR;ACTB;RIMS2;CCND3;SGSM3;HSF1;ERBB2;AKT1;SSSCA1;OTX2;FADD;TP53
Mean corpuscular hemoglobin concentration determination	3/101	0.6099290639239113	0.7715176702347168	0	0	0.956669864055833	0.4729896513092343	CCND3;ATXN2;FRS3
Otitis Media	3/101	0.6099290639239113	0.7715176702347168	0	0	0.956669864055833	0.4729896513092343	POLD4;IDUA;DNAH5
Bronchitis, Chronic	2/66	0.6111059569191333	0.7715176702347168	0	0	0.9767394822006472	0.4810294650351966	LRRC6;TP53
Shigella Infections	2/66	0.6111059569191333	0.7715176702347168	0	0	0.9767394822006472	0.4810294650351966	WASL;RELA
Diffuse Astrocytoma	2/66	0.6111059569191333	0.7715176702347168	0	0	0.9767394822006472	0.4810294650351966	SYP;TP53
Pulmonary Stenosis	2/66	0.6111059569191333	0.7715176702347168	0	0	0.9767394822006472	0.4810294650351966	JAG1;CHD7
Recurrent aphthous ulcer	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	UBAC2
Carcinoma, Signet Ring Cell	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	WNT8B
Delirium, Dementia, Amnestic, Cognitive Disorders	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	TP53
Hemorrhagic Fevers, Viral	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	CFL1
Stage II Colon Cancer AJCC v7	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	AKT1
Optic Atrophy, Autosomal Dominant	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	SPG7
Pheochromocytoma, Extra-Adrenal	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	ERBB2
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	TP53
Tendinopathy	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	TP53
Ventricular Dysfunction, Left	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	ATP1A3
Abnormal mitochondria in muscle tissue	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	NDUFS8
Acute Chest Syndrome	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	LDLR
Welts	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	MAP2
Adult Learning Disorders	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	SYP
Bartter Disease	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	SHBG
Bilateral Wilms Tumor	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	TP53
Bone necrosis	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	TP53
Childhood Rhabdomyosarcoma	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	TP53
Congenital malformation syndrome	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	CHD7
Developmental Academic Disorder	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	SYP
Ectropion	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	PLEC
Fasting Hypoglycemia	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	INSR
Gonadoblastoma	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	KCNQ1OT1
heart rate	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	CACNA2D1
Horseshoe Kidney	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	CHD7
Hypoplasia of the optic nerve	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	OTX2
Learning Disturbance	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	SYP
Lymphadenitis	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	AKT1
Lymphoid neoplasm	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	TYK2
Malignant transformation	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	TP53
Pain Disorder	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	CCT5
Poorly differentiated carcinoma	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	TP53
Protoplasmic astrocytoma	1/30	0.6114814971519738	0.7715176702347168	0	0	1.0779900841178764	0.5302316105452107	TP53
Melanoma, B16	4/136	0.6118410104012065	0.7715945197055724	0	0	0.9468713105076741	0.4651816049013261	ERBB2;HSF1;GAPDH;MTOR
Cholelithiasis	4/136	0.6118410104012065	0.7715945197055724	0	0	0.9468713105076741	0.4651816049013261	ATP11A;ALDOA;CLIC1;LDLR
Acute lymphocytic leukemia	27/907	0.6147031765647388	0.7750148857005539	0	0	0.957189943277633	0.46578371881072744	HDAC4;FLII;MTR;HMGB1;SPG7;FHIT;HDAC9;ACTB;RIMS2;FCGRT;MDK;FPGS;ERBB2;IGF2BP1;TRIM24;AKT1;EIF5A;INSR;TCF12;ATP11A;TYK2;MTOR;KAT2A;FER;ERCC1;GAPDH;TP53
Cardiac conduction abnormality	3/102	0.616604427035466	0.7770328405070199	0	0	0.9469574185943715	0.45788003257749027	PEX6;ERCC8;HCCS
Intervertebral Disc Degeneration	3/102	0.616604427035466	0.7770328405070199	0	0	0.9469574185943715	0.45788003257749027	AIMP2;ADAMTS5;PDLIM7
Calcification of coronary artery	11/375	0.6168200338660949	0.7771150499804921	0	0	0.9436113968133673	0.45593224572305524	CNTNAP2;RALYL;GRM5;NEGR1;PDE4D;PDSS2;PIP5K1B;AMPD3;LDLR;CNIH3;ANKS1B
Mastocytosis, Systemic	2/67	0.6193097045922653	0.7785632884571556	0	0	0.961662932536719	0.46078060265835963	AKT1;MTOR
Congenital muscular dystrophy (disorder)	2/67	0.6193097045922653	0.7785632884571556	0	0	0.961662932536719	0.46078060265835963	AGK;PLEC
Joint swelling	2/67	0.6193097045922653	0.7785632884571556	0	0	0.961662932536719	0.46078060265835963	TYK2;TP53
neurofibroma	2/67	0.6193097045922653	0.7785632884571556	0	0	0.961662932536719	0.46078060265835963	MDK;TP53
Oxyphilic Adenoma	2/67	0.6193097045922653	0.7785632884571556	0	0	0.961662932536719	0.46078060265835963	SCG3;TP53
Malignant Neoplasms	43/1438	0.6213748576034026	0.7785632884571556	0	0	0.9607908909636421	0.45716423630832104	SEMA5B;ACSS2;FLII;RAB1B;CHD7;TACSTD2;MSI1;CASC2;MTR;PTPN23;HMGB1;SPG7;NDRG2;FHIT;HDAC9;STK33;CCND3;ZNRF3;CAPNS1;SALL2;AKT2;SUFU;HSF1;ERBB2;TRIM24;AKT1;CAPN1;LDLR;MAP2K5;PDLIM7;URGCP;TPM2;USP22;TCF12;SMARCA2;YWHAZ;MTOR;HIPK2;SGSM3;ERCC1;SDC1;TRIB3;TP53
Meningioma, benign, no ICD-O subtype	7/241	0.6222777047870789	0.7785632884571556	0	0	0.9343288576567532	0.4432164731788377	TCN2;MDK;AKT1;NDRG2;TP53;YWHAZ;MTOR
Metastatic Prostate Carcinoma	7/241	0.6222777047870789	0.7785632884571556	0	0	0.9343288576567532	0.4432164731788377	JAG1;CTBP1;ERCC1;ERBB2;AKT1;TP53;MAP2K5
Lupus Erythematosus, Discoid	9/309	0.6223624937747051	0.7785632884571556	0	0	0.9368248772504092	0.4442728678466572	PSME3;FLII;ERBB2;FOXJ1;TYK2;HMGB1;LDLR;HDAC9;MTOR
Electrocardiogram abnormal	3/103	0.623202166778757	0.7785632884571556	0	0	0.9374392220421394	0.44330029740649085	PEX6;ERCC8;HCCS
HIV Coinfection	3/103	0.623202166778757	0.7785632884571556	0	0	0.9374392220421394	0.44330029740649085	PSME3;CLIC1;CCT5
Hydrops Fetalis	3/103	0.623202166778757	0.7785632884571556	0	0	0.9374392220421394	0.44330029740649085	IDUA;PEX6;PEX26
Drug habituation	4/138	0.623315197737915	0.7785632884571556	0	0	0.9326419848807909	0.4408626201238699	AGBL4;GRM5;INSR;FHIT
Measles	4/138	0.623315197737915	0.7785632884571556	0	0	0.9326419848807909	0.4408626201238699	STAT2;ERBB2;AKT1;SDC1
Recurrent upper respiratory tract infection	1/31	0.6235436244048311	0.7785632884571556	0	0	1.0420032310177707	0.49217621054127964	SGSH
Alopecia, Male Pattern	1/31	0.6235436244048311	0.7785632884571556	0	0	1.0420032310177707	0.49217621054127964	HDAC9
Diagnosis, Psychiatric	1/31	0.6235436244048311	0.7785632884571556	0	0	1.0420032310177707	0.49217621054127964	CNTNAP2
Lipomatosis, Multiple	1/31	0.6235436244048311	0.7785632884571556	0	0	1.0420032310177707	0.49217621054127964	TP53
Stage II Colon Cancer	1/31	0.6235436244048311	0.7785632884571556	0	0	1.0420032310177707	0.49217621054127964	AKT1
Refractory anemia, without ringed sideroblasts, without excess blasts	1/31	0.6235436244048311	0.7785632884571556	0	0	1.0420032310177707	0.49217621054127964	TP53
Thick skin	1/31	0.6235436244048311	0.7785632884571556	0	0	1.0420032310177707	0.49217621054127964	CHD7
Activated Protein C Resistance	1/31	0.6235436244048311	0.7785632884571556	0	0	1.0420032310177707	0.49217621054127964	SHBG
Acute interstitial pneumonia	1/31	0.6235436244048311	0.7785632884571556	0	0	1.0420032310177707	0.49217621054127964	TP53
Adenocarcinoma in Situ	1/31	0.6235436244048311	0.7785632884571556	0	0	1.0420032310177707	0.49217621054127964	TP53
Atherosclerosis of aorta	1/31	0.6235436244048311	0.7785632884571556	0	0	1.0420032310177707	0.49217621054127964	LDLR
Autoimmune Lymphoproliferative Syndrome	1/31	0.6235436244048311	0.7785632884571556	0	0	1.0420032310177707	0.49217621054127964	FADD
Chronic interstitial cystitis	1/31	0.6235436244048311	0.7785632884571556	0	0	1.0420032310177707	0.49217621054127964	TP53
Deformity of limb	1/31	0.6235436244048311	0.7785632884571556	0	0	1.0420032310177707	0.49217621054127964	TPM2
Endocrine Gland Neoplasms	1/31	0.6235436244048311	0.7785632884571556	0	0	1.0420032310177707	0.49217621054127964	ERBB2
Intervertebral disc disorder	1/31	0.6235436244048311	0.7785632884571556	0	0	1.0420032310177707	0.49217621054127964	ADAMTS5
Longevity	1/31	0.6235436244048311	0.7785632884571556	0	0	1.0420032310177707	0.49217621054127964	SYBU
Lymphatic obstruction	1/31	0.6235436244048311	0.7785632884571556	0	0	1.0420032310177707	0.49217621054127964	AKT1
Onset of lymphedema around puberty	1/31	0.6235436244048311	0.7785632884571556	0	0	1.0420032310177707	0.49217621054127964	AKT1
Opportunistic Infections	1/31	0.6235436244048311	0.7785632884571556	0	0	1.0420032310177707	0.49217621054127964	PDLIM7
Oral Ulcer	1/31	0.6235436244048311	0.7785632884571556	0	0	1.0420032310177707	0.49217621054127964	UBAC2
Plasma Cell Neoplasm	1/31	0.6235436244048311	0.7785632884571556	0	0	1.0420032310177707	0.49217621054127964	TP53
Progressive intrahepatic cholestasis (disorder)	1/31	0.6235436244048311	0.7785632884571556	0	0	1.0420032310177707	0.49217621054127964	JAG1
Hyperinsulinism	11/377	0.6238171442661267	0.7787166670452518	0	0	0.9383563487577055	0.4428084763761735	BBS2;CAPN10;IFT172;AKT2;INSR;ERBB2;AKT1;PDE6B;SHBG;LDLR;AGPAT2
Malignant neoplasm of urinary bladder	34/1144	0.6267703394633999	0.7814648137645344	0	0	0.9549857024259755	0.44614553166600857	HDAC4;NUMA1;XYLT2;MSI1;CASC2;MTR;HMGB1;NDRG2;FHIT;HDAC9;ACTB;RELA;RIMS2;CCND3;MED30;MDK;AKT2;SUFU;ERBB2;TRIM24;AKT1;MAP4;URGCP;USP22;RHOC;MAPK15;MTOR;HIPK2;HIC2;SPINT1;ERCC1;SDC1;SHBG;TP53
Recurrent infections	2/68	0.627379549595405	0.7814648137645344	0	0	0.9470432480141218	0.4415149519169001	INSR;FADD
Short palpebral fissure	2/68	0.627379549595405	0.7814648137645344	0	0	0.9470432480141218	0.4415149519169001	CHD4;SMARCA2
Undifferentiated leukemia	2/68	0.627379549595405	0.7814648137645344	0	0	0.9470432480141218	0.4415149519169001	TP53;RELA
Wiskott-Aldrich Syndrome	2/68	0.627379549595405	0.7814648137645344	0	0	0.9470432480141218	0.4415149519169001	WASL;SYP
Adenomatous polyp of colon	2/68	0.627379549595405	0.7814648137645344	0	0	0.9470432480141218	0.4415149519169001	TP53;FHIT
Human papilloma virus infection	2/68	0.627379549595405	0.7814648137645344	0	0	0.9470432480141218	0.4415149519169001	ERBB2;TP53
Leishmaniasis	2/68	0.627379549595405	0.7814648137645344	0	0	0.9470432480141218	0.4415149519169001	AKT1;CAPN1
Persistent infection	2/68	0.627379549595405	0.7814648137645344	0	0	0.9470432480141218	0.4415149519169001	LAD1;TP53
Acute pancreatitis	3/104	0.6297219094212166	0.7838157099924971	0	0	0.9281095046295553	0.4292292721467903	ERBB2;AGPAT2;LMF1
Electrocardiographic changes	3/104	0.6297219094212166	0.7838157099924971	0	0	0.9281095046295553	0.4292292721467903	PEX6;ERCC8;HCCS
Ischemia	3/104	0.6297219094212166	0.7838157099924971	0	0	0.9281095046295553	0.4292292721467903	AKT2;HMGB1;TP53
Congenital Heart Defects	8/277	0.6301676090731999	0.783867302671726	0	0	0.928687708044804	0.42883961108148105	CHRM3;TMEM87B;ALG9;JAG1;FRAS1;FLII;CHD7;MTR
Dwarfism	8/277	0.6301676090731999	0.783867302671726	0	0	0.928687708044804	0.42883961108148105	PDE4D;ERCC1;HCCS;OTX2;MTR;MAP4;TP53;SMARCA2
Prostatic Intraepithelial Neoplasias	5/174	0.6302183905961729	0.783867302671726	0	0	0.9241833838456728	0.42668518024412994	ERBB2;TACSTD2;AKT1;TP53;RELA
Slender long bone	1/32	0.6352318488208829	0.7851058233003863	0	0	1.008338110375736	0.4575487750511759	ERCC1
Myopathies, Nemaline	1/32	0.6352318488208829	0.7851058233003863	0	0	1.008338110375736	0.4575487750511759	TPM2
Squamous cell carcinoma of the hypopharynx	1/32	0.6352318488208829	0.7851058233003863	0	0	1.008338110375736	0.4575487750511759	TP53
Subacute Sclerosing Panencephalitis	1/32	0.6352318488208829	0.7851058233003863	0	0	1.008338110375736	0.4575487750511759	SDC1
POLYDACTYLY, POSTAXIAL	1/32	0.6352318488208829	0.7851058233003863	0	0	1.008338110375736	0.4575487750511759	TMEM231
Tires quickly	1/32	0.6352318488208829	0.7851058233003863	0	0	1.008338110375736	0.4575487750511759	AGK
Verrucous carcinoma	1/32	0.6352318488208829	0.7851058233003863	0	0	1.008338110375736	0.4575487750511759	TP53
African Trypanosomiasis	1/32	0.6352318488208829	0.7851058233003863	0	0	1.008338110375736	0.4575487750511759	SYBU
Amblyopia	1/32	0.6352318488208829	0.7851058233003863	0	0	1.008338110375736	0.4575487750511759	XYLT2
Anhedonia	1/32	0.6352318488208829	0.7851058233003863	0	0	1.008338110375736	0.4575487750511759	ATP1A3
Cannabis Dependence	1/32	0.6352318488208829	0.7851058233003863	0	0	1.008338110375736	0.4575487750511759	AKT1
Cataplexy	1/32	0.6352318488208829	0.7851058233003863	0	0	1.008338110375736	0.4575487750511759	GNAO1
Decrease in appetite	1/32	0.6352318488208829	0.7851058233003863	0	0	1.008338110375736	0.4575487750511759	TP53
Dysphonia	1/32	0.6352318488208829	0.7851058233003863	0	0	1.008338110375736	0.4575487750511759	TTC19
Easy fatigability	1/32	0.6352318488208829	0.7851058233003863	0	0	1.008338110375736	0.4575487750511759	AGK
Grade I Astrocytoma	1/32	0.6352318488208829	0.7851058233003863	0	0	1.008338110375736	0.4575487750511759	TP53
NADH:Q(1) Oxidoreductase deficiency	1/32	0.6352318488208829	0.7851058233003863	0	0	1.008338110375736	0.4575487750511759	NDUFS8
Neurotoxicity Syndromes	1/32	0.6352318488208829	0.7851058233003863	0	0	1.008338110375736	0.4575487750511759	MTOR
Omenn Syndrome	1/32	0.6352318488208829	0.7851058233003863	0	0	1.008338110375736	0.4575487750511759	CHD7
Peritoneal Fibrosis	1/32	0.6352318488208829	0.7851058233003863	0	0	1.008338110375736	0.4575487750511759	AIMP2
Ovarian Failure, Premature	5/175	0.6352355172985495	0.7851058233003863	0	0	0.9186991869918699	0.4168684428300263	DNAH6;SSSCA1;SHBG;DNAI1;ACVR2B
Drug Dependence	5/175	0.6352355172985495	0.7851058233003863	0	0	0.9186991869918699	0.4168684428300263	AGBL4;GRM5;INSR;PPP1R1B;FHIT
Histiocytosis, Langerhans-Cell	2/69	0.6353158964864968	0.7851058233003863	0	0	0.9328599719847365	0.4231760014449329	FADD;TP53
Optic Atrophy, Hereditary, Leber	2/69	0.6353158964864968	0.7851058233003863	0	0	0.9328599719847365	0.4231760014449329	TP53;ACTB
Adenomatous Polyps	2/69	0.6353158964864968	0.7851058233003863	0	0	0.9328599719847365	0.4231760014449329	ERBB2;TP53
Hepatolenticular Degeneration	2/69	0.6353158964864968	0.7851058233003863	0	0	0.9328599719847365	0.4231760014449329	TP53;ANKS1B
Malignant neoplasm of salivary gland	2/69	0.6353158964864968	0.7851058233003863	0	0	0.9328599719847365	0.4231760014449329	JAG1;ERBB2
Biliary Atresia	3/105	0.6361633402390707	0.7855895202761094	0	0	0.9189627228525121	0.41564677001788985	JAG1;SPINT1;HMGB1
M5b Acute differentiated monocytic leukemia	3/105	0.6361633402390707	0.7855895202761094	0	0	0.9189627228525121	0.41564677001788985	HMGB1;TP53;RELA
Pick Disease of the Brain	3/105	0.6361633402390707	0.7855895202761094	0	0	0.9189627228525121	0.41564677001788985	RIMS2;MSI1;CKB
Lupus Nephritis	6/210	0.6370127640898927	0.7864505410455245	0	0	0.9185667752442996	0.4142420038880327	FLII;ERBB2;HMGB1;MTOR;LY6E;OTUB1
Malignant neoplasm of large intestine	15/516	0.6374623586826821	0.7868176426252929	0	0	0.9342801999307171	0.4206690485037696	RAB1B;USP22;KEAP1;FOXK1;CHD4;ACTN4;LEMD1;RAD52;BCL9;ADAMTS5;AIMP2;AKT2;ERBB2;AKT1;TP53
Pectus excavatum	4/141	0.6401195465903978	0.7893717017278665	0	0	0.9120769741207697	0.4068778377947174	CHRM3;TPM2;AKT1;ACTB
Encephalomyelitis	10/348	0.6409853139592171	0.7893717017278665	0	0	0.9235619361722767	0.41075300138817794	AIMP2;GRM5;PSMD7;JAG1;PNMA1;SORT1;SYVN1;FADD;TP53;DNALI1
Byzanthine arch palate	8/280	0.642114071237792	0.7893717017278665	0	0	0.9183006535947712	0.40679737292671064	SETD5;INSR;TPM2;PEX6;CHAMP1;AKT1;PEX26;ARCN1
Atrial Premature Complexes	3/106	0.6425262012964605	0.7893717017278665	0	0	0.9099935484886155	0.40253353755172044	CTBP1;MSI1;TP53
Malignant Testicular Germ Cell Tumor	3/106	0.6425262012964605	0.7893717017278665	0	0	0.9099935484886155	0.40253353755172044	ERCC1;SHBG;TP53
Anemia, Diamond-Blackfan	2/70	0.6431192532018473	0.7893717017278665	0	0	0.919093851132686	0.40571110265859356	AIMP2;TP53
Respiratory Tract Infections	2/70	0.6431192532018473	0.7893717017278665	0	0	0.919093851132686	0.40571110265859356	FOXJ1;TP53
Glaucoma, Open-Angle	2/70	0.6431192532018473	0.7893717017278665	0	0	0.919093851132686	0.40571110265859356	ATXN2;TP53
alpha-Thalassemia	2/70	0.6431192532018473	0.7893717017278665	0	0	0.919093851132686	0.40571110265859356	TP53;SMARCA2
Deformity of face	2/70	0.6431192532018473	0.7893717017278665	0	0	0.919093851132686	0.40571110265859356	INSR;HCCS
Distortion of face	2/70	0.6431192532018473	0.7893717017278665	0	0	0.919093851132686	0.40571110265859356	INSR;HCCS
Funny looking face	2/70	0.6431192532018473	0.7893717017278665	0	0	0.919093851132686	0.40571110265859356	INSR;HCCS
Neck Neoplasms	2/70	0.6431192532018473	0.7893717017278665	0	0	0.919093851132686	0.40571110265859356	ERBB2;TP53
Neurofibromatosis 2	2/70	0.6431192532018473	0.7893717017278665	0	0	0.919093851132686	0.40571110265859356	SEMA3F;TP53
Ovarian adenocarcinoma	2/70	0.6431192532018473	0.7893717017278665	0	0	0.919093851132686	0.40571110265859356	ERBB2;TP53
Pulmonary arterial hypertension	2/70	0.6431192532018473	0.7893717017278665	0	0	0.919093851132686	0.40571110265859356	IDUA;CBLN2
Metastatic melanoma	12/417	0.6445873833244005	0.7893717017278665	0	0	0.9247076023391813	0.4060806115313843	IGSF8;PRKCI;RAB5B;MAP2;SGSM3;ERBB2;IGF2BP1;NEK10;AKT1;TP53;TM9SF4;MTOR
Refractory cancer	5/177	0.645143698725267	0.7893717017278665	0	0	0.9079221024768387	0.3979260949394063	ERCC1;ERBB2;AKT1;TP53;MTOR
Carcinoma of larynx	5/177	0.645143698725267	0.7893717017278665	0	0	0.9079221024768387	0.3979260949394063	CAPN10;INSR;ERCC1;CAPN1;TP53
Hemoglobin low	5/177	0.645143698725267	0.7893717017278665	0	0	0.9079221024768387	0.3979260949394063	ABCD4;TMEM67;NPHP1;ACTN4;PLEC
Lymphatic Metastasis	4/142	0.6456110170847431	0.7893717017278665	0	0	0.9054206662902315	0.3961741439933131	CAPNS1;ERBB2;SSSCA1;SHBG
Mycosis Fungoides	4/142	0.6456110170847431	0.7893717017278665	0	0	0.9054206662902315	0.3961741439933131	GNAO1;SGSM3;AKT1;TP53
Congenital contractural arachnodactyly	6/212	0.6460708300839283	0.7893717017278665	0	0	0.909553777552892	0.3973350542243753	ERBB2;AKT1;SSSCA1;ACTN4;TP53;RELA
Chromosome 5, trisomy 5q	1/33	0.6465577425336801	0.7893717017278665	0	0	0.9767770597738288	0.4259654128499876	TP53
Scapular weakness	1/33	0.6465577425336801	0.7893717017278665	0	0	0.9767770597738288	0.4259654128499876	TPM2
Severe Congenital Microcephaly	1/33	0.6465577425336801	0.7893717017278665	0	0	0.9767770597738288	0.4259654128499876	TSEN34
Spastic	1/33	0.6465577425336801	0.7893717017278665	0	0	0.9767770597738288	0.4259654128499876	SPG7
Muscular Dystrophy, Emery-Dreifuss	1/33	0.6465577425336801	0.7893717017278665	0	0	0.9767770597738288	0.4259654128499876	LMNB2
Superinfection	1/33	0.6465577425336801	0.7893717017278665	0	0	0.9767770597738288	0.4259654128499876	PDLIM7
Usher Syndrome	1/33	0.6465577425336801	0.7893717017278665	0	0	0.9767770597738288	0.4259654128499876	PEX6
Anemia of chronic disease	1/33	0.6465577425336801	0.7893717017278665	0	0	0.9767770597738288	0.4259654128499876	AKT1
Angiomyolipoma	1/33	0.6465577425336801	0.7893717017278665	0	0	0.9767770597738288	0.4259654128499876	MTOR
Cholestatic liver disease	1/33	0.6465577425336801	0.7893717017278665	0	0	0.9767770597738288	0.4259654128499876	SPG7
Chronic Airflow Obstruction	1/33	0.6465577425336801	0.7893717017278665	0	0	0.9767770597738288	0.4259654128499876	TP53
Death in early adulthood	1/33	0.6465577425336801	0.7893717017278665	0	0	0.9767770597738288	0.4259654128499876	ACTB
Fibrillary Astrocytoma	1/33	0.6465577425336801	0.7893717017278665	0	0	0.9767770597738288	0.4259654128499876	TP53
Fulminant hepatitis	1/33	0.6465577425336801	0.7893717017278665	0	0	0.9767770597738288	0.4259654128499876	RELA
Gastric Cardia Adenocarcinoma	1/33	0.6465577425336801	0.7893717017278665	0	0	0.9767770597738288	0.4259654128499876	TP53
Gastric Mucosa-Associated Lymphoid Tissue Lymphoma	1/33	0.6465577425336801	0.7893717017278665	0	0	0.9767770597738288	0.4259654128499876	TP53
Iron-Refractory Iron Deficiency Anemia	1/33	0.6465577425336801	0.7893717017278665	0	0	0.9767770597738288	0.4259654128499876	IDUA
Metabolic Bone Disorder	1/33	0.6465577425336801	0.7893717017278665	0	0	0.9767770597738288	0.4259654128499876	KCNMA1
Metaphyseal widening	1/33	0.6465577425336801	0.7893717017278665	0	0	0.9767770597738288	0.4259654128499876	ARCN1
Microlissencephaly	1/33	0.6465577425336801	0.7893717017278665	0	0	0.9767770597738288	0.4259654128499876	TSEN34
Mixed oligoastrocytoma	1/33	0.6465577425336801	0.7893717017278665	0	0	0.9767770597738288	0.4259654128499876	TP53
Oral cleft	1/33	0.6465577425336801	0.7893717017278665	0	0	0.9767770597738288	0.4259654128499876	ACTB
Polyarteritis Nodosa	1/33	0.6465577425336801	0.7893717017278665	0	0	0.9767770597738288	0.4259654128499876	TP53
Pleural effusion disorder	3/107	0.6488102896955156	0.7919347135442666	0	0	0.9011968582471014	0.38987120378491347	RIMS2;TP53;FHIT
Experimental Organism Basal Cell Carcinoma	8/282	0.6499562767625406	0.793146171973745	0	0	0.9115023138209055	0.3927209404229219	AIMP2;AKT2;SUFU;AKT1;MSI1;TP53;MTOR;UBAC2
Neurofibromatoses	2/71	0.6507902243613614	0.7937889732120641	0	0	0.9057267482763472	0.389071159608507	MDK;TP53
Pediatric Obesity	2/71	0.6507902243613614	0.7937889732120641	0	0	0.9057267482763472	0.389071159608507	BBS2;SORT1
Invasive carcinoma of breast	11/385	0.6511449494480642	0.7940342375525238	0	0	0.9178981937602627	0.39379944133036476	AKT2;ERBB2;AKT1;KEAP1;SSSCA1;EBAG9;FHIT;TP53;HDAC6;MTOR;ACTB
Scleroderma	5/179	0.6548818018106081	0.7978699375576974	0	0	0.8973927670311186	0.37986682033554126	AIMP2;FLII;CSAD;TP53;RELA
Secondary Neoplasm	3/108	0.6550154555718517	0.7978699375576974	0	0	0.8925677240101876	0.3776422330322496	MDK;ERBB2;TP53
Severe myopia	3/108	0.6550154555718517	0.7978699375576974	0	0	0.8925677240101876	0.3776422330322496	MYCBP2;PDE6B;ZNF644
Mechanical Allodynia	3/108	0.6550154555718517	0.7978699375576974	0	0	0.8925677240101876	0.3776422330322496	CACNA2D1;INSR;HMGB1
Biliary Cirrhosis, Secondary	1/34	0.6575325201351071	0.7978699375576974	0	0	0.9471288001174916	0.39709422078385537	TYK2
Winged scapula	1/34	0.6575325201351071	0.7978699375576974	0	0	0.9471288001174916	0.39709422078385537	TPM2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis	1/34	0.6575325201351071	0.7978699375576974	0	0	0.9471288001174916	0.39709422078385537	HMGB1
Broad-based gait	1/34	0.6575325201351071	0.7978699375576974	0	0	0.9471288001174916	0.39709422078385537	ATCAY
Cleft Lip with or without Cleft Palate	1/34	0.6575325201351071	0.7978699375576974	0	0	0.9471288001174916	0.39709422078385537	TCN2
Dysautonomia	1/34	0.6575325201351071	0.7978699375576974	0	0	0.9471288001174916	0.39709422078385537	CCT5
Female infertility	1/34	0.6575325201351071	0.7978699375576974	0	0	0.9471288001174916	0.39709422078385537	TP53
Gestational trophoblastic disease	1/34	0.6575325201351071	0.7978699375576974	0	0	0.9471288001174916	0.39709422078385537	TP53
Infant Acute Lymphoblastic Leukemia	1/34	0.6575325201351071	0.7978699375576974	0	0	0.9471288001174916	0.39709422078385537	FHIT
Infective endocarditis	1/34	0.6575325201351071	0.7978699375576974	0	0	0.9471288001174916	0.39709422078385537	GAPDH
Left ventricular noncompaction cardiomyopathy	1/34	0.6575325201351071	0.7978699375576974	0	0	0.9471288001174916	0.39709422078385537	PLEC
Malignant neoplasm of vulva	1/34	0.6575325201351071	0.7978699375576974	0	0	0.9471288001174916	0.39709422078385537	TP53
Monocytosis	1/34	0.6575325201351071	0.7978699375576974	0	0	0.9471288001174916	0.39709422078385537	TP53
Myelodysplastic Syndrome with Isolated del(5q)	1/34	0.6575325201351071	0.7978699375576974	0	0	0.9471288001174916	0.39709422078385537	TP53
Narrow nose	1/34	0.6575325201351071	0.7978699375576974	0	0	0.9471288001174916	0.39709422078385537	SMARCA2
Neuroectodermal Tumors	1/34	0.6575325201351071	0.7978699375576974	0	0	0.9471288001174916	0.39709422078385537	TP53
Prolonged bleeding time	1/34	0.6575325201351071	0.7978699375576974	0	0	0.9471288001174916	0.39709422078385537	TP53
alpha^+^ Thalassemia	2/72	0.658329504882694	0.7979003004769613	0	0	0.8927415626444752	0.3732103475296752	TP53;SMARCA2
Contact hypersensitivity	2/72	0.658329504882694	0.7979003004769613	0	0	0.8927415626444752	0.3732103475296752	HDAC4;PSMD12
Eating Disorders	2/72	0.658329504882694	0.7979003004769613	0	0	0.8927415626444752	0.3732103475296752	HDAC4;NEGR1
Familial primary gastric lymphoma	2/72	0.658329504882694	0.7979003004769613	0	0	0.8927415626444752	0.3732103475296752	TP53;ACTB
Neutrophil count decreased	2/72	0.658329504882694	0.7979003004769613	0	0	0.8927415626444752	0.3732103475296752	ABCD4;TCN2
Schizoaffective Disorder	3/109	0.6611415996673875	0.8009329083640551	0	0	0.8841014036268005	0.3658298811881491	CNTNAP2;CAPN10;CPLX2
Hyperalgesia, Thermal	3/109	0.6611415996673875	0.8009329083640551	0	0	0.8841014036268005	0.3658298811881491	CACNA2D1;INSR;HMGB1
Generalized osteopenia	4/145	0.6617514055714678	0.8014837740785905	0	0	0.8860182370820668	0.3658061975344241	CHD7;XYLT2;COG1;OTX2
Adenocarcinoma of prostate	6/216	0.6637722929205435	0.8037430201062251	0	0	0.8920428106095859	0.3655735241147159	DLG1;HSF1;ERBB2;ARHGAP1;AKT1;TP53
Patent ductus arteriosus	7/251	0.664208820408419	0.8040832007193042	0	0	0.8955686893268794	0.366429712070293	CHRM3;SGSM3;USP22;CHD7;ERBB2;TP53;ACTB
Photodysphoria	5/181	0.6644477407178877	0.804184057149893	0	0	0.8871027346637103	0.36264675379845285	BBS2;IFT172;TACSTD2;PDE6B;UBAC2
Cardiomyopathy, Hypertrophic, Familial	2/73	0.6657378737597317	0.805103126901821	0	0	0.8801221568895574	0.35808585725885805	CACNB2;CAPN1
Withdrawal Symptoms	2/73	0.6657378737597317	0.805103126901821	0	0	0.8801221568895574	0.35808585725885805	CHRNB2;GNAO1
Congenital small ears	2/73	0.6657378737597317	0.805103126901821	0	0	0.8801221568895574	0.35808585725885805	MBD5;PLEC
Congenital myopathy (disorder)	3/110	0.6671886718669309	0.805103126901821	0	0	0.875793332222542	0.35441815345427236	TPM2;CHD7;RBCK1
Deep Vein Thrombosis	3/110	0.6671886718669309	0.805103126901821	0	0	0.875793332222542	0.35441815345427236	AKT1;MTR;RELA
COLORBLINDNESS, PARTIAL, DEUTAN SERIES	1/35	0.6681670493966545	0.805103126901821	0	0	0.9192245557350566	0.3706470253819009	MTOR
Split-Hand/Foot Malformation	1/35	0.6681670493966545	0.805103126901821	0	0	0.9192245557350566	0.3706470253819009	CDH3
Neoplasms, Germ Cell and Embryonal	1/35	0.6681670493966545	0.805103126901821	0	0	0.9192245557350566	0.3706470253819009	ERCC1
Abnormality of the metacarpal bones	1/35	0.6681670493966545	0.805103126901821	0	0	0.9192245557350566	0.3706470253819009	SMARCA2
Varicose Ulcer	1/35	0.6681670493966545	0.805103126901821	0	0	0.9192245557350566	0.3706470253819009	TP53
Coagulation factor measurement	1/35	0.6681670493966545	0.805103126901821	0	0	0.9192245557350566	0.3706470253819009	KCNT2
Follicular neoplasm	1/35	0.6681670493966545	0.805103126901821	0	0	0.9192245557350566	0.3706470253819009	TP53
Hepatitis B Virus-Related Hepatocellular Carcinoma	1/35	0.6681670493966545	0.805103126901821	0	0	0.9192245557350566	0.3706470253819009	TP53
Hereditary Melanoma	1/35	0.6681670493966545	0.805103126901821	0	0	0.9192245557350566	0.3706470253819009	CDK2AP2
Inflammatory abnormality of the eye	1/35	0.6681670493966545	0.805103126901821	0	0	0.9192245557350566	0.3706470253819009	HMGB1
Limb defects	1/35	0.6681670493966545	0.805103126901821	0	0	0.9192245557350566	0.3706470253819009	TP53
Lipoidosis	1/35	0.6681670493966545	0.805103126901821	0	0	0.9192245557350566	0.3706470253819009	AP1S1
Neonatal Jaundice	1/35	0.6681670493966545	0.805103126901821	0	0	0.9192245557350566	0.3706470253819009	JAG1
PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	1/35	0.6681670493966545	0.805103126901821	0	0	0.9192245557350566	0.3706470253819009	SGSM3
Primary malignant neoplasm	30/1032	0.6696153261861943	0.806660141195863	0	0	0.9326093575560743	0.37402472822555394	ACSS2;FLII;RAB1B;CASC2;MTR;PTPN23;HMGB1;SPG7;HDAC9;STK33;ZNRF3;SALL2;HSF1;ERBB2;TRIM24;AKT1;LDLR;MAP2K5;URGCP;TPM2;USP22;SMARCA2;YWHAZ;MTOR;HIPK2;SGSM3;ERCC1;SDC1;TRIB3;TP53
Chronic heart failure	2/74	0.6730161880844341	0.810548384445578	0	0	0.8678532901833873	0.34365766271797965	ERBB2;TP53
Congenital cataract	3/111	0.6731566691254683	0.810548384445578	0	0	0.8676391139924365	0.34339176549553146	MAF;AGK;LEMD2
Neoplasm Invasiveness	5/183	0.6738397535793235	0.8111818883060665	0	0	0.8770439389787156	0.3462244532195473	CFL1;SHBG;ALDOA;ACTB;RELA
Conventional (Clear Cell) Renal Cell Carcinoma	18/631	0.6751468839598931	0.8125661612260661	0	0	0.9153989149816002	0.35959158419298354	SEMA5B;CADM4;JAG1;KEAP1;HMGB1;NDRG2;SLC5A3;FHIT;HDAC9;SMARCA2;MTOR;RELA;PDZD2;KCNMA1;ERBB2;AKT1;LDLR;TP53
Dystonic disease	4/148	0.6773862606865045	0.812904293107349	0	0	0.8674242424242424	0.33787355780708866	TSEN34;NDUFS8;ATP1A3;TTC19
T-Cell Lymphoma	9/324	0.6775691432663195	0.812904293107349	0	0	0.8915127425765723	0.3470156961888575	CREBZF;CCND3;MAF;AKT2;AKT1;NDRG2;TP53;PDLIM7;MTOR
Proteinuria	5/184	0.6784700725590932	0.812904293107349	0	0	0.8720988327201707	0.3383001392639782	INSR;SDC1;PDSS2;ERCC8;ACTN4
Reduced tensile strength of hair	1/36	0.6784718625951414	0.812904293107349	0	0	0.8929148396030464	0.34637262286646586	CDH3
Thickened nuchal skin fold	1/36	0.6784718625951414	0.812904293107349	0	0	0.8929148396030464	0.34637262286646586	INSR
5q-syndrome	1/36	0.6784718625951414	0.812904293107349	0	0	0.8929148396030464	0.34637262286646586	TP53
Ulnohumeral dislocation	1/36	0.6784718625951414	0.812904293107349	0	0	0.8929148396030464	0.34637262286646586	SETD5
Almond-shaped palpebral fissure	1/36	0.6784718625951414	0.812904293107349	0	0	0.8929148396030464	0.34637262286646586	UBE2A
Decreased testosterone in males	1/36	0.6784718625951414	0.812904293107349	0	0	0.8929148396030464	0.34637262286646586	CHD7
Dislocation of elbow joint	1/36	0.6784718625951414	0.812904293107349	0	0	0.8929148396030464	0.34637262286646586	SETD5
Fatigable weakness of respiratory muscles	1/36	0.6784718625951414	0.812904293107349	0	0	0.8929148396030464	0.34637262286646586	ATXN2
Fractured hair	1/36	0.6784718625951414	0.812904293107349	0	0	0.8929148396030464	0.34637262286646586	CDH3
Fragile hair	1/36	0.6784718625951414	0.812904293107349	0	0	0.8929148396030464	0.34637262286646586	CDH3
Hammer Toe	1/36	0.6784718625951414	0.812904293107349	0	0	0.8929148396030464	0.34637262286646586	GDAP1
Lichen Sclerosus et Atrophicus	1/36	0.6784718625951414	0.812904293107349	0	0	0.8929148396030464	0.34637262286646586	TP53
Paranoid Schizophrenia	1/36	0.6784718625951414	0.812904293107349	0	0	0.8929148396030464	0.34637262286646586	YWHAZ
Peripheral arterial occlusive disease	1/36	0.6784718625951414	0.812904293107349	0	0	0.8929148396030464	0.34637262286646586	LDLR
Plexiform Neurofibroma	1/36	0.6784718625951414	0.812904293107349	0	0	0.8929148396030464	0.34637262286646586	TP53
Radiohumeral dislocation	1/36	0.6784718625951414	0.812904293107349	0	0	0.8929148396030464	0.34637262286646586	SETD5
Stomach Neoplasms	24/835	0.6785848040741596	0.812904293107349	0	0	0.9220036577594982	0.3575030642618053	JAG1;URGCP;CPSF1;PGAP3;WNT8B;RHOC;NDRG2;FHIT;MTOR;ACTB;RELA;KAT2A;SPINT1;MDK;ERCC1;PPP1R1B;ERBB2;RANBP10;AKT1;SDC1;CKB;FADD;CTNNA2;TP53
Skin Erosion	3/112	0.6790456333870792	0.812904293107349	0	0	0.8596345144454522	0.33273610697867945	JUP;TP53;PLEC
Bilateral cataracts (disorder)	3/112	0.6790456333870792	0.812904293107349	0	0	0.8596345144454522	0.33273610697867945	AGK;ERCC1;APEH
Cholera	3/112	0.6790456333870792	0.812904293107349	0	0	0.8596345144454522	0.33273610697867945	ERBB2;XYLT2;VPS54
Endometrial Hyperplasia	2/75	0.6801653777720378	0.8134910141925228	0	0	0.8559205568116327	0.32988830851673756	CCND3;TP53
Impaired exercise tolerance	2/75	0.6801653777720378	0.8134910141925228	0	0	0.8559205568116327	0.32988830851673756	RSPH4A;AGK
Malignant Fibrous Histiocytoma	2/75	0.6801653777720378	0.8134910141925228	0	0	0.8559205568116327	0.32988830851673756	TP53;MTOR
MYOTONIC DYSTROPHY 1	2/75	0.6801653777720378	0.8134910141925228	0	0	0.8559205568116327	0.32988830851673756	INSR;ERBB2
Neoplasm, Residual	6/220	0.6809091249785483	0.8141921235282594	0	0	0.8751864592529452	0.33635728329787973	MBD5;MDK;ERBB2;SDC1;TP53;HDAC9
Diabetes Mellitus, Experimental	3/113	0.6848556501939501	0.8169797095531176	0	0	0.8517754530720495	0.3224372064607975	INSR;TP53;RELA
Streptozotocin Diabetes	3/113	0.6848556501939501	0.8169797095531176	0	0	0.8517754530720495	0.3224372064607975	INSR;TP53;RELA
Alloxan Diabetes	3/113	0.6848556501939501	0.8169797095531176	0	0	0.8517754530720495	0.3224372064607975	INSR;TP53;RELA
Stable angina	2/76	0.6871864399370018	0.8169797095531176	0	0	0.844310329747223	0.3167427169666044	ACSS2;ACCS
Axonal neuropathy	2/76	0.6871864399370018	0.8169797095531176	0	0	0.844310329747223	0.3167427169666044	GDAP1;CCT5
Congenital pectus carinatum	2/76	0.6871864399370018	0.8169797095531176	0	0	0.844310329747223	0.3167427169666044	CHRM3;ACTB
Inflammatory pain	2/76	0.6871864399370018	0.8169797095531176	0	0	0.844310329747223	0.3167427169666044	PDE4D;CCT5
Platyspondyly	2/76	0.6871864399370018	0.8169797095531176	0	0	0.844310329747223	0.3167427169666044	XYLT2;HDAC6
Primary infection NOS	2/76	0.6871864399370018	0.8169797095531176	0	0	0.844310329747223	0.3167427169666044	AIMP2;LDLR
Eosinophilia	5/186	0.6875985698603857	0.8169797095531176	0	0	0.8623725463773975	0.32300171087170226	SHARPIN;NUMA1;CHD7;HMGB1;SHBG
Tuberculosis	17/602	0.6879016719007258	0.8169797095531176	0	0	0.9057702938299953	0.33885715399995775	FHIT;MTOR;ACTB;RELA;RIMS2;AIMP2;PSMD7;NKRF;SGSM3;AKT1;SDC1;SSSCA1;PDE6B;RBCK1;PKP3;GAPDH;TP53
Salivary Gland Pleomorphic Adenoma	1/37	0.6884571662352608	0.8169797095531176	0	0	0.868066774367259	0.3240512157105281	ERBB2
Sessile Serrated Adenoma/Polyp	1/37	0.6884571662352608	0.8169797095531176	0	0	0.868066774367259	0.3240512157105281	TP53
Spinocerebellar Ataxia Type 4	1/37	0.6884571662352608	0.8169797095531176	0	0	0.868066774367259	0.3240512157105281	ATXN2
Simple syndactyly of toes, first web space	1/37	0.6884571662352608	0.8169797095531176	0	0	0.868066774367259	0.3240512157105281	ARCN1
Truncus Arteriosus, Persistent	1/37	0.6884571662352608	0.8169797095531176	0	0	0.868066774367259	0.3240512157105281	TP53
Thyroid Hormone Resistance Syndrome	1/37	0.6884571662352608	0.8169797095531176	0	0	0.868066774367259	0.3240512157105281	SHBG
ACTH-Secreting Pituitary Adenoma	1/37	0.6884571662352608	0.8169797095531176	0	0	0.868066774367259	0.3240512157105281	GAPDH
Aplasia/Hypoplasia of the radius	1/37	0.6884571662352608	0.8169797095531176	0	0	0.868066774367259	0.3240512157105281	TPM2
Bacterial Endocarditis	1/37	0.6884571662352608	0.8169797095531176	0	0	0.868066774367259	0.3240512157105281	GAPDH
Brittle hair	1/37	0.6884571662352608	0.8169797095531176	0	0	0.868066774367259	0.3240512157105281	CDH3
Brucellosis	1/37	0.6884571662352608	0.8169797095531176	0	0	0.868066774367259	0.3240512157105281	RELA
Carcinoma testes	1/37	0.6884571662352608	0.8169797095531176	0	0	0.868066774367259	0.3240512157105281	TP53
Congenital hypoplasia of breast	1/37	0.6884571662352608	0.8169797095531176	0	0	0.868066774367259	0.3240512157105281	CHD7
Corpus Luteum Cyst	1/37	0.6884571662352608	0.8169797095531176	0	0	0.868066774367259	0.3240512157105281	CDH3
Escherichia coli Infections	1/37	0.6884571662352608	0.8169797095531176	0	0	0.868066774367259	0.3240512157105281	YWHAZ
Fatigable weakness of swallowing muscles	1/37	0.6884571662352608	0.8169797095531176	0	0	0.868066774367259	0.3240512157105281	ATXN2
Fuchs Endothelial Dystrophy	1/37	0.6884571662352608	0.8169797095531176	0	0	0.868066774367259	0.3240512157105281	TP53
Increased calcium level in kidney	1/37	0.6884571662352608	0.8169797095531176	0	0	0.868066774367259	0.3240512157105281	KCNQ1OT1
Macular dystrophy	1/37	0.6884571662352608	0.8169797095531176	0	0	0.868066774367259	0.3240512157105281	CDH3
Oculocerebrorenal Syndrome	1/37	0.6884571662352608	0.8169797095531176	0	0	0.868066774367259	0.3240512157105281	ARHGAP1
Pseudoxanthoma Elasticum	1/37	0.6884571662352608	0.8169797095531176	0	0	0.868066774367259	0.3240512157105281	XYLT2
QRS complex feature	1/37	0.6884571662352608	0.8169797095531176	0	0	0.868066774367259	0.3240512157105281	CACNB2
HIV Infections	23/806	0.689143215325622	0.8175596168999157	0	0	0.9150285270541725	0.34067076623797754	HEXA;SYP;HMGB1;FHIT;HDAC6;HIPK2;GNAO1;AIMP2;DLG1;PSMD7;MDK;PSME3;KCNMA1;AKT1;ULK1;SSSCA1;LDLR;TP53;CLIC1;SYBU;CCT5;PDLIM7;PLEC
Downward slant of palpebral fissure	6/222	0.689262238938261	0.8175596168999157	0	0	0.8669923995656895	0.32263689214556895	RERE;TPM2;CHD7;AKT1;ACTB;MTOR
Carcinoma, Endometrioid	3/114	0.6905868464660266	0.818754948964539	0	0	0.8440579964080774	0.3124816994385806	ERBB2;SHBG;TP53
Lymphocyte Count measurement	3/114	0.6905868464660266	0.818754948964539	0	0	0.8440579964080774	0.3124816994385806	RERE;DIP2A;PLCB1
Pulmonary Fibrosis	12/432	0.6914484866734604	0.8195884814514778	0	0	0.8909774436090225	0.3287409409445196	CHRM3;SPINT1;DPP9;ERBB2;AKT1;SDC1;SSSCA1;ATP11A;HMGB1;CSAD;TP53;MTOR
Vomiting	5/187	0.6920964964766732	0.8199804433267875	0	0	0.8575895649066381	0.31561859093132505	TCN2;PDE4D;ERCC1;PPOX;TP53
Childhood Glioblastoma	5/187	0.6920964964766732	0.8199804433267875	0	0	0.8575895649066381	0.31561859093132505	HDAC4;STAT2;AKT1;TP53;HDAC6
Lung Diseases, Interstitial	4/151	0.6925117519219326	0.8202843763310905	0	0	0.8495891863238803	0.31216461486512503	LRRC34;DPP9;AKT1;TP53
Adenocarcinoma	50/1712	0.6939016820932207	0.8215775726087069	0	0	0.9351447210082969	0.3417252568361321	KEAP1;MTR;HMGB1;ABCC10;ACTB;CCND3;CDH3;MAGED4B;AKT2;CFL1;AKT1;SSSCA1;SYBU;EIF5A;RHBDF1;CTNNBIP1;ACTN4;SYP;SPINT1;RABEP2;RIN1;GAPDH;TP53;PLEC;TACSTD2;WNT8B;FHIT;HDAC9;RELA;SHARPIN;ERBB2;CKB;FADD;MAP2K5;PDLIM7;KCNJ3;JAG1;INSR;SMARCA2;MTOR;AIMP2;TMEM54;SGSM3;ERCC1;PPP1R1B;CDK2AP2;SDC1;PLCH1;SHBG;EBAG9
Decreased width of tooth	2/77	0.6940804338253898	0.8215775726087069	0	0	0.8330097087378641	0.30418801142875146	CDH3;IDUA
High-Grade Prostatic Intraepithelial Neoplasia	2/77	0.6940804338253898	0.8215775726087069	0	0	0.8330097087378641	0.30418801142875146	ERBB2;TP53
Cirrhosis	12/433	0.6944378637383642	0.8218124295396992	0	0	0.8888142267783473	0.3241084096898623	BCL9;CNTNAP2;JAG1;MBOAT7;ERBB2;AKT1;PDSS2;GAPDH;TP53;SMARCA2;YWHAZ;ACTB
Astrocytoma	21/741	0.6952970690542544	0.8226377646139617	0	0	0.9085976627712855	0.3301990074930054	FLII;ACTN4;SPG7;NDRG2;SMARCA2;YWHAZ;MTOR;ACTB;HIPK2;RIMS2;AIMP2;GRM5;MDK;MAP2;ERBB2;AKT1;SSSCA1;GAPDH;TP53;LHX9;PLEC
Septicemia	13/468	0.6959364220429514	0.8226377646139617	0	0	0.8907978347846552	0.32291151640141313	KEAP1;HMGB1;MTOR;RELA;RIMS2;AIMP2;FER;PSME3;PPP6R2;SUFU;GAPDH;SYBU;PLEC
Acquired Immunodeficiency Syndrome	5/188	0.6965500699621934	0.8226377646139617	0	0	0.852858856457417	0.3084070674248284	AIMP2;ACSS2;ACCS;TP53;PDLIM7
Photophobia	5/188	0.6965500699621934	0.8226377646139617	0	0	0.852858856457417	0.3084070674248284	BBS2;IFT172;TACSTD2;PDE6B;UBAC2
Arthritis, Reactive	1/38	0.6981328514935058	0.8226377646139617	0	0	0.8445618477928656	0.3034898057800095	TP53
Sensorimotor neuropathy	1/38	0.6981328514935058	0.8226377646139617	0	0	0.8445618477928656	0.3034898057800095	GDAP1
Hyperparathyroidism, Secondary	1/38	0.6981328514935058	0.8226377646139617	0	0	0.8445618477928656	0.3034898057800095	TP53
Subfertility	1/38	0.6981328514935058	0.8226377646139617	0	0	0.8445618477928656	0.3034898057800095	TTC19
Arteriovenous hemangioma	1/38	0.6981328514935058	0.8226377646139617	0	0	0.8445618477928656	0.3034898057800095	MAP2
Coffin-Siris syndrome	1/38	0.6981328514935058	0.8226377646139617	0	0	0.8445618477928656	0.3034898057800095	SMARCA2
DOWN SYNDROME CRITICAL REGION	1/38	0.6981328514935058	0.8226377646139617	0	0	0.8445618477928656	0.3034898057800095	GAPDH
End Stage Liver Disease	1/38	0.6981328514935058	0.8226377646139617	0	0	0.8445618477928656	0.3034898057800095	PPP6R2
Growth abnormality	1/38	0.6981328514935058	0.8226377646139617	0	0	0.8445618477928656	0.3034898057800095	SGSH
Hypoplasia of the brainstem	1/38	0.6981328514935058	0.8226377646139617	0	0	0.8445618477928656	0.3034898057800095	CHMP1A
Infectious Mononucleosis	1/38	0.6981328514935058	0.8226377646139617	0	0	0.8445618477928656	0.3034898057800095	PDLIM7
Lichen Planus	1/38	0.6981328514935058	0.8226377646139617	0	0	0.8445618477928656	0.3034898057800095	TP53
Lipoid nephrosis	1/38	0.6981328514935058	0.8226377646139617	0	0	0.8445618477928656	0.3034898057800095	ACTN4
Mediastinal (Thymic) Large B-Cell Lymphoma	1/38	0.6981328514935058	0.8226377646139617	0	0	0.8445618477928656	0.3034898057800095	AKT1
Renal Cell Carcinoma	39/1348	0.6981596818105332	0.8226377646139617	0	0	0.9266826117084292	0.3329639493822424	ACSS2;KEAP1;ACCS;APEH;NDRG2;SLC5A3;FHIT;RELA;ABR;CDH3;PDZD2;RNPEP;CHMP1A;ERBB2;IGF2BP1;AKT1;SSSCA1;FADD;CAPN1;LDLR;BBS2;JUP;INSR;SYVN1;TYK2;MTOR;TAPBP;GNAO1;AIMP2;SPINT1;TEP1;NFIC;SGSM3;KCNMA1;AKT1S1;CDK2AP2;EBAG9;GAPDH;TP53
Stomach Carcinoma	70/2378	0.6987349322418057	0.8231279074140988	0	0	0.941421143847487	0.33748424657709275	CHRM3;KEAP1;MSI1;CASC2;MTR;TMEM97;HMGB1;ACTB;MAGED4B;MDK;AKT2;TRIM24;AKT1;SSSCA1;ZFPL1;CLIC1;RHBDF1;STARD3;ACTN4;RHOC;YWHAZ;ST7L;SPINT1;KCNMA1;TRIB3;ULK1;RIN1;ALDOA;GAPDH;TP53;LY6E;OTUB1;HDAC4;CTBP1;IDUA;TACSTD2;WNT8B;FOXK1;NDRG2;FHIT;HDAC6;RELA;MED30;HSF1;ERBB2;PDSS2;CKB;MIR92B;PDLIM7;CCDC134;JAG1;INSR;USP22;FOXJ1;SORBS2;MAPK15;MTOR;PPP1CA;LRFN2;AIMP2;VANGL2;CAPN10;NFIC;SGSM3;ERCC1;PPP1R1B;PTPN9;ERCC8;SHBG;EBAG9
Lymphoma, T-Cell, Cutaneous	7/260	0.6994194458336338	0.8236828527198949	0	0	0.8633042962428025	0.3086353012605981	RIMS2;JAG1;STAT2;AKT1;TP53;HDAC9;HDAC6
Immunologic Deficiency Syndromes	18/641	0.7002171204321154	0.8236828527198949	0	0	0.9002255723297942	0.32080872403033295	LAD1;KEAP1;TYK2;SPG7;FHIT;ACVR2B;MTOR;ACTB;SALL2;GIPC1;SGSM3;ERBB2;AKT1;SDC1;TP53;VPS39;PDLIM7;PLEC
Pleural Effusion, Malignant	2/78	0.7008484765193471	0.8236828527198949	0	0	0.8220064724919094	0.2921933541545203	PSMD7;MDK
Thick lower lip vermilion	2/78	0.7008484765193471	0.8236828527198949	0	0	0.8220064724919094	0.2921933541545203	INSR;SMARCA2
Cardiac Hypertrophy	2/78	0.7008484765193471	0.8236828527198949	0	0	0.8220064724919094	0.2921933541545203	AKT1;RBCK1
Crohn's disease of large bowel	2/78	0.7008484765193471	0.8236828527198949	0	0	0.8220064724919094	0.2921933541545203	TYK2;YWHAZ
Full lower lip	2/78	0.7008484765193471	0.8236828527198949	0	0	0.8220064724919094	0.2921933541545203	INSR;SMARCA2
Giant Cell Glioblastoma	2/78	0.7008484765193471	0.8236828527198949	0	0	0.8220064724919094	0.2921933541545203	JAG1;TP53
Marinesco-Sjogren syndrome	2/78	0.7008484765193471	0.8236828527198949	0	0	0.8220064724919094	0.2921933541545203	SSSCA1;TP53
Peripheral Vascular Diseases	2/78	0.7008484765193471	0.8236828527198949	0	0	0.8220064724919094	0.2921933541545203	SHBG;LDLR
Adult Glioblastoma	5/189	0.7009592078680531	0.8236828527198949	0	0	0.8481795687522092	0.3013629378473603	HDAC4;STAT2;AKT1;TP53;HDAC6
Exanthema	6/225	0.7015197423076358	0.8237501882390896	0	0	0.854981928517246	0.3030964260494827	TRAF3IP2;KEAP1;AKT1;HMGB1;TP53;FHIT
Malignant Head and Neck Neoplasm	13/470	0.7016347566219514	0.8237501882390896	0	0	0.8868056481818608	0.3142327530885504	RHBDF1;JAG1;TACSTD2;KEAP1;FHIT;SMARCA2;MTOR;ERCC1;ERBB2;AKT1;FADD;TP53;PDLIM7
Alzheimer Disease, Early Onset	3/116	0.7018134827431717	0.8237501882390896	0	0	0.8290328595401673	0.2935502591680616	CHRNB2;IDUA;INSR
Familial (FPAH)	3/116	0.7018134827431717	0.8237501882390896	0	0	0.8290328595401673	0.2935502591680616	INSR;ATP13A2;TP53
Pancytopenia	3/116	0.7018134827431717	0.8237501882390896	0	0	0.8290328595401673	0.2935502591680616	TCN2;TP53;HDAC9
Coronary Artery Disease	28/981	0.7022951641488563	0.8237734918845031	0	0	0.9145302175207737	0.32319635210763553	RERE;ACSS2;MTR;ACCS;HDAC9;SMG6;ATXN2;APH1B;AKT1;THSD7A;LDLR;JUP;KCNH7;SORT1;INSR;PDE4D;KIF6;YWHAZ;PAFAH2;KAT2A;MAF;CAPN10;KCNMA1;TRIB3;SHBG;GAPDH;TP53;ST6GALNAC5
Squamous cell carcinoma of tongue	4/153	0.7023115335222756	0.8237734918845031	0	0	0.838098143467271	0.2961656078733205	MAU2;AKT1;TRIB3;TP53
Familial lichen amyloidosis	4/153	0.7023115335222756	0.8237734918845031	0	0	0.838098143467271	0.2961656078733205	CDH3;ERBB2;NDRG2;TP53
Cerebellar atrophy	5/190	0.7053238444412923	0.8259326739039058	0	0	0.8435508679411119	0.29448211307687977	ATXN2;ATP13A2;SPG7;TTC19;LY6E
Dermatitis	5/190	0.7053238444412923	0.8259326739039058	0	0	0.8435508679411119	0.29448211307687977	PLCB3;SHARPIN;TRAF3IP2;TYK2;TP53
Hypogonadism, Isolated Hypogonadotropic	3/117	0.7073093689605295	0.8259326739039058	0	0	0.8217179902755267	0.28455036364790504	SOX3;CHD7;OTX2
Leukemia, B-Cell	3/117	0.7073093689605295	0.8259326739039058	0	0	0.8217179902755267	0.28455036364790504	MAGED4B;COG1;TP53
Polyendocrinopathies, Autoimmune	2/79	0.7074917376125586	0.8259326739039058	0	0	0.8112890345900055	0.2807297993061637	NPHP1;MTOR
Gliosis	2/79	0.7074917376125586	0.8259326739039058	0	0	0.8112890345900055	0.2807297993061637	NDUFS8;LMNB1
Short toe	1/39	0.7075085037485663	0.8259326739039058	0	0	0.8222940226171244	0.28451836142669895	PDE4D
Skin lesion	1/39	0.7075085037485663	0.8259326739039058	0	0	0.8222940226171244	0.28451836142669895	PDLIM7
Obesity, Abdominal	1/39	0.7075085037485663	0.8259326739039058	0	0	0.8222940226171244	0.28451836142669895	AKT2
Static Tremor	1/39	0.7075085037485663	0.8259326739039058	0	0	0.8222940226171244	0.28451836142669895	ATXN2
Streptococcal pneumonia	1/39	0.7075085037485663	0.8259326739039058	0	0	0.8222940226171244	0.28451836142669895	ACTB
Sweet Syndrome	1/39	0.7075085037485663	0.8259326739039058	0	0	0.8222940226171244	0.28451836142669895	TP53
Adenocarcinoma of rectum	1/39	0.7075085037485663	0.8259326739039058	0	0	0.8222940226171244	0.28451836142669895	TP53
Alcohol consumption	1/39	0.7075085037485663	0.8259326739039058	0	0	0.8222940226171244	0.28451836142669895	SLIT1
Clonus	1/39	0.7075085037485663	0.8259326739039058	0	0	0.8222940226171244	0.28451836142669895	CCT5
Disorder of macula of retina	1/39	0.7075085037485663	0.8259326739039058	0	0	0.8222940226171244	0.28451836142669895	BBS1
Fasting blood glucose measurement	1/39	0.7075085037485663	0.8259326739039058	0	0	0.8222940226171244	0.28451836142669895	CTNNA2
Malignant neoplasm of adrenal cortex	1/39	0.7075085037485663	0.8259326739039058	0	0	0.8222940226171244	0.28451836142669895	TP53
Myofibrillar Myopathy	1/39	0.7075085037485663	0.8259326739039058	0	0	0.8222940226171244	0.28451836142669895	CHD7
Neonatal diabetes mellitus	1/39	0.7075085037485663	0.8259326739039058	0	0	0.8222940226171244	0.28451836142669895	SOX3
Orbital separation diminished	1/39	0.7075085037485663	0.8259326739039058	0	0	0.8222940226171244	0.28451836142669895	ARCN1
Anorexia	3/118	0.7127273238510169	0.8318371295533097	0	0	0.8145303361285322	0.27584588420536105	HMGB1;TP53;C1QL3
Inflammatory disorder	5/192	0.7139194318719847	0.8318406905126284	0	0	0.8344419807834442	0.28119456734639225	AIMP2;PDZD2;AKT1;HMGB1;TP53
Dementia, Vascular	2/80	0.7140114355520031	0.8318406905126284	0	0	0.8008464027881503	0.2697701565852541	TP53;MTOR
Abnormality of the fingernails	2/80	0.7140114355520031	0.8318406905126284	0	0	0.8008464027881503	0.2697701565852541	TRAF3IP2;PEX6
Microdontia (disorder)	2/80	0.7140114355520031	0.8318406905126284	0	0	0.8008464027881503	0.2697701565852541	CDH3;IDUA
Prion Diseases	2/80	0.7140114355520031	0.8318406905126284	0	0	0.8008464027881503	0.2697701565852541	LRFN5;MTR
Brain Ischemia	7/264	0.7142693528665522	0.8318406905126284	0	0	0.8496899219885617	0.28591653169506814	MAP2;MDK;AKT1;MSI1;HMGB1;TP53;RELA
Myeloproliferative disease	7/264	0.7142693528665522	0.8318406905126284	0	0	0.8496899219885617	0.28591653169506814	NUMA1;AKT1;ERCC8;ULK1;SSSCA1;TYK2;TP53
Degenerative Diseases, Spinal Cord	1/40	0.7165934121830925	0.8318406905126284	0	0	0.8011681371939854	0.26698661167596216	TTC19
Depression, Neurotic	1/40	0.7165934121830925	0.8318406905126284	0	0	0.8011681371939854	0.26698661167596216	DIXDC1
Short thorax	1/40	0.7165934121830925	0.8318406905126284	0	0	0.8011681371939854	0.26698661167596216	IFT172
Muscular Dystrophy, Oculopharyngeal	1/40	0.7165934121830925	0.8318406905126284	0	0	0.8011681371939854	0.26698661167596216	RIMS2
Pneumonia, Bacterial	1/40	0.7165934121830925	0.8318406905126284	0	0	0.8011681371939854	0.26698661167596216	HMGB1
Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome	1/40	0.7165934121830925	0.8318406905126284	0	0	0.8011681371939854	0.26698661167596216	TP53
AIDS Dementia Complex	1/40	0.7165934121830925	0.8318406905126284	0	0	0.8011681371939854	0.26698661167596216	TP53
Contracture of joint of hand	1/40	0.7165934121830925	0.8318406905126284	0	0	0.8011681371939854	0.26698661167596216	CDH3
Fibrodysplasia Ossificans Progressiva	1/40	0.7165934121830925	0.8318406905126284	0	0	0.8011681371939854	0.26698661167596216	AIMP2
Hereditary Nonpolyposis Colorectal Neoplasms	1/40	0.7165934121830925	0.8318406905126284	0	0	0.8011681371939854	0.26698661167596216	TP53
Hereditary retinal dystrophy	1/40	0.7165934121830925	0.8318406905126284	0	0	0.8011681371939854	0.26698661167596216	PDE6B
Hypokalemia	1/40	0.7165934121830925	0.8318406905126284	0	0	0.8011681371939854	0.26698661167596216	TP53
Hypoplasia of thumb	1/40	0.7165934121830925	0.8318406905126284	0	0	0.8011681371939854	0.26698661167596216	LMNB2
Mitochondrial Respiratory Chain Deficiencies	1/40	0.7165934121830925	0.8318406905126284	0	0	0.8011681371939854	0.26698661167596216	SPG7
Motor symptoms	1/40	0.7165934121830925	0.8318406905126284	0	0	0.8011681371939854	0.26698661167596216	ATP1A3
Polyglandular Type I Autoimmune Syndrome	1/40	0.7165934121830925	0.8318406905126284	0	0	0.8011681371939854	0.26698661167596216	RIMS2
Psychiatric symptom	1/40	0.7165934121830925	0.8318406905126284	0	0	0.8011681371939854	0.26698661167596216	AKT1
Giant Cell Arteritis	3/119	0.7180676567553983	0.8331777391360347	0	0	0.8074666070530375	0.26742606460423624	JAG1;ERBB2;TP53
Hyperalgesia	3/119	0.7180676567553983	0.8331777391360347	0	0	0.8074666070530375	0.26742606460423624	CACNA2D1;INSR;HMGB1
Mammary Neoplasms, Human	13/476	0.7183394248072742	0.8333059814599312	0	0	0.8750360267718945	0.2894733676235068	JAG1;MTR;RELA;RALYL;AKT2;CFL1;ERBB2;AKT1;ALDOA;TP53;CLIC1;VPS39;CCT5
Granulocyte count	2/81	0.7204088328391557	0.8353315791143722	0	0	0.7906681414116586	0.25928886763305903	MAST2;CHD7
Primary immune deficiency disorder	2/81	0.7204088328391557	0.8353315791143722	0	0	0.7906681414116586	0.25928886763305903	LAD1;TYK2
Cocaine Dependence	4/157	0.7212300321769182	0.8360961880417929	0	0	0.816017316017316	0.26667213042323284	HDAC4;GRM5;TYK2;GABRG2
Platelet distribution width measurement	3/120	0.7233307087981783	0.8380050082218417	0	0	0.8005236254831068	0.2592805960124876	ST7L;ATXN2;PLCB1
Platelet distribution width result	3/120	0.7233307087981783	0.8380050082218417	0	0	0.8005236254831068	0.2592805960124876	ST7L;ATXN2;PLCB1
Fatty Liver	12/443	0.7233630692100689	0.8380050082218417	0	0	0.8677341555745512	0.2810105106843914	SORT1;AKT2;PSME3;INSR;SGSM3;HSF1;HMGB1;SHBG;LDLR;AGPAT2;ACVR2B;RELA
Trichohepatoenteric Syndrome	7/267	0.7250788929741563	0.838106308761461	0	0	0.839754046931861	0.2699597744915638	RIMS2;KCNQ1OT1;INSR;SGSM3;CNTN4;TP53;AGPAT2
Schwartz-Jampel Syndrome	1/41	0.7253965787712878	0.838106308761461	0	0	0.7810985460420032	0.25076135308457675	TRAF3IP2
Nephrotic Syndrome, Minimal Change	1/41	0.7253965787712878	0.838106308761461	0	0	0.7810985460420032	0.25076135308457675	MAF
Arterial Occlusive Diseases	1/41	0.7253965787712878	0.838106308761461	0	0	0.7810985460420032	0.25076135308457675	LDLR
Breaking out	1/41	0.7253965787712878	0.838106308761461	0	0	0.7810985460420032	0.25076135308457675	UBAC2
Congenital anomaly of the kidney	1/41	0.7253965787712878	0.838106308761461	0	0	0.7810985460420032	0.25076135308457675	BBS2
Growth Hormone-Secreting Pituitary Adenoma	1/41	0.7253965787712878	0.838106308761461	0	0	0.7810985460420032	0.25076135308457675	MTOR
Hemophilia B	1/41	0.7253965787712878	0.838106308761461	0	0	0.7810985460420032	0.25076135308457675	SOX3
Intestinal Polyps	1/41	0.7253965787712878	0.838106308761461	0	0	0.7810985460420032	0.25076135308457675	YWHAZ
Irregular hyperpigmentation	1/41	0.7253965787712878	0.838106308761461	0	0	0.7810985460420032	0.25076135308457675	AKT1
Lytic lesion	1/41	0.7253965787712878	0.838106308761461	0	0	0.7810985460420032	0.25076135308457675	TP53
Monoclonal B-Cell Lymphocytosis	1/41	0.7253965787712878	0.838106308761461	0	0	0.7810985460420032	0.25076135308457675	GPM6A
Disseminated Malignant Neoplasm	5/195	0.7264783247616295	0.8390324584347751	0	0	0.8211382113821138	0.2623919495001466	RHBDF1;KCNMA1;ERBB2;PKP3;TP53
Hyperlipidemia, Familial Combined	2/82	0.7266852329632457	0.8390324584347751	0	0	0.7807443365695793	0.24926189082972716	OSBP;LDLR
Cholecystolithiasis	2/82	0.7266852329632457	0.8390324584347751	0	0	0.7807443365695793	0.24926189082972716	ATP11A;LDLR
Malignant tumor of colon	58/2001	0.7275379330296521	0.8398293584760425	0	0	0.9261698624316141	0.2946045747331385	CHRM3;CHD7;DIXDC1;KEAP1;MSI1;MTR;HMGB1;ACTB;LMNB1;RIMS2;MDK;AKT2;CFL1;FPGS;AKT1;SSSCA1;CLIC1;SYBU;EIF5A;RHBDF1;CACNA2D1;TPM2;TYK2;AMPD3;YWHAZ;SPINT1;MALL;ULK1;PLCB1;RIN1;GAPDH;TP53;TACSTD2;SEMA3F;NDRG2;PPOX;FHIT;HDAC9;HDAC6;RELA;HSF1;ERBB2;IGF2BP1;CKB;RPS27A;LDLR;MAP2K5;PDLIM7;JAG1;STAT2;USP22;MTOR;HIPK2;BCL9;AIMP2;SGSM3;ERCC1;SDC1
Polyhydramnios	3/121	0.7285168511132236	0.8407715691275435	0	0	0.7936983215669038	0.2513995957687517	CHD7;OTX2;PLEC
Carcinoma, Neuroendocrine	2/83	0.732841975876441	0.8436239603966407	0	0	0.7710655639458228	0.23966659715582306	MAP2;ERBB2
Diabetes	36/1268	0.7336317874878112	0.8436239603966407	0	0	0.9080457214018858	0.28126537168427385	RPAIN;LAD1;CHRM3;BNC2;HCCS;HMGB1;AGPAT2;ACTB;RELA;RIMS2;FCGRT;AKT2;KCNQ1OT1;HSF1;AKT1;MAP6;FADD;LDLR;EIF5A;JAG1;NEGR1;SORT1;INSR;SYP;PLXDC2;YWHAZ;ACVR2B;MTOR;GNAO1;CAPN10;SGSM3;KCNMA1;TRIB3;SHBG;GAPDH;TP53
Reduced bone mineral density	1/42	0.7339267271562107	0.8436239603966407	0	0	0.7620079593364593	0.23572417675988463	CHD7
Degenerative Diseases, Central Nervous System	1/42	0.7339267271562107	0.8436239603966407	0	0	0.7620079593364593	0.23572417675988463	TTC19
Mitral regurgitation, mild	1/42	0.7339267271562107	0.8436239603966407	0	0	0.7620079593364593	0.23572417675988463	IDUA
Vascular Neoplasms	1/42	0.7339267271562107	0.8436239603966407	0	0	0.7620079593364593	0.23572417675988463	MTOR
Cerebellar Diseases	1/42	0.7339267271562107	0.8436239603966407	0	0	0.7620079593364593	0.23572417675988463	ATCAY
Choanal Atresia	1/42	0.7339267271562107	0.8436239603966407	0	0	0.7620079593364593	0.23572417675988463	CHD7
Dyskeratosis Congenita	1/42	0.7339267271562107	0.8436239603966407	0	0	0.7620079593364593	0.23572417675988463	TP53
Epiretinal Membrane	1/42	0.7339267271562107	0.8436239603966407	0	0	0.7620079593364593	0.23572417675988463	RELA
Hernia	1/42	0.7339267271562107	0.8436239603966407	0	0	0.7620079593364593	0.23572417675988463	IDUA
Isochromosomes	1/42	0.7339267271562107	0.8436239603966407	0	0	0.7620079593364593	0.23572417675988463	TP53
Melancholia	1/42	0.7339267271562107	0.8436239603966407	0	0	0.7620079593364593	0.23572417675988463	DIXDC1
PITUITARY ADENOMA PREDISPOSITION (disorder)	1/42	0.7339267271562107	0.8436239603966407	0	0	0.7620079593364593	0.23572417675988463	TP53
Postnatal microcephaly	1/42	0.7339267271562107	0.8436239603966407	0	0	0.7620079593364593	0.23572417675988463	CHMP1A
Ptosis	1/42	0.7339267271562107	0.8436239603966407	0	0	0.7620079593364593	0.23572417675988463	ACTB
Ragged-red muscle fibers	1/42	0.7339267271562107	0.8436239603966407	0	0	0.7620079593364593	0.23572417675988463	SPG7
Rat Adrenal Gland Pheochromocytoma	1/42	0.7339267271562107	0.8436239603966407	0	0	0.7620079593364593	0.23572417675988463	ATCAY
Absence Seizures	3/123	0.7386600337480358	0.8473766208450149	0	0	0.7803889789303079	0.2363934780618616	KCNMA1;SMARCA2;GABRG2
Peripheral T-Cell Lymphoma	3/123	0.7386600337480358	0.8473766208450149	0	0	0.7803889789303079	0.2363934780618616	TP53;HDAC9;PDLIM7
Retrusion of upper jaw bones	2/84	0.7388804348846806	0.8473766208450149	0	0	0.7616228589470361	0.2304816730431951	PDE4D;AKT1
Venous Thromboembolism	2/84	0.7388804348846806	0.8473766208450149	0	0	0.7616228589470361	0.2304816730431951	CHRM3;FBXO15
Decreased projection of maxilla	2/84	0.7388804348846806	0.8473766208450149	0	0	0.7616228589470361	0.2304816730431951	PDE4D;AKT1
Deficiency of upper jaw bones	2/84	0.7388804348846806	0.8473766208450149	0	0	0.7616228589470361	0.2304816730431951	PDE4D;AKT1
Distal muscle weakness	2/84	0.7388804348846806	0.8473766208450149	0	0	0.7616228589470361	0.2304816730431951	LRSAM1;GDAP1
Hypoplasia of the maxilla	2/84	0.7388804348846806	0.8473766208450149	0	0	0.7616228589470361	0.2304816730431951	PDE4D;AKT1
Hypotrophic maxilla	2/84	0.7388804348846806	0.8473766208450149	0	0	0.7616228589470361	0.2304816730431951	PDE4D;AKT1
Maxillary retrognathia	2/84	0.7388804348846806	0.8473766208450149	0	0	0.7616228589470361	0.2304816730431951	PDE4D;AKT1
Myocardial Infarction	27/966	0.7389950522733131	0.8473766208450149	0	0	0.8941861655415416	0.2704591719638497	CHRM3;MTR;SEMA3F;HMGB1;CPLX2;SMG6;ATXN2;PDZD2;MDK;KCNQ1OT1;CFL1;AKT1;CKB;LDLR;SYBU;SORT1;KIF6;YWHAZ;MTOR;PLCB3;KCNMA1;AKT1S1;SDC1;TRIB3;PLCB1;SHBG;TP53
Juvenile psoriatic arthritis	4/161	0.7392446862660899	0.847474831105402	0	0	0.7950616262718173	0.2402090340022083	RERE;ANKRD9;MAP2;SH3BGRL2
Carcinoma of urinary bladder, superficial	1/43	0.7421923114187349	0.8487828867917729	0	0	0.7438264481883222	0.2217695419194667	TP53
CATARACT, ANTERIOR POLAR	1/43	0.7421923114187349	0.8487828867917729	0	0	0.7438264481883222	0.2217695419194667	SPATS2L
Secondary physiologic amenorrhea	1/43	0.7421923114187349	0.8487828867917729	0	0	0.7438264481883222	0.2217695419194667	CHD7
Macular dystrophy, corneal type 1	1/43	0.7421923114187349	0.8487828867917729	0	0	0.7438264481883222	0.2217695419194667	AKT1
Acute respiratory failure	1/43	0.7421923114187349	0.8487828867917729	0	0	0.7438264481883222	0.2217695419194667	TP53
Yolk Sac Tumor	1/43	0.7421923114187349	0.8487828867917729	0	0	0.7438264481883222	0.2217695419194667	TP53
Depressive Syndrome	1/43	0.7421923114187349	0.8487828867917729	0	0	0.7438264481883222	0.2217695419194667	DIXDC1
Erythrokeratoderma	1/43	0.7421923114187349	0.8487828867917729	0	0	0.7438264481883222	0.2217695419194667	JUP
intracranial glioma	1/43	0.7421923114187349	0.8487828867917729	0	0	0.7438264481883222	0.2217695419194667	TP53
Ketotic hypoglycemia	1/43	0.7421923114187349	0.8487828867917729	0	0	0.7438264481883222	0.2217695419194667	ALDOA
Radial deviation of finger	1/43	0.7421923114187349	0.8487828867917729	0	0	0.7438264481883222	0.2217695419194667	BBS1
Nicotine Dependence	3/124	0.7436179542149262	0.8502251299519332	0	0	0.7738992994628769	0.22925054760287597	CHRNB2;PPP1R1B;RAPGEF4
Alzheimer's Disease, Focal Onset	2/85	0.744802013299527	0.8506379678965648	0	0	0.752407689008461	0.22168703131628686	CHRNB2;INSR
Cicatrix, Hypertrophic	2/85	0.744802013299527	0.8506379678965648	0	0	0.752407689008461	0.22168703131628686	AKT1;TP53
Acute Confusional Senile Dementia	2/85	0.744802013299527	0.8506379678965648	0	0	0.752407689008461	0.22168703131628686	CHRNB2;INSR
Demyelinating Diseases	2/85	0.744802013299527	0.8506379678965648	0	0	0.752407689008461	0.22168703131628686	TP53;LMNB1
Primary physiologic amenorrhea	2/85	0.744802013299527	0.8506379678965648	0	0	0.752407689008461	0.22168703131628686	PEX6;CHD7
Leukemogenesis	20/730	0.746611208978664	0.852515847989778	0	0	0.8765258215962441	0.25613022323833545	EIF5A;RERE;JAG1;FLII;RAB1B;TCF12;FHIT;SMARCA2;MTOR;RELA;IQCG;HIPK2;MLLT6;RIMS2;FER;AKT2;AKT1;SSSCA1;TP53;PDLIM7
Age related macular degeneration	10/382	0.750078410859158	0.8536846111830062	0	0	0.8376520359598096	0.24088990358817022	AGBL4;CDH3;KCNT2;TEP1;MAP2;AKT2;SGSM3;NPHP1;TMEM97;HDAC9
Multiple Sclerosis, Acute Fulminating	1/44	0.7502015242151892	0.8536846111830062	0	0	0.7264905887214937	0.20880313714043094	TYK2
Split hand foot deformity 1	1/44	0.7502015242151892	0.8536846111830062	0	0	0.7264905887214937	0.20880313714043094	CDH3
Acquired aplastic anemia	1/44	0.7502015242151892	0.8536846111830062	0	0	0.7264905887214937	0.20880313714043094	TP53
Birth Weight	1/44	0.7502015242151892	0.8536846111830062	0	0	0.7264905887214937	0.20880313714043094	RABGAP1
Birthmark	1/44	0.7502015242151892	0.8536846111830062	0	0	0.7264905887214937	0.20880313714043094	MTOR
Chromosome Breakage	1/44	0.7502015242151892	0.8536846111830062	0	0	0.7264905887214937	0.20880313714043094	TCN2
Confusion	1/44	0.7502015242151892	0.8536846111830062	0	0	0.7264905887214937	0.20880313714043094	UBAC2
Endometriosis of uterus	1/44	0.7502015242151892	0.8536846111830062	0	0	0.7264905887214937	0.20880313714043094	ACVR2B
Neurocognitive Disorders	1/44	0.7502015242151892	0.8536846111830062	0	0	0.7264905887214937	0.20880313714043094	TP53
Neuromyelitis Optica	1/44	0.7502015242151892	0.8536846111830062	0	0	0.7264905887214937	0.20880313714043094	HMGB1
Peripheral motor neuropathy	1/44	0.7502015242151892	0.8536846111830062	0	0	0.7264905887214937	0.20880313714043094	AGPAT2
Acquired Hypogammaglobulinemia	2/86	0.750608141102086	0.8536846111830062	0	0	0.7434119278779473	0.2132637292243925	FCGRT;TP53
Distal limb muscle weakness due to peripheral neuropathy	2/86	0.750608141102086	0.8536846111830062	0	0	0.7434119278779473	0.2132637292243925	LRSAM1;GDAP1
Headache	2/86	0.750608141102086	0.8536846111830062	0	0	0.7434119278779473	0.2132637292243925	TP53;DNAI1
Herpes NOS	2/86	0.750608141102086	0.8536846111830062	0	0	0.7434119278779473	0.2132637292243925	ERBB2;TP53
Leukoencephalopathies	2/86	0.750608141102086	0.8536846111830062	0	0	0.7434119278779473	0.2132637292243925	TCN2;MTR
Muscle Cramp	2/86	0.750608141102086	0.8536846111830062	0	0	0.7434119278779473	0.2132637292243925	ATXN2;AMPD3
Cystic Fibrosis	16/594	0.7524301219530527	0.8555685083065735	0	0	0.8617062719127386	0.24510989134117714	CHRM3;SLC15A2;HEXA;FOXJ1;HMGB1;HDAC9;YWHAZ;HDAC6;ACTB;GNAO1;AIMP2;POLD4;PLCB3;MDK;CAPN10;SGSM3
Difficulties with night vision	3/126	0.7533088402789899	0.8561909141327952	0	0	0.7612365102581333	0.2156430701126102	PEX6;PDE6B;PEX26
Left-Sided Heart Failure	3/126	0.7533088402789899	0.8561909141327952	0	0	0.7612365102581333	0.2156430701126102	ATP1A3;TP53;LDLR
Cardiomyopathy, Dilated	11/419	0.7541426066922762	0.8564856455395856	0	0	0.8399014778325123	0.2369981876894528	JUP;TPM2;ERBB2;AKT1;HCCS;RBCK1;CKB;SPG7;GAPDH;TP53;MAP2K5
Medullary carcinoma of thyroid	6/239	0.7543533973894379	0.8564856455395856	0	0	0.8030224657840657	0.22636747512913835	ERBB2;AKT1;SYP;NDRG2;TP53;MTOR
Anemia	13/490	0.754985458351371	0.8564856455395856	0	0	0.8487250422222913	0.23853993628243075	ABCD4;IDUA;ACTN4;RHOC;PPOX;FHIT;TMEM67;ERCC1;NPHP1;ERBB2;EBAG9;TP53;PLEC
Rectal Carcinoma	7/276	0.7558104805987288	0.8564856455395856	0	0	0.8112761299477856	0.2271286144650635	RIMS2;SGSM3;ERCC1;ERBB2;AKT1;SSSCA1;TP53
Contact Dermatitis	2/87	0.7563002720848063	0.8564856455395856	0	0	0.7346278317152104	0.20519389247337938	HDAC4;PSMD12
DOSAGE-SENSITIVE SEX REVERSAL	2/87	0.7563002720848063	0.8564856455395856	0	0	0.7346278317152104	0.20519389247337938	CHRM3;RELA
Multiple tumors	2/87	0.7563002720848063	0.8564856455395856	0	0	0.7346278317152104	0.20519389247337938	AKT1;TP53
Polycystic Ovary Syndrome	14/526	0.7570419620179716	0.8564856455395856	0	0	0.8513562293729373	0.23696359409142873	INSR;HOOK3;SLC5A3;YWHAZ;AGPAT2;ACTB;SOX3;CAPN10;AKT2;NFIC;CAPN5;AKT1;SHBG;TTLL9
Tumor Progression	60/2090	0.757154218039666	0.8564856455395856	0	0	0.9157283603096411	0.25474493747491483	PHF1;HP1BP3;ARHGAP1;KEAP1;MSI1;HMGB1;RIMS2;SOX3;CCND3;MDK;AKT2;CFL1;CHMP1A;TRIM24;AKT1;SSSCA1;SYBU;EIF5A;TRPC5;LMO4;TAPBP;SPINT1;PSME3;AKT1S1;PKP3;GAPDH;TP53;OTUB1;FLII;TACSTD2;SEMA3F;NDRG2;FHIT;HDAC9;HDAC6;RELA;S100A16;MAP2;HSF1;ERBB2;OTX2;CKB;CTNNA2;PDLIM7;KCNJ3;JAG1;URGCP;AGK;INSR;USP22;FOXJ1;MTOR;HIPK2;BCL9;AIMP2;FER;GIPC1;PPP1R1B;SDC1;EBAG9
Pituitary Diseases	6/240	0.757851430773844	0.8564856455395856	0	0	0.7995489852167377	0.22168927940635605	RIMS2;SSSCA1;TP53;YWHAZ;GAPDH;ACTB
HYDATIDIFORM MOLE, RECURRENT, 1	1/45	0.7579623048764731	0.8564856455395856	0	0	0.7099427228667939	0.19674048051423954	ERBB2
Leukemia, Plasma Cell	1/45	0.7579623048764731	0.8564856455395856	0	0	0.7099427228667939	0.19674048051423954	TP53
Obesity, Visceral	1/45	0.7579623048764731	0.8564856455395856	0	0	0.7099427228667939	0.19674048051423954	SGSM3
Tall stature	1/45	0.7579623048764731	0.8564856455395856	0	0	0.7099427228667939	0.19674048051423954	AGPAT2
Young onset Parkinson disease	1/45	0.7579623048764731	0.8564856455395856	0	0	0.7099427228667939	0.19674048051423954	ATP13A2
Ascites	1/45	0.7579623048764731	0.8564856455395856	0	0	0.7099427228667939	0.19674048051423954	CHRM3
Cafe-au-Lait Spots	1/45	0.7579623048764731	0.8564856455395856	0	0	0.7099427228667939	0.19674048051423954	MTOR
Chondrodysplasia	1/45	0.7579623048764731	0.8564856455395856	0	0	0.7099427228667939	0.19674048051423954	HDAC6
Congenital neutropenia	1/45	0.7579623048764731	0.8564856455395856	0	0	0.7099427228667939	0.19674048051423954	AKT1
Diminished sweating	1/45	0.7579623048764731	0.8564856455395856	0	0	0.7099427228667939	0.19674048051423954	ROGDI
Distal Muscular Dystrophies	1/45	0.7579623048764731	0.8564856455395856	0	0	0.7099427228667939	0.19674048051423954	TPM2
Enteritis	1/45	0.7579623048764731	0.8564856455395856	0	0	0.7099427228667939	0.19674048051423954	AIMP2
Infectious Otitis Media	1/45	0.7579623048764731	0.8564856455395856	0	0	0.7099427228667939	0.19674048051423954	POLD4
Melanoderma (disorder)	1/45	0.7579623048764731	0.8564856455395856	0	0	0.7099427228667939	0.19674048051423954	HCCS
Nicotinamide adenine dinucleotide coenzyme Q reductase deficiency	1/45	0.7579623048764731	0.8564856455395856	0	0	0.7099427228667939	0.19674048051423954	NDUFS8
Left Ventricular Hypertrophy	5/203	0.7580125136729687	0.8564856455395856	0	0	0.7876324217787632	0.2182178035965625	BBS1;AKT1;CKB;MTOR;RAPGEF4
Childhood asthma	3/127	0.7580428294694398	0.8564856455395856	0	0	0.7550582945574319	0.20916276920668422	DPP10;ADCY2;HMGB1
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)	4/166	0.760506970858047	0.8587065819083213	0	0	0.7703222703222703	0.2108911288501168	AIMP2;ERCC1;SGSM3;TP53
Classical Hodgkin's Lymphoma	4/166	0.760506970858047	0.8587065819083213	0	0	0.7703222703222703	0.2108911288501168	TP53;FHIT;LDLR;PDLIM7
Keratoconus	4/166	0.760506970858047	0.8587065819083213	0	0	0.7703222703222703	0.2108911288501168	BBS2;IFT172;PDE6B;ACTB
Abnormality of the skeletal system	2/88	0.7618798810029928	0.8598810275220499	0	0	0.7260480168585836	0.19746064518835182	IDUA;MTOR
Facial muscle weakness of muscles innervated by CN VII	2/88	0.7618798810029928	0.8598810275220499	0	0	0.7260480168585836	0.19746064518835182	TPM2;CHD7
Hereditary Nonpolyposis Colorectal Cancer	3/128	0.7627032338275697	0.8603768530832279	0	0	0.7489789303079416	0.2028881086256535	SGSM3;ERBB2;TP53
Sepsis	14/529	0.7641865118671409	0.8603768530832279	0	0	0.8462622961325259	0.2275966542451486	KEAP1;HMGB1;YWHAZ;MTOR;RELA;RIMS2;AIMP2;FER;PSME3;PPP6R2;SUFU;SDC1;GAPDH;SYBU
Squamous cell carcinoma of skin	5/205	0.7654550109178004	0.8603768530832279	0	0	0.7796747967479675	0.20839525053837246	STAT2;ERCC1;ERBB2;TP53;HDAC9
Regional enteritis	1/46	0.7654823472284601	0.8603768530832279	0	0	0.6941303177167475	0.1855057197656638	TYK2
Telangiectasia of the skin	1/46	0.7654823472284601	0.8603768530832279	0	0	0.6941303177167475	0.1855057197656638	KIAA0319L
Telangiectasis	1/46	0.7654823472284601	0.8603768530832279	0	0	0.6941303177167475	0.1855057197656638	TP53
Sleep Apnea, Central	1/46	0.7654823472284601	0.8603768530832279	0	0	0.6941303177167475	0.1855057197656638	SLC5A3
Thrombasthenia	1/46	0.7654823472284601	0.8603768530832279	0	0	0.6941303177167475	0.1855057197656638	LAD1
Toxoplasmosis	1/46	0.7654823472284601	0.8603768530832279	0	0	0.6941303177167475	0.1855057197656638	IGF2BP1
Adult Diffuse Large B-Cell Lymphoma	1/46	0.7654823472284601	0.8603768530832279	0	0	0.6941303177167475	0.1855057197656638	TP53
Childhood Diffuse Large B-Cell Lymphoma	1/46	0.7654823472284601	0.8603768530832279	0	0	0.6941303177167475	0.1855057197656638	TP53
Choreoathetoid movements	1/46	0.7654823472284601	0.8603768530832279	0	0	0.6941303177167475	0.1855057197656638	ATP1A3
Cutaneous Mastocytosis	1/46	0.7654823472284601	0.8603768530832279	0	0	0.6941303177167475	0.1855057197656638	TP53
Disseminated Intravascular Coagulation	1/46	0.7654823472284601	0.8603768530832279	0	0	0.6941303177167475	0.1855057197656638	HMGB1
Hypohidrosis	1/46	0.7654823472284601	0.8603768530832279	0	0	0.6941303177167475	0.1855057197656638	ROGDI
IIeocolitis	1/46	0.7654823472284601	0.8603768530832279	0	0	0.6941303177167475	0.1855057197656638	TYK2
Ketosis	1/46	0.7654823472284601	0.8603768530832279	0	0	0.6941303177167475	0.1855057197656638	INSR
Malonic aciduria	1/46	0.7654823472284601	0.8603768530832279	0	0	0.6941303177167475	0.1855057197656638	AKT1
Nodular Sclerosis Classical Hodgkin Lymphoma	1/46	0.7654823472284601	0.8603768530832279	0	0	0.6941303177167475	0.1855057197656638	PDLIM7
Seizures, Focal	3/129	0.7672906162540779	0.86172465118712	0	0	0.7429960639036814	0.19681196690215785	MBOAT7;PLCB1;GABRG2
Chronic liver disease	3/129	0.7672906162540779	0.86172465118712	0	0	0.7429960639036814	0.19681196690215785	SHBG;RPS27A;TP53
Myocardial Diseases, Secondary	2/89	0.7673484606739795	0.86172465118712	0	0	0.7176654391250976	0.19004804534119568	AKT1;TP53
Nasopharyngeal Neoplasms	2/89	0.7673484606739795	0.86172465118712	0	0	0.7176654391250976	0.19004804534119568	ERBB2;TP53
Coronary heart disease	25/913	0.7675937338694081	0.8618128213419729	0	0	0.8749716102657279	0.23142533445446878	SEMA5B;GABRB1;MTR;FHIT;HDAC9;SMG6;ATXN2;AKT1;LDLR;SORT1;INSR;SMARCA2;KIF6;YWHAZ;TMEM231;CACNB2;KIF9;MAF;TCN2;CAPN10;TRIB3;SHBG;GAPDH;TP53;ST6GALNAC5
Childhood Leukemia	4/168	0.7686267524515507	0.8627851991028701	0	0	0.7608489071903706	0.2002172337466259	FCGRT;MTR;HMGB1;SPG7
Esophageal Neoplasms	17/637	0.7702915230929049	0.8636831198835662	0	0	0.8530465949820788	0.22263341856352353	PRKCI;TPM2;FBXL19;FOXK1;MTR;FHIT;MTOR;ACTB;RELA;RIMS2;MDK;KCNQ1OT1;ERCC1;ERBB2;AKT1;GAPDH;TP53
Ulcerative Colitis	25/915	0.7711974183304474	0.8636831198835662	0	0	0.8729109621376641	0.2267917681082258	TRAF3IP2;IDUA;KEAP1;MSI1;MTR;HMGB1;APEH;FHIT;RELA;CDH3;FZD3;INSR;FNDC3A;TYK2;YWHAZ;UBAC2;GNAO1;AIMP2;KAT2A;MAF;TCN2;SGSM3;CDK2AP2;SDC1;TP53
Delayed Puberty	3/130	0.7718055581274196	0.8636831198835662	0	0	0.7371074158679922	0.19092750026532995	INSR;CHD7;ALDOA
Periodontitis, Juvenile	2/90	0.7727075197898818	0.8636831198835662	0	0	0.7094733745219182	0.18294102446006727	AKT1;TP53
Venous Thrombosis	2/90	0.7727075197898818	0.8636831198835662	0	0	0.7094733745219182	0.18294102446006727	TP53;UBAC2
Bacteremia	2/90	0.7727075197898818	0.8636831198835662	0	0	0.7094733745219182	0.18294102446006727	SUFU;SGSM3
Degenerative disorder	2/90	0.7727075197898818	0.8636831198835662	0	0	0.7094733745219182	0.18294102446006727	LMNB1;SGSH
Dehydration	2/90	0.7727075197898818	0.8636831198835662	0	0	0.7094733745219182	0.18294102446006727	CAPN1;PLEC
Hip circumference	2/90	0.7727075197898818	0.8636831198835662	0	0	0.7094733745219182	0.18294102446006727	INSR;ATP13A2
Motor neuron atrophy	2/90	0.7727075197898818	0.8636831198835662	0	0	0.7094733745219182	0.18294102446006727	KEAP1;VPS54
Polycythemia Vera	5/207	0.7727231114289245	0.8636831198835662	0	0	0.7718747484504548	0.19901593560428177	SGSM3;PTPN9;SSSCA1;TYK2;TP53
Severe congenital neutropenia	1/47	0.7727691072642434	0.8636831198835662	0	0	0.6790054084427899	0.17503060011863492	AKT1
Hypertension, Renovascular	1/47	0.7727691072642434	0.8636831198835662	0	0	0.6790054084427899	0.17503060011863492	RELA
Tracheoesophageal Fistula	1/47	0.7727691072642434	0.8636831198835662	0	0	0.6790054084427899	0.17503060011863492	CHD7
Antiphospholipid Syndrome	1/47	0.7727691072642434	0.8636831198835662	0	0	0.6790054084427899	0.17503060011863492	ATXN2
ATRICHIA WITH PAPULAR LESIONS	1/47	0.7727691072642434	0.8636831198835662	0	0	0.6790054084427899	0.17503060011863492	TRIB3
Hyperparathyroidism	1/47	0.7727691072642434	0.8636831198835662	0	0	0.6790054084427899	0.17503060011863492	PLCB3
Mitral Valve Insufficiency	1/47	0.7727691072642434	0.8636831198835662	0	0	0.6790054084427899	0.17503060011863492	IDUA
Peripheral demyelinating neuropathy	1/47	0.7727691072642434	0.8636831198835662	0	0	0.6790054084427899	0.17503060011863492	GDAP1
Protein measurement	1/47	0.7727691072642434	0.8636831198835662	0	0	0.6790054084427899	0.17503060011863492	NDRG2
Carcinogenesis	119/4065	0.7757471756456296	0.866665116134514	0	0	0.9290319513026658	0.23590779804619116	CHRM3;GLDC;XYLT2;DIXDC1;KEAP1;MSI1;CASC2;APEH;ACTB;RIMS2;SOX3;CCND3;SOX1;MAGED4B;CAPNS1;SALL2;FCGRT;AKT2;TRIM24;AKT1;SEPHS1;SYBU;ANKS1B;STARD3;PRKCI;LMO4;FNDC3A;ACTN4;FBXO10;MAF;PSME3;TRIB3;PKP3;RIN1;TP53;TSTA3;CTBP1;FLII;TACSTD2;NDRG2;FHIT;SHARPIN;PDZD2;S100A16;KCNQ1OT1;MAP6;OTX2;FADD;MAP2K5;JAG1;INSR;FOXN3;SMARCA2;GNAO1;AIMP2;VANGL2;GIPC1;TADA3;PPP1R1B;SDC1;SHBG;RPAIN;RERE;BNC2;LDB1;PHF1;HP1BP3;MTR;CHD4;PTPN23;HMGB1;CSAD;MDK;SSSCA1;UNC45A;EIF5A;RHBDF1;RHOC;YWHAZ;PLCB3;KCNMA1;AKT1S1;GAPDH;HDAC4;IDUA;RAB1B;AMBRA1;SEMA3F;SPG7;HDAC9;HDAC6;RELA;MLLT6;TBRG1;ZNRF3;HSF1;ERBB2;IGF2BP1;CKB;RPS27A;MIR92B;LDLR;PDLIM7;URGCP;AGK;USP22;FOXJ1;SORBS2;DHRS1;MTOR;HIPK2;RAD52;NBR2;TMEM54;NFIC;CROCC;SGSM3;ERCC1;EBAG9
Glioblastoma	55/1937	0.7757726058897565	0.866665116134514	0	0	0.905071802732924	0.22979396144180242	MAST2;ARHGAP1;MSI1;MTR;CHD4;HMGB1;ACTB;ADAMTS5;CCND3;MAGED4B;CAPNS1;SALL2;FCGRT;MDK;AKT2;CREB3L2;TRIM24;AKT1;SSSCA1;SYBU;EIF5A;PRKCI;PDE4D;SYP;RHOC;TAPBP;SPINT1;TEP1;GAPDH;TP53;PLEC;HDAC4;IGSF8;IDUA;SPG7;NDRG2;HDAC9;HDAC6;RELA;HSF1;ERBB2;FADD;MIR92B;LDLR;KCNJ3;JAG1;STAT2;INSR;SMARCA2;MTOR;PPP1CA;AIMP2;TCN2;SGSM3;ERCC1
Neoplastic Cell Transformation	3/131	0.7762486579914782	0.8668876017550944	0	0	0.7313107779578606	0.18522813039082311	MIR92B;TP53;RELA
Dental caries	4/170	0.7765296899759716	0.8668876017550944	0	0	0.7516038178688781	0.1900959393711104	CDH3;ERCC8;TP53;PLEC
Lymphadenopathy	2/91	0.7779585803985358	0.8668876017550944	0	0	0.7014654012581361	0.17612533221933357	CHD7;TP53
Meningitis	2/91	0.7779585803985358	0.8668876017550944	0	0	0.7014654012581361	0.17612533221933357	MDK;UBAC2
Leukopenia	6/246	0.7780743366211369	0.8668876017550944	0	0	0.7793159609120521	0.19555625646454933	CREBZF;STAT2;ERCC1;MTR;SPG7;TP53
Adult T-Cell Lymphoma/Leukemia	13/500	0.7791247182130758	0.8668876017550944	0	0	0.8308576531837664	0.207368897422109	IFT172;TARS;NDRG2;DNALI1;RELA;TM9SF3;POLD4;DLG1;FCGRT;AKT1;SSSCA1;FEZF2;TP53
Papillary thyroid carcinoma	15/571	0.7794971715513299	0.8668876017550944	0	0	0.8394078125929009	0.20910170642188042	HDAC4;JAG1;INSR;USP22;HOOK3;HMGB1;MTOR;RELA;ZNRF3;MDK;SGSM3;TRIM24;AKT1;SSSCA1;TP53
Nonalcoholic Steatohepatitis	5/209	0.7798181267602031	0.8668876017550944	0	0	0.7642276422764228	0.19005925517793218	INSR;KEAP1;AKT1;TP53;LDLR
Renal tubular disorder	1/48	0.7798298104797666	0.8668876017550944	0	0	0.6645241123294263	0.16525357369735064	ABCC10
Right Ventricular Hypertrophy	1/48	0.7798298104797666	0.8668876017550944	0	0	0.6645241123294263	0.16525357369735064	KEAP1
Mental Retardation, X-Linked 1	1/48	0.7798298104797666	0.8668876017550944	0	0	0.6645241123294263	0.16525357369735064	SYP
Abnormal urinary amino-acid findings	1/48	0.7798298104797666	0.8668876017550944	0	0	0.6645241123294263	0.16525357369735064	DHTKD1
Agyria	1/48	0.7798298104797666	0.8668876017550944	0	0	0.6645241123294263	0.16525357369735064	ACTB
Alcoholic Steatohepatitis	1/48	0.7798298104797666	0.8668876017550944	0	0	0.6645241123294263	0.16525357369735064	TP53
Cone dystrophy	1/48	0.7798298104797666	0.8668876017550944	0	0	0.6645241123294263	0.16525357369735064	CDH3
contracture of elbow	1/48	0.7798298104797666	0.8668876017550944	0	0	0.6645241123294263	0.16525357369735064	TPM2
Corneal Neovascularization	1/48	0.7798298104797666	0.8668876017550944	0	0	0.6645241123294263	0.16525357369735064	INSR
Cutis marmorata	1/48	0.7798298104797666	0.8668876017550944	0	0	0.6645241123294263	0.16525357369735064	SETD5
Delayed myelination	1/48	0.7798298104797666	0.8668876017550944	0	0	0.6645241123294263	0.16525357369735064	GNAO1
Fabry Disease	1/48	0.7798298104797666	0.8668876017550944	0	0	0.6645241123294263	0.16525357369735064	ERBB2
keratoacanthoma	1/48	0.7798298104797666	0.8668876017550944	0	0	0.6645241123294263	0.16525357369735064	TP53
Neuroblastic tumors	1/48	0.7798298104797666	0.8668876017550944	0	0	0.6645241123294263	0.16525357369735064	TP53
Paresthesia	1/48	0.7798298104797666	0.8668876017550944	0	0	0.6645241123294263	0.16525357369735064	TP53
Cardiac Arrhythmia	3/132	0.7806205304802909	0.8670206106860399	0	0	0.7256040104029249	0.17970753258632297	PEX6;ERCC8;HCCS
Nausea and vomiting	3/132	0.7806205304802909	0.8670206106860399	0	0	0.7256040104029249	0.17970753258632297	CHRM3;KIAA0319L;UBAC2
Night Blindness	3/132	0.7806205304802909	0.8670206106860399	0	0	0.7256040104029249	0.17970753258632297	PEX6;PDE6B;PEX26
precancerous lesions	3/132	0.7806205304802909	0.8670206106860399	0	0	0.7256040104029249	0.17970753258632297	MDK;TP53;FHIT
Diabetes Mellitus, Non-Insulin-Dependent	47/1672	0.7819072461260683	0.8682631388009285	0	0	0.8962115720230903	0.22048521505171437	CHRM3;GPM6A;PGAP3;CTBP1;XYLT2;HCCS;MTR;HMGB1;FHIT;HDAC9;ACTB;RELA;RIMS2;NKRF;AKT2;SESN1;CAPN5;AKT1;MAP6;PDSS2;CAPN1;MIR92B;LDLR;KCNJ3;SYT4;PRKCI;SLC2A11;NEGR1;SORT1;LINC00271;INSR;KIF6;ACVR2B;MTOR;GNAO1;LRFN2;BCL9;AIMP2;TEP1;CAPN10;SGSM3;PTPN9;TRIB3;SHBG;GAPDH;TP53;PPIL6
Cardiomyopathies, Primary	2/92	0.7831031753179841	0.8688443988929458	0	0	0.6936353829557713	0.16958748524417325	AKT1;TP53
Acute kidney injury	2/92	0.7831031753179841	0.8688443988929458	0	0	0.6936353829557713	0.16958748524417325	TCN2;TP53
Bell Palsy	2/92	0.7831031753179841	0.8688443988929458	0	0	0.6936353829557713	0.16958748524417325	TPM2;CHD7
Facial Paresis	2/92	0.7831031753179841	0.8688443988929458	0	0	0.6936353829557713	0.16958748524417325	TPM2;CHD7
Vesicular Stomatitis	3/133	0.7849218052624165	0.8705606206048354	0	0	0.7199850392719113	0.1743596245930526	STAT2;ERBB2;DNAI1
Sparse eyelashes	1/49	0.7866714586347875	0.8705606206048354	0	0	0.6506462035541195	0.15611902884596046	CDH3
Abnormality of vision	1/49	0.7866714586347875	0.8705606206048354	0	0	0.6506462035541195	0.15611902884596046	CDH3
Antisocial behavior	1/49	0.7866714586347875	0.8705606206048354	0	0	0.6506462035541195	0.15611902884596046	PPP1R1B
cardiac event	1/49	0.7866714586347875	0.8705606206048354	0	0	0.6506462035541195	0.15611902884596046	ERBB2
Congenital absence of germinal epithelium of testes	1/49	0.7866714586347875	0.8705606206048354	0	0	0.6506462035541195	0.15611902884596046	GAPDH
Dryness of eye	1/49	0.7866714586347875	0.8705606206048354	0	0	0.6506462035541195	0.15611902884596046	JAG1
Endogenous depression	1/49	0.7866714586347875	0.8705606206048354	0	0	0.6506462035541195	0.15611902884596046	DIXDC1
Fibrinogen assay	1/49	0.7866714586347875	0.8705606206048354	0	0	0.6506462035541195	0.15611902884596046	PLEC
Intracranial Hemorrhages	1/49	0.7866714586347875	0.8705606206048354	0	0	0.6506462035541195	0.15611902884596046	MAP2
Malignant hyperpyrexia due to anesthesia	1/49	0.7866714586347875	0.8705606206048354	0	0	0.6506462035541195	0.15611902884596046	CACNA2D1
Polyarthritis	1/49	0.7866714586347875	0.8705606206048354	0	0	0.6506462035541195	0.15611902884596046	TYK2
Tonic - clonic seizures	4/173	0.7879829292083393	0.8710697668812979	0	0	0.7381464689156997	0.17588469381168303	MAPK10;KCNMA1;EFHC1;GABRG2
Fever	4/173	0.7879829292083393	0.8710697668812979	0	0	0.7381464689156997	0.17588469381168303	CHD7;HSF1;HMGB1;UBAC2
Muscular Dystrophies, Limb-Girdle	2/93	0.7881428463500288	0.8710697668812979	0	0	0.6859774529677443	0.16331471901724923	SYVN1;PLEC
Osteoarthritis, Knee	2/93	0.7881428463500288	0.8710697668812979	0	0	0.6859774529677443	0.16331471901724923	BCL9;ANKRD6
Coughing	2/93	0.7881428463500288	0.8710697668812979	0	0	0.6859774529677443	0.16331471901724923	DPP9;ATP11A
Pregnancy Complications	2/93	0.7881428463500288	0.8710697668812979	0	0	0.6859774529677443	0.16331471901724923	PDZD2;SLC5A3
Tumor Immunity	3/134	0.7891531261102042	0.871999862248778	0	0	0.7144518539596917	0.16917855587140548	ERBB2;AKT1;TP53
Single transverse palmar crease	1/50	0.7933008373384467	0.8747285458074928	0	0	0.6373347400349477	0.1475766201140724	PEX6
stage, prostate cancer	1/50	0.7933008373384467	0.8747285458074928	0	0	0.6373347400349477	0.1475766201140724	TP53
Chronic inflammatory disorder	1/50	0.7933008373384467	0.8747285458074928	0	0	0.6373347400349477	0.1475766201140724	TP53
Clostridium; difficile (disorder)	1/50	0.7933008373384467	0.8747285458074928	0	0	0.6373347400349477	0.1475766201140724	HCCS
Giant Cell Tumors	1/50	0.7933008373384467	0.8747285458074928	0	0	0.6373347400349477	0.1475766201140724	TP53
Hepatitis D Infection	1/50	0.7933008373384467	0.8747285458074928	0	0	0.6373347400349477	0.1475766201140724	SSSCA1
Lymphedema	1/50	0.7933008373384467	0.8747285458074928	0	0	0.6373347400349477	0.1475766201140724	AKT1
Moyamoya Disease	1/50	0.7933008373384467	0.8747285458074928	0	0	0.6373347400349477	0.1475766201140724	TCN2
Middle Cerebral Artery Occlusion	3/135	0.7933151498064471	0.8747285458074928	0	0	0.7090025047885664	0.16415869760206966	CHRM3;MAP2;SYP
Mycoses	3/135	0.7933151498064471	0.8747285458074928	0	0	0.7090025047885664	0.16415869760206966	JAG1;MDK;MTOR
Lymphoid leukemia	5/213	0.7934949085439507	0.8747401210228535	0	0	0.7493746091307066	0.17333645860906885	GPM6A;FPGS;TYK2;ATP11A;TP53
Lymphoma	36/1307	0.7942750223753889	0.8754133750556643	0	0	0.8782912818080898	0.20229288031581572	CREBZF;GLDC;FLII;HEXA;HCCS;MTR;SEMA3F;HMGB1;SPG7;FHIT;HDAC9;HDAC6;ACTB;RELA;RIMS2;CCND3;FCGRT;MDK;DPP9;AKT2;HSF1;ERBB2;IGF2BP1;AKT1;SSSCA1;PDLIM7;EIF5A;JAG1;SYVN1;TYK2;MTOR;AIMP2;SDC1;SHBG;GAPDH;TP53
Juvenile arthritis	8/326	0.7956465596723208	0.876738042726344	0	0	0.7835738068812431	0.17912513857145973	ANKRD9;RERE;ATXN2;MAP2;SH3BGRL2;HMGB1;TP53;HDAC9
Osteosarcoma	30/1103	0.7971984613677917	0.8774544663882303	0	0	0.8675343958803924	0.19662807683128702	GLDC;CASC2;HMGB1;SPG7;HDAC9;AGPAT2;RELA;CCND3;GRM5;MDK;AKT2;HSF1;FPGS;ERBB2;IGF2BP1;AKT1;SSSCA1;FADD;PDLIM7;JAG1;URGCP;USP22;YWHAZ;MTOR;SGSM3;ERCC1;KCNMA1;SDC1;ALDOA;TP53
Rheumatism	2/95	0.7979136166837177	0.8774544663882303	0	0	0.6711556529909176	0.15151670226657343	AIMP2;PDLIM7
Limb ischemia	2/95	0.7979136166837177	0.8774544663882303	0	0	0.6711556529909176	0.15151670226657343	AKT1;HMGB1
Hypertensive disease	36/1310	0.7985308193012942	0.8774544663882303	0	0	0.8760779338078751	0.19710151652711735	LAD1;CNTNAP2;IDUA;IFT172;ARHGAP1;MTR;HMGB1;HDAC9;HDAC6;RELA;AKT2;RNPEP;CAPN5;NPHP1;AKT1;FADD;CAPN1;SEPHS1;LDLR;BBS2;BBS1;TRPC5;CACNA2D1;INSR;PDE4D;ACTN4;YWHAZ;MTOR;CACNB2;CAPN10;KCNMA1;ERCC8;CNTN4;SHBG;TP53;CBLN2
Anaplastic thyroid carcinoma	4/176	0.798962895927794	0.8774544663882303	0	0	0.7251585623678647	0.1627551478735773	TRAF3IP2;ERBB2;AKT1;TP53
Mucosa-Associated Lymphoid Tissue Lymphoma	4/176	0.798962895927794	0.8774544663882303	0	0	0.7251585623678647	0.1627551478735773	SLC35B2;TP53;ACTB;RELA
Cockayne Syndrome, Type I	1/51	0.7997245220377278	0.8774544663882303	0	0	0.6245557350565428	0.13958068592760045	ERCC8
Lymphohistiocytosis, Hemophagocytic	1/51	0.7997245220377278	0.8774544663882303	0	0	0.6245557350565428	0.13958068592760045	PDLIM7
Tapering fingers (finding)	1/51	0.7997245220377278	0.8774544663882303	0	0	0.6245557350565428	0.13958068592760045	CHD4
Tachycardia, Ventricular	1/51	0.7997245220377278	0.8774544663882303	0	0	0.6245557350565428	0.13958068592760045	JUP
Albinism	1/51	0.7997245220377278	0.8774544663882303	0	0	0.6245557350565428	0.13958068592760045	HPS6
Autoimmune Primary Adrenal Insufficiency	1/51	0.7997245220377278	0.8774544663882303	0	0	0.6245557350565428	0.13958068592760045	GNAO1
Bicuspid aortic valve	1/51	0.7997245220377278	0.8774544663882303	0	0	0.6245557350565428	0.13958068592760045	ACTB
Congenital adrenal hyperplasia	1/51	0.7997245220377278	0.8774544663882303	0	0	0.6245557350565428	0.13958068592760045	TP53
Epistaxis	1/51	0.7997245220377278	0.8774544663882303	0	0	0.6245557350565428	0.13958068592760045	HPS6
Frequent nosebleeds	1/51	0.7997245220377278	0.8774544663882303	0	0	0.6245557350565428	0.13958068592760045	HPS6
Hyperpigmentation	1/51	0.7997245220377278	0.8774544663882303	0	0	0.6245557350565428	0.13958068592760045	HCCS
NONAKA MYOPATHY	1/51	0.7997245220377278	0.8774544663882303	0	0	0.6245557350565428	0.13958068592760045	SHBG
Premature coronary artery disease	1/51	0.7997245220377278	0.8774544663882303	0	0	0.6245557350565428	0.13958068592760045	LDLR
Rabies (disorder)	1/51	0.7997245220377278	0.8774544663882303	0	0	0.6245557350565428	0.13958068592760045	HDAC6
Fibrosis, Liver	14/545	0.7998760937188236	0.8774544663882303	0	0	0.8200667524379557	0.18311963156791247	BBS2;CHRM3;BBS1;IFT172;INSR;NDRG2;AIMP2;SPINT1;DPP9;TMEM67;AP1S1;SSSCA1;FADD;TP53
Alzheimer Disease, Late Onset	6/253	0.8000320134716218	0.8774544663882303	0	0	0.7569531445752944	0.16887892259252987	CHRNB2;INSR;PHF1;AMPH;LDLR;GAPDH
Hypertrophic Cardiomyopathy	8/328	0.8010186721326021	0.8783502010569252	0	0	0.7785947712418301	0.1727476169640987	CACNB2;AGK;TPM2;AKT1;HCCS;TP53;GAPDH;AGPAT2
Pruritus	3/137	0.8014339923148772	0.8786191922535609	0	0	0.6983478071554706	0.15458114856994773	AIMP2;CHD7;MTOR
Platelet mean volume determination (procedure)	4/177	0.80251940384311	0.8792911450698957	0	0	0.7209293596576833	0.15860391484214895	ST7L;TCF12;DCAF5;WDR66
Telecanthus	2/96	0.802647826379326	0.8792911450698957	0	0	0.6639812710872409	0.14596913377105683	ALG9;ACTB
Idiopathic pulmonary hypertension	2/96	0.802647826379326	0.8792911450698957	0	0	0.6639812710872409	0.14596913377105683	RNPEP;HMGB1
Asthma	36/1313	0.802727481122246	0.8792911450698957	0	0	0.8738749852501045	0.19202528801257993	DPP10;CHRM3;BNC2;PGAP3;DNAH5;ADCY2;HCCS;HMGB1;HDAC9;HDAC6;ACTB;RELA;RIMS2;ATXN2;PSMD7;FCGRT;CFL1;ERBB2;SLC16A7;PIP5K1B;LDLR;STARD3;BBS1;JAG1;STAT2;PDE4D;ORMDL1;YWHAZ;MTOR;ANO3;TAPBP;AIMP2;EFHC1;SPATS2L;GAPDH;TP53
Primary biliary cirrhosis	8/329	0.8036646688764062	0.8801311737133434	0	0	0.776128519943803	0.16964087505784176	PDZD2;SPINT1;DPP9;OGDH;SSSCA1;TYK2;TP53;EBAG9
Coronary Arteriosclerosis	20/760	0.8048860502346343	0.8802079115021604	0	0	0.8396396396396396	0.182247615971841	EIF5A;SORT1;INSR;MTR;HMGB1;HDAC9;KIF6;YWHAZ;MAF;APH1B;CAPN10;AKT2;KCNQ1OT1;AKT1;TRIB3;SHBG;LDLR;GAPDH;TP53;ST6GALNAC5
Abdominal discomfort	3/138	0.8053921814495946	0.8802079115021604	0	0	0.6931388438681794	0.150013224637769	PPOX;TP53;UBAC2
X-linked agammaglobulinemia	1/52	0.8059488849125819	0.8802079115021604	0	0	0.6122778675282714	0.13208973924517153	DNALI1
Aminoaciduria	1/52	0.8059488849125819	0.8802079115021604	0	0	0.6122778675282714	0.13208973924517153	DHTKD1
Chronic progressive external ophthalmoplegia	1/52	0.8059488849125819	0.8802079115021604	0	0	0.6122778675282714	0.13208973924517153	SPG7
Congenital absence of kidney	1/52	0.8059488849125819	0.8802079115021604	0	0	0.6122778675282714	0.13208973924517153	FRAS1
Endocrine System Diseases	1/52	0.8059488849125819	0.8802079115021604	0	0	0.6122778675282714	0.13208973924517153	SHBG
Flexion contracture - elbow	1/52	0.8059488849125819	0.8802079115021604	0	0	0.6122778675282714	0.13208973924517153	TPM2
Hoarseness	1/52	0.8059488849125819	0.8802079115021604	0	0	0.6122778675282714	0.13208973924517153	FLII
Idiopathic crescentic glomerulonephritis	1/52	0.8059488849125819	0.8802079115021604	0	0	0.6122778675282714	0.13208973924517153	MTOR
Parasitic Diseases	1/52	0.8059488849125819	0.8802079115021604	0	0	0.6122778675282714	0.13208973924517153	GAPDH
Progressive microcephaly	1/52	0.8059488849125819	0.8802079115021604	0	0	0.6122778675282714	0.13208973924517153	COG1
Range of joint movement increased	1/52	0.8059488849125819	0.8802079115021604	0	0	0.6122778675282714	0.13208973924517153	CHAMP1
Major Depressive Disorder	13/513	0.8079585863460749	0.8822163478209413	0	0	0.8086985172981878	0.17245049180323788	CHRM3;CNTNAP2;GPM6A;TYK2;MTOR;BCL9;LRFN5;GRM5;MAF;MAP2;SGSM3;PPP1R1B;PLCB1
Osteosarcoma of bone	28/1042	0.8095650067438096	0.88378368290072	0	0	0.8566687989764913	0.18097831213324794	CASC2;HMGB1;SPG7;HDAC9;AGPAT2;CCND3;GRM5;MDK;AKT2;HSF1;FPGS;ERBB2;IGF2BP1;AKT1;SSSCA1;FADD;PDLIM7;JAG1;URGCP;USP22;YWHAZ;MTOR;SGSM3;ERCC1;KCNMA1;SDC1;ALDOA;TP53
Henoch-Schoenlein Purpura	2/98	0.8118216848508063	0.8838064791575281	0	0	0.6500809061488673	0.1355253327417852	FCGRT;SPG7
Mycobacterium Infections	2/98	0.8118216848508063	0.8838064791575281	0	0	0.6500809061488673	0.1355253327417852	PSMD7;TYK2
Myelofibrosis	2/98	0.8118216848508063	0.8838064791575281	0	0	0.6500809061488673	0.1355253327417852	AKT1;TP53
RESTING HEART RATE	1/53	0.8119801012074195	0.8838064791575281	0	0	0.6004722256741643	0.12506602191509633	SLC35F1
Prostate cancer, familial	1/53	0.8119801012074195	0.8838064791575281	0	0	0.6004722256741643	0.12506602191509633	PDSS2
Tachycardia	1/53	0.8119801012074195	0.8838064791575281	0	0	0.6004722256741643	0.12506602191509633	PPOX
Thick vermilion border	1/53	0.8119801012074195	0.8838064791575281	0	0	0.6004722256741643	0.12506602191509633	IDUA
Thrombocytopenia due to platelet alloimmunization	1/53	0.8119801012074195	0.8838064791575281	0	0	0.6004722256741643	0.12506602191509633	FCGRT
Turner Syndrome, Male	1/53	0.8119801012074195	0.8838064791575281	0	0	0.6004722256741643	0.12506602191509633	SGSM3
Tumor-Associated Vasculature	1/53	0.8119801012074195	0.8838064791575281	0	0	0.6004722256741643	0.12506602191509633	EML2
Abnormality of pelvic girdle bone morphology	1/53	0.8119801012074195	0.8838064791575281	0	0	0.6004722256741643	0.12506602191509633	IFT172
Bradycardia	1/53	0.8119801012074195	0.8838064791575281	0	0	0.6004722256741643	0.12506602191509633	CACNA2D1
Cone-Rod Dystrophies	1/53	0.8119801012074195	0.8838064791575281	0	0	0.6004722256741643	0.12506602191509633	CDH3
Myeloid neoplasm	1/53	0.8119801012074195	0.8838064791575281	0	0	0.6004722256741643	0.12506602191509633	NUMA1
Cholangitis, Sclerosing	3/140	0.8131095931671344	0.8846632373658423	0	0	0.6829490470726023	0.14129490326468105	KEAP1;FNDC3A;TYK2
Gastrointestinal pain	3/140	0.8131095931671344	0.8846632373658423	0	0	0.6829490470726023	0.14129490326468105	PPOX;TP53;UBAC2
Liver neoplasms	36/1321	0.8136294008825661	0.8850424634310886	0	0	0.8680507435637759	0.1790357246456798	DPP10;MSI1;HMGB1;SPG7;NDRG2;FHIT;HDAC9;RELA;RIMS2;NUDCD3;MAGED4B;CAPNS1;DPP9;KCNQ1OT1;HSF1;ERBB2;AKT1;SSSCA1;LDLR;PDLIM7;CCDC134;URGCP;STAT2;INSR;YWHAZ;MTOR;GNAO1;AIMP2;SPINT1;SDC1;TRIB3;SCG3;SHBG;GAPDH;TP53;TTLL9
Cardiomyopathies	12/480	0.8145413734716909	0.8858480256948019	0	0	0.7975708502024291	0.16360575322253237	RERE;JUP;IDUA;AGK;KCNQ1OT1;ERBB2;AKT1;RBCK1;TYK2;HMGB1;TP53;PLEC
Idiopathic pulmonary arterial hypertension	7/297	0.8177217504168832	0.88848333671505	0	0	0.7517016369466164	0.15126729477337783	HDAC4;IDUA;AKT1;CAPN1;HMGB1;TP53;CBLN2
Hemophilia, NOS	1/54	0.8178241549445613	0.88848333671505	0	0	0.5891120797390801	0.11847511383638967	ACTB
Cerebral Aneurysm	1/54	0.8178241549445613	0.88848333671505	0	0	0.5891120797390801	0.11847511383638967	TCN2
Cognition	1/54	0.8178241549445613	0.88848333671505	0	0	0.5891120797390801	0.11847511383638967	NEGR1
Congenital ichthyosis	1/54	0.8178241549445613	0.88848333671505	0	0	0.5891120797390801	0.11847511383638967	AP1S1
Sjogren's Syndrome	6/260	0.8202743674938406	0.8907707357024939	0	0	0.7358229244145784	0.14577858895744758	RIMS2;CHRM3;TRAF3IP2;DGKQ;HMGB1;TP53
Malignant Pleural Mesothelioma	6/260	0.8202743674938406	0.8907707357024939	0	0	0.7358229244145784	0.14577858895744758	DPP10;BBS1;AIMP2;AKT1;TP53;MTOR
Myalgia	2/100	0.8206131737532931	0.8909514457892896	0	0	0.6367479030447131	0.12588725421745459	RBCK1;UBAC2
Triglycerides measurement	8/336	0.8214475460847422	0.8916700101167713	0	0	0.7592858281523992	0.1493417996904757	SEMA5B;MAU2;NUMA1;BNC2;INSR;PPP1R1B;PDSS2;LDLR
Delayed bone age	4/183	0.8227993076707182	0.8921970681917892	0	0	0.696546470289487	0.13585648717787416	SETD5;CTBP1;INSR;CHD7
Bone Diseases, Developmental	1/55	0.82348684506092	0.8921970681917892	0	0	0.5781726799497398	0.11228558864066239	TP53
Scoliosis, unspecified	1/55	0.82348684506092	0.8921970681917892	0	0	0.5781726799497398	0.11228558864066239	CHD7
Atherogenesis	1/55	0.82348684506092	0.8921970681917892	0	0	0.5781726799497398	0.11228558864066239	LDLR
Dysmorphic features	1/55	0.82348684506092	0.8921970681917892	0	0	0.5781726799497398	0.11228558864066239	TPM2
Ganglioneuroma	1/55	0.82348684506092	0.8921970681917892	0	0	0.5781726799497398	0.11228558864066239	SYP
Gingivitis	1/55	0.82348684506092	0.8921970681917892	0	0	0.5781726799497398	0.11228558864066239	PDLIM7
Protein C antigen measurement	1/55	0.82348684506092	0.8921970681917892	0	0	0.5781726799497398	0.11228558864066239	ACSS2
Protein C measurement	1/55	0.82348684506092	0.8921970681917892	0	0	0.5781726799497398	0.11228558864066239	ACSS2
Myositis	3/143	0.8241990299818585	0.8927815105735158	0	0	0.6682102338504283	0.12919392960845696	TRIM24;TARS;HMGB1
Hypertension, Portal	2/101	0.8248694103664712	0.892843148846655	0	0	0.6302834166911837	0.12134858952520797	TMEM67;MTOR
Forced expiratory volume function	2/101	0.8248694103664712	0.892843148846655	0	0	0.6302834166911837	0.12134858952520797	CHRM3;ARMC2
Neuromuscular Diseases	2/101	0.8248694103664712	0.892843148846655	0	0	0.6302834166911837	0.12134858952520797	RIMS2;PLEC
Pain	12/485	0.8249469883403209	0.892843148846655	0	0	0.7889312340046735	0.15181889028790727	ATXN2;AKT2;CACNA2D1;ERBB2;AKT1;PLCB1;SHBG;TP53;MTOR;CCT5;KCNJ3;ANO3
Endothelial dysfunction	6/262	0.8257511857191199	0.8935264086675903	0	0	0.7299979641693811	0.13976670872737337	AIMP2;TRAF3IP2;AKT1;TRIB3;HMGB1;RELA
Cutaneous Melanoma	7/301	0.8280081520552893	0.8938524227680557	0	0	0.7413190398508506	0.13991083198164084	MAGED4B;MAP2;ERBB2;MIB2;AKT1;TP53;MTOR
Renal Insufficiency	6/263	0.8284394523342767	0.8938524227680557	0	0	0.7271194818692253	0.13685226716160526	CHRM3;TMEM67;NPHP1;ERCC8;CHD4;LDLR
Respiratory insufficiency due to muscle weakness	1/56	0.8289737912048453	0.8938524227680557	0	0	0.5676310765163753	0.10646871014669712	TPM2
Treatment related acute myeloid leukaemia	1/56	0.8289737912048453	0.8938524227680557	0	0	0.5676310765163753	0.10646871014669712	TP53
Autoimmune arthritis	1/56	0.8289737912048453	0.8938524227680557	0	0	0.5676310765163753	0.10646871014669712	AIMP2
Channelopathies	1/56	0.8289737912048453	0.8938524227680557	0	0	0.5676310765163753	0.10646871014669712	KCNJ3
Glucocorticoid Receptor Deficiency	1/56	0.8289737912048453	0.8938524227680557	0	0	0.5676310765163753	0.10646871014669712	JAG1
Gonorrhea	1/56	0.8289737912048453	0.8938524227680557	0	0	0.5676310765163753	0.10646871014669712	LY6E
Laryngeal Diseases	1/56	0.8289737912048453	0.8938524227680557	0	0	0.5676310765163753	0.10646871014669712	TP53
Paralysed	1/56	0.8289737912048453	0.8938524227680557	0	0	0.5676310765163753	0.10646871014669712	ATXN2
Parathyroid Neoplasms	1/56	0.8289737912048453	0.8938524227680557	0	0	0.5676310765163753	0.10646871014669712	TP53
Progressive sensorineural hearing impairment	1/56	0.8289737912048453	0.8938524227680557	0	0	0.5676310765163753	0.10646871014669712	ATP1A3
Adult Acute Myeloblastic Leukemia	2/102	0.8290347020695792	0.8938524227680557	0	0	0.623948220064725	0.11698608870048342	TP53;MTOR
Childhood Acute Myeloid Leukemia	2/102	0.8290347020695792	0.8938524227680557	0	0	0.623948220064725	0.11698608870048342	ABCC10;TP53
Heart Decompensation	2/102	0.8290347020695792	0.8938524227680557	0	0	0.623948220064725	0.11698608870048342	ATP1A3;TP53
Respiratory Failure	4/185	0.8291657342782621	0.8938524227680557	0	0	0.6887780727559734	0.12903239393071503	ATXN2;NDUFS8;TPM2;PEX6
Hypersensitivity	4/185	0.8291657342782621	0.8938524227680557	0	0	0.6887780727559734	0.12903239393071503	RERE;ATXN2;SLC15A2;SUFU
MIXED LINEAGE LEUKEMIA	4/185	0.8291657342782621	0.8938524227680557	0	0	0.6887780727559734	0.12903239393071503	RIMS2;RAB1B;TP53;PDLIM7
Malnutrition	5/225	0.8305506448894425	0.8949720043345787	0	0	0.7080561714708056	0.13146221952704198	INSR;AKT1;MTR;HMGB1;MTOR
Pulmonary Emphysema	5/225	0.8305506448894425	0.8949720043345787	0	0	0.7080561714708056	0.13146221952704198	HDAC4;KEAP1;TP53;SYBU;TAPBP
Diabetic Nephropathy	14/561	0.8315344599237071	0.8957683324908853	0	0	0.7954036719942561	0.146738088243178	HDAC4;JAG1;IDUA;INSR;XYLT2;HCCS;ACTN4;HMGB1;RELA;RIMS2;MDK;AKT1;SHBG;SYBU
Chronic Obstructive Airway Disease	17/669	0.831636311782366	0.8957683324908853	0	0	0.8097956027632797	0.14929396509496168	CHRM3;BNC2;PDE4D;DNAH5;ADCY2;MSI1;HMGB1;YWHAZ;ACTB;ARMC2;PDZD2;SPINT1;MDK;ERCC1;FAM19A2;CNTN4;TP53
Myopathy	10/415	0.8320232914561556	0.8959984101365727	0	0	0.7680631451123254	0.14124285226342526	RIMS2;AGK;TPM2;INSR;CHD7;AKT1;AMPH;RBCK1;LMNB2;PLEC
Respiratory Distress Syndrome, Adult	4/186	0.8322770951713937	0.8960850058012005	0	0	0.6849578992436135	0.12575131560013564	GABRB1;KEAP1;HMGB1;YWHAZ
Severe Sepsis	2/103	0.8331105858412201	0.896711056567847	0	0	0.6177384728764138	0.11279218177300995	PGAP3;HMGB1
Thrombocytopenia	8/341	0.8333714821423343	0.896711056567847	0	0	0.7476888653359242	0.13628557058132568	ABCD4;TCN2;FCGRT;FLII;ERCC1;TP53;HDAC9;MTOR
Graft-vs-Host Disease	5/226	0.8333791030757294	0.896711056567847	0	0	0.7048155096935584	0.12846435097371417	PSMD7;SUFU;TP53;EBAG9;RELA
Spondylarthropathies	1/57	0.8342904390214416	0.8969446617147515	0	0	0.5574659589199169	0.10099816428091726	ALDOA
Abnormality of epiphysis morphology	1/57	0.8342904390214416	0.8969446617147515	0	0	0.5574659589199169	0.10099816428091726	IDUA
Abnormality of the voice	1/57	0.8342904390214416	0.8969446617147515	0	0	0.5574659589199169	0.10099816428091726	CHD7
Carotid Artery Diseases	1/57	0.8342904390214416	0.8969446617147515	0	0	0.5574659589199169	0.10099816428091726	TP53
Colon Carcinoma	58/2091	0.8354027501397199	0.8979537048090832	0	0	0.8805999933481891	0.1583682783351493	CHRM3;PGAP3;CHD7;DIXDC1;KEAP1;MSI1;MTR;HMGB1;ACTB;LMNB1;RIMS2;MDK;AKT2;CFL1;FPGS;AKT1;SSSCA1;CLIC1;SYBU;EIF5A;RHBDF1;TPM2;TYK2;AMPD3;YWHAZ;SPINT1;MALL;ULK1;RIN1;GAPDH;TP53;TACSTD2;SEMA3F;NDRG2;PPOX;FHIT;HDAC9;HDAC6;HSF1;ERBB2;IGF2BP1;CKB;RPS27A;LDLR;MAP2K5;PDLIM7;BBS2;JAG1;STAT2;USP22;MTOR;HIPK2;BCL9;AIMP2;CAPN10;SGSM3;ERCC1;SDC1
Hepatocarcinogenesis	13/527	0.8358402911060846	0.8982371853683189	0	0	0.7860883723613613	0.14095957739738693	HDAC4;URGCP;ARHGAP1;MTOR;PSME3;KCNQ1OT1;ERBB2;IGF2BP1;TRIM24;AKT1;SSSCA1;SHBG;TP53
Dyspnea	4/188	0.8383583384922312	0.9007559029787632	0	0	0.677442123094297	0.11943958926375851	ATXN2;DNAH7;OTX2;LDLR
Respiratory Tract Diseases	1/58	0.8394420658499689	0.9011708758439219	0	0	0.5476575121163166	0.09584982122089145	SGSM3
Carcinoma, Lobular	1/58	0.8394420658499689	0.9011708758439219	0	0	0.5476575121163166	0.09584982122089145	ERBB2
Extrapyramidal Disorders	1/58	0.8394420658499689	0.9011708758439219	0	0	0.5476575121163166	0.09584982122089145	AKT1
Heart valve disease	1/58	0.8394420658499689	0.9011708758439219	0	0	0.5476575121163166	0.09584982122089145	IDUA
Glioblastoma Multiforme	22/854	0.8425966474418973	0.9043695688431413	0	0	0.8201537175199383	0.14046519150605213	RHBDF1;JAG1;MTR;HMGB1;HDAC6;MTOR;ACTB;PPP1CA;TAPBP;SOX1;MAGED4B;TCN2;FCGRT;AKT2;ERBB2;IGF2BP1;AKT1;TRIB3;SSSCA1;FADD;MIR92B;TP53
Pancreatitis	6/269	0.8438804062462543	0.9050260759321812	0	0	0.7103082696523452	0.12057091723850179	PDZD2;IFT172;TMEM67;HSF1;TP53;LMF1
Acne	1/59	0.8444337857124053	0.9050260759321812	0	0	0.5381872876162888	0.09100152460759268	UBAC2
Well Differentiated Pancreatic Endocrine Tumor	1/59	0.8444337857124053	0.9050260759321812	0	0	0.5381872876162888	0.09100152460759268	MTOR
Alopecia Areata	1/59	0.8444337857124053	0.9050260759321812	0	0	0.5381872876162888	0.09100152460759268	ATXN2
Forgetful	1/59	0.8444337857124053	0.9050260759321812	0	0	0.5381872876162888	0.09100152460759268	SPG7
Nephrocalcinosis	1/59	0.8444337857124053	0.9050260759321812	0	0	0.5381872876162888	0.09100152460759268	KCNQ1OT1
Malignant neoplasm of kidney	10/421	0.8444341598577744	0.9050260759321812	0	0	0.7566112241234892	0.1279342639566721	BBS2;GIPC1;HSF1;AKT1S1;ERBB2;SYVN1;AKT1;FHIT;TP53;MTOR
Heart Failure, Right-Sided	2/106	0.8448170387567666	0.9050610398621414	0	0	0.5998257406024396	0.10115173208248936	ATP1A3;TP53
Teratocarcinoma	2/106	0.8448170387567666	0.9050610398621414	0	0	0.5998257406024396	0.10115173208248936	PSMD7;TP53
Cytomegalovirus Infections	6/270	0.8463411861796643	0.9065059585858041	0	0	0.7075806929227124	0.11804760264783058	AIMP2;STAT2;WASL;TP53;RELA;MTOR
Transient Ischemic Attack	4/191	0.8471333179227433	0.907166387696796	0	0	0.666469893742621	0.11056548697105334	PDE4D;HSF1;NDRG2;TP53
Hairy Cell Leukemia	2/107	0.8485504924981522	0.9081378489986695	0	0	0.5940822931114194	0.09756357338930677	ERBB2;TP53
Androgenetic Alopecia	1/60	0.8492705542203115	0.9081378489986695	0	0	0.5290380876755839	0.08643290400353952	HDAC9
Autoimmune thyroiditis	1/60	0.8492705542203115	0.9081378489986695	0	0	0.5290380876755839	0.08643290400353952	ERBB2
Bullous pemphigoid	1/60	0.8492705542203115	0.9081378489986695	0	0	0.5290380876755839	0.08643290400353952	PLEC
Dry Eye Syndromes	1/60	0.8492705542203115	0.9081378489986695	0	0	0.5290380876755839	0.08643290400353952	JAG1
Factor V Leiden mutation	1/60	0.8492705542203115	0.9081378489986695	0	0	0.5290380876755839	0.08643290400353952	CHRM3
Post-Traumatic Osteoporosis	1/60	0.8492705542203115	0.9081378489986695	0	0	0.5290380876755839	0.08643290400353952	GAPDH
Lung Neoplasms	31/1177	0.8510044371482675	0.9096705574102836	0	0	0.837420777073574	0.13510774005653556	CLTB;KEAP1;MTR;SEMA3F;HMGB1;ABCC10;FHIT;ACTB;RELA;MAGED4B;AKT2;ERBB2;IGF2BP1;AKT1;FADD;KCNJ3;EIF5A;PRKCI;CADM4;JAG1;SMARCA2;YWHAZ;MTOR;RAD52;TEP1;ERCC1;SDC1;AMPH;SERINC2;GAPDH;TP53
Primary Sj??gren's syndrome	3/151	0.8510559491251396	0.9096705574102836	0	0	0.6318279381488457	0.1018995717982462	RIMS2;CHRM3;TP53
Hamman-Rich syndrome	5/233	0.8521150248358451	0.9099546272036122	0	0	0.6829268292682927	0.109291345280561	DPP9;ATP11A;HMGB1;TP53;FHIT
Carcinoma, Lewis Lung	2/108	0.8522020889445594	0.9099546272036122	0	0	0.5884472125541919	0.09411129638231809	AIMP2;EML2
Leukemia, Myelomonocytic, Chronic	2/108	0.8522020889445594	0.9099546272036122	0	0	0.5884472125541919	0.09411129638231809	XYLT2;TP53
Malabsorption	2/108	0.8522020889445594	0.9099546272036122	0	0	0.5884472125541919	0.09411129638231809	PEX6;PEX26
Myocardial Failure	2/108	0.8522020889445594	0.9099546272036122	0	0	0.5884472125541919	0.09411129638231809	ATP1A3;TP53
Renal carcinoma	12/500	0.8535334860799888	0.9105283443226949	0	0	0.7640746333045729	0.12100688452566391	BBS2;TEP1;GIPC1;HSF1;AKT1S1;ERBB2;SYVN1;AKT1;SSSCA1;FHIT;TP53;MTOR
Gastrointestinal Hemorrhage	1/61	0.8539571739192253	0.9105283443226949	0	0	0.5201938610662359	0.08212520739236731	UBAC2
Hypernasal voice	1/61	0.8539571739192253	0.9105283443226949	0	0	0.5201938610662359	0.08212520739236731	SPG7
Increased CSF lactate	1/61	0.8539571739192253	0.9105283443226949	0	0	0.5201938610662359	0.08212520739236731	NDUFS8
Nasal voice	1/61	0.8539571739192253	0.9105283443226949	0	0	0.5201938610662359	0.08212520739236731	SPG7
Noonan Syndrome	1/61	0.8539571739192253	0.9105283443226949	0	0	0.5201938610662359	0.08212520739236731	SGSM3
Common Variable Immunodeficiency	3/152	0.8541488802779461	0.9105283443226949	0	0	0.627554849727519	0.09893387615907819	FCGRT;SDC1;TP53
Decreased platelet count	3/152	0.8541488802779461	0.9105283443226949	0	0	0.627554849727519	0.09893387615907819	ABCD4;TCN2;MTOR
Myeloid Leukemia	12/501	0.8553025323251107	0.9115701148806293	0	0	0.7624717468517921	0.11917435969383539	RIMS2;JAG1;STAT2;SGSM3;AKT1;TRIB3;FOXN3;HMGB1;FHIT;HDAC9;TP53;IQCG
Oligospermia	2/109	0.8557733049419546	0.9118838020494888	0	0	0.5829174606055106	0.09078925959609746	SLC16A7;MTR
Sezary Syndrome	3/153	0.857185620720202	0.9130122192666951	0	0	0.6233387358184765	0.09605699177154967	ERBB2;AKT1;TP53
Abdominal Pain	3/153	0.857185620720202	0.9130122192666951	0	0	0.6233387358184765	0.09605699177154967	PPOX;TP53;UBAC2
Mammary Neoplasms	66/2387	0.858115488387911	0.9136903650762684	0	0	0.8756138039591425	0.13398343555052594	RPAIN;NUMA1;MSI1;MTR;WASL;APEH;ACTB;RIMS2;CCND3;CDH3;CAPNS1;MDK;AKT2;CFL1;TRIM24;AKT1;SSSCA1;CLIC1;VPS39;STARD3;PRKCI;LMO4;RHOC;SPINT1;RABEP2;TRIB3;RIN1;ALDOA;GAPDH;TP53;ACSS2;CTBP1;SEMA3F;NDRG2;FHIT;HDAC9;HDAC6;RELA;HSF1;ERBB2;IGF2BP1;SLIT1;FADD;LDLR;CCT5;KCNJ3;JAG1;JUP;INSR;MIB2;FOXJ1;PUM1;MAPK15;MTOR;HIPK2;PPP1CA;RAD52;AIMP2;RALYL;GIPC1;NFIC;TADA3;PPP1R1B;SDC1;SHBG;EBAG9
Cerebral Ischemia	6/275	0.8581758963003496	0.9136903650762684	0	0	0.694246999987891	0.10618243576245619	AKT1S1;CAPN1;HMGB1;TP53;YWHAZ;RELA
Macular degeneration	1/62	0.858498298526435	0.9138453567012598	0	0	0.5116396090998173	0.07806115219837864	CDH3
Reperfusion Injury	2/110	0.8592656048281564	0.9139091676789282	0	0	0.577490111470694	0.0875920845388714	AKT1S1;RELA
Borderline Personality Disorder	2/110	0.8592656048281564	0.9139091676789282	0	0	0.577490111470694	0.0875920845388714	AKT1;APBA3
Neutrophil count (procedure)	2/110	0.8592656048281564	0.9139091676789282	0	0	0.577490111470694	0.0875920845388714	MAST2;CHD7
Post-Traumatic Stress Disorder	2/110	0.8592656048281564	0.9139091676789282	0	0	0.577490111470694	0.0875920845388714	GAPDH;ACTB
Sarcoidosis	5/236	0.8595924603098971	0.9140686903048453	0	0	0.6739520641959666	0.10196684823076359	PSMD12;ATXN2;TYK2;GAPDH;ACTB
Bacterial Infections	6/276	0.8604506790136072	0.9147930691508583	0	0	0.6916395222584147	0.1039527158530885	LAD1;AKT1;RBCK1;FADD;HMGB1;RELA
Carcinoma breast stage IV	9/392	0.8612543655349284	0.9153432147111306	0	0	0.7306132565284834	0.109128332415996	AIMP2;RAB1B;KCNMA1;ERBB2;AKT1;PTPN9;HMGB1;TP53;MTOR
Rheumatic Fever	1/63	0.8628984378680575	0.9153432147111306	0	0	0.5033613007452186	0.07422479152447721	TP53
Lichen Planus, Oral	1/63	0.8628984378680575	0.9153432147111306	0	0	0.5033613007452186	0.07422479152447721	TP53
Abdomen distended	1/63	0.8628984378680575	0.9153432147111306	0	0	0.5033613007452186	0.07422479152447721	INSR
Idiopathic hypogonadotropic hypogonadism	1/63	0.8628984378680575	0.9153432147111306	0	0	0.5033613007452186	0.07422479152447721	CHD7
Iron deficiency	1/63	0.8628984378680575	0.9153432147111306	0	0	0.5033613007452186	0.07422479152447721	AIMP2
Kidney Calculi	1/63	0.8628984378680575	0.9153432147111306	0	0	0.5033613007452186	0.07422479152447721	HIPK2
Lymphangioleiomyomatosis	1/63	0.8628984378680575	0.9153432147111306	0	0	0.5033613007452186	0.07422479152447721	MTOR
Monocytic leukemia	1/63	0.8628984378680575	0.9153432147111306	0	0	0.5033613007452186	0.07422479152447721	TP53
Neutrophilia (disorder)	1/63	0.8628984378680575	0.9153432147111306	0	0	0.5033613007452186	0.07422479152447721	TP53
Biliary cirrhosis	3/155	0.8630935536546709	0.9153432147111306	0	0	0.6150729335494327	0.09055853416265881	RPS6KA4;TYK2;PLCB1
Focal glomerulosclerosis	3/155	0.8630935536546709	0.9153432147111306	0	0	0.6150729335494327	0.09055853416265881	NPHP1;PDSS2;ACTN4
Allergic asthma	4/197	0.8634804442338656	0.9155656413214235	0	0	0.6455487517663684	0.09475624653647212	HMGB1;SHBG;YWHAZ;MTOR
Malignant neoplasm of prostate	91/3239	0.8643468388467583	0.9162963001353943	0	0	0.8869987966074419	0.12930771072120184	RPAIN;RERE;CHRM3;CHD7;ARHGAP1;KEAP1;MTR;HMGB1;ABCC10;ACTB;RIMS2;CCND3;PSMD7;CDH3;SOX1;CAPNS1;MDK;AKT2;CFL1;TRIM24;AKT1;SLC16A7;SSSCA1;SYBU;EIF5A;STARD3;PRKCI;SLC2A11;KCNH7;TPM2;PDE4D;TCF12;SYP;FRS3;YWHAZ;TBC1D2;SPINT1;TEP1;KCNMA1;TRIB3;PKP3;GAPDH;TP53;LY6E;HDAC4;IGSF8;HKR1;CTBP1;FLII;TACSTD2;FOXK1;SEMA3F;SPG7;NDRG2;FHIT;HDAC9;HDAC6;RELA;ABR;PDZD2;S100A16;HSF1;ERBB2;PLEK2;FADD;LDLR;MAP2K5;PDLIM7;BBS2;CADM4;JAG1;JUP;AGK;SORT1;INSR;HOOK3;SMARCA2;MTOR;HIPK2;AIMP2;FER;TCN2;GIPC1;NFIC;SGSM3;ERCC1;CDK2AP2;SDC1;SHBG;EBAG9;FGF11
Hepatitis	7/317	0.8646465927096231	0.9164260851360403	0	0	0.7024680313634689	0.10216302992064817	KEAP1;FADD;HMGB1;TP53;LDLR;ACTB;RELA
Infant, Premature	6/278	0.8649100445054175	0.9164607402821555	0	0	0.6864820846905537	0.09962898860451287	RIMS2;CAPNS1;SUFU;MTR;SHBG;EML2
Myoclonic Seizures	3/156	0.8659662558780555	0.9164607402821555	0	0	0.6110210696920584	0.08793163683545703	PRDM8;MBOAT7;GABRG2
Synovitis	2/112	0.8660192461776776	0.9164607402821555	0	0	0.5669314504265961	0.08155203830411316	HMGB1;TP53
Glomerulosclerosis (disorder)	2/112	0.8660192461776776	0.9164607402821555	0	0	0.5669314504265961	0.08155203830411316	ACTN4;PLEC
Precursor Cell Lymphoblastic Leukemia Lymphoma	15/618	0.8661077761931117	0.9164607402821555	0	0	0.7720488466757124	0.11097887583018273	EIF5A;IDUA;ATP11A;TYK2;HMGB1;SPG7;FHIT;MLLT6;KAT2A;MDK;ERCC1;FPGS;AKT1;TP53;ANKS1B
Retinopathy of Prematurity	1/64	0.8671619620703832	0.9164607402821555	0	0	0.4953457958304485	0.07060139464259463	CFL1
Osteoporosis, Senile	1/64	0.8671619620703832	0.9164607402821555	0	0	0.4953457958304485	0.07060139464259463	GAPDH
Autosomal dominant retinitis pigmentosa	1/64	0.8671619620703832	0.9164607402821555	0	0	0.4953457958304485	0.07060139464259463	PDE6B
Chronic Fatigue Syndrome	1/64	0.8671619620703832	0.9164607402821555	0	0	0.4953457958304485	0.07060139464259463	SESN1
Cytogenetically normal acute myeloid leukemia	1/64	0.8671619620703832	0.9164607402821555	0	0	0.4953457958304485	0.07060139464259463	TP53
Diaphragmatic Hernia	1/64	0.8671619620703832	0.9164607402821555	0	0	0.4953457958304485	0.07060139464259463	KCNMA1
Esophagitis	1/64	0.8671619620703832	0.9164607402821555	0	0	0.4953457958304485	0.07060139464259463	YWHAZ
Mitral Valve Prolapse Syndrome	1/64	0.8671619620703832	0.9164607402821555	0	0	0.4953457958304485	0.07060139464259463	XYLT2
Muscle biopsy shows dystrophic changes	1/64	0.8671619620703832	0.9164607402821555	0	0	0.4953457958304485	0.07060139464259463	PLEC
Hypercholesterolemia	5/240	0.869068267772052	0.9182876319456073	0	0	0.662342155336447	0.09294885763371927	JAG1;SORT1;CAPN10;FLII;LDLR
Virus Diseases	22/875	0.8710733130726888	0.9202180870727015	0	0	0.7990566444616091	0.11029309706799803	LRSAM1;STAT2;FOXJ1;TYK2;HMGB1;SPG7;HDAC9;HDAC6;MTOR;ACTB;RELA;NMRAL1;TAPBP;RIMS2;AIMP2;ERBB2;AKT1;LDLR;TP53;LSM14A;PDLIM7;SKP1
Systemic Inflammatory Response Syndrome	1/65	0.871293106226861	0.920262164925489	0	0	0.4875807754442649	0.06717733937810254	HMGB1
Tumor Angiogenesis	12/511	0.8720883124613781	0.9208578890273095	0	0	0.7467962240270014	0.1022099548648627	ABR;TRPC5;JAG1;MDK;ERBB2;AKT1;SDC1;SEMA3F;HMGB1;TP53;MTOR;PDLIM7
Solid Neoplasm	21/840	0.8722134997656114	0.9208578890273095	0	0	0.7945293437780917	0.10862888284830166	CHRM3;CTBP1;IFT172;FLII;PDE4D;MSI1;FOXK1;SPG7;FHIT;HDAC9;MTOR;SALL2;MDK;AKT2;ERCC1;OSBP;ERBB2;AKT1;SDC1;GAPDH;TP53
leiomyosarcoma	2/114	0.8724744496815509	0.920945252441637	0	0	0.5567498844197873	0.07595288227237441	AKT1;TP53
Creatine phosphokinase serum increased	3/159	0.8742683320814965	0.9226503451495148	0	0	0.5991771599551178	0.08051019728379229	RBCK1;GDAP1;PLEC
Arachnodactyly	1/66	0.8752959740760716	0.922918205901568	0	0	0.48005467876227165	0.06394001583094897	AKT1
Bronchiolitis	1/66	0.8752959740760716	0.922918205901568	0	0	0.48005467876227165	0.06394001583094897	TAPBP
Congenital arteriovenous malformation	1/66	0.8752959740760716	0.922918205901568	0	0	0.48005467876227165	0.06394001583094897	AKT1
Giant Cell Tumor of Bone	1/66	0.8752959740760716	0.922918205901568	0	0	0.48005467876227165	0.06394001583094897	TP53
Epileptic drop attack	2/115	0.8755936461949281	0.922918205901568	0	0	0.5517942549474468	0.07330761588878756	MAPK10;GABRG2
Pancreatic intraepithelial neoplasia	2/115	0.8755936461949281	0.922918205901568	0	0	0.5517942549474468	0.07330761588878756	ERBB2;TP53
Kaposi Sarcoma	7/323	0.8766297688296455	0.9238219097291207	0	0	0.688913209573172	0.0907095689108152	RIMS2;JAG1;INSR;SGSM3;AKT1;SDC1;TP53
Muscular Dystrophy	4/203	0.8783090656062644	0.9242420741049592	0	0	0.6258891861906938	0.08121333811514726	RIMS2;HDAC9;LMNB1;PLEC
Liver Neoplasms, Experimental	2/116	0.8786424129615216	0.9242420741049592	0	0	0.5469255663430421	0.0707597395434351	MIR92B;TP53
Complex partial seizures	2/116	0.8786424129615216	0.9242420741049592	0	0	0.5469255663430421	0.0707597395434351	ERCC1;MTOR
Experimental Hepatoma	2/116	0.8786424129615216	0.9242420741049592	0	0	0.5469255663430421	0.0707597395434351	MIR92B;TP53
Primary microcephaly	2/116	0.8786424129615216	0.9242420741049592	0	0	0.5469255663430421	0.0707597395434351	TUBGCP6;ERCC8
Short distal phalanx of finger	1/67	0.879174542627705	0.9242420741049592	0	0	0.4727566456160963	0.06087773909415923	JAG1
Toxic Epidermal Necrolysis	1/67	0.879174542627705	0.9242420741049592	0	0	0.4727566456160963	0.06087773909415923	TRAF3IP2
Abnormality of cardiovascular system morphology	1/67	0.879174542627705	0.9242420741049592	0	0	0.4727566456160963	0.06087773909415923	FLII
Uremia	1/67	0.879174542627705	0.9242420741049592	0	0	0.4727566456160963	0.06087773909415923	LDLR
Arteriopathic disease	1/67	0.879174542627705	0.9242420741049592	0	0	0.4727566456160963	0.06087773909415923	MTR
Fine hair	1/67	0.879174542627705	0.9242420741049592	0	0	0.4727566456160963	0.06087773909415923	CDH3
Idiopathic Inflammatory Myopathies	1/67	0.879174542627705	0.9242420741049592	0	0	0.4727566456160963	0.06087773909415923	TARS
Polycystic Kidney, Autosomal Dominant	3/161	0.8795471673268408	0.9242577797367046	0	0	0.5915310916439284	0.07592188373909382	AIMP2;ERBB2;MTOR
Eosinophilic disorder	3/161	0.8795471673268408	0.9242577797367046	0	0	0.5915310916439284	0.07592188373909382	NUMA1;HMGB1;SHBG
Embryonal Carcinoma	4/205	0.8829323642545708	0.9274382144821252	0	0	0.6195968210893584	0.07714394250357444	TCN2;MDK;OTX2;TP53
Thin skin	1/68	0.882932665489949	0.9274382144821252	0	0	0.46567646420562775	0.057979671162146015	PPOX
Red Blood Cell Count measurement	2/118	0.8845340809420391	0.9284643866436894	0	0	0.53744001785515	0.06594079175049351	CCND3;MAST2
Anemia, Hemolytic	2/118	0.8845340809420391	0.9284643866436894	0	0	0.53744001785515	0.06594079175049351	EPB41;ALDOA
Allergic rhinitis (disorder)	3/163	0.8846282197820291	0.9284643866436894	0	0	0.5840761750405187	0.07160062085281832	CHRM3;FOXJ1;ACTB
Inflammatory dermatosis	3/163	0.8846282197820291	0.9284643866436894	0	0	0.5840761750405187	0.07160062085281832	TRAF3IP2;TYK2;TP53
Cytopenia	4/206	0.8851862514985378	0.9288614310141002	0	0	0.6164973640221165	0.07518629383135382	EPB41;MTR;ALDOA;TP53
Diphtheria	1/69	0.8865740772626125	0.929940091595937	0	0	0.4588045234248788	0.055235749778071	FADD
hiv-infection/aids	1/69	0.8865740772626125	0.929940091595937	0	0	0.4588045234248788	0.055235749778071	ABCC10
Hepatoma, Novikoff	2/119	0.8873796526968036	0.9305961942242453	0	0	0.5328188532072027	0.06366245905421851	MIR92B;TP53
Congenital anemia	4/208	0.8895808924208393	0.9321274947136201	0	0	0.6103896103896104	0.07141853538076325	EPB41;MTR;ALDOA;TP53
Chromosome 8, trisomy	1/70	0.8901023967514929	0.9321274947136201	0	0	0.45213176933342697	0.052636624619353575	ERBB2
Leukoplakia, Oral	1/70	0.8901023967514929	0.9321274947136201	0	0	0.45213176933342697	0.052636624619353575	TP53
Stromal Neoplasm	1/70	0.8901023967514929	0.9321274947136201	0	0	0.45213176933342697	0.052636624619353575	TP53
Abnormality of brain morphology	1/70	0.8901023967514929	0.9321274947136201	0	0	0.45213176933342697	0.052636624619353575	PLCB1
Knee joint valgus deformity	1/70	0.8901023967514929	0.9321274947136201	0	0	0.45213176933342697	0.052636624619353575	IDUA
Metabolic acidosis	1/70	0.8901023967514929	0.9321274947136201	0	0	0.45213176933342697	0.052636624619353575	OGDH
Immune System Diseases	5/250	0.8904210708355191	0.9322723043107706	0	0	0.6349759415961507	0.07369582518571506	ATXN2;AKT1;SDC1;RBCK1;TYK2
Malignant neoplasm of esophagus	16/673	0.8912135820742774	0.932913063026102	0	0	0.7549064078139648	0.08694345401421144	PRKCI;TPM2;FBXL19;FOXK1;MTR;FHIT;MTOR;ACTB;RIMS2;AIMP2;KCNQ1OT1;ERCC1;ERBB2;AKT1;GAPDH;TP53
Myocardial Ischemia	10/448	0.8916307596923604	0.9330679072014786	0	0	0.708960251515832	0.08131999437464493	EIF5A;AKT2;KCNQ1OT1;RAB1B;ERBB2;HMGB1;RHOC;ALDOA;LDLR;ACTB
Trisomy	4/209	0.8917225993939827	0.9330679072014786	0	0	0.6073804244535952	0.06960590718267945	LRSAM1;ERBB2;TP53;GAPDH
Hepatoma, Morris	2/121	0.8928768209587773	0.9338154103064199	0	0	0.5238095238095238	0.059351100325543846	MIR92B;TP53
Hypodontia	2/121	0.8928768209587773	0.9338154103064199	0	0	0.5238095238095238	0.059351100325543846	BBS1;CTBP1
Leukemia, Myeloid, Chronic-Phase	1/71	0.8935211307982288	0.9338154103064199	0	0	0.44564966535887374	0.05017359912838199	TP53
Abnormality of the skull	1/71	0.8935211307982288	0.9338154103064199	0	0	0.44564966535887374	0.05017359912838199	TCF12
Duodenal Ulcer	1/71	0.8935211307982288	0.9338154103064199	0	0	0.44564966535887374	0.05017359912838199	TP53
Gout	1/71	0.8935211307982288	0.9338154103064199	0	0	0.44564966535887374	0.05017359912838199	AGBL4
Glomerulonephritis	4/210	0.8938278641972527	0.9339471092137892	0	0	0.6044004539150171	0.06783915684065285	FLII;ERBB2;YWHAZ;OTUB1
Infratentorial atrophy	3/167	0.8942203860488344	0.9341683758035934	0	0	0.5697118235363877	0.06369550089461852	ATP13A2;SPG7;TTC19
Acute Megakaryocytic Leukemias	2/122	0.89553098521344	0.9353484501986777	0	0	0.5194174757281553	0.05731172284181276	AKT1;TP53
Non-alcoholic Fatty Liver Disease	7/334	0.8963138961508774	0.9359524325528774	0	0	0.6653546253199036	0.07283277581167083	INSR;TRIM24;AKT1;HMGB1;TP53;LDLR;MTOR
Lupus Erythematosus, Systemic	28/1113	0.8966173857053997	0.9359524325528774	0	0	0.7975152571926766	0.087029695211076	RPAIN;TRAF3IP2;FLII;MTR;HMGB1;NADSYN1;HDAC9;RELA;RIMS2;ATXN2;PSMD7;FCGRT;MAN2A1;ERBB2;AKT1;KIAA0319L;LDLR;PDLIM7;STAT2;FOXJ1;TYK2;MTOR;PSME3;ARMC3;SGSM3;SDC1;TP53;LY6E
secondary acute myeloid leukemia	1/72	0.8968336776319368	0.9359524325528774	0	0	0.43935015586247694	0.04783857793450185	TP53
Hyperuricemia	1/72	0.8968336776319368	0.9359524325528774	0	0	0.43935015586247694	0.04783857793450185	PRPSAP1
Fibrosis	3/169	0.8987430272059191	0.9377556964668262	0	0	0.5627892444982523	0.06008232637079571	AKT1;TP53;FHIT
Infection	11/492	0.8997992266444979	0.9379761910360311	0	0	0.7096907441735028	0.07493171930542558	CTBP1;AKT1;MSI1;FADD;HMGB1;LDLR;FHIT;TP53;HDAC6;RELA;PLEC
Urinary tract infection	1/73	0.9000433303691329	0.9379761910360311	0	0	0.4332256327409801	0.04562401897876045	AIMP2
Dysplastic Nevus	1/73	0.9000433303691329	0.9379761910360311	0	0	0.4332256327409801	0.04562401897876045	TP53
Failure to Thrive	1/73	0.9000433303691329	0.9379761910360311	0	0	0.4332256327409801	0.04562401897876045	ERCC1
Guillain-Barre Syndrome	1/73	0.9000433303691329	0.9379761910360311	0	0	0.4332256327409801	0.04562401897876045	YWHAZ
Inborn Errors of Metabolism	1/73	0.9000433303691329	0.9379761910360311	0	0	0.4332256327409801	0.04562401897876045	ABCD4
Coinfection	3/171	0.9030909254038769	0.9397012584792258	0	0	0.5560314887705488	0.05667742287020667	TP53;LDLR;PDLIM7
Arthropathy	2/125	0.9031308353802819	0.9397012584792258	0	0	0.5066698239797932	0.05162349719178818	AIMP2;SYVN1
Familial M??ni??re disease	2/125	0.9031308353802819	0.9397012584792258	0	0	0.5066698239797932	0.05162349719178818	MTR;RELA
Degenerative polyarthritis	24/976	0.9031363762589136	0.9397012584792258	0	0	0.7794822627037392	0.07941498678288994	HDAC4;JAG1;LMO4;ATP1A3;SORBS2;HMGB1;YWHAZ;ACTB;RELA;LMNB1;ADAMTS5;AIMP2;NDUFS8;SGSM3;ERCC1;ERBB2;AKT1;SDC1;TRIB3;ALDOA;GAPDH;TP53;CLIC1;PDLIM7
Spondylarthritis	1/74	0.9031532799663922	0.9397012584792258	0	0	0.4272689047734968	0.04352289018839897	ALDOA
Uveomeningoencephalitic Syndrome	1/74	0.9031532799663922	0.9397012584792258	0	0	0.4272689047734968	0.04352289018839897	TRAF3IP2
Keratitis	1/74	0.9031532799663922	0.9397012584792258	0	0	0.4272689047734968	0.04352289018839897	PLEC
Necrotizing enterocolitis in fetus OR newborn	1/74	0.9031532799663922	0.9397012584792258	0	0	0.4272689047734968	0.04352289018839897	HMGB1
Restenosis	4/215	0.9038240555438507	0.940209887087484	0	0	0.5899242937157629	0.05965347868757255	INSR;HMGB1;SPG7;TP53
Idiopathic Pulmonary Fibrosis	8/379	0.9046837434704772	0.9409147889425289	0	0	0.6697672779803745	0.06709048849656359	JAG1;DPP9;SDC1;ATP11A;TP53;FHIT;HDAC9;HIPK2
Generalized seizures	2/126	0.9055473111271469	0.9414844477079088	0	0	0.5025576782545151	0.049861639178369686	EFHC1;PLCB1
Dyslipidemias	4/216	0.9057205404604787	0.9414844477079088	0	0	0.5871110022053418	0.05813835861851614	SORT1;AKT2;INSR;LDLR
Arteriosclerosis	27/1087	0.9057779941957668	0.9414844477079088	0	0	0.7869165420471539	0.07787408134988796	TRAF3IP2;HMGB1;HDAC9;RELA;LMNB1;ABR;ADAMTS5;DPP9;AKT2;OSBP;AKT1;SSSCA1;CAPN1;LDLR;JUP;SORT1;INSR;PDE4D;KIF6;YWHAZ;AIMP2;CAPN10;ZNF318;SDC1;TRIB3;SHBG;TP53
Mitral Valve Stenosis	1/75	0.9061666188079054	0.9415096674706985	0	0	0.4214731694537833	0.04152862968528256	HCCS
Polycythemia	1/75	0.9061666188079054	0.9415096674706985	0	0	0.4214731694537833	0.04152862968528256	SSSCA1
Pneumonia	11/497	0.9063960553214802	0.9415587565630975	0	0	0.7022035719353728	0.06901180958715951	RPAIN;AIMP2;FER;AKT2;CHD7;FBXO15;HCCS;HMGB1;TP53;DNAI1;MTOR
Glaucoma	8/381	0.907587642297396	0.9426071011641766	0	0	0.6661059419299444	0.0645890572275814	BBS2;IDUA;AGK;IFT172;SUFU;PDE6B;PLXDC2;TP53
Respiration Disorders	1/76	0.9090863434134976	0.9434052656146497	0	0	0.41583198707592894	0.039635109872022165	SGSM3
Autoimmune thrombocytopenia	1/76	0.9090863434134976	0.9434052656146497	0	0	0.41583198707592894	0.039635109872022165	FCGRT
Chest Pain	1/76	0.9090863434134976	0.9434052656146497	0	0	0.41583198707592894	0.039635109872022165	TP53
Familial dilated cardiomyopathy	1/76	0.9090863434134976	0.9434052656146497	0	0	0.41583198707592894	0.039635109872022165	PDLIM7
Arthralgia	2/128	0.910212194458601	0.9441944241192393	0	0	0.49452920326706734	0.046524083943451984	TYK2;UBAC2
beta^+^ Thalassemia	2/128	0.910212194458601	0.9441944241192393	0	0	0.49452920326706734	0.046524083943451984	RERE;SHBG
Inflammatory Bowel Diseases	22/911	0.9104615191355929	0.9442635221538721	0	0	0.7652091147469443	0.07177940350014363	TRAF3IP2;IDUA;AMBRA1;TYK2;HMGB1;FHIT;TM9SF4;MTOR;ACTB;UBAC2;GNAO1;AIMP2;KAT2A;ATXN2;CCND3;FER;PSMD7;SUFU;SDC1;ULK1;GAPDH;TP53
Neoplastic Syndromes, Hereditary	1/77	0.9119153573161479	0.9453918889889372	0	0	0.41033925686591277	0.03783660453396007	TP53
PANIC DISORDER 1	1/77	0.9119153573161479	0.9453918889889372	0	0	0.41033925686591277	0.03783660453396007	GPM6A
tumor vasculature	2/129	0.9124629199367578	0.9457698295694272	0	0	0.4906097902810692	0.04494369828250108	TRPC5;CAPN5
Cerebrovascular accident	18/768	0.9144758054798389	0.9467186883149407	0	0	0.7427242524916944	0.06640271816210475	SEMA5B;JAG1;ACSS2;PDE4D;MTR;HMGB1;ACCS;HDAC9;KIF6;RELA;TCN2;KCNMA1;PPP1R1B;AKT1;MAP6;CAPN1;LDLR;TP53
Sudden infant death syndrome	1/78	0.9146564745676722	0.9467186883149407	0	0	0.40498919497303987	0.03612775846089609	CHRNB2
Abnormal vision	1/78	0.9146564745676722	0.9467186883149407	0	0	0.40498919497303987	0.03612775846089609	XYLT2
Bronchial Hyperreactivity	1/78	0.9146564745676722	0.9467186883149407	0	0	0.40498919497303987	0.03612775846089609	CHRM3
Cerebral arterial aneurysm	1/78	0.9146564745676722	0.9467186883149407	0	0	0.40498919497303987	0.03612775846089609	TP53
Narrow thorax	1/78	0.9146564745676722	0.9467186883149407	0	0	0.40498919497303987	0.03612775846089609	IFT172
Lyme Disease	2/130	0.914660683195917	0.9467186883149407	0	0	0.48675161812297735	0.04341927650374066	SGSM3;PDLIM7
Atherosclerosis	28/1134	0.9152450737720773	0.9471338688934912	0	0	0.7814745124871707	0.06921004717047874	TRAF3IP2;HMGB1;HDAC9;LMNB1;ABR;ADAMTS5;DPP9;AKT2;OSBP;AKT1;SSSCA1;CAPN1;LDLR;JUP;SORT1;INSR;PDE4D;KIF6;YWHAZ;AIMP2;MAF;CAPN10;SGSM3;ZNF318;SDC1;TRIB3;SHBG;TP53
Metastatic Neoplasm	12/544	0.9167234695720778	0.9482938201418811	0	0	0.6992481203007519	0.06079921297469067	SHARPIN;CAPNS1;MDK;AKT2;USP22;ERBB2;AKT1;CASC2;ACTN4;HMGB1;TP53;LY6E
Disorder of eye	2/131	0.9168065980874909	0.9482938201418811	0	0	0.48295326258749155	0.04194871002271933	VANGL2;CAPN5
Cerebrovascular Disorders	3/178	0.9170117802795292	0.9482938201418811	0	0	0.5335957397545729	0.04622804571154498	JAG1;TCN2;LDLR
Serum total cholesterol measurement	6/307	0.9172884277708976	0.9482938201418811	0	0	0.6194011276202019	0.05347495704745509	SEMA5B;SORT1;CAPN5;LDLR;ARCN1;PLEC
Conduction disorder of the heart	1/79	0.9173124216399008	0.9482938201418811	0	0	0.3997763141543432	0.034503560322516266	JUP
Ankylosing spondylitis	7/348	0.9174669312518199	0.9482938201418811	0	0	0.6375691876402291	0.05491940772003895	KEAP1;FNDC3A;TYK2;LDLR;RELA;PDLIM7;TAPBP
Myasthenia Gravis	3/179	0.9188447104626477	0.9495279871367653	0	0	0.5305363194342124	0.0449036112850457	AIMP2;HMGB1;PDLIM7
Abnormality of the metaphysis	1/80	0.9198858408621875	0.9500339779328107	0	0	0.3946954050019427	0.0329593171304604	IFT172
Intestinal Diseases	1/80	0.9198858408621875	0.9500339779328107	0	0	0.3946954050019427	0.0329593171304604	LMNB1
Lordosis	1/80	0.9198858408621875	0.9500339779328107	0	0	0.3946954050019427	0.0329593171304604	SETD5
beta Thalassemia	2/133	0.9209472479511731	0.9509401353469855	0	0	0.47553052199906126	0.03916113743849193	RERE;SHBG
Lobar Pneumonia	1/81	0.9223792923696528	0.9522285623184908	0	0	0.3897415185783522	0.03149063142501171	ACTB
Celiac Disease	6/312	0.9242628646657606	0.9537700839057788	0	0	0.6091205211726385	0.04797357829632428	GNAO1;ATXN2;FCGRT;ERBB2;SDC1;HMGB1
Ischemic stroke	8/394	0.9246884313896702	0.9537700839057788	0	0	0.6432320769413119	0.05036406119701419	TCN2;CAPN10;PDE4D;MTR;HMGB1;LDLR;HDAC9;TP53
Osteoporosis, Age-Related	1/82	0.9247952574403749	0.9537700839057788	0	0	0.3849099503380602	0.03009337972727216	GAPDH
Thalassemia	1/82	0.9247952574403749	0.9537700839057788	0	0	0.3849099503380602	0.03009337972727216	ACVR2B
Non-medullary thyroid carcinoma	1/82	0.9247952574403749	0.9537700839057788	0	0	0.3849099503380602	0.03009337972727216	MTOR
Hepatitis, Chronic	3/183	0.9258128245762296	0.954629025820023	0	0	0.5186385737439222	0.03997831989868547	SPINT1;PDSS2;TP53
Vasculitis	2/136	0.9267961719880775	0.9550407758547487	0	0	0.464811863015022	0.03533574932783935	HMGB1;UBAC2
Bulbous nasal tip	1/83	0.9271361401825221	0.9550407758547487	0	0	0.3801962252255802	0.028763693393765843	MBD5
Bulbous nose	1/83	0.9271361401825221	0.9550407758547487	0	0	0.3801962252255802	0.028763693393765843	MBD5
Maturity onset diabetes mellitus in young	1/83	0.9271361401825221	0.9550407758547487	0	0	0.3801962252255802	0.028763693393765843	INSR
Potato nose	1/83	0.9271361401825221	0.9550407758547487	0	0	0.3801962252255802	0.028763693393765843	MBD5
Ulcer	3/184	0.9274670647250937	0.9551912695295504	0	0	0.5157463040733544	0.03883466255389607	CHRM3;SDC1;TP53
Triple Negative Breast Neoplasms	14/632	0.9283911695640977	0.9559524933865824	0	0	0.7013681950719344	0.0521131410473364	GDF11;IDUA;RAB1B;KEAP1;MSI1;ABCC10;HDAC9;MTOR;SGSM3;ERBB2;AKT1;SDC1;CAPN1;TP53
Prostate carcinoma	85/3145	0.9293562388516635	0.9566144729609212	0	0	0.8473520249221184	0.062079677501139775	RPAIN;RERE;CHRM3;ARHGAP1;MTR;HMGB1;ABCC10;ACTB;RIMS2;CCND3;PSMD7;CDH3;CAPNS1;MDK;AKT2;CFL1;TRIM24;AKT1;SLC16A7;SSSCA1;SYBU;EIF5A;STARD3;PRKCI;SLC2A11;KCNH7;TPM2;PDE4D;TCF12;FNDC3A;SYP;FRS3;YWHAZ;ARMC2;MAU2;SPINT1;TEP1;KCNMA1;TRIB3;GAPDH;TP53;LY6E;HDAC4;IGSF8;HKR1;CTBP1;FLII;DNAH5;TACSTD2;FOXK1;SEMA3F;SPG7;NDRG2;FHIT;HDAC9;HDAC6;RELA;SHARPIN;PDZD2;S100A16;HSF1;ERBB2;FADD;LDLR;MAP2K5;PDLIM7;BBS2;CADM4;JAG1;AGK;SORT1;INSR;HOOK3;MTOR;HIPK2;AIMP2;FER;GIPC1;SGSM3;ERCC1;NEK10;SDC1;SHBG;EBAG9;FGF11
Mitochondrial Myopathies	1/84	0.9294042702664057	0.9566144729609212	0	0	0.37559608385075033	0.02749794055853835	AGK
Hematologic Neoplasms	12/557	0.9303048299456885	0.9573507290241574	0	0	0.682098020280058	0.04927678845720644	HDAC4;ERBB2;AKT1;COG1;HMGB1;SPG7;RPS27A;FHIT;HDAC9;TP53;MTOR;PDLIM7
Hashimoto Disease	3/186	0.9306744579724956	0.9573510929980127	0	0	0.5100565932460079	0.036645389331787466	FCGRT;ERBB2;TP53
Cardiovascular Diseases	18/787	0.9315253905625679	0.9573510929980127	0	0	0.7236346983829368	0.051328734562616836	BBS1;SORT1;INSR;KEAP1;MTR;KIF6;YWHAZ;CAPN10;KCNMA1;ZNF318;HSF1;CAPN5;AKT1;TRIB3;MAP4;SHBG;LDLR;TP53
Hip Dislocation, Congenital	1/85	0.931601905318693	0.9573510929980127	0	0	0.37110546965151164	0.026292709620760663	CHRM3
Alcoholic Liver Diseases	1/85	0.931601905318693	0.9573510929980127	0	0	0.37110546965151164	0.026292709620760663	HMGB1
Convex nasal bridge	1/85	0.931601905318693	0.9573510929980127	0	0	0.37110546965151164	0.026292709620760663	ERCC1
Increased tendency to bruise	1/85	0.931601905318693	0.9573510929980127	0	0	0.37110546965151164	0.026292709620760663	PLEC
Prominent nasal bridge	1/85	0.931601905318693	0.9573510929980127	0	0	0.37110546965151164	0.026292709620760663	ERCC1
Hyperlipidemia	4/232	0.9318578732285266	0.9574237552375797	0	0	0.5454545454545454	0.038495439524312974	SDC1;ACTN4;LDLR;YWHAZ
leukemia	50/1941	0.9323170677462195	0.957705149296852	0	0	0.811275942367818	0.05685610077529623	RERE;LAD1;LRSAM1;NUMA1;LDB1;MTR;HMGB1;ACTB;RIMS2;CCND3;MAGED4B;FCGRT;FPGS;AKT1;SSSCA1;ANKS1B;EIF5A;TYK2;TRIB3;RIN1;GAPDH;TP53;FLII;MYCBP2;SPG7;FHIT;HDAC9;HDAC6;RELA;MLLT6;POLD4;HSF1;ERBB2;IGF2BP1;CKB;RPS27A;LDLR;PDLIM7;JAG1;USP22;MTOR;HIPK2;RAD52;AIMP2;TCN2;SGSM3;ERCC1;SDC1;ERCC8;EBAG9
Recurrent urinary tract infection	1/86	0.9337312328795453	0.9583958314839106	0	0	0.3667205169628433	0.02514479417824298	CHRM3
Leishmaniasis, Visceral	1/86	0.9337312328795453	0.9583958314839106	0	0	0.3667205169628433	0.02514479417824298	PSMD7
Malaria, Cerebral	1/86	0.9337312328795453	0.9583958314839106	0	0	0.3667205169628433	0.02514479417824298	EIF5A
Myocardial Reperfusion Injury	1/86	0.9337312328795453	0.9583958314839106	0	0	0.3667205169628433	0.02514479417824298	HMGB1
Essential Hypertension	5/278	0.9349819480315603	0.9594890205375505	0	0	0.5690163495041544	0.03825386346342649	CAPN10;INSR;XYLT2;MTR;LDLR
Uveal melanoma	4/236	0.9372761763224519	0.96165242788057	0	0	0.5359381997313032	0.034716626810994994	AKT1;HMGB1;TP53;EML2
Retroviridae Infections	1/88	0.9377933792343254	0.9617965871014909	0	0	0.35825302211575955	0.023009026848156706	TP53
Iron Overload	1/88	0.9377933792343254	0.9617965871014909	0	0	0.35825302211575955	0.023009026848156706	SHBG
Carcinoma of lung	65/2476	0.9381174253954975	0.9617965871014909	0	0	0.8242888263626547	0.052655694549221185	CHRM3;GLDC;DIXDC1;KEAP1;MSI1;MTR;WASL;HMGB1;ACTB;RIMS2;ADAMTS5;CCND3;PSMD7;SOX1;MDK;AKT2;CFL1;TRIM24;AKT1;SSSCA1;EIF5A;PRKCI;PDE4D;FNDC3A;ATP11A;ACTN4;YWHAZ;TAPBP;MAU2;RABEP2;TEP1;ARMC3;AKT1S1;PKP3;ALDOA;GAPDH;TP53;HDAC4;TSTA3;TACSTD2;SEMA3F;FHIT;HDAC9;RELA;POLD4;HSF1;ERBB2;PDSS2;LDLR;JAG1;INSR;USP22;SMARCA2;MTOR;HIPK2;PPP1CA;RAD52;LRFN2;AIMP2;SGSM3;ERCC1;NEK10;SDC1;PLCH1;EBAG9
Periodontitis	4/237	0.9385682309529568	0.9617965871014909	0	0	0.5336101666573769	0.03383073700367523	LAD1;STAT2;HMGB1;TP53
Multiple Myeloma	32/1312	0.9387741369774694	0.9617965871014909	0	0	0.7695578231292517	0.04862094369792629	HDAC4;CHRM3;LRRC34;MTR;HMGB1;SPG7;FHIT;HDAC9;HDAC6;ACTB;RELA;CCND3;MAGED4B;AKT2;CFL1;ERBB2;AKT1;SLC16A7;SSSCA1;JAG1;SLC2A11;MIB2;MTOR;TAPBP;BCL9;AIMP2;MAF;SGSM3;CDK2AP2;SDC1;GAPDH;TP53
Leprosy	2/143	0.9388944365958449	0.9617965871014909	0	0	0.4415754320732631	0.027842314462082456	ERBB2;LDLR
High density lipoprotein measurement	6/324	0.9389349915863424	0.9617965871014909	0	0	0.5857660869030791	0.03690855511463787	STARD3;SEMA5B;CCND3;CAPN5;RANBP10;TP53
Hematopoietic Neoplasms	3/192	0.939530053310036	0.9617965871014909	0	0	0.4937099637261712	0.03079539202770409	AKT1;TP53;FHIT
Acute Kidney Insufficiency	1/89	0.9397302425383127	0.9617965871014909	0	0	0.35416360699074756	0.0220156672146622	TP53
Wheezing	1/89	0.9397302425383127	0.9617965871014909	0	0	0.35416360699074756	0.0220156672146622	DPP10
Cerebral Palsy	1/89	0.9397302425383127	0.9617965871014909	0	0	0.35416360699074756	0.0220156672146622	IDUA
Hemophilia A	1/89	0.9397302425383127	0.9617965871014909	0	0	0.35416360699074756	0.0220156672146622	ACTB
Overweight	4/238	0.9398360613124088	0.9617965871014909	0	0	0.5313020313020314	0.03296719635745465	INSR;SHBG;TP53;LDLR
Autoimmune Diseases	25/1060	0.9408345118033509	0.9625729304102646	0	0	0.7447326756789673	0.04541977060859935	TRAF3IP2;FLII;HMGB1;HDAC9;LMNB2;ABR;ATXN2;FCGRT;MAN2A1;ERBB2;AKT1;KIAA0319L;PDLIM7;JAG1;KCNH7;FOXJ1;ATP11A;TYK2;MTOR;GNAO1;AIMP2;SGSM3;AMPH;PKP3;TP53
Low density lipoprotein cholesterol measurement	5/283	0.940967191260189	0.9625729304102646	0	0	0.5586360180148564	0.03399132904386695	MAU2;SORT1;ADCY2;LDLR;PLEC
Age at menarche	1/90	0.9416068916065674	0.9630366942059648	0	0	0.3501660888348369	0.02106858454258482	MAP2K5
Myeloid Leukemia, Chronic	20/876	0.941968804923635	0.9632162215760478	0	0	0.7213395638629283	0.04312393024559711	HMGB1;FHIT;HDAC9;AGPAT2;MTOR;ACTB;RELA;RIMS2;AIMP2;CCND3;VANGL2;ERBB2;AKT1;MAP6;SSSCA1;FADD;RIN1;LDLR;GAPDH;TP53
Acute leukemia	10/492	0.9429492222940288	0.9640280080742909	0	0	0.642745391469968	0.03775669276581533	RIMS2;LDB1;MDK;FLII;INSR;AKT1;FHIT;HDAC9;TP53;MLLT6
Ichthyoses	1/91	0.9434251955896866	0.9641331640908641	0	0	0.3462574044157243	0.02016540840971823	AP1S1
Nonsyndromic Deafness	1/91	0.9434251955896866	0.9641331640908641	0	0	0.3462574044157243	0.02016540840971823	ELMOD3
Diarrhea	6/329	0.9442630515523249	0.9646079166678031	0	0	0.5765472312703583	0.033065269305256204	TCN2;ERBB2;AKT1;AP1S1;ANKS1B;SGSH
Osteopenia	6/329	0.9442630515523249	0.9646079166678031	0	0	0.5765472312703583	0.033065269305256204	KCNMA1;CHD7;XYLT2;COG1;OTX2;LDLR
Eczema	9/454	0.9449223105997225	0.9648812619582193	0	0	0.6267676860552787	0.03550799762162086	RIMS2;HDAC4;TMEM232;PLCB3;EFHC1;HMGB1;SMARCA2;PDLIM7;ANO3
Depressive Symptoms	2/147	0.9449297554721727	0.9648812619582193	0	0	0.42930476509318155	0.02431783408275803	AIMP2;AKT1
Thyroid associated opthalmopathies	1/92	0.9451869654501709	0.9648812619582193	0	0	0.34243462514868006	0.01930390413158338	GAPDH
Fatigue	6/330	0.9452774437489287	0.9648812619582193	0	0	0.574737604053565	0.032344395097705855	SOX3;ATXN2;AGK;INSR;OTX2;UBAC2
Lactic acidemia	2/148	0.9463475191900123	0.965577735881327	0	0	0.4263421554284701	0.023510817630459764	NDUFS8;AGK
Aortic Aneurysm, Abdominal	5/288	0.9464523386307377	0.965577735881327	0	0	0.548622482691258	0.03019325453696998	SORT1;FCGRT;TP53;LDLR;GAPDH
Subarachnoid Hemorrhage	1/93	0.9468939561622611	0.965577735881327	0	0	0.33869494977874554	0.01848196386031789	HMGB1
Joint laxity	1/93	0.9468939561622611	0.965577735881327	0	0	0.33869494977874554	0.01848196386031789	OTX2
Panic Disorder	1/93	0.9468939561622611	0.965577735881327	0	0	0.33869494977874554	0.01848196386031789	GPM6A
Migraine Disorders	5/290	0.9485143389876994	0.9666920496592742	0	0	0.5447154471544715	0.028792771838034765	INSR;MTR;CSAD;PPOX;UBAC2
Traditional Serrated Adenoma	1/94	0.9485478683866446	0.9666920496592742	0	0	0.33503569753504614	0.017697598497305036	TP53
Myelodysplasia	1/94	0.9485478683866446	0.9666920496592742	0	0	0.33503569753504614	0.017697598497305036	TP53
Mild cognitive disorder	2/150	0.9490794626186236	0.9670431117533611	0	0	0.4205370418962652	0.021978422654716803	TP53;KIF6
Graves Disease	6/335	0.9501056473374979	0.9677526623072377	0	0	0.5658544795699137	0.028961616511231976	CHRM3;ATXN2;AKT1;TP53;PDLIM7;MTOR
Intermittent migraine headaches	1/95	0.9501503499510302	0.9677526623072377	0	0	0.33145430172206375	0.016948930237411983	UBAC2
Sparse hair	1/96	0.9517029976423381	0.9687612944289153	0	0	0.32794830371567046	0.0162341855199478	ERCC8
Thin, sparse hair	1/96	0.9517029976423381	0.9687612944289153	0	0	0.32794830371567046	0.0162341855199478	ERCC8
Cardiac fibrosis	1/96	0.9517029976423381	0.9687612944289153	0	0	0.32794830371567046	0.0162341855199478	HSF1
Hyperlipoproteinemia Type IIa	2/153	0.952930037238912	0.9698193053270376	0	0	0.41211770505154416	0.019869756982575166	SORT1;LDLR
Pneumonitis	6/339	0.9536887572871842	0.9703321188207576	0	0	0.5589400475393961	0.026503769421913088	AIMP2;FER;AKT2;HMGB1;TP53;MTOR
Chronic Lymphocytic Leukemia	26/1120	0.953955654142308	0.9703321188207576	0	0	0.7316245945130772	0.03448738798836181	SLC35B2;GPM6A;SPG7;FHIT;HDAC9;RELA;MAGED4B;DPP9;HSF1;ERBB2;AKT1;SSSCA1;FADD;PDLIM7;FZD3;JAG1;INSR;PDE4D;COG1;MTOR;RAD52;BCL9;AIMP2;ERCC1;SDC1;TP53
Hypercholesterolemia, Familial	2/154	0.954150597025935	0.9703321188207576	0	0	0.40938511326860844	0.019213983257336992	LDLR;LMF1
Osteogenesis Imperfecta	3/204	0.9541849512088024	0.9703321188207576	0	0	0.463944459227364	0.021757954571784706	SOX3;INSR;ERCC8
Hypercalcemia	1/98	0.9546649328041327	0.9706292293393188	0	0	0.3211531735589494	0.014899855166750525	TP53
Aplastic Anemia	2/155	0.9553408777147855	0.9709344456302874	0	0	0.40668824163969797	0.018580390981169547	RIMS2;TP53
Other specified transient cerebral ischemias	2/155	0.9553408777147855	0.9709344456302874	0	0	0.40668824163969797	0.018580390981169547	PDE4D;HSF1
Elevated creatine kinase	2/156	0.9565015796129711	0.9719229578135734	0	0	0.40402639431765647	0.017968200645678643	RBCK1;PLEC
melanoma	63/2454	0.9570983427844431	0.9723083209961324	0	0	0.8036622973493509	0.035239893580087646	CHRM3;KEAP1;HMGB1;CSAD;ACTB;RIMS2;CCND3;PSMD7;CDH3;MAGED4B;AKT2;TRIM24;AKT1;SSSCA1;CAPN1;SYBU;PRKCI;SLC15A2;PDE4D;TCF12;CTNNBIP1;ACTN4;RHOC;EML2;TAPBP;MAU2;KCNMA1;AKT1S1;RIN1;GAPDH;TP53;IGSF8;RAB5B;CTBP1;IDUA;EPB41;RAB1B;TACSTD2;SPG7;HDAC9;TM9SF4;HDAC6;RELA;MAP2;HSF1;ERBB2;IGF2BP1;PDSS2;PLEK2;FADD;LDLR;SYT4;JAG1;STAT2;MIB2;SMARCA2;MTOR;AIMP2;VANGL2;SGSM3;ERCC1;CDK2AP2;SDC1
Visual seizure	3/207	0.9572913487799822	0.9723083209961324	0	0	0.45705024311183146	0.01994909782392381	SYT4;CNTNAP2;YWHAZ
Childhood Neuroblastoma	1/100	0.9574454854130755	0.9723083209961324	0	0	0.31463259411563127	0.013682268366688328	HIPK2
Hypertriglyceridemia	2/157	0.9576333889067945	0.9723083209961324	0	0	0.40139889341267354	0.017376661683554652	LDLR;LMF1
Cardiomyopathy, Familial Idiopathic	7/388	0.9586500890224777	0.9731494127024485	0	0	0.5694339186394523	0.024046705442787964	GNAO1;CACNB2;BCL9;ERBB2;TACSTD2;GAPDH;TP53
Myxoid cyst	3/209	0.9592515364031569	0.9735687235136518	0	0	0.45256565592988307	0.018827612968349536	ATXN2;OTX2;SYP
Breast Carcinoma	136/4963	0.9598980552301039	0.974033604835888	0	0	0.8471665065822928	0.034672993969149614	KEAP1;MSI1;ZDHHC7;ACTB;RIMS2;CCND3;CDH3;MAGED4B;CAPNS1;AKT2;CFL1;CAPN5;FPGS;TRIM24;AKT1;DIP2A;VPS39;SYBU;STARD3;LMO4;TPM2;CTNNBIP1;ATP11A;ACTN4;FBXO10;FRS3;MAF;SPINT1;TEP1;PSME3;TRIB3;ULK1;AMPH;RBCK1;RIN1;TP53;TSTA3;CTBP1;FLII;TACSTD2;NDRG2;FHIT;SHARPIN;S100A16;MAP2;OTX2;FADD;MAP2K5;BBS2;CCDC134;JAG1;JUP;INSR;FOXN3;GNAO1;BCL9;AIMP2;RALYL;VANGL2;GIPC1;TADA3;PPP1R1B;SDC1;SHBG;RPAIN;NUMA1;MAST2;ARHGAP1;MTR;PTPN23;WASL;HMGB1;ABCC10;DNALI1;MDK;SSSCA1;CLIC1;ANKRD6;UNC45A;RHBDF1;ELOVL1;TRPC5;PDE4D;TYK2;RHOC;YWHAZ;SHROOM4;KAT2A;KCNMA1;AKT1S1;ETF1;ALDOA;GAPDH;ST6GALNAC5;OTUB1;HDAC4;HIST1H2BM;IDUA;WBP2;RAB1B;SEMA3F;SPG7;HDAC9;HDAC6;RELA;ZNRF3;HSF1;ERBB2;IGF2BP1;CKB;CTNNA2;NCAM2;RPS27A;LDLR;CCT5;PDLIM7;KCNJ3;AGK;SORT1;STAT2;USP22;SYVN1;FOXJ1;MAPK15;MTOR;HIPK2;PPP1CA;RAD52;TMEM54;NFIC;SGSM3;ERCC1;NEK10;PTPN9;EBAG9;PFKP
Behcet Syndrome	4/258	0.9606685083413907	0.9746240383015916	0	0	0.4889559259638	0.019619783883011693	TRAF3IP2;SPG7;TP53;UBAC2
Respiratory distress	1/104	0.9625061280512689	0.9759136099213179	0	0	0.30235111438743983	0.01155430128451002	OTX2
Tonic Seizures	1/104	0.9625061280512689	0.9759136099213179	0	0	0.30235111438743983	0.01155430128451002	PLCB1
Enterovirus Infections	1/104	0.9625061280512689	0.9759136099213179	0	0	0.30235111438743983	0.01155430128451002	COG1
Nephritis	2/162	0.9628820885005711	0.9761033019558555	0	0	0.38875404530744334	0.014704356061413975	FLII;OTUB1
Hepatitis A	4/261	0.9631438276363155	0.9761771526229609	0	0	0.4831724695537925	0.018144346054789144	HMGB1;TP53;LDLR;ACTB
Premature Obstetric Labor	1/105	0.9636744440147658	0.9763930007818206	0	0	0.2994283583944327	0.011079374783510993	ACVR2B
Blast Phase	3/214	0.9637891357524623	0.9763930007818206	0	0	0.44172613240953396	0.016292073248741448	SGSM3;TP53;FHIT
Systemic Scleroderma	11/562	0.9639235855241579	0.9763930007818206	0	0	0.617235717116811	0.02267924974536067	AIMP2;LRRC34;FLII;NFIC;AKT1;TRIB3;SSSCA1;CSAD;KIAA0319L;TP53;RELA
Multiple Sclerosis	25/1106	0.9646100150137299	0.9768968366825311	0	0	0.7112539743001733	0.02562746851552123	CNTNAP2;SPEF2;HCCS;HMGB1;RELA;LMNB1;ATXN2;GRM5;PSMD7;CDH3;FCGRT;MAP2;PDLIM7;JAG1;KCNH7;SORT1;STAT2;TYK2;AIMP2;SGSM3;KCNMA1;SDC1;GAPDH;TP53;LY6E
Chronic graft-versus-host disease	1/106	0.9648064093752255	0.9769042953862003	0	0	0.29656127394414955	0.010625140921316981	SHBG
Osteoporosis	8/441	0.9657209549940959	0.9774402773633201	0	0	0.5719935395251249	0.01995133655251462	TMEM135;JAG1;CHD7;XYLT2;THSD7A;SHBG;OSBPL1A;GAPDH
Liver diseases	12/606	0.9658458723921833	0.9774402773633201	0	0	0.6242025518341308	0.021691669051214637	RERE;JAG1;SPINT1;JUP;TEP1;DPP9;TMEM67;PEX6;AKT1;GAPDH;TP53;PEX26
Dermatitis, Allergic Contact	1/107	0.9659031533464543	0.9774402773633201	0	0	0.2937482854268906	0.010190628900606282	NUMA1
Dermatitis, Atopic	9/484	0.9663119115606803	0.9776624821741574	0	0	0.5862520458265139	0.020090041004140576	RIMS2;TMEM232;PLCB3;SHARPIN;TRAF3IP2;FCGRT;EFHC1;HMGB1;PDLIM7
Acute GVH disease	2/166	0.9666259311551546	0.9777887673145115	0	0	0.3791933064961718	0.012871221087776446	SUFU;HMGB1
Irritable Bowel Syndrome	2/167	0.9675035669905353	0.9784850164788819	0	0	0.3768755516328332	0.012450523764874186	PDZD2;TRAF3IP2
Abortion, Tubal	1/110	0.9689928309810125	0.9797994424789419	0	0	0.2856190066843533	0.008996446176917642	MAP2
Cyst	2/169	0.9691926944001917	0.9798098287676429	0	0	0.3723233145359766	0.011650677055957282	PRKCI;SDC1
Diabetes, Autoimmune	1/111	0.9699592976483565	0.9803930471830055	0	0	0.28300778381553826	0.00863206839879682	FCGRT
Muscular Dystrophy, Facioscapulohumeral	1/112	0.9708956848624835	0.9811476142685401	0	0	0.28044361000742263	0.008283251759305383	TP53
Urticaria	1/114	0.9726819310348241	0.9825684557443258	0	0	0.27545141321286115	0.007629493286032423	MAP2
Joint hyperflexibility	1/114	0.9726819310348241	0.9825684557443258	0	0	0.27545141321286115	0.007629493286032423	HDAC4
Hepatitis C	16/783	0.9735328956836393	0.9832358813549048	0	0	0.642841724444598	0.017243370159210517	IGSF8;STAT2;FHIT;HDAC9;MTOR;ACTB;TAPBP;AIMP2;PSME3;AKT1;CKB;LDLR;GAPDH;TP53;SYBU;PDLIM7
Acute Myeloid Leukemia, M1	1/116	0.9743587043705071	0.983619515600773	0	0	0.2706328580459366	0.007029895115044265	TP53
Respiratory Syncytial Virus Infections	1/116	0.9743587043705071	0.983619515600773	0	0	0.2706328580459366	0.007029895115044265	MTOR
Primary malignant neoplasm of lung	56/2268	0.9744837306261529	0.983619515600773	0	0	0.770625729419158	0.019918714073195502	CHRM3;GLDC;DIXDC1;KEAP1;MSI1;MTR;WASL;HMGB1;ACTB;ADAMTS5;CCND3;SOX1;MDK;AKT2;CFL1;TRIM24;AKT1;EIF5A;PRKCI;PDE4D;FNDC3A;ATP11A;ACTN4;YWHAZ;RABEP2;TEP1;ARMC3;AKT1S1;PKP3;ALDOA;GAPDH;TP53;HDAC4;TSTA3;TACSTD2;SEMA3F;FHIT;HDAC9;RELA;POLD4;HSF1;ERBB2;PDSS2;JAG1;INSR;USP22;SMARCA2;MTOR;HIPK2;PPP1CA;RAD52;AIMP2;SGSM3;ERCC1;SDC1;PLCH1
Arthritis	12/630	0.9764569368159774	0.9854187559978463	0	0	0.5991951967296884	0.014275603356912282	AIMP2;JAG1;FCGRT;MDK;SYVN1;AKT1;HMGB1;HDAC9;TP53;YWHAZ;RELA;UBAC2
Secondary malignant neoplasm of bone	5/330	0.9771923879551485	0.9858032810023367	0	0	0.4766729205753596	0.010997668577542584	SGSM3;ERBB2;AKT1;TP53;MAP2K5
Liver Failure, Acute	1/120	0.9774102190123787	0.9858032810023367	0	0	0.2614816524348027	0.005974552151404302	HMGB1
Neurologic Symptoms	1/120	0.9774102190123787	0.9858032810023367	0	0	0.2614816524348027	0.005974552151404302	NPHP1
Acute Myeloid Leukemia (AML-M2)	1/121	0.9781146547958562	0.9863212753141435	0	0	0.2592891760904685	0.005737649904866122	TP53
Diabetes Mellitus, Insulin-Dependent	20/956	0.9787636479933598	0.986493772246998	0	0	0.6568376068376068	0.014099076680675771	EIF5A;LAD1;PSMD12;BNC2;INSR;XYLT2;HCCS;ACTN4;TYK2;HMGB1;ACTB;GNAO1;ADAMTS5;ATXN2;FCGRT;SGSM3;FADD;RPS27A;TP53;PDLIM7
Acidosis, Lactic	2/183	0.9788583715330119	0.986493772246998	0	0	0.3432745087521679	0.007335197278221771	NDUFS8;AGK
Immune thrombocytopenic purpura	2/183	0.9788583715330119	0.986493772246998	0	0	0.3432745087521679	0.007335197278221771	FCGRT;MAP6
Hepatitis B, Chronic	3/238	0.9796801756346598	0.9871294887268321	0	0	0.39611710748646506	0.00813193245477444	HMGB1;RCOR3;TP53
Secondary malignant neoplasm of lung	13/683	0.980512736660022	0.9877217521322389	0	0	0.5980722417566205	0.0117698484845492	IGSF8;PRKCI;INSR;HMGB1;SPG7;FER;MAGED4B;SPINT1;MDK;SGSM3;ERBB2;SDC1;TP53
Allergic disposition	3/240	0.9806502148201466	0.9877217521322389	0	0	0.3927333155530025	0.007673790161069756	DPP10;AIMP2;YWHAZ
Myocarditis	1/126	0.9813211306413334	0.9880396477852479	0	0	0.2488529886914378	0.004692253174053058	GNAO1
Hepatitis C, Chronic	6/386	0.9814373508917862	0.9880396477852479	0	0	0.48859934853420195	0.00915493351727711	AIMP2;PSMD12;LDLR;TP53;MTOR;ACTB
Bronchopulmonary Dysplasia	2/188	0.9815393869445554	0.9880396477852479	0	0	0.33395970351811255	0.006222716819127503	AKT1;EML2
early pregnancy	1/129	0.9830151704643652	0.9893325026211955	0	0	0.24298263327948302	0.004162468945472611	TP53
Acute myocardial infarction	3/247	0.9837089822563386	0.9898046842554433	0	0	0.3813268857772936	0.0062633609881869124	KCNQ1OT1;HMGB1;LDLR
Pseudohyperkalemia Cardiff	1/131	0.9840584054899755	0.9898046842554433	0	0	0.23921958493848638	0.0038442655521674306	TP53
Psoriasis	16/818	0.9840589140295022	0.9898046842554433	0	0	0.6136314842033987	0.009860758340015574	TRAF3IP2;KCNH7;STAT2;FBXL19;PDE4D;KEAP1;FNDC3A;TYK2;LRRC43;UBAC2;AIMP2;PSMD7;AKT1;SDC1;GAPDH;TP53
Liver carcinoma	92/3593	0.9843642269399392	0.9899191136068506	0	0	0.7902871906727947	0.012454373784624134	BNC2;ARHGAP1;DIXDC1;KEAP1;MSI1;CASC2;MTR;CHD4;HMGB1;DNALI1;ACTB;LMNB1;RIMS2;ADAMTS5;CCND3;PSMD7;SOX1;MAGED4B;CAPNS1;MDK;AKT2;TRIM24;AKT1;SSSCA1;CLIC1;SYBU;EIF5A;SLC15A2;CACNA2D1;CTNNBIP1;ACTN4;RHOC;YWHAZ;ST7L;MAU2;TEP1;PSME3;AKT1S1;TRIB3;ULK1;SCG3;GAPDH;TP53;LY6E;OTUB1;HDAC4;ACSS2;TACSTD2;FOXK1;SPG7;NDRG2;PPOX;FHIT;HDAC9;HDAC6;RELA;DPP9;KCNQ1OT1;HSF1;ERBB2;IGF2BP1;PDSS2;FADD;RPS27A;MIR92B;LDLR;PDLIM7;FZD3;MBD5;JAG1;URGCP;STAT2;INSR;USP22;FOXJ1;FOXN3;SMARCA2;MTOR;HIPK2;PPP1CA;RAD52;GNAO1;BCL9;AIMP2;FER;CROCC;SGSM3;ERCC1;CDK2AP2;SDC1;SHBG;EBAG9
Autoimmune thyroid disease	1/132	0.9845557758933365	0.989919114750343	0	0	0.23738114910777047	0.003694773131402101	GNAO1
Neoplasm Metastasis	101/3920	0.9860819331177096	0.9912607333888978	0	0	0.792942800448624	0.011113752572034185	CHRM3;DIXDC1;KEAP1;MSI1;CASC2;TMEM97;ACCS;ACTB;RIMS2;CDH3;MAGED4B;CAPNS1;AKT2;CFL1;TRIM24;AKT1;CAPN1;SYBU;SKP1;PRKCI;LMO4;CTNNBIP1;ATP11A;ACTN4;SPINT1;TRIB3;ULK1;PKP3;RIN1;TP53;LY6E;IGSF8;CTBP1;FLII;TACSTD2;NDRG2;FHIT;SHARPIN;S100A16;KCNQ1OT1;FADD;BBS2;B3GALNT1;JAG1;INSR;BCL9;AIMP2;FER;VANGL2;SDC1;FGF11;ARHGAP1;HMGB1;ABCC10;ADAMTS5;GRM5;MDK;SSSCA1;CLIC1;ANKRD6;UNC45A;EIF5A;RHBDF1;TCF12;SYP;TYK2;RHOC;YWHAZ;TAPBP;KCNMA1;ALDOA;GAPDH;PLEC;OTUB1;HDAC4;ACSS2;IDUA;RAB1B;SEMA3F;HDAC9;HDAC6;RELA;HSF1;ERBB2;IGF2BP1;CKB;MIR92B;LDLR;PDLIM7;URGCP;USP22;FOXJ1;MTOR;HIPK2;PPP1CA;SGSM3;ERCC1;PTPN9;ERCC8;APBA3;EBAG9
Spontaneous abortion	1/138	0.9872309363679639	0.9922227691850714	0	0	0.22691414218836597	0.0029161391818307483	MAP2
Rheumatoid Arthritis	42/1833	0.9875726862713937	0.992360384321121	0	0	0.713620003129836	0.008923945566620373	PSMD12;TRAF3IP2;HEXA;CHD7;MTR;HMGB1;HDAC9;RELA;RIMS2;RPS6KA4;ADAMTS5;CCND3;PSMD7;FCGRT;MDK;FPGS;ERBB2;AKT1;SSSCA1;ZNF644;FADD;LDLR;CLIC1;PDLIM7;TRPC5;JAG1;URGCP;PDE4D;SYVN1;FOXJ1;TYK2;YWHAZ;TAPBP;AIMP2;SGSM3;KCNMA1;SDC1;SHBG;EBAG9;GAPDH;TP53;ST6GALNAC5
Kidney Failure, Acute	4/310	0.9877518995642116	0.992360384321121	0	0	0.40476190476190477	0.004988175040247959	TCN2;HMGB1;TP53;MTOR
Thyroid Diseases	1/140	0.9880155403032258	0.9924323250315008	0	0	0.22362594577003986	0.002696224999966106	INSR
Leukemia, Myelocytic, Acute	38/1703	0.9899333010213575	0.9941654293972747	0	0	0.6946843750967462	0.007028615624544837	PSMD12;KEAP1;MTR;CHD4;HMGB1;SPG7;FHIT;HDAC9;HDAC6;ACTB;RELA;MLLT6;RIMS2;NT5C;POLD4;CCND3;FCGRT;HSF1;FPGS;ERBB2;TRIM24;AKT1;SSSCA1;LDLR;JAG1;INSR;FNDC3A;MTOR;HIPK2;AIMP2;KAT2A;FER;SGSM3;ERCC1;TRIB3;ULK1;PLCB1;TP53
Benign Prostatic Hyperplasia	6/420	0.9907885942388652	0.9948310579029447	0	0	0.4476703016569891	0.004142782650389675	RERE;KCNMA1;ERBB2;NDRG2;TP53;ACTB
Pre-Eclampsia	1/152	0.9918092194765072	0.995662402147356	0	0	0.20572596261862222	0.0016919950864412497	EBAG9
Inflammation	6/429	0.9923852937695085	0.9960472321229015	0	0	0.43793748700533647	0.0033475267643831835	CHRNB2;PLCB3;AKT1;HMGB1;TP53;RELA
Malignant neoplasm of lung	57/2449	0.9937551427596527	0.9969647393814365	0	0	0.7190308725948543	0.004504324266042927	GLDC;CLTB;DIXDC1;KEAP1;MSI1;MTR;WASL;HMGB1;ACTB;ADAMTS5;CCND3;SOX1;MDK;AKT2;CFL1;TRIM24;AKT1;SSSCA1;EIF5A;PRKCI;PDE4D;FNDC3A;ACTN4;YWHAZ;RABEP2;TEP1;ARMC3;AKT1S1;PKP3;ALDOA;GAPDH;TP53;HDAC4;TSTA3;TACSTD2;SEMA3F;FHIT;HDAC9;RELA;POLD4;HSF1;ERBB2;PDSS2;FADD;JAG1;INSR;USP22;SMARCA2;MTOR;HIPK2;PPP1CA;RAD52;AIMP2;SGSM3;ERCC1;SDC1;PLCH1
Weight decreased	1/161	0.99384394088423	0.9969647393814365	0	0	0.19406300484652667	0.0011983557004941595	TP53
Hepatitis B	15/839	0.9939579264020346	0.9969647393814365	0	0	0.5583326646874749	0.003383719719220772	CNTNAP2;JAG1;URGCP;INSR;HMGB1;DNALI1;MTOR;ACTB;RELA;RAD52;ERBB2;AKT1;SSSCA1;RCOR3;TP53
Lung diseases	5/393	0.9942424301603066	0.9969647393814365	0	0	0.39795490738412537	0.002297874625276714	INSR;KEAP1;HMGB1;TP53;MTOR
Congestive heart failure	16/884	0.9942639835084992	0.9969647393814365	0	0	0.5649586474196601	0.0032499419152436397	HDAC4;JUP;ATP1A3;ATP11A;ACTN4;HMGB1;MTOR;RELA;SOX3;AIMP2;HSF1;ERBB2;AKT1;GAPDH;TP53;SYBU
Heart failure	14/815	0.99555293420945	0.998035029769931	0	0	0.5358524616506595	0.0023882855271711062	HDAC4;SEMA5B;JUP;ATP1A3;HMGB1;MTOR;RELA;SOX3;AIMP2;HSF1;ERBB2;AKT1;TP53;SYBU
Dermatologic disorders	5/406	0.9957176109701555	0.998035029769931	0	0	0.384790057376883	0.0016513591307049315	RIMS2;CHRM3;AIMP2;TP53;PLEC
Dengue Fever	1/177	0.9962955625629433	0.9982827484154383	0	0	0.17627404905272434	6.54208673566783E-4	TP53
Malignant neoplasm of breast	129/5054	0.9964575394911986	0.9982827484154383	0	0	0.7711166478852854	0.0027365001113825154	SEMA5B;KEAP1;MSI1;ACCS;ACTB;RIMS2;CCND3;CDH3;MAGED4B;CAPNS1;AKT2;CFL1;FPGS;TRIM24;AKT1;DIP2A;VPS39;STARD3;LMO4;TPM2;ACTN4;FBXO10;FRS3;SPINT1;TEP1;PSME3;ZNF318;TRIB3;ULK1;AMPH;RBCK1;RIN1;TP53;TSTA3;CTBP1;FLII;TACSTD2;NDRG2;FHIT;SHARPIN;S100A16;MAP2;OTX2;FADD;MAP2K5;JAG1;JUP;INSR;FOXN3;HOOK3;BCL9;AIMP2;RALYL;VANGL2;GIPC1;TADA3;PPP1R1B;SDC1;SHBG;ZNF532;RPAIN;NUMA1;ARHGAP1;MTR;PTPN23;WASL;HMGB1;ABCC10;DNALI1;KCNT2;MDK;SSSCA1;ZNF644;CLIC1;ANKRD6;UNC45A;RHBDF1;ELOVL1;TRPC5;TYK2;RHOC;KIF6;YWHAZ;KAT2A;KCNMA1;AKT1S1;ETF1;PLCB1;ALDOA;GAPDH;ST6GALNAC5;OTUB1;HDAC4;HIST1H2BM;IDUA;WBP2;RAB1B;SEMA3F;SPG7;HDAC9;HDAC6;RELA;HSF1;ERBB2;IGF2BP1;CKB;NCAM2;RPS27A;LDLR;CCT5;PDLIM7;KCNJ3;AGK;SORT1;STAT2;USP22;SYVN1;FOXJ1;MAPK15;MTOR;HIPK2;PPP1CA;RAD52;TMEM54;NFIC;SGSM3;ERCC1;EBAG9;PFKP
Colitis	9/608	0.9965515993523006	0.9982827484154383	0	0	0.46184174934219335	0.0015953677047497732	RIMS2;AIMP2;SDC1;FADD;HMGB1;TP53;YWHAZ;ACTB;RELA
Gastritis	1/181	0.9967374190835259	0.9982827484154383	0	0	0.1723209477652127	5.63130164885621E-4	TP53
Hepatitis, Toxic	3/325	0.9977800076267604	0.9985528813739539	0	0	0.2877779679273584	6.395750828517921E-4	CHRM3;WASL;HMGB1
Chemical and Drug Induced Liver Injury	3/325	0.9977800076267604	0.9985528813739539	0	0	0.2877779679273584	6.395750828517921E-4	CHRM3;WASL;HMGB1
Chemically-Induced Liver Toxicity	3/325	0.9977800076267604	0.9985528813739539	0	0	0.2877779679273584	6.395750828517921E-4	CHRM3;WASL;HMGB1
Drug-Induced Acute Liver Injury	3/325	0.9977800076267604	0.9985528813739539	0	0	0.2877779679273584	6.395750828517921E-4	CHRM3;WASL;HMGB1
Hepatitis, Drug-Induced	3/329	0.998001908874736	0.9985815808450408	0	0	0.2841872905708405	5.684001501445891E-4	CHRM3;WASL;HMGB1
Influenza	7/589	0.9993278027345007	0.9996382703904886	0	0	0.36882998940482	2.480098754338161E-4	AIMP2;SPINT1;TARS;HMGB1;ACTB;RELA;LY6E
Drug-Induced Liver Disease	3/377	0.9994448419325958	0.9996382703904886	0	0	0.24709002504788566	1.3721211151082548E-4	CHRM3;WASL;HMGB1
Liver Cirrhosis, Experimental	10/801	0.9998273249156384	0.9998273249156384	0	0	0.38525626411887837	6.652990210110776E-5	TRIM24;TRIB3;B9D1;CSAD;NDRG2;CLIC1;YWHAZ;PFKP;RELA;DHTKD1
